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ABSTRACT
Excessive protein depletion and poor clinical outcome are characteristic 
features of the metabolic response to severe injury. Inability to achieve 
heightened ketosis may be, in part, responsible for the extent of protein 
loss. Carnitine has a significant role in the developm ent of ketosis. 
Insufficiency of carnitine has been reported in critical illness; this may 
contribute to blunted ketosis. This hypothesis was tested by investigating 
the relationship between ketone bodies and carnitine status, in conditions 
of altered ketone body concentrations.
A study of surgical patients showed m arked urinary carnitine losses, 
associated with the extent of negative nitrogen balance. No relationship 
betw een serum  or urine carnitine, and ketones were found in these 
m oderately traum atised patients in the short term. N utritional support 
was grossly inadequate. On a basis of these findings, three areas of research 
emerged:-
1. A comparative study of adequately with inadequately fed patients, 
showed losses of fat and lean body tissue occurred in both groups. This 
suggested that nutrients, provided during the initial acute injury phase 
may be poorly utilised.
2. Carnitine status and ketones were studied in more severely stressed 
burns patients, over an extended period. Substantial carnitine losses were 
observed, which were related to nitrogen balance and percent burn  bu t not 
ketotic potential. Blunted ketosis, in the presence of hyperglucagonaem ia, 
was attributed to inadequate NEFA supply. It was suggested that 
supplem entation w ith carnitine and MCT m ay enhance ketosis following 
severe injury. W asting, despite nutrient provision, was attributed to poor 
nutrient utilisation during an extended acute injury phase.
3. Limitations of the clinical studies were overcome by study of 
carnitine and ketones, and effects of carnitine supplem entation, in a 
diabetic animal model. Supplementary carnitine is retained by tissues. 
Supplementation enhanced ketosis in non-diabetic, bu t not diabetic rats.
Changes in liver carnitine bore more similarity to ketones than did serum 
carnitine.
The thesis concludes that efficacy of carnitine supplem entation in traum a 
needs investigating. Research into m ethods of reducing catabolism  
should continue. M eanwhile, long term  nutritional support into the 
convalescent period may be advocated.
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CHAPTER ONE 
INTRODUCTION AND AIMS OF THE THESIS
1 INTRODUCTION
1.1 The Discovery of Carnitine
Carnitine (3-hydroxy-4-trimethylamino butyric acid) is a m ethyl amine 
com pound discovered to be a quantitatively im portan t com pound in 
muscle tissue in 1905 (Gulewitsch and Krimberg 1905, as cited by Schmidt- 
Sommerfeld et al.. 1985). The chemical structure of carnitine (figure 1.1 
page 2) was elucidated in 1927 by Tomita and Sendju. It was not until 25 
years later that the biological role of carnitine was recognised when it was 
found that carnitine deficient larvae of the meal worm  Tenehrio molitor 
died with an excess of body fat as they could not utilise stored fat (Fraenkel, 
1951). Later it was established that carnitine was essential in the utilisation 
of long chain fatty  acids in the m am m alian species (Fraenkel and 
Freidman, 1957; Fritz, 1955).
Little in terest was paid  to carnitine nutrition  as no overt deficiency 
syndrom e had been described; it was assumed that biosynthesis and diet 
supplied ample carnitine for health. Today more extensive knowledge of 
carnitine exists and in recent years interest in carnitine has revived due to 
identification of deficiency states in certain physiological and pathological 
conditions. In particular, the association of carnitine deficiency w ith 
im paired lipid metabolism has been recognised. A sound understanding 
of carnitine requirem ents and carnitine m etabolism  in both health and 
disease is essential if deficiency syndromes are to be understood, treated or 
prevented.
Figure 1.1 The Chemical Structure of Carnitine
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1.2 Carnitine Biosynthesis
Figure 1.2 (page 3) illustrates the sequence of carnitine biosynthesis. 
Carnitine is derived from the essential amino acids lysine and 
m ethionine. Protein bound lysine is m ethylated to form  trim ethyllysine 
(TML), and m ethionine is the m ethyl donor. Lysine m éthylation in 
m am m als occurs only in the protein bound form, m ethylase enzym es 
being highly specific for certain lysine residues present in relatively few 
proteins (Rebouche, 1986). Subsequent protein breakdow n yields free 
TML. Availability of protein bound TML is a rate lim iting step in 
biosynthesis (Rebouche, 1983), this is in tu rn  is dependent on the turnover 
rate of the proteins in which the specific lysine residues reside. TML is 
converted to carnitine via four enzymic steps; hydroxylation, aldol 
cleavage, oxidation and hydroxylation. TML hydroxylase is a 
m itochondrial enzym e, therefore only TML w hich enters the 
m itochondria is utilised for carnitine biosynthesis. TML which leaves the 
cell is metabolised by the kidney (Carter and Frenkel, 1979). Several 
cofactors are involved in carnitine biosynthesis. The hydroxylase enzymes 
are ketoglutarate dependent and require ascorbic acid and iron as cofactors.
Figure 1.2 Biosynthesis of Carnitine
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Reduced tissue carnitine concentrations have been found in both ascorbic 
acid (Ciman, Rizzoli and Siliprandi, 1979; Hughes, Hurley and Jones, 1980) 
and iron (Bartholmey and Sherman, 1985) deficiency. Pyridoxal phosphate 
is an essential cofactor to aldol cleavage (Dunn, Aronson and Englard,
1982). The enzymes of carnitine biosynthesis have been identified in most 
tissues, butyrobetaine hydroxylase being the exception. The activity of this 
enzym e m ay be a rate lim iting step since activity is only found in 
relatively few tissues, predom inantly liver and to a lesser extent the 
kidney, brain and testes (Englard, 1979). The principle site of carnitine 
synthesis is therefore the liver. A lthough no data  are available for 
hum ans, Cederblad and Lindstedt (1976) reported a value of 2pm ol/100g 
body weight for the daily rate of carnitine biosynthesis in rats.
1.3 Carnitine Storage, Transport and Excretion
In biological systems carnitine exists in both free and esterified forms, 
forming esters with acyl groups of all chain lengths. Published data refers 
to several carnitine fractions which are listed here:-
a. Free carnitine - the non-esterified form
b. Short chain acyl carnitine - carnitine esterified to short chain acyl
groups, predom inantly acetyl units
c. Long chain acyl carnitine - carnitine esterified to long chain acyl
groups
d. Acyl carnitine - esterified carnitine of all chain lengths
e. Total carnitine - the sum of free and esterified carnitine
f. Total acid soluble carnitine- the sum of free and short chain acyl
carnitine, sometimes misleadingly referred to as 'total carnitine'
Carnitine is found in all tissues involved in fat oxidation, concentrations 
being generally related to the tissues capacity to oxidise fat, a factor which 
perhaps in itself suggest an im portant role of carnitine in control of fatty 
a d d  oxidation. In hum ans carnitine is abundant in skeletal m usde, heart.
liver and kidneys (Bremer, 1983). Most studies on tissue carnitine content 
have been carried out in rats (Pearson and Tubbs, 1967; Cederblad and
Lindstedt, 1976; Brooks and McIntosh, 1975). Such studies have shown the 
body pool of carnitine to am ount to 40|im ol/100m g body weight, with 
skeletal and cardiac muscle accounting for approxim ately 98% and liver 
1.6% of total body stores. Plasma carnitine concentrations in  the rat are 
low in relation to tissue concentrations. Cederblad and Lindstedt (1976) 
report values of approximately 40|imol/L. lissue  carnitine concentrations 
show  w ide betw een-species variation . Skeletal m uscle carn itine 
concentrations determ ined using identical analytical procedures for rats, 
hum ans and sheep were 3.1|xmol/g dry weight (Cederblad and Lindstedt, 
1972), 16.2pmol/g dry weight (Cederblad, Lindstedt and Lundholm, 1974), 
and 50pm ol/g dry weight (Snoswell and Koundakjian, 1972) respectively. 
Data on hum an tissue carnitine content are very limited due to practical 
problems of obtaining samples. H um an plasm a carnitine concentrations 
similar to those found in rats have been reported (Di M auro et al., 1973), 
concentrations ranging from 23 to 70 pm ol/L . Carnitine in blood is 
p redom inan tly  in  the free form  and  th a t w hich is esterified  is 
predom inantly acetyl carnitine (Bieber, Valkner and Parrel, 1982). Mares- 
Perlman, Farrell and Gutcher (1986) report a value of 8.3 (±3.2)pmol/L for 
plasma acyl carnitine and 45.3 (±12.0)jjmol/L for plasma free carnitine for 
healthy adu lt subjects. Genuth and Hoppel (1979) report com parative 
values for acyl and  free p lasm a carn itine of 10 and  46 .8pm ol/L  
respectively. Serum carnitine concentrations are often used as an index of 
carnitine status, due to readily accessible sam ples. Serum  carnitine 
concen tra tions m ay have little  b earin g  on in d iv id u a l tis su e  
concentrations. However, changes in serum concentrations and the free to 
esterified ratio are thought to be indicative of changes in the carnitine pool 
and carnitine metabolism. Serum carnitine concentration reflects a 
balance between synthesis, intake, tissue uptake and excretion.
The majority of carnitine turnover studies have also been carried ou t in 
rats. The studies of M ehlm an, K ader and T herriau lt (1969) used  
rad io labelled  carnitine and  m easured  changes in specific activity.
Interpreting the findings as a single compartm ent metabolic model, they 
found an overall turnover rate of 14.2 days. Cederblad and Lindstedt 
(1976) described a two com partm ent model; w ith a small com partm ent 
(approximately 14pmol) representing extracellular water space and tissue 
carn itine w ith  a rela tively  fast tu rnover eg. liver, and  a larger 
com partm ent (40-50pmol) w ith  a slow  tu rnover ra te  represen ting  
rem aining tissue. They reported a daily turnover rate of 7% of the total 
body pool, which is comparable to the findings of Mehlman, Kader and 
Therriault (1969).
It appears paradoxical that the tissues richest in  carnitine are unable to 
synthesise it and m ust obtain carnitine from the circulation. The blood in 
tu rn  derives carnitine from the liver, w here endogenous biosynthesis 
occurs, or from the diet, via the gut. Uptake and release of tissue carnitine 
has been extensively studied (Vary and Neely, 1982; Bremer, 1983; Sandor 
et al., 1985; H okland and Bremer, 1986; Kispal et al.. 1987). The high 
concentrations of carnitine in skeletal muscle, liver, and heart, in relation 
to plasma, tends to suggest that active mechanisms of tissue uptake are 
involved. However, transport in liver and muscle m ay not be entirely 
active as inhibitors of glycolysis and oxidative phosphorylation only partly 
inhibit carnitine transport in cardiac and skeletal muscle (Rebouche, 1977; 
Bahl, N avin and Bressler, 1980). M olstad (1980) show ed that cardiac 
carnitine transport mechanisms involved exchange diffusion. Sartorelli, 
Ciman and Siliprandi (1985) have also found evidence in support of this 
transport mechanism.
In liver, uptake and  release of carnitine have been show n to be 
independent processes. Studies have shown an active sodium  dependent 
uptake of carnitine and a barrier m ediated release (Sandor et a l., 1985; 
Kispal et al., 1987), only uptake being energy and sodium  dependent. 
Kispal et al., (1987) have studied the effects of insulin and glucagon on 
uptake of carnitine by perfused livers. They concluded that carnitine 
concentration in rat liver is controlled by insulin and glucagon via cellular 
transport processes, insulin inhibiting and glucagon prom oting influx.
Carnitine is excreted in the urine in both the free and esterified form. 
Norm al excretion in healthy adults ranges from 100-300 |im ol/24  hours 
(Bremer, 1983). Renal clearance of carnitine is usually m uch less than 
glom erular filtration rate (Engel et al.. 1981; Rebouche and Engel, 1984), 
and studies have show n that renal reabsorbance of carnitine has an 
im portant role in the regulation of plasm a carnitine concentration. The 
process of renal reabsorption, like other carnitine transport mechanisms, 
is saturable and shows sodium  ion gradient dependence and structural 
specificity (Rebouche and Mack, 1984).
1.4 The Functions of Carnitine
Table 1.1 Metabolic Processes in  which Carnitine has an Im portant 
Function.
1. Oxidation of long chain fatty acids
2. Oxidation of medium chain fatty acids
3. Peroxisomal fatty a d d  oxidation
4. Buffering of the bound CoA to free CoA ratio
5. Removal of toxic concentrations of acyl CoA
6. Acetyl CoA metabolism
7. Production of energy from branched chain amino adds
The functions of carnitine listed in table 1.1 indicate that carnitine has a 
central role in overall energy metabolism. The most established function 
of carnitine is its role in the oxidation of long chain fatty acids. Figure 1.3 
(page 8) illustrates this process. Long chain fatty adds are activated in the 
cytosol to the coenzyme A level. The long chain acyl CoA cannot 
penetrate  the inner m itochondrial m em brane w ithou t the carnitine 
tran spo rt system . This system  consists of three m em brane bound  
enzymes; carnitine palm itoyltransferase I (CPT-I), situated on the inner 
surface of the outer mitochondrial mem brane (M urthy and Pande, 1987); 
Carnitine palmitoyl transferase U (CPT-U), situated on the inner surface of
the inner m itochondrial m em brane and carnitine palm itoyl translocase, 
situated w ithin the inner membrane. The acyl m oiety combines with 
carnitine by the action of CPT-I, acyl-carnitine is transported across the 
inner membrane by the membrane bound translocase. CPT-U, catalyses 
the recom bination of acyl units w ith CoA w ithin the matrix; carnitine 
released may re-enter the cytosol. Acyl CoA, formed in the cytosol using 
cytosolic energy (adenosine 5'triphosphate (ATP) ), is now available for 
mitochondrial E-oxidation.
Figure 1.3 M itochondrial Transport of Long Chain Fatty Acids:
The Carnitine Transport System
Outer
Membrane Intermembrane
Inner
Membrane
CPTI = Carnitine Palmitoyltransferase 1 
CTP n  = Carnitine Palmitoyltransferase 2 
Translocase = Carnitine Translocase
Fatty acid space
Co ASH
ATP
Acetylcamitine
CoASiT
CPT CPT
Carnitine ^
Acyl CoA
Acyl CoA
Beta-Oxidation
M edium  chain acyl groups m ay enter the m itochondrial m atrix 
independent of carnitine, become activated w ithin the m atrix and 
subsequently undergo E-oxidation. However, if the m edium  chain fatty 
acid is activated in the cytosol of the cell, the m edium  chain acyl CoA 
cannot penetrate the inner m itochondrial m em brane independen t of 
carnitine. In physiological situations where ATP availability w ithin the 
mitochondrial matrix is limited, eg. metabolic stress, cytosolic ATP is used 
to activate m edium  chain fatty acids and therefore subsequent oxidation 
becomes carnitine dependent (Borum, 1986). Activation of m edium  chain
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fatty acids has been shown to occur predom inantly in the cytosol (Groot 
and Hulsm ann, 1973).
Fatty acids may enter the peroxisome and become activated to their CoA 
derivatives, undergo partial oxidation and then leave the peroxisome. 
The transport of the shortened acyl product out of the peroxisome is 
facilitated by carnitine (Bieber, Valkner and Farrell, 1982).
Carnitine has an im portant role in buffering the bound CoA to free CoA 
ratio. Metabolism w ould be impaired if free CoA was not regenerated as 
CoA w ould be unavailable for metabolic reactions. By transferring the acyl 
moiety to carnitine free CoA is regenerated and metabolic processes, such 
as E-oxidation are sustained.
Carnitine has im portant detoxification functions. By rem oval of long 
chain acyl derivatives, carnitine prevents the adverse effects of such 
am phipathic intermediates. Many enzymes including adenine nucleotide 
translocase (Woldegioris et al., 1981), citrate synthetase (Mita and 
Yasumasu, 1983), pyruvate dehydrogenase (Patel, De Buysere and Olson,
1983) and pyruvate carboxylase (Utter and Scrutton, 1969), are inhibited by 
raised concentrations of acyl CoA. Long chain acyl CoA also causes 
damage to intracellular membranes by becoming non-specifically 
incorporated into the lipid bilayer, rendering cells more susceptible to 
noxious agents (Brecher, 1983). Di Lisa et al. (1985) have show n that 
hydroperoxide, calcium ion and phosphate damage to m itochondrial 
m em branes is delayed by carnitine. Carnitine, by rem oving m em brane 
bound acyl CoA, re-stabilises intracellular membranes.
Carnitine has an im portant role in transporting acetyl CoA ou t of 
peripheral cell mitochondria. Acetyl CoA w ithin the m atrix combines 
w ith carnitine to form acetylcamitine (regenerating free CoA), w hich m ay 
diffuse out of the mitochondria. Acetyl CoA m ay also combine w ith 
oxaloacetate forming citrate which is transported to the cytosol w here it 
reforms acetyl CoA. The citrate pathw ay is, however, metabolically
’expensive', as ATP is utilised in the cytosol to regenerate acetyl CoA. The 
carnitine pathw ay accomplishes the same, w ithout the use of ATP, so in 
situations w here ATP is lim ited (such as in metabolic stress), carnitine 
transport of acetyl units becomes important. The carnitine pathw ay is also 
im portant in physiological situations where oxaloacetate availability is 
low (reduced carbohydrate metabolism) and the citrate pathw ay is unable 
to operate. This m ay also be the case in the m etabolically stressed 
individual, who m ay therefore have increased dem ands upon  carnitine 
for acetyl metabolism.
Research has suggested that carnitine may have a role in branched chain 
amino acid (BCAA) metabolism, as carnitine has been shown to increase 
the oxidation of BCAA in muscle (van Hinsberg, Veerkamp and Engelen, 
1978). Acyl derivatives of BCAA have also been identified in several 
tissues (Bieber and Choi, 1977). Acyl CoA may inhibit BCAA oxidation by
suppressing the activity of a-ketoglutarate dehydrogenase (Hulsm ann et
al., 1964). Carnitine may therefore exhibit an effect on BCAA indirectly by 
buffering acyl CoA.
1.5 The Role of Carnitine in Ketogenesis
The functions detailed above indicate that carnitine has a dual role in the 
pathw ays which lead to the production of ketone bodies. Firstly, it is 
essential for transport of long chain acyl groups into the m itochondria in 
order for E-oxidation to take place. Secondly, carnitine is im portan t in 
transferring acetyl units from peripheral cell m itochondria to the liver 
where they may be utilised in ketogenesis.
1.6 Carnitine Deficiency
Both prim ary and acquired carnitine deficiency are know n to occur in 
man. Prim ary genetic carnitine deficiency has been a ttribu ted  to an 
autosomal recessive trait (Engel and Rebouche, 1984). Prim ary deficiency 
includes systemic deficiency, caused by a block in synthesis (Broquist and
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Borum, 1982), and m yopathic deficiency, caused by im paired transport of 
carnitine into m uscle (DiMauro, Trevisan and Hays, 1980). Carnitine 
deficiency m ay occur due to a metabolic defect or clinical disorder, and 
m ay arise due to decreased biosynthesis - eg. in advanced cirrhosis; 
decreased intake - such as in patients on total parenteral nutrition (TPN); 
increased excretion and increased utilisation - such as in organic acidurias, 
and finally, altered cellular uptake, w hich m ay occur secondary to 
m yopathic disorders (Rudman, Sewell and Ansley, 1977; H ahn Allardyce 
and Frolich, 1982; Seccombe, Snyder and Parsons, 1982; Borum, Broquist 
and Roelofs, 1977).
Secondary carnitine deficiency has also been reported  in  prem ature  
neonates (Penn, Schmidt-Sommerfeld and Wolf, 1980), m alnourished 
infants (Khan and Bamji, 1977), and following traum a ( Cederblad et a l., 
1981; Cederblad, Larsson and Schildt, 1984; Nanni et a l.. 1985a). Carnitine 
deficiency in traum a will be considered in m ore depth  in subsequent 
chapters.
A m arked feature of carnitine deficiency is a reduced capacity to utilise 
lip id , the characteristic features being  reduced  tissue  carn itine  
concentrations, rapid  depletion of glycogen stores w ith hypoglycaem ia, 
muscle weakness w ith triglyceride infiltration of muscle fibres, steatosis, 
elevated serum fatty acids, and blunted ketosis (Siliprandi, 1986).
Much of the research on lipid m etabolism  and carnitine deficiency in 
hum ans has been carried out in the prem ature neonate. The prem ature 
infant is susceptible to carnitine insufficiency firstly, because at birth there 
is a shift from glucose m etabolism  to fatty acid m etabolism  w ith  a 
concomitant increased dependency upon carnitine as a cofactor. Secondly, 
in the p rem ature  infant there is reduced capacity for endogenous 
biosynthesis due to im m aturity of the enzyme systems invovled (Hahn, 
1981; Rebouche, 1980). In addition to this the neonate m ay be m aintained 
on a carnitine free nutrition regime if parenterally fed or enter ally fed on a
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soy based form ula. Penn, Schmidt-Sommerfeld and Wolf (1980) have 
repo rted  reduced  plasm a carnitine concentrations in  neonates fed 
parenterally. In the neonate carnitine deficiency has serious implications 
in terms of lipid metabolism, and infants on carnitine free regimes have 
been shown to have impaired ketone body formation (Novak et al.. 1979). 
Several studies have dem onstrated  an association betw een reduced 
circulating carnitine concentrations and reduced circulating ketone body 
concentrations in neonates (Schmidt-Sommerfeld, Penn and Wolf, 1982; 
Takahashi and Sawaguchi, 1983; Yeh, Cooke and Zee, 1985). Schmidt- 
Som m erfeld  and  cow orkers (1983) d em o n stra ted  th a t carn itine  
supplementation significantly increased ketotic capacity in neonates.
The studies cited have show n that carnitine deficiency is the factor 
responsible for suppressed ketogenesis in neonates. It is possible that 
carnitine deficiency m ay be responsible, at least in part, for suppressed 
ketosis in other pathophysiological conditions such as severe metabolic 
stress. Traum a victims are susceptible to carnitine deficiency, so it is 
interesting that studies of lipid m etabolism in such patients have also 
shown blunted ketosis. Carnitine, however, is not the only factor which 
governs ketotic capacity. In situations such as in the prem ature neonate 
where carnitine is the only limiting factor, in an environm ent which is 
otherw ise favourable for ketogenesis, it m ay have prim ary  control. 
However, in o ther m ore diverse pathological situations the role of 
carnitine m ust be p u t in to  context w ith  o ther factors controlling 
ketogenesis.
1.7 The Control and Regulation of Ketogenesis
The overall control of ketogenesis is thought to be a bihorm onal system 
(Figure 1.4, page 13). For m any years it was though that insulin alone 
governed ketogenic status. Although insulin deficiency m ay be the trigger 
for ketogenesis, it is now  known that glucagon also has an im portant role. 
Enhanced lipolysis and NEFA (non-esterified fatty acid) supply to the liver, 
the result of insulin deprivation, although essential for ketogenesis, is not
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itself sufficient to ensure ketogenesis will occur. A change in liver 
metabolism from an organ directing NEFA towards triglyceride synthesis, 
to an organ diverting incoming NEFA to the mitochondria for oxidation is 
required. Studies in both animals (McGarry, W right and Foster, 1977) and 
hum ans (Gerich et a l.. 1975; Alberti et a l.. 1975; Schade and Eaton, 1975; 
Boden et al., 1977) have shown that glucagon is the factor which causes the 
switch in liver metabolism. Glucagon infusion into rats has resulted in a 
high ketogenic capacity even in the presence of hyperinsulinaem ia. It 
therefore appears that in the developm ent of ketogenesis, decreased 
insulin activity is responsible for increased delivery of fatty acids to the 
liver. Concurrently raised glucagon concentrations cause the necessary 
switch in liver metabolism from an organ of lipogenesis to one favouring 
fi-oxidation of fatty adds. It appears that at the level of liver metabolism, 
glucagon is the hormone governing the biochemical changes and insulin 
exerts only an indirect effect by antagonising glucagon (McGarry et a l.. 
1989).
Figure lA  Bi-Hormonal Model for the Control of Ketogensis Based 
upon that of McGarry and Foster (198^)
LIVERADIPOSE
TISSUE BLOOD
NF.FA NEFATriglycerides
Triglycerides
PhospholipidsKETONES
i  GLUCAGON 
w INSULIN
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The 'fine tuning’ of the control of ketone body production is carried out by 
a num ber of biochemical factors. The site at which glucagon exerts its 
effect of promoting fatty a d d  oxidation appears to be the loci of fatty acid 
oxidation itself; that is the carnitine dependent transport system (outlined 
previously, section 1.4 page 7). The control of the carnitine transport 
system is hence a central locus of control of ketogenesis.
Research aiming to uncover the factors responsible for the control of this 
transport system, found that the liver content of carnitine influenced the 
activity of CPT-I. Liver carnitine concentration increased w hen there was 
a relative excess of glucagon to insulin (McGarry, Robles-Valdes and Foster, 
1975). It has been suggested that the effect of carnitine is a mass action 
effect (McGarry et a l., 1989). This is interesting since it suggests that large 
dose carn itine  supp lem en ta tion  m ay be effective in  p rom oting  
ketogenesis, providing that the horm onal environm ent favours liver 
uptake.
Another key to the control of fatty a d d  oxidation, was the observation that 
rates of hepatic fatty a d d  oxidation and synthesis were redprocally related. 
The discovery that the product of the first committed step of fatty acid 
synthesis, namely malonyl CoA, was a potent inhibitor of CPT-I explained 
the  rec ip rocal re la tio n sh ip  and  p ro v id ed  a m ajor advance  in  
understanding the control of the carnitine system. (McGarry, M annerts 
and Foster, 1977; McGarry, Leatherman and Foster, 1978). In the fed state 
concentrations of malonyl CoA are raised, hence CPT-I is inhibited, and 
acyl CoA are diverted tow ards VLDL (very low density lipoproteins) 
synthesis. In ketotic states there is an increase in the glucagon to insulin 
ra tio  w hich  activates a nu m b er of CAM P (Cyclic ad en o sin e  
5'm onophosphate) m ediated enzyme cascade reactions which bring about 
increased rates of glycogenolysis, reduced fructose 2,6 b isphospate, 
deactivation of phosphofructokinase, decreased pyruvate kinase and acetyl 
CoA carboxylase, which leads to the reduced production of malonyl CoA. 
The relative hypoinsulinaem ia enhances lipolysis, p rovid ing  the liver 
w ith an increased NEFA supply. The increase in long chain acyl CoA
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further suppresses the activity of acetyl CoA carboxylase. Reduced 
malonyl CoA activates fatty acid oxidation, the rate of which is governed 
thereafter by fatty ad d  supply. Carnitine supply will also be an im portant 
determ inant of oxidation rate at this stage, since together with acyl CoA it 
is the cosubstrate for CPT-I. Fatty acid supply alone, may not be sufficient 
to drive oxidation in carntine deficient circumstances. The rate of B- 
oxidation  has been show n to be linearly  rela ted  to in tracellu lar 
concentration of long chain acyl CoA (McGarry and Foster, 1980) and 
inversely related to tissue malonyl CoA concentrations (Boyd et al.. 1981).
In conditions of enhanced fatty acid oxidation there appears to be kinetic 
changes in the properties of CPT-I which exhibits increased m axim um  
activity, has a lower affinity for acyl CoA and reduced sensitivity to 
malonyl CoA. These changes act synergistically to amplify the effects 
expected from  changes in m alonyl CoA concentration alone. Some 
prelim inary studies suggested glucagon m ay m ediate the kinetic changes 
(Harano et al., 1975), however. Boon and Zammit (1988) observed no effect 
of glucagon on CPT-I kinetic properties in situ. Research is currently 
focusing on how  malonyl CoA acts to inhibit CPT-I. The m olecular 
mechanisms by which this occurs are not yet understood, however, it is 
known to be readily reversible and offset by increasing the concentration 
of palmitoyl CoA. Apparently it is not an example of classical competitive 
inhibition, as the inhibitor does not appear to interact w ith the CoA 
binding site (McGarry et al., 1989).
1.8 Sum m ary
In summary; the overall control of ketogenesis is hormonal in nature, the 
process being favoured by an increase in the glucagon to insulin ratio. 
When this occurs the 'fine tuning' is regulated by biochemical factors such 
as malonyl CoA, NEFA supply, carnitine supply, and kinetic properties of 
CPT-1. W hen the horm onal environm ent favours ketogenesis, or w hen 
the horm onal control is d isrupted (eg. in metabolic stress, w hen raised 
insulin  and raised  glucagon concentrations are in coexistence) the
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biochemical factors m ay play a prim ary role in determ ining ketotic 
capacity. In such situations carnitine m ay have an im portant influence on 
ketosis, since it appears to have a direct stimulatory effect on CPT-1 and is 
an essential cosubstrate for this enzyme. In addition to the direct role of 
carnitine in fatty acid oxidation it has an essential role in transporting 
acetyl units to the liver, under certain physiological conditions.
C arnitine status and m etabolism  m ay be of u tm ost im portance in 
physiological situations where ketosis is favoured. The observation that 
carnitine deficiency and b lunted ketosis are associated in prem ature 
neonates has led to the hypothesis that carnitine deficiency m ay be 
responsible for dam pened ketosis observed in  other situations. In 
particular, carnitine status and metabolism m ay have an im portant role in 
physiological and pathological conditions where m arked alterations in 
ketotic status occur. Ketosis m ay also be effected in situations in which 
tissue availability of carnitine m ay be altered due to disturbances in 
biosynthesis, transport, excretion and intake, such as following traum a 
and in uncontrolled diabetes.
Capacity to achieve and m aintain heightened ketone body concentrations 
following injury has suggested to be of benefit, by lim iting net muscle 
protein loss. In some patients ketosis following injury appears to be 
compromised, for reasons which are unclear. In view of the suggested role 
of carnitine in the reactions controlling ketogenesis, the prim e aim of this 
research project was to evaluate changes in carnitine status during  
recovery from  injury. Also, to determ ine w hether carn itine sta tus 
influences the capacity to develop a post-injury ketotic response.
The m arked alterations in lipid metabolism in diabetes, and in particular 
the increase in concentrations of ketone bodies associated w ith  this 
condition, have suggested that carnitine requirem ent m ay be increased 
and that under hormonal conditions which favour ketogenesis, carnitine 
availability m ay be an im portant determ inant of diabetic ketosis. It was 
decided that the study of carnitine m etabolism in diabetes w ould be a
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valuable adjunct to the study of carnitine status and  ketone bodies 
following injury. Study of carnitine status in the critically ill is potentially 
limited due to sample availability, and practical and ethical considerations. 
Supplem entation studies are also difficult to im plem ent due to ethical 
limitations. A subsidiary aim of the current research was therefore; to 
study carnitine status and the effects of carnitine supplem entation in a 
condition with m arked alterations in ketone body concentrations, namely 
diabetes, using an animal model. This w ould enable the use of stringent 
experimental conditions, w ithout restrictions on sample availability.
In the ensuing chapters, the developm ent and evaluation of a m ethod 
suitable for assay of carnitine is described. The association betw een 
carnitine and ketone bodies is investigated in two different conditions of 
traum a, namely following surgery and following bum s injury. Finally the 
association between carnitine and ketone bodies is evaluated during the 
onset and reversal of diabetic ketosis in rats. Two quite different 
approaches were taken in order to achieve the single ultim ate aim of 
gaining insight into the significance of carnitine m etabolism  under 
conditions of altered ketone body status.
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CHAPTER TWO 
METHODS AND MATERIALS
2.1 Assay Techniques for the M easurement of L-Carnitine in 
Biological Samples
The earliest m ethods for the assay of carnitine involved isolation and 
crystallisation of carnitine, using basic principles of organic chemistry. 
Then followed a bioassay using Tenebrio molitor larvae, an organism  for 
which carnitine is essential for growth (Fraenkel, 1951; Carter et al., 1952). 
In this cumbersome assay the am ount of carnitine in an extract was 
determ ined by comparing the growth in the presence of standard carnitine 
solution. Such methods lacked precision, sensitivity and specificity.
The discovery and isolation of carnitine acetyltransferase (CAT) led to a 
new era of carnitine determination. Enzymatic m ethods were developed 
which were based on the following principle.
CAT
Carnitine + Acetyl CoA ^ > Acetylcarnitine + Coenzyme A (CoA)
In the earliest spectrophotometric m ethods one of the products of the 
reaction above, usually CoA, was coupled w ith another reagent to produce 
a coloured compound, the absorbance of which was related to the L- 
carnitine concentration in the original sample. Ellm an’s m ethod was the 
first such m ethod to be described (Ellman, 1959). This standard 
spectrophotom etric m ethod involved adding DTNB (5-5'-dithio-bis-2- 
nitrobenzoic acid), CAT and acetyl CoA, contained in a buffer, to the 
sam ple containing carnitine. The DTNB reacts w ith the CoA produced, 
forming thionitrobenzoic acid which absorbs strongly at a wavelength of 
412nm.
CAT
Carnitine + Acetyl C oA ----------> Acetylcarnitine + CoA
CoA + DTNB-----------> Thio-nitrobenzoic acid
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From results of early experiments using Ellman’s reagent (DTNB) it 
became apparent that there were several problems inherent in using 
DTNB. Firstly it reacts non-specifically w ith sulphydryl groups present in 
the sample, which causes high background absorbance and reduces 
sensitivity. Secondly, DTNB has an inhibiting action on CAT.
Due to the problem s of early spectrophotometric m ethods, fluorometric 
m ethods came into vogue tow ards the end of the 1960's, w hen 
W illiamson and Corkey (1969) developed a fluorometric assay based on 
the following reaction principle:-
CAT
Carnitine + Acetyl CoA  > Acetylcarnitine + CoA
succinate thiokinase 
CoA + Succinate + ATP  -> Succinyl CoA + ADP + Pj
pyruvate kinase 
ADP + Phosphoenolpyruvate ---------- > ATP + Pyruvate
lactate dehydrogenase 
Pyruvate + NADH + H+ ------------  > Lactate + NAD +
Loss of NADH fluorescence is . m easured on addition of carnitine 
acetyltransferase.
M % arry  and Foster (1976) developed a spectrophotometric m ethod which 
did  not require the use of DTNB and which was based on the following 
reaction principle:-
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CAT
Carnitine + Acetyl CoA > Acetylcarnitine + CoA
citrate cleavage enzyme
Citrate + ATP + CoA ----------------- > Oxaloacetate + ADP + Acetyl CoA
malate dehydrogenase 
Oxaloacetate + N A D H  ---------------  > Malate + NAD+
The absorbance of NAD+ produced was m easure at 340nm. The m ain 
lim itation of this m ethod was that the citrate cleavage enzym e was not 
available commercially. Early spectrophotom etric and fluorometric 
m ethods lacked sensitivity and specificity and their use declined w ith the 
introduction of highly specific and sensitive radioenzym e assays. 
Radioenzyme assays use CAT and labelled acetyl CoA (labelled in the 
acetyl moiety) and a sulphydryl group reagent to remove CoA formed. 
The reaction principle is as follows:-
CAT
L-Camitine + C-Acetyl C o A ^ = ^  C-Acetylcarnitine + CoA
Cederblad and Lindstedt (1972) were the first to describe a radioenzym e 
m ethod capable of m easuring L-camitine in the picomolar range. C- 
acetyl CoA and CAT were incubated together w ith the carnitine containing 
sam ple and subsequently passed through an ion exchange resin colum n to 
separate the labelled acetylcarnitine produced from unreacted C-acetyl 
CoA. Radioactivity of the effluent was related to the carnitine 
concentration of the original sample.
This m ethod enabled detection of as little as 10 pmoles carnitine and was 
100 times m ore sensitive than previous spectrophotom etric m ethods. 
Another advantage of the radioenzym e assay was that only a small sam ple
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size of approxim ately 20pl was required. M any modifications of this 
m ethod are currently in use. One of the disadvantages of the original 
radioenzym e m ethod w as, tha t due to the reversible na tu re  of the 
reaction, excess acetyl CoA was needed to ensure completion, which added 
to the cost of the assay. A 5:1 ratio of labelled acetyl CoA to carnitine was 
required  in order for the reaction to proceed to its fullest potential. 
A nother problem  encountered w ith the radioenzym e assay was that 
acetylcarnitine in the sample became labelled. Labelled acetyl CoA was 
d ilu ted  by the unlabelled acetyl groups, from acetylcarnitine initially 
present, and this m ay have resulted in underestim ation of free carnitine 
concentration. These problems were overcome by Bohmer, Ryding and 
Solberg (1974), who added DTNB to the reaction mixture to trap the CoA 
produced; this shifts the reaction equilibrium towards the right hand side 
and  obtains a linear response  over a w ide  range of carn itine
concentrations, w ithout the need for excess acetyl CoA. M % arry  and 
Foster (1976) used tetrathionate as the sulphydryl trapping reagent and 
found that this minimised the diluting effect of acetylcarnitine. They also 
introduced the use of a resin slurry, to replace the columns previously 
used, which added to the simplicity and speed of the assay. Ion exchange 
resin slurry was added to terminate the reaction, tubes were subsequently 
centrifuged to remove the resin slurry and the supernatant was rem oved 
and counted.
In the past the m ost commonly used assays have been those using 
spectropho tom etry  and  rad ioenzym e m ethods, a lth o u g h  several 
alternative m ethods have also been described. A gas chrom atography 
m ethod was published by Lewin, Peshin and Sklarz (1975) which was 
based on conversion of carnitine to a volatile derivative, 4-butyrolactone, 
which was analysed by chromatography. The m ethod was sensitive bu t 
unfortunately only m easured total carnitine and was no t suitable for 
detecting individual fractions, since acyl carnitine was hydrolysed in the 
process. The m ethod also lacked specificity if butyrolactone or crotonic 
acid were present in the sample. Rodriguez-Segade et al. (1985) have also 
suggested that gas chromatography overestimates carnitine concentration.
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More recently a HPLC (High performance liquid chromatography) method 
was described (Takeyama et a l., 1986), which was enzymatic in nature and 
based on the reaction principle previously described.
CAT
Carnitine + Acetyl CoA Acetylcarnitine + CoA
After completion of the above reaction an aliquot containing the CoA 
produced was injected directly into the HPLC system. Carnitine in the 
original sam ple w as assayed by direct determ ination of stoichiometric 
quantities of CoA released. Sensitivity of the m ethod was comparable to 
that of the radioenzyme methods.
In recent years, spectrophotom etric m ethods have once m ore gained 
popularity w ith the introduction of centrifugal analysers. Reproducibility 
and sensitivity have been improved by automation of the assay. Seccombe 
et al. (1976) described an autom ated carnitine assay which used an Abbot 
100 biochromatic analyser, based on the enzym atic m ethod of Ellman 
(1959). A part from this m ethod little was published on autom ated assays 
until 10 years later by which time centrifugal analyser were more widely in 
use (Rodriguez-Segade et a l., 1985; Cederblad, Harper and Lindgren, 1986). 
Seccombe and coworkers (1976) found that autom ation of the assay was 
economical in terms of time, reagents, volume and sample size required, 
w hen com pared to m anual spectrophotom etry. They also found  
improved precision due to automatic pipetting.
In 1985 Rodriguez-Segade et al. described a m ethod sim ilar to that of 
Seccombe et a l. (1976), which w as carried out on the ABA 100 and 
Centrifichem 600 centrifugal analysers. The m ethods of both  Seccombe 
and Rodriguez-Segade required  an initial b lank ru n  to  account for 
background absorbance, followed by an enzym e run. The change in 
absorbance w as corrected for the absorbance of the enzym e blank. 
Rodriguez-Segade et al. (1985) obtained excellent assay linearity analytical 
recovery and reproducibility. However, the process of carrying out tw o
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runs was time consuming and costly in terms of reagents. Cederblad, 
H arper and Lindgren (1986) described an autom ated spectrophotometric 
m ethod which did  not require a blank run. They used a Cobas-Bio 
Centrifugal Analyser. A lthough this m ethod used DTNB, to form  a 
coloured complex w ith  CoA, decreased specificity from  background 
absorbance was minimised, as the Cobas-Bio automatically corrected for 
blank absorbance of enzyme and sample blanks, precision was therefore 
improved. With their method, Cederblad and coworkers (1986) obtained a 
linear response over a wide range of concentrations (2.5 - 500pmol/L) and 
analytical recovery averaged 93%. W hen they validated the m ethod 
against the radioenzym e m ethod (Cederblad and L indstedt, 1972) a 
correlation of 0.965 was obtained. Good reproducibility was obtained 
within and between assays for both free and total carnitine in serum.
From the m ethods m entioned, autom ated spectrophotom etry appears to 
be economical in term s of tim e and expense and claims also to be 
reproducib le  and  sim ple. It w as therefore decided to evaluate  a 
spectrophotom etric m ethod based upon that of Cederblad, H arper and 
Lindgren (1986), using the Cobas-Bio Centrifugal Analyser, and evaluate its 
application for use in the proposed clinical and animal studies which were 
to be carried out as part of the present project.
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2.2 Spectrophotometric Determ ination of L-Camitine Using a
Cobas-Bio Centrifugal Analyser 
Reaction Principle
Li-carnitine is determ ined via the carnitine acetyltransferase (CAT) 
reaction, the CoA produced reacting w ith added DTNB to produce the 
coloured thiophenolate ion which absorbs strongly at a w avelength of 
412nm.
CAT
L-Carnitine + AcetylCoA Acetylcarnitine + CoA
CoA + DTNB------------>Thiophenolate Ion
Materials
Potassium phosphate buffer, O.lmol/L, pH  7.5.
DTNB (5 ,5-dithio-bis-2-nitrobenzoic acid), 1 nunol/L
EDTA (ethylenediaminetetra - acetic acid)(5mm ol/L disodium  salt), 
5m m ol/L
Acetyl coenzyme A, 1.5m m ol/L
Carnitine acetyltransferase (approximately 100 un its /m g  protein),
(EC 2.3.1.7. from pigeon breast muscle)
Reagent Mixture
4ml phosphate buffer 
1ml DTNB 
0.8ml Acetyl CoA 
2ml ETDA
The above reagent m ixture provides sufficient for 25 sam ple plus
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'Start' Reagent
Dilute lOp.1 of enzyme solution (CAT) in 392 |il phosphate buffer.
Assay Procedure
Samples and standards are automatically pippeted into the assay rotor into 
which reagent is subsequently pippeted, enzyme blanks are automatically 
included. An incubation period of centrifugation is then undertaken to 
enable samples and reagent to mix thoroughly. During this tim e any 
background colour resu lting  from  interaction of DTNB and  thiols 
contained in the sample occurs. At the end of the incubation period a 
blank reading is taken. The enzyme is then added and a second period of 
centrifugation occurs during  w hich absorbance read ings are  taken 
throughout the course of the reaction until end point. On printout mode 
' 1' absorbance is automatically corrected for blanks and results are obtained 
in pm ol/L .
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The Cobas-Bio is programmed as follows:-
1 . un its pmol
2 . Calculation factor 0
3. Standard 1 25
4. Standard 2 50
5. Standard 3 100
6 . Lim it 800
7. Temperature (^C) 37.0
8 . Type of analysis 6
9. W avelength 412
10 . Sample volum e (|il) 15
11. D iluent Volume (47) 47
12 . Reagent volume (pi) 200
13. Incubation time (sec) 120
14. Start reagent volume (pi) 10
15. Time of first reading (sec) 1.0
16. Time interval 60
17. Num ber of readings 10
18. Blanking m ode 1
19. Printout mode 1
Linearity
A  series of L-carnitine standards (5-800 pm ol/L) were tested and analytical 
values compared to theoretical value. These data are presented in table 2.1 
(page 27).
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Table 2.1 Analytical Values vs. Theoretical Values for a Range of 
C arn itine  S tandards 5-800pl. Values R epresen t M ean (±sd) of 5 
D eterm inations.
CARNITINE STANDARD ANALYTICAL VALUE
pm ol/L  pm o l/L
5 5.73 (±0.87)
25 25.57 (±1.26)
50 50.23 (±2.20)
100 99.74 (±1.52)
200 190.33 (±1.29)
400 378.07(±2.22)
800 800.16 (±11.9)
The assay was linear over the range tested. This was comparable with data 
of Cederblad, H arper and Lindgren (1986), who obtained a linear response 
from 2.5 - 800pmol/L from carnitine standards.
Reproducibility Test Using L-Camitine Standards
W ithin and between run precision were tested using a range of L-camitine 
standards 0-800 pm ol/L . The results are presented in table 2.2 (page 28). 
W ithin run  precision was good, coefficients of variation ranged from 
0.62% to 10.5%, the lowest standard giving the poorest result. W ithin the 
usual physiological range for serum  (25 - lOOpmol/L), precision was 
excellent. Between run precision was poorer and coefficient of variation 
ranged from 4.39% to 16.24%, again the poorest precision was for the 
low est concentration of standard. Within the range of 25-lOOpmol/L 
excellent between run  reproducibility was obtained, w ith coefficients of 
variation ranging from 4.39% to 6.84%.
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Table 2.2 W ith in  and  Betw een A ssay P recision  of L C arn itine  
S tan d ard s 5-800pmol/L. V alues R ep resen t M ean (± sd) of 5 
D eterm inations.
Standard W ithin run  values Between run  values
pm ol/L mean (± sd) CV % mean (± sd) CV %
5 6.56 (±0.69) 10.50 5.50 (±0.89) 16.26
25 25.73 (±0.56) 2.17 25.61 (± 1.56) 6.08
50 48.13 (±1.12) 2.32 50.23 (±2.20) 4.39
100 94.76 (± 0.59) 0.62 99.69 (±6.82) 6.84
200 190.33 (±1.29) 0.68 197.69 (±20.66) 10.45
400 437.00 (±4.71) 1.08 372.27 (±25.75) 6.93
800 800.16 (±11.9) 1.49 821.78 (±40.39) 4.91
Deproteinisation of Serum Samples
The next stage in evaluation of the m ethod was to carry out precision tests 
of biological samples ie. serum and urine. Before analysis of serum can be 
carried  ou t depro tein isation  w as necessary to rem ove in terfering  
substances. Several methods of deproteinisation were available including 
acid deproteinisation, using perchloric acid (PCA), ultrafiltration (using 
m em brane filter cones) (Seccombe et a l.. 1976), and heat deproteinsation 
(Rodriguez-Segade et al., 1985). Ultrafiltration was not used due to the cost 
of the membrane filter cones. A part from expense, another disadvantage 
of this m ethod was poor volume recovery of samples (25-45%) (Seccombe 
et a l., 1976). The heat deproteinisation m ethod described by Rodriguez- 
Segade e t a l . (1985), involves heating the sample for 5 m inutes at 100°C 
and subsequently freezing the sample for 30 m inutes at -20°C. V olum e 
recovery was in the region of 45%. A part from being simple to perform  
and economical, heat deproteinsation avoids sample dilution incurred by 
PCA deproteinisation by addition of ad d  and subsequent neutralisation.
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As heat deproteinisation was a new technique, which had not been widely 
used, it was decided to compare the m ethod of heat deproteinsation with 
the more conventional m ethod of acid deproteinisation, in order to select 
a m ethod to be used in the evaluation of the carnitine assay and for 
further studies.
Heat Deproteinisation Procedure
0.5ml serum  samples were heated in a w ater bath at 100°C for five 
minutes. Coagulated serum  was frozen at -20°C for 30 m inutes. Samples 
were thaw ed and centrifuged at high speed for five minutes. The 
resulting supernatant was removed, and volume recovery was noted.
PCA Deproteinisation Procedure
lOOpl of IM PCA were added to 200pl serum. Samples were mixed and 
then centrifuged in a microcentrifuge at high speed for 10 m inutes. To 
120pl of supernatant, 50pl 0.25M phosphate buffer were added. Samples 
were neutralised with approximately 30pl IM KOH. Samples were chilled 
prior to analysis so KCl formed from the neutralisation process settled at 
the bottom  of each tube. KCl may interfere w ith the action of CAT, so it 
was im portant that aliquots taken from the sample tubes for analysis 
contained m inim um  KCl.
To determ ine percentage recovery, serum  samples were deproteinised and 
analysed w ith and w ithout the addition of 5pl of 800 pM  L-carnitine. 
Recovery was calculated using the equation given on page 42.
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Table 2.3 Com parison of M ethods of Serum D eproteinisation Prior to 
the Assay of L-Camitine. M ean Values O btained for Serum Carnitine. 
Recovery of Carnitine and Reproducibility.
HEAT DEPROTEINISED PCA DEPROTEINISED 
SAMPLE SAMPLE
M ean value
for serum  45.86 ±1.2 45.15 ± 0.84
free carnitine
% recovery of
L-carnitine 71.4% 75.0%
% hydrolysis of
added acetylcarnitine negligible 5.8%
W ithin assay precision 1.9% 2.6%
Between assay precision 3.5 -16.0% 17.4 - 42.0%
Table 2.3 presents a comparison of the two m ethods of serum 
deproteinsation tested. Mean values of five replicates for m easurem ent of 
free carnitine on a pooled serum  sam ple were similar for both methods. 
Percentage recoveries were also similar. Rodriguez-Segade et al. (1985) 
obtained a m ean recovery of 100 .8 % for heat deproteinised sam ples which 
were subsequently analysed using autom ated spectrophotometry. The 
present value for recovery following heat deproteinisation was lower than 
this, indicating that some carnitine may be trapped in the coagulant. 
Fishlock, Bieber and Snoswell (1984) have also found PCA deproteinsation 
results in considerable quantities (up to 25%) of carnitine being trapped in 
the protein precipitate.
To compare the relative extent to which acetylcarnitine in the sam ple m ay 
be hydrolysed (causing overestimation of free carnitine) by the two 
different m ethods, a sample was analysed w ith and w ithout the addition 
of acetylcarnitine. Negligible ester hydrolysis was found in PCA 
deproteinised samples, however, in the heat deproteinised sam ples 5.8%
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hydrolysis of acetylcarnitine added was observed. W ithin assay precision 
was good using both m ethods of deproteinisation. The value obtained of 
2.6% was comparable to that obtained by Cederblad, Harper and Lindgren 
(1986) for heat deproteinised serum. W hen between assay reproducibility 
was tested, variation in the heat deproteinised samples was so m arked that 
the m ethod was considered unsuitable and PCA deproteinisation was 
selected.
Tests o f Reproducibility using PCA Deproteinised Serum
Carnitine was m easured in deproteinised serum  of five healthy adults. 
W ithin and between day values obtained are presented in table 2.4. 
W ithin run  precision was excellent. The coefficient of variation ranged 
from 1.6% to 4.3%. Cederblad Harper and Lindgren (1986) obtained a value 
of 2.7% for w ithin run  precision. Between run  precision was poorer, the 
coefficient of variation ranging from 3.51% to 16.0%, that obtained by 
Cederblad, H arper and Lindgren (1986) was only 3.7%. The reason for the 
variability was unclear and no systematic trends were observed.
The values obtained for serum  free carnitine were slightly higher than 
published data for serum  concentrations in healthy adults (Genuth and 
Hoppel, 1979; Mares-Perlman, Farrell and Gutcher, 1986; Rebouche and 
Engle, 1983) of approximately 45pmol/L.
Table 2.4 W ithin and Between run  Reproducibility of the Carnitine 
Assay M ean Values (t sd) of 5 Replicates from 5 Serum Samples O btained 
From Healthy Individuals.
nple W ithin run  values 
mean (± sd) CV %
Between ru n  values 
m ean (±sd) CV %
A 59.08 (±2.56) 4.3 59.62 (± 7.46) 12.5
B 67.74 (± 1.07) 1.6 55.02 (±8.97) 16.0
C 57.12 (± 1.85) 3.2 53.72 (± 7.38) 13.75
D 50.28 (± 1.95) 3.9 52.94 (± 1.85) 3.4
E 69.78 (±1.86) 2.7 62.48 (± 4.34) 7.0
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Determination of Total Acid Soluble Carnitine (TASC).
Alkali hydrolysis of short chain esters in serum  enables determ ination of 
TASC. By subtracting the free carnitine value from this, a value for short 
chain acyl carnitine is obtained.
Hydrolysis Procedure (Jackson, 1987, personal communication)
Excess alkali (60|il IM KOH) and 50|i.l phosphate buffer (0.25M) are added 
to lOOpl of PCA deproteinised serum extract. Samples are incubated at 
37°C for 30 m inutes during which time hydrolysis occurs. Samples are 
subsequently neutralised with approximately 20|xl of 1.25 M HCl. Samples 
are chilled prior to analysis to enable KClÿo settle to the bottom  of the tube 
so the assay aliquot has a m inim um  salt content. The conditions used are 
adequate to hydrolyse the concentrations of short chain esters found in 
biological samples (Jackson, 1987, personal communication).
Free carnitine (FC) and total acid soluble carnitine (TASC) were m easured 
on deproteinised serum  from four healthy adults. The results obtained 
are presented in table 2.5. Values obtained from TASC were lower than 
those obtained for FC. At first it was thought this m ay be due to incorrect 
neutralisation of samples. Individual neutralisation of each sam ple 
elim inated this possibility. Altering the conditions of ester hydrolysis did 
not have any effect on the results.
Table 2.5 M ean Values ft sd) Obtained for Free Carnitine and Total 
Acid Soluble Carnitine M easurem ents in  Deproteinised Serum from 4 
Healthy Adults.
Sam ple FREE CARNITINE TOTAL ACID SOLUBLE CARNITINE
A 55.7 (±  11.3) 55.5 (±  13.3)
B 79.9 (± 5.8) 73.2 (± 15.5)
C 62.3 (± 11.8) 66.0 (± 22 .6)
D 81.3 (± 11.8) 77.3 (± 10.9)
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It was considered that an assay interférant, produced during the hydrolysis 
procedure, reacted w ith DTNB resulting in the reaction not going to 
completion. U nstable absorbance at end poin t w as often observed 
suggesting some reaction was still occurring and the colour w ithin the 
sample was not stable.
lOOpM L-carnitine standard  w as prepared  in a 4% album in solution 
(Bovine serum  album in. Sigma), this mim icked the protein  content of 
serum. Albumin standards were assayed by the methods for both free and 
total acid soluble carnitine. Values obtained were compared to those of 
standards prepared in water. The results in table 2.6 (page 34) show that 
the presence of albumin leads to the production of non-carnitine specific 
colour and overestimation of carnitine concentration. This indicates that 
even though the Cobas-Bio takes a blank reading before the addition of the 
enzyme, further non-specific reactions continue to occur after addition of 
the enzyme. This may only be overcome by carrying out an enzyme blank 
run  and subtracting changes in absorbance from this, from the absorbance 
changes of the enzyme run. This w ould greatly add to the complexity of 
the assay and introduce a new possible source of error. Problems may also 
be encountered when measuring concentration of carnitine in tissues such 
as liver which have a high thiol content. The question of w hy TASC 
values were below those obtained for FC rem ained unansw ered. The 
m ethod was considered unsuitable for the purpose required. It was 
decided to evaluate an alternative m ethod and test its suitability for 
determination of FC and TASC in samples of blood, urine and tissue.
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Table 2.6 Absorbance Changes and Final Concentrations of 'Carnitine* 
O btained using L-Camitine Standard (100|iM), in  W ater and 4% A lbum in 
Solution and A lbum in Alone.
Sam ple Change In Absorbance ’Carnitine’ Concentration
Arm Obtained |im ol/L
lOOjiM L-carnitine in
water. No pre-treatment 0.021 101.87
lOOfiM L-carnitine in 
water treated as an
FC sample 0.018 88.60
lOOp-M L-carnitine in 
water treated as a
TASC sample 0.027 102.90
lOOpM L-carnitine in 
4% albumin treated as
FC sample 0.024 124.90
lOOfiM L-carnitine in 
4% albumin treated as
TASC sample 0.041 182.60
4% albumin solution
treated as TASC sample 0.013 61.80
FC = Free Carnitine
TASC = Total Acid Soluble Carnitine
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2.3 Radioenzyme Assay for the Determ ination of L-Camitine in 
Biological Samples
A radioenzym e m ethod based upon that of Cederblad and Lindstedt (1972) 
was evaluated. Modifications of this original m ethod included the use of 
DTNB to inhibit the reverse reaction (Bohmer, Rydning and Solberg, 
1974), the use of MOPS buffer (3-[N-morpholine] propanesulphonic acid) 
(Brass and Hoppel, 1978), and the use of an ion exchange resin slurry
(M % arry and Foster, 1976).
Reaction Principle
CAT
L-Carnitine + ^^C-Acetyl CoA — ^^C-Acetylcarnitine + CoA 
CoA + DTNB — >  Thiobenzoic acid
Incubation of carnitine w ith ^^C-acetyl CoA and CAT yields labelled acetyl­
carnitine. The reverse reaction is inhibited by the addition of DTNB. The 
acetylcarnitine formed is separated from the unreacted acetyl CoA by the 
use of an ion exchange resin. The radioactivity of the resulting effluent is 
counted.
Materials and Reagents
^^C Acetyl CoA 2-10 pci (222 M bq/m m ol) (Amersham
International). Dilute to 1.1m w ith  distilled water. 
Store at -18°C.
Acetyl CoA (Sigma Laboratories) lOmg in 2.3ml distilled water.
Store at -18°C.
MOPS Buffer 0.2M (Sigma Laboratories), 4.19g in 100ml distilled
water. Store at 4°C.
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EDTA (ethylenediaminetetra - acetic add ) 5m m ol/L  (BDH
Laboratories), 46mg in 25ml 0.2M MOPS. Store at 
4°C.
DTNB (5, 5' - dithiobis - (2 - nitrobenzoic acid) (Sigma
Laboratories ) 6 .1mg in 5ml MOPS buffer.
CAT (Carnitine acetyltransferase) EC 2.3.1.7. (Sigma
Laboratories), 118 u n i ts /m g  p ro te in . 5 m g 
pro tein /m l from pigeon breast muscle, crystalline 
suspension in 2.9M (NH4)2 SO4 solution.
Ion Exchange Resin Dowex 2 x 8-200. dry mesh 100-200 strongly basic
anion exchange resin 1:5 volume: volum e resin in 
water.
Phosphate Buffer 0.25M. 0.25M solutions of di-potassium  hydrogen
o rth o p h o sp h a te  an d  p o tass iu m  d i-h y d ro g en  
orthophosphate are mixed in a ratio of 5:1 to obtain 
a pH  of 7.5.
Liquid Scintillant Optiphase 'safe'. (ESA chemicals, LKB Scintillation
Products).
L-Carnitine (Sigma Laboratories).
Potassium Hydroxide IM.
Hydrochloric ad d  1.25M.
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Reagent M ix ture  (for 10 samples).
1ml MOPS/EDTA 
lOpl C Acetyl CoA
27pl Acetyl CoA 
lOpl CAT 
lOOpl DTNB
Assay Procedure
1. Add 100 pi reagent to 50pl neutral sample extract
2. Mix and incubate, at 37°C for 30 minutes
3. A dd 1ml resin slurry
4. Mix 4 times in 10 m inutes
5. Centrifuge tubes 3 minutes
6 . Remove 0.65ml supernatant into scintillation vial
7. A dd 4ml Liquid scintillant
8 . Count radioactivity for 5 minutes
The sample and reagent are incubated together for 30 m inutes to allow all 
carnitine present to be converted to C acetylcarnitine. A ddition of the 
resin slurry and thorough mixing removes all the unreacted acetyl CoA. 
The resin is rem oved by centrifugation and radioactivity of the 
supernatant is counted. A range of working standards from 0 to 50pM are 
included in each run. A standard curve of CPM (counts per m inute) 
against concentration of standards is calculated from which carnitine 
concentrations of the samples are determined.
Linearity
Linearity was tested using a range of carnitine standards 0-50pM in 
distilled water, (since concentrations found in serum  and urine of healthy 
individuals would fall into this assay range). Figure 2.1 (page 38) indicates 
that the assay was linear in this region.
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Figure 2.1 The Radioenzyme Assay of L-Camitine: Linearity of the
Assay Using a Series of L-Camitine Standards (0-50 p.mol/L). 
Concentration Against Counts Per M inute (CPM).
FIGURE 2.1
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Carnitine standard pmol/L.
Within and Between Run Reproducibility
Precision tests were carried out using a range of L-camitine standards (in 
distilled water) from 5 to 50piM. Five replicates of each w ere m easured on 
five consecutive runs. The m ean values obtained for CPM of each 
standard are presented in table 2.7 (page 39).
Both w ithin and between assay precision were excellent. The coefficient of 
variation for w ithin run  assay precision ranged from 3.4% to 6.2%. The 
coefficient of variation for between run  assay precision ranged from  4.2% 
to 7.6%.
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Table 2.7 W ithin and Between Run R eproducibility  of Radioenzym e 
M ethod U sing C arnitine S tandards 5-50^iM. M ean Values (CPM) for 
counts per m inute (± sd) of 5 Determ inations and Coefficient of V ariation 
(CV).
STANDARD W ithin Run Values Between Run Values
p m ol/L mean (± sd) CV% mean (± sd) CV%
5 245.6 (15.2) 6.2 229 (17.4) 7.6
10 507.6 (28.1) 5.5 520 31.0) 6.0
15 702.4 (24.1) 3.4 698 (29.2) 4.2
20 985.2(40.5) 4.1 997(51.0) 5.1
25 1300 (72.6) 5.6 1286 (92.6) 7.2
50 2647(131.6) 5.0 2543 (156.8) 6.2
Pre-Treatment of Serum Samples for the Radioenzyme Assay
Prior to the analysis by the radioenzym e assay, serum  sam ples w ere 
deproteinised using PCA. For analysis of TASC, samples were pretreated 
by alkali hydrolysis. Figure 2.2 (page 40) sum m arises the sam ple 
preparation procedure.
Tests of Reproducibility using Serum from Healthy Adults
Five serum  samples were obtained from healthy adults. Samples were 
taken through the pre-treatment procedure outlined in figure 2.2  (page 40). 
Each sample was m easured five times w ithin the same run  and in five 
separate runs to determine within and between run  precision respectively. 
Results of these analyses are presented in table 2.8 (page 41). Within assay 
reproducibility was good, the coefficient of variation ranged from 3 .5 % to 
6.0%. The coefficient of variation for between assay reproducibility ranged 
from 4.3% to 8.7%.
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Figure 2.2 Pre-treatment of Serum Samples for the Radioenzyme Assay
120|il supernatant
Add 50pl 0.25M 
phosphate bufferi
Neutralise with 
approximately 30pl 
IMKOH
200|il serum  + lOOjil IM PCAi
MixI
Centrifuge 10 m inutes in 
microcentrifuge, high speed
Chili 30 m inutes
i
Free carnitine analysis
Dilution factor = 2.5
lOOpl supernatant 
1
A dd 50pl 0.25M 
phosphate buffer
i
A dd excess alkali 
60pl IMKOH
Stand at room  
tem perature 
for 30 m inutesi
N eutralise w ith 
approximately 8.5pil 
1.25M HCli
Chill 30 m inutesi
Total acid soluble 
carnitine analysis
Dilution factor = 3.3
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Table 2.8 W ithin and Between Assay Precision of FC (Free Carnitine) 
and TASC (total Acid Soluble Carnitine), Determ ination in  Serum From 4 
H ealthy A dults M ean Values (± sd) pmol/L and Coefficient of Variation 
(CV).
Sam ple W ithin Assay Values Between Assay Values
pm ol/L pm ol/L
mean (± sd) CV% mean (± sd) CV%
A 32.5 (1.9) 5.9 31.5 (1.8) 5.6
B 35.7 (1.3) 3.7 35.8 (1.5) 4.3
C 33.8 (1.2) 3.5 34.1 (2.6) 7.7
D 38.4 (2.2) 6.0 36.5 (3.2) 8.7
Analytical Recovery
Analytical recovery was determ ined by spiking serum  sam ples w ith  L- 
camitine prior to analysis. A serum sample was assayed w ith and without 
the addition of 5|xl of lOOOjiM L-carnitine. The mean FC concentration of 
the neat serum  sam ple w as 37.3 (± 6.3) pm ol/L . The calculated 
concentration of carnitine in the spiked samples was 124.8 pm ol/L . The 
m ean value obtained for the spiked sam ple was 119 (± 7.2) pm ol/L . 
Analytical recovery was therefore 95%. Calculations are presented on the 
following page.
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Carnitine concentration in spiked sample =
(Sample Volume x Sample Concentration) + (Volume added x Concentration added)
Total Volume
(50 x37.3)+ (5 X 1000)
55 = 124.8
Analytical Value = 119 (± 7.2) pm ol/L
Theoretical Value = 124.8 pm ol/L
119 X 100 = 95%
124.8
Determination of Free and Total Acid Soluble Carnitine in Urine
Sample Preparation
Samples were pre-treated w ith PCA to rem ove traces of pro tein  and 
interférants. Aliquots for analysis of FC were neutralised. Aliquots for 
analysis of TASC underw ent alkali hydrolysis of esters. The sam ple 
preparation procedure is outlined in figure 2.3 (page 43).
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Figure 2.3 Pre-Treatment of Urine Samples for the Radioenzyme Assay
200}!I Urine + 1 00 i^l IM PCA
Mix
Centrifuge 10 m inutes
Supernatant
120^11 100 i^l
Add 50pl 0.25M 
phosphate buffer
1
N eutralise w ith 
approximately 30|il 
IM K O Hi
Chill 30 m inutes
Assay of Free Carnitine
Add 50pl 
phosphate buffer
V
Add excess alkali, 90|il 
IM  KOH. Stand at room 
tem perature for 1 hour.
N eutralise w ith 
approximately 60jil 
1.25M HCl
V
Chill 30 m inutes
Assay of Total A dd  
Soluble Carnitine
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It was found that urine samples required more alkali, and a longer period 
of hydrolysis com pared to serum  sam ples in order for esters to be 
hydrolysed. Concentrations of TASC obtained after a 90 m inute hydrolysis 
w ere no t significantly different to those obtained after 60 m inutes 
hydrolysis.
Within and Between Assay Reproducibility for Analysis o f Urine 
Carnitine
W hen initial analysis of PCA treated ’neat' urine was carried out, some 
values obtained were above the assay range. It would have been possible 
to extend the linear range of the assay by increasing the acetyl Co A content 
of the reagent m ixture, however, this w ould have m ade the assay more 
costly. To avoid the need for extending the linear range of the assay above 
the 50}iM standard, urine samples were diluted so that the values obtained 
fell w ithin the linear range of the assay. Urine sam ples from  healthy 
individuals (unless obviously dilute) were diluted 1:5 w ith distilled water. 
Samples of neat and diluted urine w ere assayed sim ultaneously. As 
urinary carnitine content was raised in patient samples (see Chapter 3 
figure 3.2, page 98 and Chapter 4 table 4.5, page 171), a 1:10 dilution was 
sometimes necessary. For patients samples neat urine and a 1:10 dilution 
were assayed simultaneously.
W ithin and betw een assay reproducibility  for u rine carnitine are 
presented in table 2.9 (page 45). The coefficient of variation for w ithin 
assay precision was 3.7%, that of betw een assay precision w as 5.4%, 
indicating that the assay was adequately reproducible.
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Table 2.9 W ithin and Between Assay Reproducibility for Analysis of 
Urine Carnitine from 2 H ealthy A dults M ean (± sd) Concentration 
(jimol/L) and 24 H our Urinary Carnitine Excretion, of Free Carnitine (FC) 
and Total Acid Soluble Carnitine (TASC).
Sample W ithin Assay Values Between Assay Values
m ean (± sd) CV% m ean (± sd) CV%
A;
(1813ml urine volume)
FC
pm ol/L  46.4(1.5) 3.2 47.8(2.5) 5.2
|im ol/24  hours 84.2 86.7
TASC
pm ol/L  114.3 (2.8) 2.5 114.8 (6.1) 5.2
nm ol/24  hours 207.2 208.1
B:
(1110ml urine volume)
FC
pm ol/L  97.2 (4.8) 5.0 96.2 (6 .8) 5.4
nm ol/24  hours 107.9 106.8
TASC
nm ol/L  148.8 (6.2) 4.2 154 (9.1) 5.9
nm ol/24  hours 165.2 171.5
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Determination of Tissue Carnitine Concentrations
To m easure tissue carnitine, neutral extracts of tissues m ust be prepared. 
Carnitine m ay be extracted from the tissue by hom ogenisation in either 
chloroform -m ethane, absolute ethanol or perchloric acid. M ethods 
involving the use of organic solvents require evaporation of solvent prior 
to analysis. PCA extraction requires neutralisation w ith  potassium  
hydroxide. It was decided to extract using an organic solvent to avoid pH  
disturbances and problems in neutralisation. Extraction and pre-treatm ent 
methods for tissue samples are outlined in figure 2.4. (page 47).
The tissue extraction procedure was based upon the m ethod of Brooks, 
Bahl and Bressler (1985). lOOmg of tissue were weighed and homogenised 
in 4m l of absolu te e thanol using  a Potter-E lvenjem  h an d  held  
hom ogeniser. The homogenate was allowed to stand for 10 m inutes to 
ensure complete extraction. Samples were centrifuged to remove debris. 
Two mis of supernatant were dried  under nitrogen and subsequently 
reconstituted in 1ml 0.25M phosphate buffer. For the analysis of FC a 
further 1 in 2 dilution w ith buffer was carried out. For TASC analysis, 
esters were hydrolysed by the addition of IM  KOH. Hydrolysis took place 
over a two hour period at room tem perature. Sample were neutralised 
with 1.25M Hcl and chilled to precipitate the salt formed by neutralisation.
Analysis of Rat Liver Carnitine Concentration: Within and Between 
Assay Reproducibility
W ithin and between assay reproducibility of the tissue m ethod were tested 
by replicate analysis of liver carnitine of a healthy rat. Replicate analysis of 
five samples from this liver measured in the same run  gave a mean value 
of 430 (± 19) n m o l/g  wet weight, and a coefficient of variation of 4.6%. 
Between assay reproducibility was tested by replicate analysis in  five 
separate runs the mean value obtained for liver carnitine was 344.8 (± 29) 
nm o l/g  w et weight and the coefficient of variation was 8.5%.
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Figure 2.4 O utline of Extraction and Pre-treatment Procedure for the 
Analysis of Tissue Carnitine.
lOOmg tissue + 4ml absolute ethanol
„ iHomogenise.I
Stand 10 m inutes
i
Centrifuge 3000 RPM 5 minutes
i
Dry 2ml supernatant under N 2
i
Reconstitute into 1ml 0.25M phosphate buffer
/  \
Mix 0.5ml w ith To lOOpl add 50pl
0.5ml 0.25 M 0.25M phosphate
phosphate buffer buffer
Assay of Free Carnitine
A dd30pl IM K O H
I
Stand at room  
tem perature for 2  
hours
1
N eutralise w ith 13.5pl 
(approximately)
1.25M HClI
Chill 30 m inutesI
Assay of Total A dd  
Soluble Carnitine
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Example o f Calculation to Express Results as nmol Carnitine per Gram 
Wet Weight Liver
lOOmg liver in 4ml ethanol = 25g tissue/L
2ml supernatant = 25g/L
1ml phosphate buffer = 50g/L
Free carnitine 0.5mls extract + 0.5mls buffer = 25g/L
TASC lOOpl extract + 30pl KOH + 70pl buffer = 25g/L
Result obtained in pmole carnitine/L  = the num ber of pmoles
of carnitine in 25g liver
Divide by 25 = Number of pmoles in Ig  liver 
X by 1000 = Number of nmoles in 1 g liver 
(ie. multiply by a factor of 40)
Analytical Recovery
lOOg of tissue were homogenated in 4ml ethanol.
lOOpl of lOOOpM/L carnitine were added to half the tissue homogenate. 
Spiked and non-spiked aliquots of hom ogenate w ent through the usual 
analysis procedure. Analytical recovery was 103.6%. Details of results are 
presented in table 2.10 (page 49). Calculation of analytical recovery is 
presented on page 49.
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Table 2.10 Radioactivity (CPM) and Concentration of Carnitine 
O btained Before and After Correction for D ilution in  Rat Liveiv W ith and 
W ithout the A ddition of L-Camitine.
W ithout Added + lOOjil, IGOOjiM
Carnitine L-Carnitine
Counts per m inute 430 1189
pm ol/L  8.4 25.8
X factor of 40 336 1368
Calculation of Analytical Recovery 
Concentration of
Spiked Sample = /Sam ple size x \  Vol of carnitine added x
concentration of sample/  I concentration of carnitine
\added
TOTAL VOLUME
(400uL x.8.8 um ol/L) + (lOOul x lOOOuM) = 33pm ol/L  
4100
concentration of spiked sample in theory is
33|im ol/L (or x 40 = 1320 nm ol/g  wet weight)
.*. % recovery = 1368 x 100 = 103.6%
1320
Data From Normal Healthy Adults
Table 2.11 (page 50 ) presents the concentrations of serum carnitine 
fractions in ten, non-fasting healthy adults. There were no sex differences 
in serum  carnitine concentrations. Table 2.12 (page 51) presents values for 
24 hour urinary excretion of carnitine fractions in 30 healthy adults.
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Table 2.11. Concentrations of Serum Carnitine Fractions ( pmol/L) in  
Healthy Adults
( n=10).
Subject TASC FC SCAC SEX
1 31.5 26.3 5.2 M
2 35.8 28.6 7.2 M
3 34.4 24.0 10.4 F
4 36.5 34.2 2.3 F
5 44.1 38.5 5.6 M
6 53.1 41.7 11.4 F
7 54.5 48.5 6.0 F
8 53.8 45.2 8.6 F
9 56.0 54.7 1.3 M
10 60.2 48.0 12.2 M
M edian 48.6 40.1 6.6
(Range) (31.5-60.2) (24.0-54.7) (1.3-12.2)
TASC = Total acid soluble camitine.
FC = Free camitine,
SCAC = Short chain acyl camitine.
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Table 2.12. Urinary Excretion of Cam itine Fractions (pmol/ 24 Hours) in  
Healthy Female Adults (n=30).
Subject TASC FC SCAC
1 77.7 59.2 18.5
2 75.8 34.5 41.3
3 81.8 31.8 50.0
4 54.6 9.5 45.1
5 211.4 58.2 163.2
6 93.8 60.5 33.3
7 112.2 66.9 45.3
8 80.6 27.9 52.7
9 53.9 13.1 40.2
10 50.5 16.7 33.8
11 268.4 154.7 133.7
12 105.7 56.8 48.9
13 218.4 75.2 143.2
14 78.1 20.1 58.0
15 124.8 45.8 79.0
16 75.8 6.8 69.0
17 109.4 44.9 64.5
18 57.5 34.5 23.0
19 100.8 70.7 30.1
20 138.8 137.1 1.7
21 106.5 55.8 50.7
22 127.7 70.6 57.1
23 137.4 98.8 38.6
24 158.7 139.1 19.6
25 147.5 111.8 35.7
26 56.0 14.9 41.1
27 117.2 11.8 105.4
28 88.0 51.6 36.9
29 42.0 21.7 20.3
30 115.9 90.3 78.4
M edian 102.6 53.7 53.7
Range (42.0-268.4) (6.8-154.7) (1.7-133.7)
TASC = Total acid soluble camitine.
FC = Free carnitine.
SCAC = Short chain acyl camitine.
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2.4 M easurement of Non-Esterified Fatty Acids (NEFA), using a 
WAKO NEFA-C-KIT
Introduction
Early m ethodology for the m easurem ent of NEFA in serum  and plasm a 
involved titration of NEFA w ith alkali to an acid base indicator point 
(Dole and Meinertz, 1960; Friedberg e ta l., 1960). The titrim etric m ethod of 
Dole involved a lengthy extraction procedure, to rem ove phospholipids 
and other possible interférants, using isopropane-heptane-sulphuric acid 
m ixture. Titration m ethods were difficult to perform  w ith small am ounts 
of sam ple and relied on subjective evaluation of indicator toning, and so 
were not highly sensitive. They also lacked accuracy and precision.
In 1964, Duncombe described a colorimetric m ethod for the determ ination 
of NEFA in serum. This involved transform ation of fatty acids to their 
copper soaps and subsequent extraction into organic solvents. The organic 
phase was removed and copper was colorimetrically m easured. This 
m ethod was not entirely sensitive as the copper-nitrate-triethanolam ine 
reagent used was unstable and blank readings were relatively high and 
unstable. M any modifications of Duncombe's original m ethod exist, too 
num erous to m ention them  all. Mikac-Devic, Stanovic and Boskovic 
(1973) increased the stability of the reagent to obtain lower stable blank 
readings and increased sensitivity by using separate solutions of 
copper nitrate and triethanolam ine and m ixing them  im m ediately prior 
to analysis. They also removed interfering phospholipids by the lise of 
sodium  chloride. Previous investigators had used phosphate buffer 
(Itaya and Ui, 1965), Silicic add , (Regouw et al.. 1971; Laurell and 
Tibbling, 1967) and chromatography (Regouw et al.. 1971) to remove 
phospholipids. Laurell and Tibbling (1967) found removal of 
phospholipid with phosphate buffer was not satisfactory. However, 
the silicic acid m ethod they used also rem oved NEFA yielding 
low values. Chrom atographic m ethods for the rem oval of 
phospholipids were tim e consuming. Limitations of the original 
m ethod included bilirubin interference and aqueous phase
52
contamination when m easuring small quantities. Novak (1965) overcame 
these limitations by using cobalt in the place of copper. NEFA form ed
soaps w ith cobalt that gave a colour reaction with a-nitroso-fi-naphthol.
Novak (1965) also used a solvent to extract the colour com pound which 
was less dense than w ater and thereby lim ited the problem  of aqueous 
phase contamination.
Penelli (1973), combined the extraction m ethod of Dole and M einertz 
(1960) with the colormetric m ethod of Duncombe (1964). The colorimetric 
m ethod of Mackenzi et a l. (1967) involved complexing NEFA w ith  the 
uranyl ion and the basic dye rhodamine to form a coloured product which 
was determ ined spectrophotometrically. These investigators used zeolite 
to remove phospholipids. Reproducibility, accuracy and sensitivity were 
comparable to the titration m ethod bu t they claimed the assay to be 
simpler.
The NEFA colorimetric method was further simplified by the introduction 
of autom ation. C arruthers and Young (1973) described an autom ated 
fluorimetric method in which a Dole extract of plasma was mixed with an 
alcoholic so lu tion  of sodium  fluoresceinate  and  the  decrease in 
fluorescence was recorded in an auto analyser and related to the original 
fatty acid concentration. A utom ation im proved assay precision and 
sensitivity. The m ain d isadvantage of this m ethod  and  all those 
m entioned was the lengthy extraction procedure, which also requires a 
larger original sample. Wako Chemicals have developed an enzym atic 
colorimetric m ethod for the determ ination of NEFA concentrations in 
serum, which requires no extraction or pretreatm ent of sam ple (Shimizu 
et al., 1979). It claims to be accurate, precise, simple and fast. It has also 
been autom ated for use w ith the Cobas-Bio centrifugal analyser. This 
m ethod was evaluated and subsequently used for determ ination of NEFA 
in the clinical and animal experiments.
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Reaction Principle
ACS
RCOOH + ATP + CoA >Acyl-CoA + AMP + PP^ (NEFA)
ACOD
ACYL -  CoA + O2  > 2 ,3,-Trans-Enoyl-CoA + H2O2
PEROXIDASE
4-Aminoantipyrine + MEHA + 2H 2O2 > P urp le  quinoneim ine dye +
4H2O
(RCOOH = NEFA, ATP = adenosine triphosphate, AMP = adenosine monophosphate, 
CoA=Coenz:yme A, PP^ =pyrophosphate.
MEHA = 3 m ethyl-N-ethyl-N-(fi-hydroxyethyl)-aniline. ACS= Acyl-CoA synthetase, 
ACOD=Acyl-CoA oxidase).
The enzymatic m ethod relies upon the acylation of CoA by the fatty acids 
in the presence of acyl-CoA synthetase. The acyl-CoA produced is oxidised 
by the presence of acyl-CoA oxidase, with the generation of hydrogen 
peroxide. In the presence of peroxidase and hydrogen peroxide, oxidative 
condensation between MEHA and 4-amino-antipyrine occurs to form a 
purple adduct. The intensity of the colour purple is stoichiometric to the 
original NEFA concentration, which can be m easured colorimetrically at 
550nm. The chemical reactions are sum m arised above.
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Chemical Reagents
Reagent A
Acyl - CoA synthetase 
Ascorbate oxidase 
CoA 
ATP
4-am inoantipyrine
0.3 units/m l 
1.5 units/m l 
0.7m g/m l 
3.0m g/m l 
0.3m g/m l
Solvent A
Phosphate buffer, PH 6.9 
M agnesium  chloride
0.05M
3mM
Mix one vial of reagent A w ith 10ml solvent A. Store at 4°C for up  to five 
days. This is the assay 'reagent*
Reagent B
Acyl-CoA oxidase
Peroxidase
MEHA
6.6  un its /m l 
7.5 un its /m l 
0.4m g/m l
Solvent B
phenoxyethanol 0.3% (V/V)
Mix one vial of reagent B w ith 20ml of solvent B. Store at 4°C for up  to 
five days. This is the assay 'start reagent'.
No extraction or pre-treatment of sample is required.
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Automated Assay  -  Cobas -  Bio Programme
U nits
Calculation factor 
Standard 1 
Standard 2  
Standard 3 
Lim it
Temperature (°C)
Type of analysis 
W avelength (nm)
Sample Volume (|il)
D iluent volume (|il)
Reagent Volume (fxl) 
Incubation time (seconds) 
Start reagent Volume (|il) 
Time of first reading (seconds) 
Time Interval (seconds) 
N um ber of readings 
Blanking mode 
Printout m ode
m m ol/L
0
1.0
1.0
1.0
6.0
37.0
6
550
5
5
100
900
75
0.5
60
11
1
1
(3)
Reproducibility
W ithin and between assay precision were evaluated using a serum  sample 
from five healthy adults following a 12 hour fast. Five aliquots of each 
sam ple w ere analysed in the sam e run  to determ ine w ith in  assay 
precision. A liquots from  each sam ple w ere also m easured  in  five 
consecutive runs to determine between run reproducibility. W ithin run  
precision was excellent, the coefficient of variation ranged from 2 % to 
5.1%. Between run  precision was also very good, the coefficient of 
variation ranging from 3.6% to 8.5%. The values obtained fell w ithin the 
norm al range for serum  NEFA of 0.3 - 1.0 m m ol/L , quoted  by the 
manufacturers. Data are presented in table 2.13 (page 57).
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Table 2.13 W ithin and Between Assay Reproducibility of
Serum NEFA Measurements on 5 Serum Samples From Healthy Fasted 
Adult Subjects. Mean Values (± sd) mmol/L and Coefficients of Variation 
(CV).
Sam ple W ithin assay values Between assay values
mean (± sd) CV mean (± sd) CV
A 0.32 (0.02) 5.1% 0.34 (0.03) 8.5%
B 0.66 (0 .02) 2 .6 % 0.67 (0.02) 3.6%
C 0.51(0.01) 2 .0 % 0.52 (0.02) 4.4%
D 0.61 (0 .01) 2 .2 % 0.63 (0.04) 5.6%
E 0.40 (0.02) 4.1% 0.42 (0.03) 6 .6 %
Analytical Recovery
A  series of recovery determinations were carried out by m easuring five 
aliquots of a serum sample with the addition of 20|il of 1.0 mM oleic acid 
and five identical aliquots, w ithout oleic add . Analytical recovery ranged 
from 101 to 109%. This overestimation m ay have been due to possible 
imprecise pippeting of the small volume of oleic acid. Data on recovery 
experiments are presented in table 2.14.
Table 2.14 Analytical Recovery of NEFA Assay. Human Serum 
Measured With and Without the Addition of 20pl Immol/L Oleic Acid. 
NEFA Concentrations Obtained, mmol/L and % Recoveries of Five 
Determinations.
NEFA Concentration 
w ithout oleic acid
0.50
0.52
0.52
0.51
0.51
NEFA concentration 
with oleic a d d
0.63
0.67
0.68
0.63
0.67
% recovery
103
107
109
101
101
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2.5 Determination of Glucose by an Automatic Analyser
The automated glucose assay described by Stevens (1971) was used for the 
determ ination of glucose in plasm a of rats. H um an sam ples were 
determ ined in a hospital laboratory by a m ethod outlined in section 2.7.3. 
page 67. The autom ated assay employs the use of a Beckman Instrum ents 
glucose analyser (Glucose Analyser 2), which is an instrum ent specifically 
designed to measure glucose in serum or plasma.
Reaction Principle
The m ethod is based on the principle that when glucose is oxidised by 
glucose oxidase, the rate of oxygen utilisation by an oxygen electrode is 
proportional to the glucose concentration. The peroxide form ed m ust be 
removed by a pathw ay which does not lead back to oxygen. The addition 
of ethanol to the reagent destroys peroxide, via a catalase reaction, w ith the 
formation of acetaldelyde and water. To ensure complete rem oval of 
peroxide, iodide and molybdate are added which results in the rem oval of 
peroxide and formation of iodine and water. The reaction equations are 
sum m arised below.
glucose oxidase 
Glucose + O2 -------------> Gluconolactone + H 2 O2
catalase
H 2O2 + C2 H5O H  > CH3CHO + 2H2O
molybdate 
H 2O2 + 2H+ + 21--------->%2 + 2H 2O
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Materials and Reagents
Beckman glucose analyser 2 
Beckman Blue tip pipettor
Beckman glucose analyser reagent (enzyme reagent)
Beckman aqueous glucose standard - D glucose 8.3m m ol/L 0.2% (W /V). 
Benzoic a d d  preservative.
Enzyme Reagent
1401.U./ml glucose oxidase
5% denatured ethanol
10~2 molar potassium  iodide
Catalase
Molybdate
Phosphate buffer
Store at 2-8°C. Pre-warm to 34°C before use.
Operating Procedure
The reagent bottle is connected to the analyser which pum ps an exact 
volum e into a reaction cup which contains the oxygen electrode. The 
oxygen setting is set at 23.5. A precise volume of sample is injected into 
the reaction cup using a blue tip pipette and a 'fast forward five technique'. 
As glucose is utilised, a digital meter provides a direct readout of glucose 
concentration in m m ol/L . Waste is drained into a waste bottle. Prior to 
sam ple analysis, the m achine is calibrated w ith  an aqueous glucose 
standard. Calibration is repeated once every 10 samples, during a series of 
analyses, adjusting the oxygen supply if necessary.
As the m ethod does not rely on optical properties of a solution, uraemic, 
icteric, tu rb id  and haem olysed sam ples can be determ ined w ithou t 
interferences. This is im portant for ra t blood plasm a w hich is often
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haemolysed. The m ethod is simple and quick and requires only lOpl of 
sample. As the instrument was used routinely within the laboratory a full 
evaluation  of the m ethod was considered unnecessary. H ow ever, 
prev ious evaluation  has show n the coefficient of varia tion  of 10 
consecutive samples to be 1.0%.
2.6 A nthropom etric M ethods
A nthropom etric  m easurem ents w ere used  to  assess and  m onito r 
nutritional status and to estimate changes in body components in terms of 
fat and protein.
2.6.1 Body Weight
In the clinical studies of the present research, patients were weighed in a 
sitting scales and a note of clothing w orn was m ade so that this could 
rem ain constant for subsequent m easurem ents. Absolute w eight was 
compared to ideal weight for height tables (M etropolitan Life Insurance 
Tables, 1960) to obtain percentage ideal weight. Weight was also compared 
to previous weight, obtained from clinical records or recall. The latter is 
subject to error and was only used when a previous weight could not be 
found. W eight was m onitored betw een adm ission and discharge in 
clinical studies, in order for weight changes during hospitalisation to be 
compared between various patient groups.
The M etropolitan Life Insurance tables for ideal w eight were compiled 
from an American population who were applying for life insurance. The 
ideal weight range for a particular height is based upon the weight for this 
given height associated with the lowest mortality. The use of reference 
tables has been criticised as they do not allow for the wide spread variation 
w hich occurs w ithin norm al individuals, different races and different 
geological areas. The use of percentage ’ideal’ w eight as an objective 
criteria  in  assessing nu tritional sta tu s in clinical settings is no t
recom m ended (Russel, M % andy and Jèllitte, 1984). In the present study
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percentage ideal weight was used as part of a m ultivariable nutritional 
assessment, not to categorise patients bu t in order to carry out relative 
comparison between different groups of patients.
2.6.2 Triceps Skinfold Thickness
W eight alone does not distinguish betw een relative contributions and 
losses of fat and protein, therefore triceps skinfold thickness (TSF) was 
used to assess and monitor adiposity. TSF is an index of subcutaneous fat. 
A lthough fat is largely subcutaneous, splanchnic organs also contain 
considerable quantities. Total body fat is difficult to measure directly so it 
has to be assumed that changes in subcutaneous fat represent changes in 
total body fat. It has not been clearly defined as to w hat extent and under 
w hat conditions the relationship between subcutaneous fat and total body 
fat holds true. Studies in which total body fat has been correlated with 
subcutaneous fat have obtained correlation coefficients ranging from 0.4  to 
0.9 (Brozek and Keys, 1951; Brozek and Mori, 1958; Young et al., 1963; 
Durnin and Womersley, 1974). In the current research subcutaneous fat 
was estim ated by m easurem ent of TSF using Holtain skinfold calipers. 
The measurement is taken at the m id point of the upper arm  between the 
acromial process and the process of the ulna. The skinfold is pinched 
betw een the thum b and forefinger p inching aw ay from  underly ing  
muscle. The calipers are applied below the fingers so the pressure applied 
to the point of measurement is from the calipers and not the fingers. The 
callipers are designed to exert a constant pressure over a wide range of jaw 
openings, however, measurements are less accurate when m easurem ent is 
above 20mm (Tanner, 1959). The m ethod is therefore less accurate for 
obese people in which it is also difficult to pinch the skinfold accurately. 
In the present research all measurements were carried out by one observer. 
Hull et a l. (1980) found that when measurements were m ade by different 
observers on different days a coefficient of variation of 17% was obtained. 
Reproducibility is improved by using the same observer. Edwards et a l. 
(1955), using the same observer, obtained coefficients of variation ranging 
from 4.3% to 8.5%. Variability in skin fold compressibility introduces a
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source of erro r in to  the m easurem ent. It has been found  that 
compressibility decreases w ith age and that female skin folds are more 
compressible (Brozek and Kinzey, 1960).
Other m ethods for measuring subcutaneous fat include radiographic and 
ultrasonic methods. The shadow of skin and subcutaneous fat can easily 
be distinguished from underlying m uscle on an X-ray (Tanner, 1965). 
U ltrasound relies in reflection of soundwaves from various tissue plane 
boundaries. It has been claimed that skinfold thickness m easurem ents 
correlate slightly better with total body fat than ultrasonic or radiographic 
m easurem ents, a lthough the la tte r tw o m ethods p rov ide  a better 
estimation of subcutaneous fat (Himes, 1980). The overall advantages of 
skinfold calipers are that they are cheap, portable and with a little practice 
measurements which are adequately reproducible may be obtained.
2.6.3 M id-Upper Arm Muscle Circumference
M id-upper arm  muscle circumference (MUAMC) was used as an index of, 
and to monitor changes in, lean tissue following surgery and to compare 
relative losses betw een different groups of patients. MUAMC was 
calculated from measurements of TSF and m id-upper arm  circumference 
(MUAC), by the method described by Jelliffe (1966).
MUAMC (cm) = MUAC (cm) - 71 x TSF (mm)
The calculation assumes that the arm and muscle are circular and that the 
bone area is negligible, and these assumption introduce a degree of error. 
It is very im portant that serial m easurem ents are taken by the same 
observer at an identical site. The point of the two measurements m ust not 
vary, as even slight displacem ent from the m id point m ay significantly 
effect serial measurements. W hen different observers have been used, a 
cumulative error (TSF and MUAC) of 33% has been obtained (Mullen et 
al., 1979). This was reduced to 10% by using the same observer. In the 
present studies all measurements were carried out by a single observer.
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2.7 M ethods Carried out in Hospital Laboratories and by O ther 
M embers of the Research Team
The methods described below are well established methods used routinely 
within the hospital laboratories.
2.7.1 Spectrophotometric M ethod for the Determ ination of 
C-hydroxybutyrate and Acetoacetate in Plasma
Plasm a ketone bodies (C-hydroxybutyrate and  aceotoacetate) w ere 
de term ined  by a colorim etric enzym ic m ethod using  an Encore 
Centrifugal Analyser. The m ethod was based on the catalytic action of C- 
hydroxybutyrate dehydrogenase (ECl.1.1.30)
pH  9.5
C-Hydroxybutyrate + NAD+ ^ Acetoacetate + NADH
pH 7.0
The above reaction is reversible, the direction of the equilibrium  is 
dependent upon  the pH  of the m edium . W hen C-hydroxybutyrate 
dehydrogenase is added to the sample in the presence of NAD+ at pH  9.5, 
the  am ount of N A D H  p roduced  is d irectly  p ropo rtiona l to  the 
concentration of C-hydroxybutyrate in  the  orig inal sam ple and  is 
m easured spectrophotometrically at 340 nm. Likewise when the enzyme 
is added to the sample in the presence of NADH at pH  7.0, the am ount of 
NADH utilised is directly proportional to the acetoacetate content of the 
original sample, and can be determined spectrophotometrically at 340nm 
by the decrease in absorbance.
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Chemicals and Reagents
a) C-hydroxybutyrate
0.1 m ol/L  tris buffer pH  9.5, 9.6ml
C-hydroxybutryate dehydrogenase 25mg/5ml 3ku /g , 0.2ml 
Ê-NAD+ 117mmol/L, 0.2ml
b) Acetoacetate
O.lmol/L phospate buffer pH  7.0, 9.2ml
fî-hydroxybutyrate dehydrogenase 25mg/5ml 3ku/g , 0.2ml 
NADH 9.0mmol/L, 0.2ml (made up  fresh)
The above reagent mixtures are stable for 6 hours at 4°C.
Standards:
lOm mol/L C-hdyroxybutyrate (monosodium salt), diluted w ith buffer to 
make working standards.
lOmmol acetoacetate (lithum salt), diluted with buffer to m ake working 
standards.
Encore Settings -  Reaction Procedure
Reagent volum e 200pl
Diluent volum e 40pl
Sample volum e 12pl
Assay type end point 
First reading 4 seconds 
Final reading 120 seconds 
W avelength 340nm 
Temperature 30°C
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The reaction was linear form 0.025 to 5.0 m m ol/L . The detection lim it was 
0.02 m m ol/L . For within batch precision tests carried out on plasm a from 
norm al adults, the coefficient of variation obtained was 3.6%. For between 
batch precision, the coefficient of variation was 9.1%. Mean analytical 
recovery was 99.0%. During the analysis of C-hydroxybutyrate, acetoacetate 
did not interfere w ith the assay up  to a concentration of 2.5 m m ol/L . 
Laboratory quality control was carried out using Test point 2 (Technicon 
Diagnostics) (T2) as an internal standard (IS). T2 + 20|il, lOm m ol/L C- 
hydroxybutyrate or acetoacetate formed a 'high' IS. T2 alone form ed a 
'low' IS.
2.7.2 Determ ination of Serum Glycerol Using a Randox Laboratories 
Glycerol Kit
Serum glycerol was determ ined by a spectrophotometric enzymic m ethod 
available in kit form, and adapted for use on the Encore Centrifugal 
Analyser.
Reaction Principle
glycerol kinase 
Glycerol + A T P  >  Glycerol 3 phosphate + ADP
glycerol phosphate oxidase
Glycerol - 3 - Phosphate + O2 -------------- ^  Dihydroxyacetone Phosphate
+  H 2 O 2
2H2O2 + 3, 5 Dichloro - 2 -Hydroxybenzene Sulphonic Acid
peroxidase
+ 4 - Amino Phenazone — —^  N- (4 - Antipyrl) - 3 - Chloro -
5- sulphonate- p  - benzoquineim ine
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Glycerol present in the sample undergoes phosphorylation in the presence 
of ATP and glycerol kinase to form glycerol - 3 - phosphate. Subsequent 
oxidation yields dihydroxyacetone phosphate and hydrogen peroxide. The 
hydrogen peroxide released reacts with 3, 5, dichloro - 2 - hydroxybenzene 
sulphoric acid and 4 - aminophenazone to form a colour product, N  - (4 - 
antipyrl) - 3 - chloro - 5 - sulphonate - p - benzoquineimine, which absorbs 
at a wavelength of 500nm.
Sample and reagent are incubated together for five m inutes at 37°C. 
Absorbance is read against a blank, within 30 minutes.
Reagent Composition
4 aminophenazone > 0.4 m m ol/L
3, 5 - dichloro - 2 - hydroxybenzene sulphonic a d d  1.5 m m ol/L
ATP 1.0 m m ol/L
Glycerol kinase > 0.4 U /m l
Glycerol - 3 - phosphate oxidase > 1.5 U /m l
Peroxidase > 0.5 U /m l
Pipes buffer 40 m m ol/L
Glycerol standard 2.29 m m ol/L. Dilute 1 in 10 for 'high' standard.
Dilute 1 in 30 for 'low' standard.
Normal Laboratory Reference Values:
Males 0.028 to 0.108 m m ol/L  
Females 0.036 to 0.124 m m ol/L
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2.7.3 M easurement of Plasma Glucose Using a YSI Model 23AM 
Glucose Analyser
The YSI glucose analyser is specifically designed for m easurem ent of 
glucose in serum  and plasma and whole blood. Glucose is oxidised via the 
glucose oxidase reaction to yield hydrogen peroxide (H2O2). The glucose 
analyser contains a probe which oxidises a constant proportion of the H2O2 
at an anode. The current created is directly proportional to the glucose 
concentration in the sample. The reaction is completed at a cathode, at 
which oxygen is reduced to water.
glucose oxidase 
Glucose + 0 2  ------- > Gluconic A dd  + H2O2
H 2O2  > 2H+ + O2 + 2e-
4H+ + O2  > 2 H 2O -  4e-
2.7.4 Im m unodiffusion Assay for the Determ ination of Retinol 
B inding Protein in  Serum
Determ ination of Retinol binding protein (RBP) was carried out using a 
single, radial im m unodiffusion m ethod. L-C Partigen Im m unodiffusion 
Plates were used (Behring), which contain an antibody specific to RBP.
20|il samples are pipetted into wells contained w ithin the agar gel. An 
imm unological reaction is allowed to occur over a period of tw o to three 
days. The immunological reaction results in the form ation of a radial 
precipitate, the diam eter of which is directly proportional to the 
concentration of RBP within the original sample. A series of standards are 
included, stock standard of 100 m g/1 is diluted with 0.9% saline to form a 
range of working standards form 6.25 to 50mg/L. The squares of the 
diameters are calculated and plotted against concentration to  form a 
standard curve from which concentrations of samples are determ ined.
Assay range 5 -8 2  m g/L.
Adult reference range 45 - 60mg/L.
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2.7.5 Im m unoturbi-dim etric M ethod for the D eterm ination of 
A lbum in in  Plasma and Serum
Album in present in plasm a and serum  was determ ined using an 
Im m unoturbi-dim etric m ethod, developed for use on a Roche Cobas Fara 
centrifugal analyser. The sample is incubated w ith albumin antisera, after 
which the turbidity of the sample is m easured by spectrophotometry.
Reagents
Guildhay Antisera 
Diluent for antisera
Diluent for Samples 
Standards
Controls
- sheep anti-hum an album in
- 4% PEG in phosphate buffered saline (PBS) 
(Beckman) 40g PEG 6000 made up
to 1 litre w ith PBS
- PBS (Beckman)
- 8 dilutions of the laboratory batch standard 
7.5-60g/L
- 'Low' and 'High' seronorm  and Beckman 
Calibrator 1
Assay Procedure
Samples, standards and controls are dilued 1:10 in PBS (45pl + 450 pi). 
250pl are pippetted into cobas cups. To prepare the working antisera, 
0.375ml of antisera are diluted in 15ml PEG solution and allowed to stand 
for five minutes. A range of working standards are prepared in PBS. The 
sample rota (containing samples, standards and controls) and reagent 
(antisera) are loaded into the Cobas. The Cobas Para has a built in program  
for the analysis of albumin. The assay was linear over the range of 
standards used. The assay is sensitive; concentrations as low as 5g /L  can be 
accurately determined.
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2.7.6 Determination of Urinary Urea - BUN Enzymatic Assay
An enzymatic urease m ethod was used in which urea is quantified by 
m easuring ammonia evolved in the urease hydrolysis of urea.
urease
Urea + H2O  > 2NH3 + CO2
The ammonia produced aminates alpha-ketoglutaric a d d  to glutamic acid 
w ith  the concurrent oxidation of N A D H 2 to NAD. The reaction is 
catalysed by glutam ate dehydrogenase (GMD). Decrease in NADH2 
absorbance at 340nm is proportional to the concentration of urea in the 
original sample.
GMD
N H 3 + Ketoglutaric A dd  + NADH + H + —> Glutamate + NAD + H 2O
The reagent m ixture used was 'D ri-stat Bun Rate Reagent w hich is 
available as a kit (Beckman).
Reagent Composition 
a-Ketoglutaric a d d  5.0 m m ol/L
NA DH 0.28 m m ol/L
Urease > 14000 lU /L
Glutamate dehydrogenase > 2000 lU /L
pH  7.5
One vial of reagent is reconstituted in 20ml of deionised water.
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This enzymatic m ethod was carried out using the Centrifichem centrifugal 
analyser, with the following settings:-
To - 050 sec 
AT 0.3min
Abnormal absorbance 0.5p 
Blank - auto 
Testmode - terminal 
Printout - concentration 
Temperature - 30°C 
Filter 340nm.
The P I000 autom ated pipette was program m ed to pipette 5pl sample with 
55pl diluent (saline), and 350pl reagent.
The m ethod was linear up  to 40mmol/L.
Calculation of 24 hour Urinary Nitrogen Excretion
From  the 24 hour u rine  sam ple volum e and  u rea  concentration  
(mmol/L), 24 hour urinary urea excretion (m m ol/24 hours) are calculated. 
Twenty-four hour nitrogen excretion was determined using the following 
equation
(Urea m m ol/24 hours x 60 x 28) 
1000x60
ie. Urea m m ol/24 hours x 0.028 = Nitrogen g /24  hours.
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2.7.7 Measurement of Plasma IGF-1 (Insulin Like Growth Factor 1) by
Radioimmunoassay
The m ethod used was that of Teale and Marks (1990), and Baxter and 
Brown (1982).
Sample Preparation
Plasma samples were extracted w ith acid-ethanol prior to assay by the 
m ethod described by Daughaday, M ariz and Blethen (1980). Extraction is 
carried out to separate IGF-1 from binding proteins.
Standard
A  pooled serum  sample from a norm al adult population was used as a 
standard reference.
A ssay Procedure
Sample extracts diluted 1:4 w ith buffer (0.05M phosphate. pH  7.4). 50pl 
aliquots of standards or samples were incubated w ith 200pl antiserum  
(m ouse m onoclonal antibody p reparation  ICPL - M23), and  200pl 
iodinated IGF-1 tracer (350 pg /tube) for 18 hours at 4°C. Aliquots of 200pl 
double antibody/PE G  solution (Donkey anti-m ouse serum , G uildhay 
Ahtisera Ltd), were added to each incubate and m aintained for 2 hours at 
4°C. After this period tubes were centrifuged and supernatant aspirated. 
Residual pellets were counted and unknow n concentrations com puted 
from  standard  counts. The sensitivity of this m ethod was 0.03 U /m l. 
Coefficient of variation for between assay was 17.9% at 0.16U/ml, 10.0% at 
0.4 U /m l, 8 .6 % at 0.65 U /m l and 9% at 1.38 U /m l.
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2.7.8 Determination of Plasma Insulin, Glucagon and Cortisol by
Radioimmunoassay
Plasma concentrations of insulin, glucagon and cortisol were determ ined 
by radioimmunoassay.
Assay Principle
Samples are initially incubated w ith an anti-serum  and horm one tracer, 
after which a second antiserum is added to tubes which are incubated 
again to separate free and bound fractions. Incubates are centrifuged and 
pellets counted.
Insu lin
Buffer 0.04m phosphate pH  7.4 (containing 0.01m EDTA).
Charcoal Stripped serum (for diluting insulin standard). 
insulin 'antiserum (Guildhay).
Label (Amersham International, p roduct N ° 1M38) Iodinated insulin, 50 
pg (2nCi), are added to each tube.
Standards (NIBSC 661 304), working range of standards 23.5 to 1500 
pm ol/L .
Second A ntiserum  (Guildhay), Donkey anti-guineapig serum  (batch: 
HPIDI8/X1-B), dilute 1:20 for use.
Quality Controls Serum pools were spiked w ith insulin  to five levels, 
freeze dried and stored at 4°C.
Assay Procedure
50pl of sample were incubated with 200pl antiserum  and 200pl label for 24 
hours. This was followed by a two hour phase separation w ith a second 
antiserum  (200pl). After which tubes were centrifuged and pellets 
counted.
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The assay was sensitive to 20pm ol/L . Between assay precision tests 
obtained a coefficient of variation of 9 .5 %.
Glucagon
Buffer 0.04M phosphate pH  7.4.
Assay Diluent 0.04M phosphate buffer containing 0.2% BSA and 
lOOpg/ml aprotinin (make up fresh for each assay).
Glucagon Antiserum  (Guildhay). Rabbit antiglucagon serum.
Iodinated Glucagon (Amersham product No. 1M160).
Glucagon Standard (Sigma) lOpg/m l in diluent store-20°C. For assay use, 
this stock standard  is d iluted 1:5 w ith diluent then 1:40 w ith  fasting 
volunteer serum  containing 200pg/m l aprotinin. Top assay standard is 
5000pg/ml and is diluted to form a range of working standards.
Second Antiserum  (Guildhay). Donkey anti-rabbit.
Assay Procedure
300pl plasma were mixed with 20% PEG solution and incubated for 10 
minutes on a cold tray. They were Centrifuged, (3000 rpm , 20 m inutes at 
4°C) and 200pl aliquots were added to assay tubes. 200pl of antiserum were 
added. Samples were then incubated for 24 hours at 4°C. lOOpl of label 
were added. Samples were then incubated for a further 24 hours. lOOpl of 
second antiserum were added, followed by a two hour separation phase at 
4°C. Tubes were centrifuged, aspirated and pellets counted.
The assay was sensitive to 5pm ol/L. Between assay reproducibility tests 
obtained a coefficient of variation of 9 .7%.
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Cortisol
Buffer C itrate/phosphate buffer pH4.
Antiserum  (Guildhay)
Iodinated Cortisol Conjugate (Guildhay)
Standard Cortisol in absolute ethanol (36.2mg/10ml: lOmmol/L) forms a 
stock solution w hich is d ilu ted  further to form a range of w orking 
standards ranging from 47 to 3000 m m ol/L.
Second Antibody (Guildhay)
Wash Solution 0.1% TWEEN.
Assay Procedure
lOOpl antiserum  were added to 20pl of sample and lOOpl tracer. Tubes 
were mixed and left at room  tem perature for 30 minutes. 400pl of solid 
phase second antibody suspension were added to each tube which were 
then mixed and left at room tem perature for 10 m inutes. 500pl 0.1% 
TWEEN were added to each tube. Tubes were mixed then centrifuged at 
1500 rpm  for 10 minutes, aspirated and pellets counted.
The assay was sensitive to 25nmol/L. A coefficient of variation of 8.2% 
was obtained for between assay reproducibility.
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CHAPTER THREE 
AN OBSERWIONAL STUDY OF SURGICAL PATIENTS
3.1 The Metabolic Responses to Trauma
Study of the metabolic responses to traum a began in the 1930's, when Sir 
David Cuthbertson m ade the observation that in patients with long bone 
fractures there was an increase in urinary nitrogen (Cuthbertson, 1932). 
He categorised the injury response into two phases, the 'Ebb' and 'Flow' 
phases. The 'Ebb phase' referred to the early shock phase in which the 
body acted to conserve energy, and direct it tow ards preservation of 
cardiovascular and respiratory function, in an attem pt to survive. The Ebb 
phase, which on average lasts 48 hours, leads into the 'Flow phase'. This 
is a metabolic phase, when body processes accelerate and is the phase in 
which catabolism occurs.
It is now  recognised that all forms of major injury, including major 
surgery, cause metabolic changes which may ultim ately lead to depletion 
of body fuel stores and poor nutritional status. Surgical patients, in 
addition to undergoing the catabolic response inherent of the operative 
p rocedure , m ay also have pre-ex isting  m aln u tritio n  as a d irec t 
consequence of their disease. Poor nutritional status of surgical patients is 
a cause of concern, since previous research has show n poor nutritional 
status to jeopardise outcome. Depletion of body protein has been shown 
to, im pair im m une response (Cannon et a l.. 1944; N eum ann et al.. 1975), 
w ound healing (Temple, Voitz and Snelling, 1975), and organ function, 
and increase m ortality (Studley, 1936). The problem  of m alnutrition in 
surgical patients is, however, not necessarily one of adequate nu trien t 
p rov ision  b u t ra th e r one of im paired  n u tr ie n t u tilisa tion , as a 
consequence of surgical stress. In order to provide a sound basis for 
feeding critically ill patients, ie. when to feed, how  m uch, and how  long to 
feed a patient, a greater understanding  of the underly ing  m etabolic 
responses are required.
Over the past 60 years m uch research has been carried ou t on the 
metabolic response to traum a, bu t although inform ation in this area of 
clinical nutrition is continually expanding, m any controversial aspects
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and questions rem ain unanswered. The following account summarises 
current knowledge and discusses the rationale for the current study.
Surgical or accidental injury result in a sequence of events initiated by 
afferent im pulses to the brain form baroreceptors, chem oreceptors, and 
pain  receptors. These afferent stim uli lead to activation of effector 
m echanisms coordinated by the hypothalam us. Sym pathetic ou tpu t is 
increased and the pituitary is activated. Sympathetic activation of the 
pancreas results in increased production of glucagon and inhibition of 
insulin release. Sympathetic activity also results in increased secretion of 
adrenaline from the adrenal m edulla (Traynor and Hall, 1981). Activation 
of the p itu itary  causes less im m ediate effects w hich m ay be m ore 
persistent. Hypothalam ic peptides, corticotrophin releasing factor and 
grow th horm one releasing factor, are produced resulting in increased 
secretion of adrenocorticotrophic hormone (ACTH) and grow th horm one 
respectively. Stimulation of the posterior p itu itary  results in increased 
vasopressin release. Insulin concentrations following injury show wide 
variab ility  (Stoner e t a l., 1979; Vitek, Lang and  Cowley, 1979). 
C oncentrations m ay initially be suppressed , especially if adrenaline 
concentrations are elevated, and m ay be low  in relation to circulating 
glucose concentrations. In the flow phase of injury insulin concentrations 
may become elevated, although there m ay be a reduction in its metabolic 
efficiency and an 'insulin resistant state' can result. This may be due to 
coexisting h igh  concentrations of catabolic horm ones (adrenaline, 
glucagon and cortisol) (Traynor and Hall, 1981), which act synergistically, 
antagonising the action of insulin (Shamoon, Hendler and Sherwin, 1981).
The a ltera tion  in m etabolic horm one profile  in itia tes catabolism . 
Superficially the m etabolic features resem ble a starvation  response. 
However, the catabolic response to injury is more complicated, a num ber 
of m etabolic abnorm alities exist, the aetiology of w hich are poorly  
understood.
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In starvation, deficit of exogenous fuel results in lowering of blood 
glucose. This initiates a horm onal response, secretion of insulin is 
inhibited whereas that of glucagon and cortisol rises. The reduced insulin 
to glucagon ratio activates the enzymes of the glycogenolytic pathway. 
Liver glycogen is converted to glucose and released into the blood, 
providing a constant supply of energy to the brain which has an essential 
requirement for glucose. Muscle glycogen is catabolised to glucose-1- 
phosphate, which may only be utilised for energy at the site of production. 
Liver glycogen becomes depleted in approximately 24 hours, after which 
blood glucose concentrations are m aintained by gluconeogenesis. 
Glucagon stimulates the gluconeogenic pathw ay, which is m aintained by 
alanine from muscle branched chain amino acids (BCAA) (Beisel and 
W annemacher, 1980). As BCAA are converted to alanine, protein 
synthesis is kerbed and there is a negative protein balance in muscle. The 
nitrogen moiety of alanine is converted to urea, which is reflected in the 
increase in urinary nitrogen loss. During initial days of starvation, 
nitrogen losses may amount to 12-14g/day.
Insulin is a potent inhibitor of lipolysis, therefore, reduced insulin 
concentrations observed in starvation rem ove this inhibition, triglyceride 
lipase is activated and lipolysis enhanced. Non-esterified fatty acids 
(NEFA) and glycerol are released into the blood stream. NEFA provide an 
efficient source of energy to m any tissues through B-oxidation and 
oxidation of acetyl CoA via the citric acid cycle. W hen the rate of 
peripheral tissue acetyl CoA production exceeds the rate of its removal 
into the citric acid cycle, acetyl CoA is rem oved from the m itochondrial 
m atrix by the citrate carrier system or the carnitine shuttle (see Chapter 1 
page 9). Acetyl CoA is diverted out of peripheral tissue tow ards the liver 
where it provides the substrate for ketogenesis. W ithin a few days of 
fasting, an adaptational response allows increased utilisation of ketone 
bodies as a source of energy; they are oxidised in the citric acid cycle 
entering at the succinate level. Of greatest importance is the ability for the 
brain to adapt to utilising ketone bodies for energy, it may obtain up  to 50% 
of energy requirem ents through the oxidation of these lipid m etabolites
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(Owen et al.. 1967; Sokoloff, 1976). This reduces requirem ent for hepatic 
gluconeogenesis thereby sparing muscle amino adds. Ketone bodies also 
stim ula te  in su lin  secretion, w hich causes fu rth er suppression  of 
gluconeogenesis. This adaptational response means that w ithin three to 
five days of fasting, urinary nitrogen losses decrease so that a fully adapted 
starved individual rarely looses more than 5g urinary  nitrogen per 24 
hours (Owen et al.. 1980). A lthough the metabolic response to traum a 
resembles the catabolic processes described above, a num ber of differences 
exist. Mobilisation of body fuels in starvation takes place to satisfy a 
reduced supply of exogenous fuel. Trauma, by contrast, is accompanied by 
a rapid inappropriate mobilisation of body stores, which is not linked to an 
energy inbalance and  is in itia ted  by neuroendocrine m echanism s. 
Following severe traum a the mobilisation of body stores is accompanied 
by hyperglycaemia, excessive protein loss and an inability to achieve a 
heightened ketosis. The catabolic response is such that it m ay be refractory 
to nutrient provision.
Several studies have reported elevated concentrations of blood glucose 
following traum a (Smith et al.. 1975; Foster et al., 1979: Stoner et al.. 1979). 
The m agnitude of the increase appears to be related to injury severity 
(Clarke, 1970). Sym pathetic innervation  to the liver and  ra ised  
concentrations of adrenaline, glucagon and cortisol, initiate glycogenolysis 
and gluconeogenesis. This increases hepatic glucose output, resulting in 
hyperglycaemia. Several studies have shown rapid  depletion of hepatic 
glycogen following abdominal surgery in m an (Annam unthodo, Keating 
and Patrick, 1958; Sunzel, 1963; Hall, Traynor and Paterson, 1983). 
Following glycogen depletion hepatic glucose production is sustained by 
gluconeogenesis, the m ain substrate for w hich is carbon units from  
muscle amino acids. Raised blood glucose concentrations persist, even in 
the presence of hyperinsulinaem ia, due to the insulin  resistan t state 
which characterises this condition. The reduction in metabolic efficiency 
of insulin results in im paired cellular glucose uptake and utilisation. 
Hyperglycaemia is therefore sustained by constant glucose production and 
im paired utilisation. The proportion of glucose which enters the body
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cells is thought to be only partially oxidised to lactate, which is returned to 
the liver and reconverted to glucose (Cori Cycle). It has been suggested 
th a t increased glucose p roduction  is a consequence of increased 
requirement, due to this partial oxidation (Long, 1977). However, infusion 
of exogenous glucose exacerbates the hyperglycaemic state and does not 
inhibit the rate of gluconeogenesis to the extent seen in norm al control 
subjects (Shaw, Klein and Wolfe, 1985; Wolfe et al.. 1986).
The most marked feature of the metabolic response to physiological stress, 
which distinguishes it from starvation, is the excessive, sustained loss of 
body protein and failure of the adaptive response. The metabolic response 
to surgery and injury is accompanied by a net loss of skeletal amino acids. 
There appears to be a flux of amino adds from peripheral sites to the liver. 
Liver uptake of am ino acids is enhanced and they fuel accelerated 
gluconeogenesis, w ith consequent urea production and urinary  nitrogen 
loss. Amino acids are also utilised for the synthesis of acute phase 
proteins, for which there is an increased demand following injury (Souba 
and Wilmore, 1982).
There is some debate as to whether negative nitrogen balance observed is a 
consequence of increased protein breakdown, decreased synthesis, or both. 
Results from studies fall into two categories; those that indicate protein 
catabolism results from a fall in synthesis below the breakdow n rate 
(O’Keefe, Sender and James, 1974; Crane, Picou and Smith, 1977), and 
those which suggest protein catabolism is due to an increase in the 
breakdown rate (Kien e ta l., 1978; Clague et al.. 1983; Birkhahn et al.. 1980). 
It is possible that both occur, bu t operate at different periods following 
injury (Wolfe, Jahoor and Hartl, 1989). W ernerman, von der Decken and 
Vinnars (1986) show ed protein synthesis to be decreased follow ing 
abdom inal surgery, and found concentration and size d istribution  of 
ribosomes were reduced when compared to pre-surgical values.
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Alanine is the major fuel for gluconeogenesis following injury (Shaw, 
K lein and  Wolfe, 1985; G um p et a h , 1975; Long et a l .. 1976). 
Gluconeogenesis does not appear to be controlled prim arily by alanine 
supply but more likely by glucagon stimulation, since blockage of the latter 
kerbs gluconeogenesis in the presence of a sustained alanine flux. Also, 
infusing alanine does not increase glucose production (Wolfe, Jahoor and 
Shaw, 1980). It is thought that alanine serves as a carrier of three carbon 
units from peripheral sites to the liver, bu t in doing so leads to increased 
loss of body nitrogen. One recent theory p u t forw ard to explain this 
phenom ena is tha t in m uscle, pyruvate  is converted to alanine in 
preference to lactate to prevent redox disturbances (Wolfe, Jahoor and 
Hartl, 1989). Depletion of muscle glutamine may lead to insufficient non- 
essential amino acids for protein synthesis. It has also been suggested that 
the enhanced alanine flux reflects the need for increased transport of 
amino acids, from their largest store in muscle, to the liver, for synthesis 
of vital acute phase proteins (Souba and Wilmore, 1982). O'Donnel and 
coworkers (1976) have suggested that following injury there is a deficit of 
peripheral fuel, w ith respect to glucose and fat, and that protein is oxidised 
to fill this deficit.
In addition to reduced glutam ine synthesis, glutam ine is lost from the 
muscle and diverted to the gut where it is utilised for energy (Souba and 
W ilmore, 1982). Glutamine is also converted to alanine in the gut, which 
is used in gluconeogenesis (Gump et al., 1975).
Following traum a leucine oxidation is increased (Wolfe et al.. 1983) which 
may either be due to increased availability, or due to obligatory oxidation 
in response to the deficit of peripheral fuel substrates. The prim ary 
stimulus which initiates and sustains muscle amino acid loss is not clearly 
understood. Proposed mechanisms outlined above are speculative and 
based on lim ited experim ental evidence. The effects of m etabolic 
horm ones on protein catabolism have been extensively studied. H igh 
experimental concentrations of glucagon (Fitzpatrick et al.. 1977; Wolfe et 
al., 1979a; Landau and Lugibihi, 1969), glucocorticoids (Sapir et a l.. 1977),
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and catecholamines (Miles et ah, 1984), have been found to raise plasma 
am ino acid concentrations and urinary  nitrogen excretion in norm al 
individuals. A synergistic effect of these hormones has also been reported 
(Bessey et a l.. 1984; Gelfand et a l., 1984). However, even at high horm one 
concentrations, the extent and nature of proteolysis observed following 
traum a cannot be reproduced. The existence of fundam ental differences 
suggests horm ones only play a partial role and other m ediators are 
involved in proteolysis following traum a. These m ay include tissue 
in jury  factors and  lym phokines (Clowes, Villee and  Saravis, 1983; 
Goldberg et a l.. 1984). Much controversy exists over the exact nature of 
protein loss in injury and the mechanisms responsible for the initiation of 
this response. However, it is recognised that the extent of protein loss 
varies according to severity of injury.
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3.2 The Ketotic Response to Surgery:
Relationship to Carnitine Status, Circulating Concentrations of 
Metabolic Hormones and Indices of Protein Status and 
N utritional Outcome.
3.2.1 Introduction
Despite the excessive loss of body protein observed in severe injury, in the 
m ild to m oderate forms of injury the body seems able to conserve protein 
to some extent. A better understanding of how the body acts to conserve 
protein in the m ilder forms of injury, m ay provide a therapeutic basis for 
preventing major losses which are observed in severe injury. W ith this in 
m ind, m uch attention has been paid to the role of ketone bodies in protein 
conservation; as it has been suggested that the ability to conserve body 
protein in the m ilder forms of injury, m ay be due to the developm ent of a 
heightened ketosis (Cahill, 1970; Sherwin, Hendler and Felig, 1975). 
However, in severe injury the production of ketone bodies is kerbed and 
this may contribute to the extent of nitrogen loss. In addition to the 
im portant role of ketone bodies as a source of metabolic fuel, it has also 
been hypothesised that they may exert a direct protein sparing effect on 
muscle. A lthough the mechanism by which ketones exert this effect is 
unclear, it has been suggested that ketone bodies decrease alanine 
production by causing a shift of pyruvate towards lactate (Nosadini et al., 
1980).
The protein sparing effect of ketones was first observed in fasted 
individuals, who showed a reduction in urinary nitrogen after prolonged 
starvation. In these subjects, decreased alanine release from m uscle 
coincided w ith an increase in ketone bodies (Felig,1969). It was 
hypothesised that ketone bodies provided a protein sparing signal, 
curtailing muscle release of amino acids. Subsequent studies show ed that 
infusion of ketone bodies, to overnight fasted subjects, decreased plasm a 
alanine concentrations, in the absence of a change in plasm a insulin  
(Sherwin, Hendler and Felig, 1975; Fery and Balasse, 1980; Miles, Haym ond
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and Gerich, 1980). This lead to the suggestion that hyperketonaemia per 
se m ight be protein sparing and m ight decrease glucose production by 
limiting the availability of gluconeogenic substrate (Sherwin, Hendler and 
Felig, 1975). Anim al studies carried ou t confirm ed these findings. 
Palaiologos and Felig (1976) were the first to show a direct effect of ketone 
bodies on muscle, decreasing alanine production from 48 hour starved 
rats. Snell and Duff (1982) also found ketone bodies reduced alanine
released form muscle in rats. Goodman, M^Elaney and Ruderman (1981),
found that starvation induced hyperketonaem ia in the ra t resulted  in 
decreased urinary  nitrogen loss.
Initial studies, in which ketone bodies were infused into fasted hum ans, 
were criticised by contrasting reports stating that the apparent reduction in 
plasm a alanine and urinary nitrogen excretion were due to the effect on 
pH  of ketone bodies. This could have corrected the m ild acidaemia of 
starvation , thereby reducing renal am m oniagenesis and  consequent 
nitrogen excretion (Fery and Balasse, 1980; Balasse and Oons, 1967). 
Studies of Miles and coworkers (1983) investigated the effects of infusing 
both sodium  B-hydroxybutyrate (NaBOHB) and sodium  bicarbonate 
(NaHCOg), in post absorbtive individuals. Infusion of NaBOHB reduced 
p lasm a alanine bu t failed to alter the appearance of leucine. As 
appearance of leucine is an index of proteolysis, it was concluded that 
infusion of ketone bodies had  little effect on protein breakdow n. This 
does not rule out the possibility that ketones reduce protein  loss by 
stim ulating  am ino acid incorporation into protein . A decrease in 
oxidation of amino acids with a concomitant increase in protein synthesis, 
w ould spare protein w ithout an alteration in rate of protein breakdown. 
Infusion of NaHCOg had no effect on leucine, nitrogen, or carbon flux or 
appearance of alanine, but did enhance alanine clearance.
Several animal studies have also show n little effect of ketone bodies on 
muscle protein breakdown rates (Paliaologos and Felig, 1976; Snell and 
Duff, 1982). Um pleby and coworkers (1988) investigated w hether the 
metabolic changes produced by NaBOHB infusion in dogs, were due to
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alkalaemia. NaBOHB caused a reduction in alanine production rate and 
an increase in metabolic clearance. NaHCOg, caused a small increase in the 
metabolic clearance of alanine. These findings demonstrate that the fall in 
alanine concentrations after ketone infusion, was due to a ketone specific 
reduction  in alanine production  and  a sm all increase in m etabolic 
clearance due to alkalaemia. In this study, infusion of ketone bodies also 
caused an increase in leucine incorporation into protein.
Recent studies by N air et al. (1988) have produced  m ore evidence 
supporting the protein sparing effect of ketone bodies. They showed a 10% 
increase in leucine incorporation into muscle during infusion of BOHB in 
hum ans, which was not due to an increase in circulating pH. Using 
radiolabelled leucine changes in whole body leucine oxidation w ere 
followed in healthy post-absorptive adults w ho received an intravenous 
infusion of either NaBOHB, saline or NaHCOg. The change in pH  did not 
effect leucine flux, oxidation or uptake. NaBOHB caused no change in 
leucine appearance, confirming the previous observation of Miles et al. 
(1983) that ketone bodies do not effect rates of protein breakdown. Leucine 
oxidation was reduced by 30%, and there was a 10% increase in non- 
oxidative leucine disposal (indicative of pro tein  synthesis). It m ay 
therefore be concluded that ketone bodies have a direct protein sparing 
effect on muscle during starvation, not due to an inhibition of breakdown 
but possibly due to a decrease in amino acid oxidation and its subsequent 
incorporation into protein. No studies appear to have investigated the 
effects of ketone body infusion in critically ill or in jured  patients. 
However, Birkhahn, Askari and Thomford (1988) compared the effects of 
intravenous glucose or ketones in traum atised rats. Despite the fact the 
ketone fed anim als w ere hyperketonaem ic and norm oglycaem ic, and  
glucose fed anim als w ere norm oketonaem ic and  hyperglycaem ic, no 
differences in urinary  nitrogen loss or leucine kinetics were observed 
between the two groups. This does not entirely discredit the possibility 
that a heightened ketosis following injury m ay be linked to the ability to 
conserve body protein. The absence of a ketotic response following severe 
traum a m ay in part be responsible for the extent of protein loss observed.
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Interest in the role that ketosis may play in preventing protein wasting in 
critically ill patients arose in  1973, w hen Blackburn and coworkers 
observed a dam pened ketotic response in post-surgical patients - which 
was associated w ith a greater loss of urinary nitrogen. This observation 
was supported by the findings of Smith et al. (1975), who m easured ketone 
concentrations follow ing injury and found patien ts th a t developed 
hyperketonaem ia (defined as >0.2 m m ol/L) had low er plasm a alanine 
concentrations, for all samples taken during the first 24 hours post injury, 
com pared to non-hyperketonaem ic patien ts (<0.2 m m ol/L ). They 
concluded that hyperketonaem ia following injury is associated w ith a 
decrease in protein breakdow n, although their study d id  no t indicate 
whether the nitrogen conservation was due to a decrease in breakdown or 
an increase in synthesis. Wedge et a l. (1976) also found an inverse 
relationship betw een urinary  nitrogen loss and circulating ketones 
following injury. Stoner and coworkers (1979) found a dam pened ketotic 
response in m ore severely injured patients com pared to m oderately 
injured patients. Although their results showed no significant difference 
in circulating amino acid concentrations between these two groups, they 
did not m easure individual amino acid kinetics or urinary nitrogen loss. 
In 1979, Foster et al. reported an inverse relationship betw een plasm a 
alanine and plasm a ketone bodies in patients w ho had  undergone 
abdominal surgery. Rich and W right (1979) investigated the relationship 
betw een ketone bodies, protein status, and m ortality  in a group of 
m a ln o u rish ed  su rg ica l p a tien ts . P a tien ts  w ere  d iv id e d  in to  
normoketonaemic and hyperketonaemic groups on a basis of their p re­
operative fasting serum  ketone body concentrations (using 0.2 
m m ol/L  as a defining value). Despite no significant pre-operative 
d ifferences in n u tritio n a l s ta tu s be tw een  the  tw o  g ro u p s, the  
norm oketonaem ic patients had a significantly greater loss of u rinary  
nitrogen, a larger loss of arm  muscle circumference, and  low er serum  
p ro te in  concentrations post-surgically , w h en  c o m p ared  to  th e  
hyperketonaem ic group. M ortality rate was also higher in the group 
which failed to develop a heightened ketosis. From the studies discussed it 
is clear that an inverse relationship betw een protein loss and ketotic
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status exists, however, it cannot be assum ed the this relationship is causal.
It m ay be argued that the more severe stressed patient loses m ore protein 
and has lower ketone production, w ithout the two phenom ena being 
related. The suggestion that alanine itself is antiketogenic m ust also be 
considered (Nosadini et al., 1980; Nosadini et al., 1981; Nosadini et_al., 
1982). It m ay be that in severe traum a larger quantities of alanine are 
released from the muscle and this suppresses hepatic ketogenesis. In 
m ilder traum a less alanine is released, and therefore ketogenesis is 
inhibited to a lesser extent. If this were true, infusing ketone bodies w ould 
have little effect on nitrogen losses. A lthough the effects of infusing 
ketone bodies following injury and surgery have not been investigated, 
the body of knowledge from studies of starvation tends to suggest that 
ketone bodies are able to suppress alanine release. It is possible that in 
traum a both systems operate, alanine inhibiting ketogenesis at the liver, 
and ketone bodies inhibiting alanine release from muscle.
In view of the proposed protein sparing role of ketone bodies following 
injury, and im proved m orbidity and m ortality observed in 
hyperketonaemic patients, it is im portant to learn more about the factors 
influencing ketotic capacity in trauma. Elucidation of the causative factors 
which underline the blunted ketosis, which is reported to occur following 
injury, is of particular importance, as m anipulation of ketone body 
concentrations by pharmacological or nutritional means m ay be beneficial 
in terms of clinical outcome.
W illiamson (1981) pu t forward several proposals to explain w hy ketone 
body concentrations could be low following physiological stress. Increased 
utilisation was suggested, however, there is no evidence to support this, 
and Hartl et al. (1988) showed that ketone bodies provide only a m inor 
contribution to energy production in the post-operative period. 
W illiamson (1981) also hypothesised that raised vasopressin 
concentrations produced an antiketogenic effect, by stim ulating complete 
oxidation of fatty acids to carbon dioxide. There is no strong evidence to 
support this, and it has been suggested that complete oxidation of fatty
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acids may be impaired following traum a (O’Donnel e ta l., 1976). There are 
several possible stages in the pathw ays which lead to the production of 
ketone bodies w here a block m ay occur. These include lipolysis, B- 
oxidation, the fate of acetyl CoA, and the HMG CoA cycle itself. Both 
lipolysis and B-oxidation are predom inantly controlled by the metabolic 
horm ones (see Chapter 1 page 12). In stress, the changes in  horm one 
profile which are thought to occur (raised concentrations of adrenaline, 
glucagon, and cortisol, and decreased insulin to glucagon ratio) w ould 
favour both lipolysis and B-oxidation. It is possible, however, that ’insulin 
resistance’ of stress has a less pronounced effect on lipid m etabolism  
compared to carbohydrate metabolism. It is also possible that in severe 
stress the extent of hyperinsulinaemia observed has an inhibitory effect on 
lipid catabolism (Neufield, Kaminiski and W annem acher, 1977), although 
a poor association betw een circulating concentrations of insulin  and 
ketones has been found (McGarry and Foster, 1980). Previous studies in 
stressed patients have found elevated circulating NEFA and glycerol 
concentrations, indicating that lipolysis is not inhibited.
W hether or not lipid oxidation is enhanced or suppressed follow ing 
injury is a controversial issue. Several studies using indirect calorimetry 
have shown that the respiratory quotient (RQ) is low following traum a 
(Stoner et a l.. 1983; N anni et a l., 1985). In a study by Birkhahn and 
coworkers in 1981, it was concluded that fat was utilised following injury 
bu t its metabolism was abnorm al com pared to healthy individuals or 
mildly stressed patients. Despite the low concentrations of ketone bodies 
and NEFA observed in their patients, indirect calorimetry indicated that 
fat contributed to 63% of non-protein energy. It is possible tha t lipid 
oxidation is enhanced in some patients, while suppressed in others. It is 
also possible that B-oxidation is enhanced but subsequent ketogenesis is 
suppressed, due to a hepatic deficiency in ketogenic substrate or a block in 
the HMG CoA cycle. If the hormone status favours lipid catabolism and 
oxidation, as these processes proceed enhanced ketosis w ould be expected 
to occur; since this is not the case, it has been proposed that another 
cofactor or m ediator is the limiting factor responsible for the dam pened 
ketotic response.
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Interest in a possible involvem ent of carnitine in the dam pened ketotic 
response arose due to recognition of its role as a cofactor in the pathways 
which lead to the production of ketone bodies (see Chapter 1 page 10), and 
also due to the discovery of secondary deficiency states following injury. 
Carnitine availability is im portant following injury if lipid is to be utilised 
for energy, and if lipid is providing part of nutritional support. There will 
be increased dem and upon carnitine for intram itochondrial transfer of 
long chain acyl groups, to buffer the free to bound Co A ratio and for 
transport of acetyl units out of peripheral cell m itochondria to the liver, 
where they may be utilised in ketogenesis. If increased requirem ents for 
carnitine are not met, ketogenesis m ay be comprom ised. It has been 
suggested that carnitine deficiency in injury prevents adequate oxidation 
of fat, which limits energy supply to the muscle causing an obligatory use 
of amino acids for energy and thereby increasing nitrogen loss (Border et 
^ . ,  1970). It is possible that carnitine availability is reduced following 
injury; there are several factors which m ay contribute to this. Firstly 
patien ts m ay be receiving no exogenous carnitine, as in travenous 
infusions and both  enteral and  parenteral feeds are carnitine free. 
Biosynthesis may also be reduced, since if protein breakdown is increased 
there may be impaired formation of trimethyllysine (TML). TML which is 
available m ay be d iverted  ou t of the cell, ra th e r than  in to  the  
m itochondria, and m ay not therefore be utilised for carnitine synthesis. 
There may also be decreased activity of carnitine biosynthetic enzymes and 
decreased availability of specific lysine residues. Lysine and m ethionine 
present in feeds may not be directed towards carnitine synthesis. Carnitine 
excretion is also increased as a result of accidental injury (Cederblad, 
Larsson and Schildt, 1984; lapichino et a l., 1988), surgery and sepsis (Naimi 
et al., 1985a), causing a reduced size in body carnitine pool.
Data on plasm a carnitine concentrations following injury has produced 
conflicting results. Hahn, Allardyce and Frolich (1982) reported unaltered 
concentrations in surgical patients, N anni et al. (1985a) reported elevated 
plasm a carnitine in both septic and non-septic surgical patients. Anim al 
studies have also show ed elevated plasm a carnitine concentrations in
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surgical stress (French, Goode and Sugden, 1986). Raised plasm a 
concentrations m ay reflect muscle loss (DiMauro et al., 1973). Cederblad, 
Larsson and Schildt (1984) have reported reduced muscle carnitine post­
surgery. In the critically ill patient, carnitine deficiency may arise due to 
decreased availability and increased requirement. Only a few studies have 
investigated the potential benefit of carnitine supplem entation following 
injury. Bohles, Segerer and Fekl (1984) found supplem entation im proved 
nitrogen balance in traum atised piglets. H um an studies have show n 
enhanced clearance and utilisation of lipids in surgical patients following 
carnitine supplem entation (Pola et al., 1983; Testasecca, 1987), but effects on 
ketone bodies and nitrogen balance have not been investigated.
Despite its importance, there is very little documented data on changes in 
carnitine status following surgery. No study has yet been conducted to 
sim ultaneously investigate carnitine and ketotic status in the context of 
n itrogen losses, horm one profile, and  circulating concentrations of 
metabolites. M easurem ents of carnitine status which have been m ade 
following surgery, tend to appear in isolation from  other m etabolites 
measured. Therefore a major aim of the present research was to carry out 
a longitudinal observational study of carnitine m etabolism  in patients 
undergoing major surgery, and to view carnitine metabolism in context of 
the overall metabolic response to surgery.
A princip le  aim  w as also to carry  o u t a com parative  s tu d y  of 
norm oketonaem ic and hyperketonaem ic patients and unlike previous 
studies, where a lim ited num ber of param eters have been com pared, to 
cover a full, comprehensive range of metabolites. These were to include 
carn itine , lip id  m etabolites, horm one profile , p ro te in  s ta tu s  and  
nutritional indices, so that a complete picture of the catabolic response to 
surgery was obtained. To fulfil the aims it was considered preferential to 
study a relatively small group of patients in detail, rather than attem pt a 
larger scale study on a more superficial basis. It was anticipated the the 
study would include approximately 30 patients.
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3.2.2 METHOD 
Study Group
Nineteen patients adm itted to the Royal Surrey County Hospital between 
September 1987 and September 1988 requiring gastrointestinal, thoracic, or 
vascular surgery were studied. Patients were retrospectively selected from 
a larger group of surgical patients, on a basis of the nutritional support 
which they had received in the first post-operative week. Included were 
patients who received an average of under 1000 kcal/24 hours for the first 
w eek follow ing surgery  and w ho received no specialised form  of 
nutritional support. The post operative intravenous fluid regim en was 
not identical for all patients. Generally patients received dextrose saline 
from the first post-operative day, although some patients received norm al 
saline initially. Oral feeding was reintroduced around the fifth post­
operative day.
Experimental Protocol
A  blood sample was obtained on admission and on days one, three and six 
following surgery. All samples were collected by the investigator. Patients 
in whom pre-operative or consecutive samples could not be obtained were 
excluded. Aliquots of serum  and plasm a were obtained, w hich were 
stored at -18°C until time of analysis. A 24 hour urine collection was m ade 
on days one, three and six following surgery. Total volume was recorded, 
an aliquot was taken for urea determ ination and a further aliquot was 
frozen for carnitine analysis.
Patients w ere w eighed on adm ission, and  baseline an thropom etric  
m easurem ents were taken. A record of w eight loss in the six m onths 
prior to admission was recalled from each patient. Subsequent weight and 
anthropom etric m easurements were carried ou t at weekly intervals and 
immediately prior to discharge.
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A detailed record of nutrient intake, food and intravenous infusions was 
kept for all patients, and daily fluid balance was noted.
Assessment of Pre-Operative Nutritional Status
On adm ission a m ultivariable nutritional assessment was carried out, 
based upon that of Karran et al. (1982). A nutrition score was assigned to 
each patient based on a scale of 0-10, 10 being the m ost severely 
m alnourished. The score was compiled as the sum  of points aw arded for 
nutritionally related param eters which failed to meet assigned threshold 
values ie. weight loss in past six months above 10% = 2 points. W eight for 
height under 90% ideal = 1 point (using m etropolitan life assurance 
tables). Triceps skinfold thickness below 85% ideal = 2 points. M id-upper 
arm  muscle circumference below 85% ideal = 2 points (Ideal values were 
obtained from Karran et al., 1982). Plasma albumin below 30m g/L = 1 
point, and finally age above 70 years = 2 points. Scores of 1 to 4 indicated 
m ild m alnutrition, scores of 5 to 7, m oderate m alnutrition and scores 
above 7; severe m alnutrition.
Parameters Measured
Details of methods used are presented in Chapter 2 (page 18). Circulating 
concentrations of ketone bodies were m easured as an index of ketosis. 
NEFA and glycerol concentrations in serum  were m easured as an index of 
lipolysis. Changes in triceps skinfold thickness (TSF) were also m easured 
as an index of changes in body fat, in addition to this TSF was also used in 
assessment of pre-operative nutritional status. Carnitine analysis 
included m easurement of free (FC), short chain acyl (SCAC), and total acid 
soluble carnitine (TASC), in both serum  and urine, to provide an index of 
carnitine status and changes in the carnitine pool.
Concentrations of plasm a insulin, glucagon and cortisol were m easured in 
pre and post operative samples, to provide inform ation on the horm onal 
response to surgery.
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Plasm a concentrations of Insulin-like G row th Factor-1 (IGF-1) were 
m easured as an index of protein status and nutriture. Plasma albumin 
m easurements contributed to the assessment of pre-operative nutritional 
status. Changes in plasm a album in between adm ission and discharge 
were also measured. From the 24 hour urine collection 24 hour losses of 
urine nitrogen were m easured, and this together w ith inform ation on 
nitrogen intake was used in the determination of nitrogen balance. M id­
upper arm  muscle circumference (MUAMC) was m easured for assessment 
of pre-operative nutritional status and for m onitoring post-operative 
losses in lean body tissue.
Presentation of Results and Statistical Methods Used
Due to the non-Gaussian distribution of the data obtained, results have 
been expressed as m edians w ith ranges. N on-param etric m ethods of 
statistical analysis have been used throughout.
Longitudinal changes in the param eters were evaluated in the group as a 
whole. Linear relationships between param eters were investigated using 
Pearson's Correlation analysis. The Wilcoxon signed ranks test was used 
to identify significant changes between days in the group as a whole.
Patients were sub-divided into two groups on the basis of their circulating 
ketone body concentrations on the first post-operative day. Those w ith 
concentrations below 0.2 m m ol/L  formed the norm oketonaem ic group, 
whereas those with total ketone concentrations equal to or greater than 0.2 
m m ol/L  form ed the hyperketonaem ic group. The data from  the two 
groups was com pared, significant differences betw een groups being 
identified using the Mann-Whitney U Test.
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3.2.3 RESULTS
Details of Patients
Nineteen surgical patients adm itted for a variety of surgical procedures 
(listed in table 3.1, page 94) were studied, the median age was 62 years (23- 
85 years). The study group included 6 females and 13 males. M edian age 
(and age range) of the normoketonaemic group (n=10) was 69 years (52-85 
years), which was significantly older than that of the hyperketonaem ic
group (n=9), who had a median age of 60 years (23-73 years), (a<0.05). Each
group included three female patients. N utrition admission scores ranged 
form 0 to 8. The median value was 2, indicating the majority of patients 
had  signs of only m ild m alnutrition on adm ission. There w as no 
statistically significant difference in nutrition admission score between the 
two groups, scores obtained were 2 (0-8) and 3 (0-8) for normoketonaemic 
and hyperketonaemic groups respectively.
The average length of hospitalisation was 11 days and ranged from 8 to 34 
days. There was no significant difference in length of hospitalisation 
between the two groups, values of which were 12 (10-34) days, and 11 (8-16) 
days, for normoketonaemic and hyperketonaemic groups respectively.
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Table 3.1 Details of Patients
Patient N o. Nature of Sex'*" Age Admission Length of Group*
Operation Nutrition Score H ospita lisation
1 Gastrectomy F 85 8 IG N
4 Colectomy F 65 6 12 N
6 Colectomy M 73 4 IG N
8 Gastrectomy M 52 2 14 N
22 Colectomy F 62 2 11 N
23 Sepsis/
Cholesysectomy
M 78 2 28 N
24 Thorocotomy M 79 2 34 N
28 Aortic Aneurysm  
Repair
M 65 1 IG N
31 Aortic Aneurysm  
Repair
M 56 G (7 died) N
33 Thorocotomy M 77 2 12 N
3 Gastrectomy F 58 G IG H
5 Gastrectomy M 73 7 IG H
10 Colectomy M 69 2 IG H
12 P artial
Gastrectomy
M 60 3 11 H
15 Colectomy F 59 2 16 H
17 Colectomy M 61 3 12 H
20 Lobectomy M 61 4 15 H
21 P artial
Gastrectomy
F 23 G 8 H
30 Partia l
Gastrectomy
M 52 8 14 H
= Hyperketonaemic *M = M aie
= Normoketonaemic F = Fem ale
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Nutrient Intake
Details of individual patient energy and nitrogen intakes are presented in 
tables 3.i-3.iv Appendix A (page 257). Median nitrogen and energy intakes 
of both groups of patients for the first post-operative week are presented in 
table 3.2). The m edian energy intake of the first post-operative week was 
2914 kcal (sum of seven days), and ranged from 1512 to 6205 kcal. The 
m edian nitrogen intake was 8.6g (sum of seven days), and ranged from 0 
to 29.9g. Energy intakes were significantly elevated by the sixth post­
operative day, w hen m ost patients had  resum ed lim ited oral feeding. 
There were no statistically significant differences in energy or nitrogen 
intakes between the two groups on any day. Patients who were being 
m aintained of calorie free infusions at the time of the day one blood 
sam ple (n=5) belonged to both normoketonaemic and hyperketonaem ic 
groups
Table 3.2 Energy and Nitrogen Intakes of the First Post-Operative Week 
in  N orm oketonaem ic and H yperketonaem ic Patients. M edian values 
(and ranges).
Post-Operative Day
Energy Intake 
kcaI/24 hours
1 2 3 4 5 6 7
Normoketonaemic 168 312 283 356 510 1080 1146
n=10 (0-563) (0-592) (0-553) (0-540) (120-960) (342-2250) (742-2065)
Hyperketonaemic 125 370 224 320 320 960 980
n=9 (0-146) (0-850) (0-750) (100-900) (168-1000) (168-1000) (0-1420)
Nitrogen Intake 
g/24  hours
Normoketonaemic 0 0 0 0 1 2.6 43
n=10 (0-0) (0-0) (0-4.7) (0-5.0) (04.7) (0-10.1) (24-10.2)
Hyperketonaemic 0 0 0 0 1.8 4.0 4.2
n=9 (0.0) (04.0) (0-4.1) (0-53) (0-5.9) (0-9.0) (0-83)
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The Ketotic Response to Surgery
The group as a whole did not show a m arked ketotic response to surgery. 
The m edian pre-operative circulating ketone body concentration was 0.11 
(0.05-1.20) m m ol/L , and the m edian value for the first post-operative day 
was 0.18 (0.02-0.61) m m ol/L . Measurement on subsequent post-operative 
days revealed no significant change during the first post-operative week. 
M edian values (with ranges) for ketone body m easurem ents are presented 
in table 3.3 (page 104). Correlation analysis indicated no relationship 
existed between circulating ketone body concentration and energy intake. 
No significant changes in either fi-hydroxybuiyrate or acetoacetate were 
observed throughout the period of study.
Figure 3.1 Comparison of Plasma Ketone Body Concentrations 
(mmol/L) betw een Norm oketonaem ic (N) and H yperketonaem ic (H) 
Groups, Prior to and Following Surgery. M edian Values (with Ranges).
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Figure 3.1 (page 96) compares circulating ketone body concentrations of the 
norm oketonaem ic group w ith the hyperketonaem ic group, pre- 
operatively and on the post-operative days studied. Pre-operatively there 
was no statistically significant difference between the two groups. M edian 
values for total ketone bodies were 0.08 (0.05-0.73) m m ol/L , and 0.11 (0.06- 
1.20) m m ol/L , for norm oketonaem ic and hyperketonaem ic groups 
respectively. As the day one total ketone body concentration determ ined 
the group to which patients were assigned, as expected, a highly 
statistically significant difference in total ketone body concentrations
existed between the two groups at this point (a<0.001). Data on individual 
ketones showed that although there was a non-significant tendency 
tow ards higher acetoacetate concentrations in the hyperketonaem ic group
on the first post-operative day, only the difference in pOHB concentration 
between the two groups reached statistical significance. Data on individual 
ketone bodies for both groups of patients throughout the study period is 
presented in table 3.v. Appendix A (page 259). Post-operative 
m easurem ents of ketone bodies on days three and six, revealed no 
statistically significant difference between the two groups, although a 
higher m edian value was observed in the hyperketonaem ic group. 
M edian values for total ketones were 0.17 m m ol/L  and 0.26 m m ol/L  for 
day three, and 0.09 m m ol/L  and 0.14 m m ol/L  for day six, for 
norm oketonaem ic and hyperketonaemic groups respectively. In the 
norm oketonaem ic group, ketone body concentrations did  not increase in 
response to surgery. In the hyperketonaemic group, ketone bodies 
increased significantly in response to surgery. Following this there were 
no significant changes throughout the post operative course, although a 
non-significant trend towards reduced concentrations on day six existed.
Serum and Urine Carnitine Status of Surgical Patients
Data on urinary carnitine excretion for the group as a whole are presented 
graphically in figures 3.2 to 3.4 (Page 98). The median values (and ranges) 
for 24 hour TASC excretion on days one, three, and six following surgery 
were 1849,1428, and 345 pm ol/24 hours respectively.
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Figures 3.2 - 3.4 Urinary Carnitine Excretion Following Surgery (pmol/24 
hours) for the Group of Surgical Patients as a W hole (n=19). Figure 3.2: 
Total Acid Soluble Carnitine (TASC); Figure 3.3: Free C arnitine (FC); 
Figure 3.4: Short Chain Acyl Carnitine (SCAC). M edian Values (with 
Ranges).
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Figures 3.5 - 3.7 Comparison of Urinary Carnitine Excretion (pm ol/24 
hours) betw een Normoketonaemic (N) and Hyperketonaem ic (H) Groups 
Following Surgery. Figure 3.5: Total Acid Soluble Carnitine (TASC); 
Figure 3.6: Free Carnitine (FC); Figure 3.7: Short Chain Acyl Carnitine 
(SCAC). M edian Values (with Ranges).
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There was a progressive decrease in carnitine excretion from days one to 
six, w ith a significant decrease between days one and three (a<0.01) and
again between days three and six (a<0.05). Twenty four hour urinary 
excretion of FC also progressively decreased throughout the post-operative 
course, w ith a significant decrease between days three and six (a<0.05).
M edian values were 994, 278, and 37 pm ol/24 hours for days one, three, 
and six respectively. No significant changes were seen in SCAC excretion 
th roughou t the post-operative course, a lthough  there  w as a non­
significant tendency tow ards a lower concentration on day six. M edian 
values obtained were 458, 635, and 164 pm ol/24 hours for days one, three, 
and six respectively.
There were no significant differences in urinary excretion of FC, SCAC or 
TASC betw een the two groups. Data from  these m easurem ents are 
presented graphically in figures 3.5 to 3.7 (page 99). W ithin each group 
there were significant progressive decreases in urine TASC throughout the 
post-operative course. An inverse relationship  w as dem onstra ted  
betw een 24 hour carnitine excretion and  n itrogen  balance, and  a 
significant correlation (r=0.5) for this relationship was found (p<0.05). 
Correlation analysis revealed a significant direct relationship betw een 
urinary TASC and circulating ketone body concentrations on day six post­
surgery, prior to this no relationship was found between these parameters.
Serum carnitine concentrations are presented graphically in  figures 3.8 to 
3.10 (page 101). The m edian serum TASC concentration prior to surgery, 
for the group as a whole, was 51.6 (20.2-95.8) pm ol/L . Following surgery 
there were no significant changes in serum  TASC on days one and three, 
although there was a tendency towards decreased concentrations, and by 
day six concentrations had significantly decreased to 30.2 (11.5-111.0)
pm ol/L  (a<0.05). Prior to surgery the median serum FC concentration was 
36.9 (14.9-85.1) jim ol/L . Surgery d id  not significantly alter serum  FC 
concentrations. The pre-operative value for serum SCAC was 5.8 (4.0-31.8) 
pm ol/L.
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Figures 3.8 - 3.10 Serum Carnitine Concentrations (pmol/L) Prior to and 
Following Surgery for the Group as a W hole (n=19). Figure 3.8: Total 
Acid Soluble Carnitine (TASC); Figure 3.9: Free Carnitine (FC); Figure 
3.10: Short Chain Acyl Carnitine (SCAC). M edian Values (with ranges).
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Figures 3.11 - 3.13 Comparison of Serum Carnitine Concentrations 
(fimol/L) between Normoketonaemic (N) and Hyperketonaemic (H) 
groups Prior to and Following Surgery; Figure 3.11: Total Acid Soluble 
Carnitine (TASC); Figure 3.12: Free Carnitine (FC); Figure 3.13: Short 
Chain Acyl Carnitine (SCAC). Median Values (with ranges)
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There was a non-statistically significant trend tow ards increased serum  
SCAC following surgery on day one. No significant changes in SCAC were 
observed throughout the post-operative period. N o relationship was 
found betw een circulating concentrations of ketone bodies and serum  
SCAC.
Figures 3.11 to 3.13 (page 102) compare circulating concentrations of serum 
carnitine fractions betw een norm oketonaem ic and  hyperketonaem ic 
patients. Figure 3.11 shows a higher m edian serum  TASC value in the 
hyperketonaem ic group pre-surgically although this difference d id  not 
quite reach statistical significance. Following surgery there were no 
statistically significant differences in serum TASC concentrations between 
the two groups. Likewise, there were no significant difference in serum  
FC concentrations between the two groups on any day studied. A non- 
statistically  significant trend  tow ards h igher serum  SCAC in the 
hyperketonaemic group pre-surgically and on day one following surgery 
was noted.
Serum NEFA and Glycerol Concentrations
Pre and post-surgical values for serum NEFA concentrations are presented 
in table 3.3 (page 104). A wide range of values was obtained on all days 
studied . Surgery d id  not resu lt in a significant change in  NEFA 
concentration, nor did concentrations alter significantly during the post­
operative course. A direct relationship was dem onstrated between serum  
NEFA concentrations and circulating ketone bodies pre-operatively (r=0.57 
p<0.03), and on all post-operative days studied (r=0.57 p<0.03). Figure 3.14 
(page 105), show s a com parison of NEFA concentrations betw een 
norm oketonaem ic and hyperketonaem ic groups. Prior to surgery no 
significant difference in NEFA concentration existed betw een the tw o 
groups. Following surgery, the hyperketonaem ic group show ed a non- 
statistically significant trend tow ards raised NEFA concentrations. N o 
change in NEFA concentration was observed in the norm oketonaem ic 
g roup  follow ing surgery. O n day  one fo llow ing  su rg e ry  the
103
hyperketonaem ic group had significantly higher NEFA concentrations 
than the norm oketonaem ic group (a<0.01); m edian values w ere 0.55
(0.22-1.06) m m ol/L  and 0.91 (0.05-1.31) m m ol/L , for normoketonaemic and 
hyperketonaem ic groups respectively. Concentrations of NEFA w ere 
similar in both groups on the third post-operative day. However, on the 
sixth post-operative day concentrations were once m ore significantly 
higher in the hyperketonaemic group (a<0.05).
Table 3.3 Circulating Concentrations of Lipid Metabolites and Glucose of 
All Patients, Prior to Surgery and On Days one, three, and six Following 
Surgery. Median Values (with ranges), n=19.
PRE-SURGERY POST-SURGICAL DAY
0 1 3 6
TOTAL KETONES 0.11 0.18 0.17 0.10
mmol/L (0.05-0.73) (0.02-0.61) (0.05-0.81) (0.03-1.24)
fi HYDROXYBUTYRATE 0.04 0.11 0.08 0.03
mmol/L (0-0.73) (0-0.46) (0.01-0.39) (0.00-0.58)
ACETOACETATE 0.08 0.09 0.16 0.13
mmol/L (0.03-0.64) (0.03-0.25) (0-0.42) (0.03-0.66)
NEFA 059 0.63 051 054
mmol/L (0.06-1.89) (0.05-1.31) (0.08-1.67) (0.04-1.55)
GLYCEROL 0.07 0.05 0.05 0.04
mmol/L (0.01-0.62) (0.02-0.93) (0.01-057) (0.02-0.11)
GLUCOSE 5 .1 ---------  • — — -  7.4 6.4 7.2
mmol/L (4.2-8.1) (3.8-10.9) (4.8-10.2) (4.6-10.4)
• a<0.001 Wilcoxon signed ranks test.
104
Figure 3.14
Com parison of Serum Non-Esterified Fatty Acid (NEFA) Concentrations 
(mmol/L) betw een Norm oketonaem ic (N) and H yperketonaem ic (H) 
Groups Prior to and Following Surgery. M edian Values (with Ranges).
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I
** a<0.01
FIGURE 3.14
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*** a <0.05) Mann-Whitney Test 
a - denotes a significant difference between groups
Circulating concentrations of glycerol are presented in table 3.3 (page 104). 
Concentrations of glycerol were relatively low pre-operatively and surgery 
did  not cause a significant change. W hen the norm oketonaem ic and 
hyperketonaemic groups are compared (figure 3.15 page 106), pre- 
operatively no significant difference between the two groups existed. 
There was a non-significant trend towards higher glycerol concentrations 
in the hyperketonaemic group on day one following surgery.
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Figure 3.15 Com parison fo Serum  Glycerol Concentrations (mmol/L) 
betw een Normoketonaemic (N) and Hyperketonaemic (H) Groups Prior to 
and Following Surgery. M edian Values (with Ranges).
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The Response of Blood Glucose Concentration to the Surgical Procedure
Data from blood glucose measurement are presented in table 3.3 (page 104). 
Glucose concentrations significantly increased in response to surgery, from 
a m edian pre-operative value of 5.1 (4.2-8.1) m m ol/L , to 7.4 (3.8-10.9)
m m ol/L , on the first day follow ing surgery  (a<0.001). Thereafter
concentrations did not significantly alter. Figure 3.16 (page 107) compares 
c ircu lating  glucose concentrations betw een norm oketonaem ic and  
hyperketonaem ic groups. Prior to surgery, no significant difference in 
glucose concentration existed between the two groups. On the first post­
operative day, the norm oketonaem ic group had  significantly h igher 
circulating glucose concentrations com pared to the hyperketonaem ic
group (a<0.05). Median concentrations were 8.4 (5.8-10.5) m m ol/L , and 6.8 
(3.8-10.9) m m o l/L , respectively. S ign ifican tly  h ig h e r  g lucose  
concentra tions w ere m ain ta ined  in  the  norm oketonaem ic g roup
throughout the post-operative period (a<0.05). No association was found 
betw een circulating concentrations of glucose and ketone bodies. There
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was, however, a significant positive relationship betw een circulating 
glucose concentrations and nitrogen loss on the sixth post-operative day 
(r=0.677, p<0.05). No relationship between these two param eters was 
found on any other post-operative day.
Figure 3.16 Com parison of Plasma Glucose Concentrations (mmol/L) 
betw een Normoketonaemic (N) and Hyperketonaem ic (H) G roups Prior to 
and Following Surgery. M edian Values (with Ranges).
FIGURE 3.16
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a - denotes a significant difference between groups 
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Circulating Concentrations of Metabolic Hormones Following Surgery
Insulin concentrations prior to and following surgery are presented in 
table 3.4 (page 109). There was no statistically significant alteration in 
insulin concentration following surgery, although a w ide range of 
individual concentrations were obtained, ranging from 18 to 536 pm ol/L . 
Correlation analysis revealed no relationship betw een circulating insulin 
concentrations and energy intake. A comparison of circulating insulin 
concentrations in norm oketonaem ic and hyperketonaem ic groups is
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presented in figure 3.17. Prior to surgery no significant difference between 
the two groups existed. Following surgery there was a significant increase 
in insulin  concentration in the norm oketonaem ic group only. M edian 
concentration increased from a pre-surgical value of 105, to 168 pm ol/L
(a<0.05). No further significant changes were observed subsequent to this. 
On the first day following surgery the norm oketonaem ic group had 
significantly higher circulating insulin concentrations (168 (47-536)
pm ol/L ), than the hyperketonaemic group (76 (18-222) pm ol/L ) (a<0.05). 
O ther than this no significant differences between the tw o groups existed. 
Correlation analysis revealed an inverse relationship betw een circulating 
insulin and ketone body concentrations (r=0.33, p<0.01). W hen this 
relationship was investigated on individual days studied, excluding the 
pre-operative m easurem ents strengthened the relationship (r=0.42 
p<0.004). The strongest correlation existed on the first post-operative day, 
when the correlation coefficient was 0.53 (p<0.017).
Figure 3.17 Com parison of Plasma Insulin  Concentrations (pmol/L) 
betw een Normoketonaemic (N) and Hyperketonaem ic (H) G roups Prior to 
and Following Surgery. M edian Values (with Ranges).
HGURE 3.17 
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a - denotes a significant difference between groups
b - denotes a significant difference within a group between days
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Table 3.4 Circulating Concentrations of M etabolic Hormones Prior to
(PO), and Following Surgery in, Normoketonaemic and Hyperketonaem ic 
Groups and of All Patients as One Group. M edian Values (and ranges).
NORMOKETONAEMIC 
DAY (n=10)
INSULIN PO 
pmol/L
1
3
6
GLUCAGON PO 
pmol/L
1
HYPERKETONAEMIC ALL PATIENTS
105-----
(28-486)
1 6 8 -----
(47-536)
75
(38-345)
163
(61-364)
5
(5-31)
9
(5-44)
7 --------
(5-58)
5 ----
(5-8)
D» • •
(n=9) (n=19)
86 104
(31-545) (28-545)
76 133
(18-222) (18-536)
74 78
(30-198) (30-345)
111 110
(16-309) (16-364)
5 5
(5-54) (5-54)
9 8
(5-53) (5-53)
5 5
(5-10) (5-58)
9 5
(5-91) (5-91)
CORTISOL PO 
nmol/L
1
503
(163-4385) 
807 --------
(379-1285)
579 --------
(418-1183)
555
(289-732)
b* • •
451
(151-1016)
743
(366-1792)
414
(325-864)
489
(95-717)
457
(151-4385) 
764 --------
(366-1792) 
528 -------
(325-1063)
530
(95-1507)
b*«*
• • •
• •
a<0.05 Mann-Whitney Test 
a<0.05 )
a<0.01 ) Wilcoxon signed ranks test
a - denotes a significant difference between groups 
b - denotes a significant change within a group between days.
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Pre and post-operative concentrations of plasma glucagon are presented in 
table 3.4 (page 109). On day one following surgery the group as a whole 
only showed a non-statistically significant trend towards raised glucagon 
concentrations. No statistically significant changes w ere observed in 
circulating glucagon concentrations throughout the post-operative period. 
Table 3.4 (page 109) presents a comparison of glucagon concentrations 
between the two groups. No significant differences existed between the 
two groups on any day m easured. In the norm oketonaem ic group a 
significant decrease in glucagon concentration was observed between the 
third and sixth post-operative day (a<0.05).
Circulating concentrations of cortisol are presented in table 3.4 (page 109). 
On day one follow ing surgery there was a tendency for cortisol 
concentrations to increase, but this did not reach a level of significance. 
Between days one and three following surgery there was a significant
decrease in cortisol concentration in the group as a whole (a<0.05), from 
764, to 528 nm ol/L . There were no significant differences between the two 
groups prior to or following surgery. The significant decrease betw een 
days one and three was only observed in the norm oketonaem ic group
(a<0.05), who had m edian plasma cortisol concentrations of 807 and 579 
nm ol/L  for days one and three respectively.
Indices o f Protein Status: Nitrogen Balance, Plasma Albumin and
Plasma/IGF-1,
Table 3.5 (page 111) presents data from nitrogen balance calculations. All 
patients were in negative nitrogen balance on all post-operative days 
m easured. M edian values were -10.4, -4.7, and -6.7 g /2 4  hours for days 
one, three, and six respectively. On the first post-operative day there was a 
trend tow ards m ore negative nitrogen balance in the norm oketonaem ic 
group, although this did not reach statistical significance.
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Table 3.5 Indices of Protein Status Nitrogen Balance, Plasma A lbum in 
and IGF-i. Prior To and Following Surgery, in  N orm oketonaem ic and 
Hyperketonaem ic Groups and All Patients as One Group. M edian Values 
(and ranges).
NORMOKETONAEMIC HYPERKETONAEMIC ALL PATIENTS
DAY
NITROGEN 
BALANCE 
g /24  hours
-13.8
(-4.5--23.1)
•6.8
("1.0-H.0)
6.3
(-2.5-15.8)
-10.4
(-Q5--27.9)
-4.6
C3.8--92)
7.9
(-3.7--8.4)
-10.4
(-0.5--27.9)
-4.7
( 1 .0-1 1 .0)
-6.7
(-2.5-15.8)
PLASMA
ALBUMIN
g/L
PO
Change from 
admission to 
discharge
35------
(24-42)
2 9 1 =
(22-35) 
21------
(17-33)
26
(18-32)
-9
( - ^ - -20)
. . b
35  ------
(27-45)
2 5 ------
(21-28)
27
(18-34)
28
(21-34)
-6
(-3-17)
..b
3 5 ------
(24-45) 
25------
(21-35)
23
(17-34)
26
(18-34)
-6
( + 2--20)
• •b
PLASMA
IGF^
U/m L
Change from 
admission to 
discharge
PO
1
3
0.48
(0.24-0.58)
0.36 ----------
(0.16-0.53)
0 .24----------
(0.12-0.38)
0.26
(0.08-0.36)
- 0.22
C0i3--033)
• • •b
0.57
(0.24-0.84)
0.32
(0.16-0.92)
0.28
(0.16-0.68)
024
(0.12-0.41)
-0.30
(-0.12--0.52)
0 .55----------
(0.25-0.84)
0.32
(0.16-0.92)
0 .28----------
(0.12-0 .68)
025
(0.08-0.41)
- 0.22
(-0.12--052)
•** a<0.05 Mann-Whitney Test
• • •  a<0.05)
• •  a<0.01 ) Wilcoxon signed ranks test
a - denotes a significant difference between groups 
b - denotes a significant change within a group between days. 
PO - pre-operative day
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No relationship existed between nitrogen balance and ketone body 
concentrations during the post-operative course. Correlation analysis did, 
however, reveal a significant inverse relationship betw een nitrogen 
balance and circulating glucose concentrations on day six following 
surgery (r=0.677 p<0.05).
Plasma albumin concentrations are presented in table 3.5 (page 111). Pre- 
operative concentrations ranged from 24 to 45 g /L , the m edian value being 
35 g /L . Surgery resulted in a significant decrease in serum  albumin 
concentrations to 25 (21-35) g /L , on day one post surgery. Following this 
there were no further significant changes during the post surgical period 
of study. The m edian value for change in serum  album in from  adm ission 
to discharge was -6 g /L  and concentration changes ranged from +2 to -20 
g /L . Prior to surgery, plasma albumin concentrations did not differ 
significantly between normoketonaemic and hyperketonaem ic groups. In 
the norm oketonaem ic group plasm a album in significantly decreased from 
a pre-operative value of 35 (24-42) g /L , to a day one value of 29 (22-35) g /L
(a<0.01) and again to 21 (17-33) g /L , on day three following surgery
(a<0.05). In the hyperketonaemic group, a significant decrease in plasm a 
albumin concentration was observed on the first post operative day, from 
a baseline value of 35 (27-45) g /L , to 25 (21-28) g /L  (a<0.01). Following this 
concentrations were sustained. The only statistically significant difference 
between the two groups was on day one, w hen the norm oketonaem ic
group had significantly higher plasma albumin concentrations (a<0.05).
Concentrations of plasma IGF-1 are presented in table 3.5 (page 111). Pre­
operative values for the group as a whole, range from 0.25 to 0.84 U /m l 
w ith a m edian value of 0.55 U /m l. There was a significant decrease in
IGF-1 concentrations following surgery to 0.28 (0.12-0.68) U /m l (a<0.01). 
The m edian change in IGF-1 from admission to discharge was -0.22 U /m l, 
and ranged from "0.12 to "0.52 U /m l. W hen the two groups are com pared, 
no statistically significant difference in IGF-1 concentrations existed.
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Anthropometric Measurements in Surgical Patients
Patient body weights are presented in table 3.6 (page 114). Additional 
inform ation on pre-adm ission weight loss and percentage ideal w eight is 
presented in table 3.x in Appendix A (page 262). M edian admission weight 
of the group as a whole was 66.4kg and ranged from 48.8 to 86.0 kg. On 
discharge, m edian weight loss was -2.8 kg and changes ranged from +1.6 to 
-6.1 kg. There were no significant differences in weight between the two 
groups on either admission or discharge. Two patients from each group 
showed a weight loss of 10% or m ore in the six months preceding surgery. 
One patient from each group had an admission weight, w hen corrected for 
height, below 90% ideal. There was no significant difference in w eight loss 
between the two groups.
Changes in triceps skinfold thickness (TSF) from admission to discharge 
ranged from 0 to -9.2 mm, w ith a m edian value for change of -2.5 mm. 
Pre-operative values ranged from 5 to 29.3 mm, the m edian adm ission 
value being 20.0 mm (table 3.6 page 114). W hen norm oketonaem ic and 
hyperketonaemic patients were compared, the hyperketonaem ic group 
had significantly smaller TSF on admission; m edian values obtained were 
20.9 (19.0-29.3) mm, and 16.2 (5-26.3) mm, for norm oketonaem ic and 
hyperketonaemic groups respectively. There was no significant difference 
in change in TSF from admission to discharge between the two groups.
No significant changes in MUAMC were observed betw een adm ission and 
discharge in either group. There was no significant difference in MUAMC 
between the two groups on admissions or discharge. There was, however, 
a non-statistically significant trend tow ards smaller losses of MUAMC in 
the hyperketonaemic group.
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Table 3.6 Anthropom etric M easurem ents on Adm ission and Discharge in  
Norm oketonaem ic and Hyperketonaem ic Groups and All Patients. 
M edian Values (and ranges).
ADMISSION DISCHARGE CHANGE FROM 
ADMISSION TO 
DISCHARGE
WEIGHT Kg
NORMOKETONAEMIC 77.3 71.8 -2.9 "#b
(48.8-86.0) (46.0-84.0) (+1.6--6.1)
HYPERKETONAEMIC 67.0 63.0 -2.6 •••b
(51.4-72.0) (48.8-70.0) (t0.2--5.4)
ALL PATIENTS 66.4 63.1 -2.8 ••b
(48.8-86.0) (455-84.0) (+1.6--6.1)
MID-UPPER ARM MUSCLE
CIRCUMFERENCE (cm)
NORMOKETONAEMIC 21.61 2126 -0.26
(17.06-23.82) (17.42-23.62) Cl.76--0.61)
HYPERKETONAEMIC 2152 2057 -0.11
(18.24-26.34) (1856-26.10) (•4.41-1.89)
ALL PATIENTS 21.52 20.60 -0.11
(17.06-26.34) (17.42-26.10) (-4.76-1.89)
TRICEPS SKINFOLD
THICKNESS (mm)
NORMOKETONAEMIC 20.9------------1 19.4 -2.6 ••h
(19.0-29.3) **a (11.3-26.0) C0.9--9.2)
HYPERKETONAEMIC 16.2----- — * 16.0 -25 **b
(5-26.3) (4-24.1) (0--6.0)
ALL PATIENTS 20.0 18.1 -25 »b
(5.0-29.3) (4.0-26.0) (0--92)
** a<0.01 Mann-Whitney Test
••• a<0.05 )
e$ a<0.01 ) Wilcoxon signed ranks test 
a<0.001)
a - denotes a significant difference between groups
b - denotes a significant change within a group from admission to discharge
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3.2.4 DISCUSSION
Patient Numbers
It was anticipated that 30 patients w ould be studied, however, only 19 
patients were included in the final analysis. Potential subjects were 
eliminated from the study group for reasons such as; failure to obtain pre­
operative samples, failure for the intended operation to proceed, death, 
collection of insufficient data, and volunteers w ithdrawing from the study. 
In addition to these reasons, senior nursing staff im posed a lim it on the 
num ber of patients to be studied at any one time, due to the nursing time 
involved in the collection of 24 hour urine samples. A m inority  of 
patients who received adequate specialised nutritional support, were also 
excluded from the analysis. Data from such patients are considered in the 
following section (3.3 page 135).
Considering the group as a whole, 19 patients is an acceptable num ber for 
an observational study. However, when patients were sub-divided into 
two groups, numbers involved were small. This m ay have contributed to 
the num ber of non-statistically significant trends observed, from which no 
conclusion could be drawn. Nevertheless, a comprehensive set of data 
was obtained, despite the small num bers, from w hich a num ber of 
significant findings were observed.
Ketotic Status Following Surgery
The w ide range of values ob tained  for circu lating  ketone body  
concentrations illustrates that individual patients vary considerably in 
their ketotic response to surgery. Looking at this group of surgical patients 
as a whole, it appears that no significant change in ketone body  
concentration occurred in response to surgery. However, w ithin this group 
exists a subsection of patients who showed a significant increase in ketone 
body concentrations following surgery. Previous studies have subdivided 
post-surgical or accidental injury patients into two groups according to
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their circulating ketone body concentrations (Smith et ah, 1975; Rich and 
W right, 1979), and have used 0.2 m m ol/L  as the cut off point to 
discrim inate norm oketonaem ia and hyperketonaem ia. This value was 
used in the present study to subdivide patients according to their ketotic 
response, to enable comparison to be m ade w ith previous investigations. 
Fifty three percent of patients in the present study belonged to the 
norm oketonaem ic group, indicating that over half the patients failed to 
achieve a heightened ketosis following surgery. Smith et al. (1975) found a 
50% incidence of norm oketonaem ia (<0.2 m m ol/L), following accidental 
injury, which is comparable to the present study. W illiamson and Smith 
(1980) found a 65% incidence of norm oketonaem ia in injured patients. 
Rich and W right (1979) found a higher incidence of 75.5% 
norm oketonaem ia in surgical patients; although in their study  patients 
were categorised prior to surgery, according to their ketotic response to an 
overnight fast. Smith et al. (1975) reported ketone values of 0.05 (±0.01) 
m m ol/L , and 0.18 (±0.02) m m ol/L  for norm oketonaem ic and
hyperketonaem ic groups following injury. These are relatively lower than 
those obtained in the present study of 0.12 (0.02-0.18) m m ol/L , and 0.32 
(0.20-0.61) m m ol/L , for normoketonaemic and hyperketonaem ic groups 
respectively. Rich and W right (1979), report values of 0.008 (±0.045) 
m m ol/L  and 0.34 (±0.1) m m ol/L  for norm oketonaem ic and
hyperketonaemic surgical patients respectively. Foster et al. (1979) 
m easured circulating ketone concentrations in patients following 
abdominal surgery and obtained a slightly higher value than those 
previously cited, of 0.80 (± 0.28) m m ol/L , although this m easurem ent was 
taken 48 hours into the post-operative period in patients who were being 
m aintained on electrolyte solutions only. Hyperketonaem ia per se has 
not yet been fully defined. Following an overnight fast, adult subjects 
usually have ketone body concentrations of 0.1 to 0.4 m m ol/L  and the rate 
of ketogenesis may be 0.2-0.4 m m ol/m inute (Balasse and Fery, 1989). In a 
prolonged fast, circulating concentrations of 7-10 m m ol/L  have been 
reported and this concentration is achieved w hen peripheral uptake has 
become saturated (Balasse and Fery, 1989). In the hyperketonaemic 
group, in the present study, ketone body concentrations were relatively
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low  (0.32 (0.2-0.61) m m ol/L ), and  fell som ew here betw een  the 
concentrations observed following an overnight fast and those observed 
in prolonged (five days) starvation, although it should be noted that the 
majority (75%) of patients were receiving dextrose saline at the time of 
blood sampling. This data suggests that it is not just the absence of energy 
intake during surgery which is responsible for raised ketones. In the 
patients who achieved heightened ketosis following surgery intravenous 
dextrose solutions did  no t inhibit ketosis suggesting tha t the stress 
response to surgery overrides the norm al response to fuel provision. 
W ith this in m ind, it could be argued that the normoketonaemic group 
w ere less stressed and therefore ketosis was prevented by intravenous 
dextrose solutions. However, there was no evidence from  the present 
study to suggest that this group was less severely stressed, and in addition 
to this, previous studies have found tha t it is in  the m ore highly 
metabolically stressed patients that dam pened ketosis is observed (Smith 
et a l., 1975). In the studies of Smith and coworkers, of patients following 
accidental injury, moderately stressed patients had circulating ketone body 
concentrations of 0.20 (0.08-0.49) m m ol/L , while those in the severely 
stressed category had lower ketone body concentrations of 0.14 (0.06-0.29) 
m m ol/L .
The potential factors which may have contributed to the difference in 
ketotic response, observed in the present investigation, were considered. 
The first possibility to consider is that differences in energy intake and 
dextrose infusion, at the time of blood sampling, may account for variable 
ketosis. The patients w ho w ere receiving dextrose free electrolyte 
solutions at the tim e of the day  one blood sam ple d id  no t have 
significantly h igher ketone body concentrations com pared to those 
patients receiving intravenous dextrose. It should also be noted that the 
normoketonaemic group contained three patients who were not receiving 
dextrose at the tim e of day one blood sampling. The m ost im portant 
consideration is that no statistically significant difference in energy intake 
or intravenous fluid regimen existed between the two groups, at the time 
of day one blood sampling. Further evidence for a non-influential effect
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of energy intake was provided by correlation analysis, which revealed no 
association between day one energy intake and circulating ketone body 
concentrations.
Data in table 3.1 (page 94) shows that there were no major differences in 
the nature of the surgical procedures undergone by the tw o groups and 
bo th  groups contained patien ts adm itted  for a varie ty  of surgical 
procedures. N either were there significant differences in pre-surgical 
nutritional status between the two groups, both groups contained well 
nourished, mild, m oderate and severely m alnourished patients, indicated 
by the w ide range of nutrition scores obtained for each group. M edian 
scores indicated that the majority of patients only show ed signs of m ild 
m alnutrition. The nutrition score used was based upon the Southampton 
N utritional Assessment Profile (SNAP score) (Karran, 1982). This is a 
m ultivariable nutritional assessment, incorporating both anthropom etric 
and biochem ical indices. W hen the score is split in to  its various 
components (table 3.x. Appendix A, page 262), each group contained a 
similar num ber of underw eight patients and a similar num ber of patients 
w ith recent weight loss. Often, percentage ideal weight is the only criteria 
used to categorise patients according to nutritional status. It is not truly 
known how ideal such standards are. Comparison with usual body weight 
m ay avoid the use of tables, but relies on memory recall which m ay be 
poor. If percentage ideal w eight (<90%) had been used to categorise 
patients into m alnourished and adequately nourished in the  p resent 
study, only one patien t from each group w ould have fallen into the 
m alnourished group. The nutrition score revealed four patients w ith 
scores above 4, indicating m oderate malnutrition. Percentage ideal weight 
m ay underestim ate the incidence of undem utrition. However, it could 
also be argued that multifactorial assessment overestimates the incidence 
of undernutrition, as suggested by Dempsey, M ullen and Buzby (1988). 
A lthough identification of undem utrition  is an im portant issue, for the 
purpose of the present study, so long as the criteria used w ere able to 
identify  differences betw een the tw o groups they w ere considered 
acceptable.
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N ature of surgery, pre-operative nutritional status, or sex differences, are 
unlikely to account for differences observed in the ketotic response to 
surgery. The significant difference in age between the two groups could 
perhaps suggest that blunted ketosis is age related, although no 
relationship was found between age and day one ketone concentrations or 
change in ketone body concentrations in response to surgery. Previous 
studies have not reported any relationship between age and ketotic 
potential following injury or surgery, although Foster et al. (1979) found a 
tendency towards higher ketone body concentrations in older patients.
Carnitine Status of Surgical Patients and its Relationship to Post- 
Operative Ketosis
W hen observing the group as a whole, the m edian pre-operative value 
for serum  TASC of 51.6 pm ol/L  was not significantly different to that 
obtained for norm al individuals m easured by the same investigator of 48.6 
(31.5-60.2) pm ol/L  (Chapter 2, section 2.3, page 50). N anni et al. (1985a) 
obtained a pre-surgical value for plasma TASC of 46 Ct4.7) pm ol/L , which 
is comparable to the present value. If serum  carnitine is indicative of 
carnitine status, this data suggests that the group as a whole were not 
carnitine depleted prior to surgery. The fall in serum  carnitine by the sixth 
day following surgery may reflect an absence of exogenous carnitine from 
dietary sources, or m ay reflect a reduced carnitine pool resulting from 
increased loss in the urine. Reduced circulating carnitine concentrations 
have been reported previously in surgical patients receiving total 
parenteral nutrition (TPN), bu t no exogenous carnitine (Hahn, Allardyce 
and Folich, 1982). However, in their study, H ahn and coworkers did not 
observe a significant reduction in serum  carnitine until three weeks 
following the carnitine free regimen. Data from the present study 
therefore suggests that urinary carnitine loss, in addition to absence of 
exogenous carnitine supply, m ay be responsible for the m ore rap id  
reduction in circulating carnitine concentrations seen. H igher losses of 
urinary carnitine in the present study may be due to a greater degree of
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catabolism, a possible consequence of inadequate nutrien t provision. 
N ann i et al. (1985a), in a study of surgical patients, obtained plasma 
carnitine values of 52 pm ol/L  and 57 pm ol/L , for septic and non-septic 
patients respectively. These values were slightly higher that the pre- 
surgical value of 46 pm ol/L , and than the values obtained in the present 
study, considering these measurements were taken between days one and 
tw enty following surgery, and patients were receiving no exogenous 
carnitine. More comparable to the present findings were those of 
Cederblad, Larsson and Schildt (1984). In their study of injured patients, 
initial plasm a carnitine concentrations w ere no different from  norm al, 
and averaged 51.4 pm ol/L . However, concentrations declined to 37.8 
|im o l/L  on the forth day following injury.
The trend tow ards higher pre-surgical serum  TASC values in the 
hyperketonaemic group, may suggest that more carnitine was available 
pre-surgically for post-surgical ketosis. This observation w arrants further 
investigation of pre-surgical TASC and day one ketone concentrations, in a 
larger num ber of patients, as no previous study appears to have 
investigated the effect of pre-surgical carnitine availability on subsequent 
ketosis.
In general, no differences in serum  carnitine existed betw een the two 
groups, and correlation analysis confirmed that no relationship existed 
between circulating carnitine concentrations and ketone body 
concentrations. It m ust not be overlooked that the relationship betw een 
serum  carnitine and whole body carnitine status is not clear. For this 
reason it m ay be argued that m easurem ents of muscle and liver carnitine 
w ould have been more appropriate in these patients. For obvious reasons 
it was not possible to obtain such tissue samples. Inform ation on urinary  
carnitine excretion, however, supplem ents data on serum  carnitine 
m easurem ents, providing inform ation on net carnitine losses and 
possible changes in the body carnitine pool. In the present study, data 
indicated that urinary carnitine loss is increased substantially following 
surgery. The m edian value for 24 hour urinary carnitine excretion, for the
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first post-surgical day, of 1849 (123-3967) pm ol, was greater than that 
obtained for healthy adults in the same laboratory of 103 (42-268) p m o l/24 
hours (Chapter 2, section 2.3, page 51). Urinary carnitine loss progressively 
decreased throughout the post-operative period to 345 p m o l/24 hours, 
which is m ore comparable to values obtained for normals. O ther studies 
have reported increased carnitine excretion following surgery and injury 
(N anni et al.. 1985a; Cederblad, Larsson and Schildt, 1984). N anni and 
coworkers (1985a) found surgical patients to excrete significantly greater 
quantities of carnitine compared to controls, although their value of 688 
pm ol/24  hours is an average of 41 patients taken between the first and 
tw entieth day following surgery, so a direct comparison w ith data from the 
present study is not possible. Nanni and coworkers (1985a) reported a 
higher value for surgical patients who developed sepsis, of 1214 pm ol/24  
hours (average of 42 patients between first and twentieth day post sepsis). 
A part from the study of N anni et al. (1985a), and the present study, very 
little inform ation is available on urinary  carnitine losses following 
surgery. The findings of Cederblad, Larsson and Schildt (1984), in a study 
of injured patients, are very similar to those of the present study. They 
found initial losses were high, averaging 1500 pm ol/24  hours on the 
second day following injury. Similar to the present study they found 
losses decreased by day four to 750 pm ol/24  hours. In norm al individuals, 
higher urine carnitine losses have been reported in m ale subjects 
compared to female subjects. In the present study no difference in 
carnitine excretion existed between the sexes. The effect of traum a is likely 
to mask any underlying differences in carnitine excretion due to sex or 
muscle mass. No correlation was found between urinary  carnitine 
excretion and MUAMC (indicative of muscle mass).
The observation that carnitine excretion decreases w ith tim e following 
injury, suggests that it may be related to the degree of traum a. As traum a 
subsides and muscle catabolism decreases, so urinary carnitine loss m ay 
decrease. This theory was supported by the direct relationship between net 
nitrogen loss and urinary carnitine excretion in the present study. This 
relationship has also been found by previous investigators (Cederblad et
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1983; lapichino et al., 1988). In a study of m ultiply injured patients, 
Cederblad and coworkers (1983) found a significant correlation between 
urine total carnitine and net nitrogen loss during eight days following 
injury. lapichino et al. (1988) found carnitine excretion to be negatively 
related to nitrogen balance, and suggested its use as a catabolic index. They 
found that raised urinary carnitine excretion following injury was due to 
an increased excretion of the non-esterified form, the present findings 
were in agreem ent with this observation. It m ay be concluded that raised 
excretion of carnitine following injury and surgery is m ore likely to be a 
direct consequence of substrate efflux from muscle, and is unlikely to 
reflect changes in lipid metabolism. Excretion of urinary carnitine m ay be 
a more sensitive and specific index of catabolism than nitrogen balance, as 
the latter relies on estim ation of nitrogen intake and is often based on urea 
nitrogen excretion which m ay underestim ate losses. M easurem ent of 
urinary  carnitine is, however, m ore technically difficult than urea 
determ ination. There was very little difference in carnitine excretion 
betw een normoketonaemic and hyperketonaemic groups. The trend 
tow ards higher TASC excretion in the norm oketonaem ic group on the 
first post-surgical day possibly reflects a greater degree of stress in these 
patients.
Carnitine m ay only become a lim iting factor in ketogenesis w hen there is 
insufficient available. In the present study there was no evidence of 
carnitine insufficiency. However, if lipid is to be used as an exogenous fuel 
source, this will increase carnitine requirements. This, coupled w ith 
urinary losses shown to occur in the present study, m ay ultim ately lead to 
a state of carnitine insufficiency and possible im pairm ent of lipid 
metabolism. So although it is unlikely carnitine was a lim iting factor in 
lipid m etabolism in the present study, in which patients were only 
observed in the short term and did not appear to be severely stressed, 
carnitine m ay become a limiting factor in patients who are stressed to a 
higher degree, over a longer period of time. More severely stressed 
patients, apart from having potential greater loss of body carnitine, may 
rem ain on carnitine free regimens for a longer period of time.
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Circulating Concentrations of NEFA and Glycerol
NEFA concentrations were high on all days m easured. The reference 
range for norm al overnight fasted individuals is 0.2 to 0.6 m m ol./L  
(m anufacturers reference range, Wako Chemicals), m edian values were 
above or in the upper lim it of this range. Previous studies have also 
found high circulating NEFA in surgical and injured patients. Foster et al. 
(1979) obtained data comparable to that of the present study. These authors 
obtained values for serum  NEFA of 0.32 (±0.08), 0.86 (±0.15), and 1.01 
(±0.19) m m ol/L , for pre-surgery and days two and four following surgery 
respectively. They did not, however, observe such a w ide range of values 
as obtained in the present study. NEFA concentrations above the norm al 
range have also been reported in patients following accidental injury 
(Stoner et al.. 1979).
There w as no significant increase in serum  NEFA concentrations 
following surgery w hen the present study group were considered as a 
whole. Previous studies have reported significant increases in serum  
NEFA following surgery (Foster et al., 1979). In the present study, it could 
be argued that high pre-surgical values (reflecting reduced pre-surgical 
food intake) could have masked a significant increase in NEFA. However, 
a m ore probable explanation is that the group as a w hole contained 
patients who did, and who did not, exhibit lipolysis in response to surgical 
stress. In support of this, the hyperketonaemic group of patients showed a 
strong trend tow ards increased NEFA concentration following surgery, 
w hereas in  the norm oketonaem ic g roup  concentrations rem ained  
unchanged. On day one, the hyperketonaemic group had  significantly 
higher NEFA concentrations than the norm oketonaem ic group. This 
supports the concept of increased lipolysis in these patients, and suggests 
that NEFA availability m ay be a major factor determ ining the higher 
ketone body concentrations in this group. The studies of Smith et a l. 
(1975) also show ed that hyperketonaem ia w as associated w ith higher 
circulating NEFA concentrations. Stoner et a l. (1979) found a positive
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correlation between ketone bodies and circulating NEFA concentrations. 
Correlation analysis between these two variables in the present study, 
likewise revealed that a positive relationship exists. The low circulating 
concentrations of glycerol observed are not in keeping w ith the concept of 
increased lipolysis. Glycerol concentrations in the present study were also 
low in view of values previously reported. Clowes et al. (1976) report a 
value of 0.14 (±0.03)mmol/L, for post-surgical patients. Stoner et al. (1979) 
report values of 0.12 (0.07-0.19) m m ol/L , and 0.13 (0.06-0.25) m m ol/L , for 
m oderate and severely injured patients respectively. In the present study, 
the m edian value obtained for the group as a whole was 0.05 (0.02-0.93) 
m m ol/L , for the first post-surgical day. Raised NEFA concentrations in the 
absence of raised glycerol concentrations may indicate reduced peripheral 
uptake of fatty acids. However, at the present time, there is no theoretical 
basis for such a mechanism, and no supportive evidence for this proposal 
can be obtained from other studies. Alternatively the discrepancy between 
NEFA and glycerol m ay be an artifact effect arising from storage. NEFA 
concentrations have been reported to increase w ith storage due to in vitro 
hydrolysis of triglyceride. It is also possible that glycerol deterioration 
during storage accounts for the low values obtained. The latter proposal is 
probably the most likely.
Circulating Concentrations of Metabolic Hormones
Circulating concentrations of insulin w ere com paratively h igher than 
values previously reported following surgery Foster et a l. (1979) obtained 
values for plasma insulin of 5.7 (±0.8), 4.7 (±0.7) and 2.4 (±0.3) m U /L , for 
pre-surgery and days two and four following surgery respectively. Rich 
and W right (1979) obtained post-surgical insulin concentrations of 8.9 
(±1.3) and 3.6 (±0.4) m U /L , for normoketonaemic and hyperketonaem ic 
groups respectively. In addition to the relatively higher values, a m uch 
w ider range of concentrations were obtained in the present study. W hen 
the values in table 3.4 (page 109) are divided by a factor of 7.5 to convert to 
m U /L , day one post-surgical values of 22(6.3-71.5) and 10 (2.4-29) m U /L  
w ere obtained  for norm oketonaem ic and  hyperketonaem ic groups
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respectively. The present range of insulin concentrations obtained, for the 
group as a whole, were more comparable to those obtained by Smith et al. 
(1975) in patients following injury, of 1 to 87m U/L and 2 to 99m U/L for 
norm oketonaem ic and hyperketonaemic patients respectively. They 
found no significant difference between the two groups. In the present 
study, a significant difference in insulin concentration betw een the two 
groups was found on day one. Only the normoketonaemic group showed 
a significant increase in insulin concentrations as a result of surgery, and 
this is probably an im portant factor accounting for the difference in ketotic 
state. This observation was supported by the significant negative 
correlation which was found between insulin and ketone body 
concentrations. In agreem ent w ith the present findings. Rich and W right 
(1979) obtained lower insulin concentrations in hyperketonaem ic patients 
compared to normoketonaemic patients. It is possible that in the present 
study the metabolic actions of insulin on ketogenesis w ere not im paired, 
despite the fact that circulating glucose concentrations rem ained elevated. 
It is possible that insulin resistance is selective and does not effect all 
aspects of metabolism uniformly. Insulin concentrations were 
inappropriate to calorie intake and no significant relationship existed with 
energy intake. It is therefore possible that differences in stress were 
responsible for the differences in insulin concentration. It is not possible 
to evaluate w hat potential existed for counterregulatory horm ones to act 
against insulin in the present study, as catecholamines were not m easured. 
The relatively low concentrations of glucagon obtained m ay not reflect the 
overall status of counteregulatory hormones, but tended to suggest that 
the group as a whole may not have been severely stressed. The m edian 
day one glucagon concentrations obtained for the norm oketonaem ic and 
hyperketonaemic groups, of 9 (5-44) pm ol/L , and 9 (5-53) pm ol/L , are low 
w hen compared to those obtained by Rich and W right (1979) following 
surgery, of 71 (tl6) pm ol/L  and 63 (±10) pm o l/L  for norm oketonaem ic and 
hyperketonaemic patients respectively. In keeping w ith the findings of the 
present study. Rich and W right (1979) found no significant difference in 
glucagon concentrations between the two groups. Foster and coworkers 
(1979) report a value of 28 pm ol/L  for post-surgical patients, which lies
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between that of the present study and that of Rich and W right (1979). In 
both the studies of Foster et al. (1979), and Rich and W right (1979), a 
significant increase in glucagon concentration was observed following 
surgery. In the present study there was a strong trend towards elevated 
glucagon concentration, although not to a level of statistical significance. 
From the present data  it can be said that post-operative circulating 
concentrations of glucagon were not an im portant factor determ ining 
circulating ketone body concentrations. Glucagon concentrations m ay 
have been low due to dextrose inhibition, overriding the effects of stress.
A w ide range of post-operative cortisol concentrations, as seen in the 
present investigation, has also been found in previous studies. Values of 
sim ilar m agnitude to those presently reported  have also been found 
(Stoner et al., 1979). When compared to data of fasting subjects by Foster et 
(1979), the present values of post surgical patients are higher. Following 
a one day fast, Foster and coworkers (1979) recorded a value of 231 (±35) 
nm ol/L . In the present study, despite dextrose infusion in the majority of 
patients, day one median plasma cortisol concentration was 764 (366-1792) 
nm ol/L , and on day three was 528 (325-1063) nm ol/L . Foster et a l. (1979), 
report a value of 523 (±111) nm ol/L  for day one post surgical patients. 
Cortisol concentrations observed in the present study were therefore more 
than a response to semi-starvation. If cortisol concentrations are an index 
of metabolic stress, data from the present study suggests both groups of 
patients to be equally stressed. However, the reliability of plasm a cortisol 
as an index of stress is questionable, and no conclusions were m ade as to 
the relative severity of stress between the two groups on the basis of this 
m easurem ent alone.
The significant increase in blood glucose following surgery is probably a 
combined effect of increased hepatic output and intravenous (IV) dextrose 
infused, although patients who were being m aintained on dextrose free 
electrolyte infusions at the tim e of blood sam pling d id  n o t have 
significantly lower blood glucose concentrations. The increase in blood 
glucose in these patients may be in response to starvation, although Hartl
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et a l. (1988) found higher circulating concentrations of glucose in 36 hour 
fasted post-surgical patients compared to 36 hour fasted controls. The 
median values of 5.1 (4.2-8.1), 7.4 (3.8-10.9), 6.4 (4.8-10.2), and 7.2 (4.6-10.4) 
m m ol/L , for pre-surgery and days one, three, and six following surgery, are 
comparably higher than those reported by Clowes et a l. (1976), Foster et a l. 
(1979), and Rich and W right (1979). In their study of surgical patients, 
Foster and coworkers (1979) obtained mean plasma glucose concentrations 
of 4.9 (±0.3), 5.1 (±0.3) and 4.0 (±0.3), m m ol/L  for pre-surgery and days two 
and four following surgery respectively. Clowes et al. (1976) obtained a 
post-surgical value of 5.0 (±0.6) m m ol/L  in cases of uncomplicated surgery. 
Rich and Wright (1979) obtained values of 5.1 (±0.39) and 4.2 (±0.08), for 
norm oketonaem ic and hyperketonaem ic patients respectively, w hich 
although lower than values presently reported, they are sim ilar in that 
low er concentrations w ere observed in the hyperketonaem ic group. 
However, these authors did not find a significant increase betw een pre- 
surgical and post-surgical blood glucose. It is possible that the relatively 
higher blood glucose concentrations observed in the norm oketonaem ic 
group reflects a higher degree of stress in these patients. Clarke (1970) 
found that the m agnitude of increase in blood glucose following injury 
was related to the degree of stress.
Indices of Protein Status following Surgery,
The net nitrogen losses which occurred during the first 24 hours following 
surgery are comparable to values previously reported by Foster et a l. (1979) 
and Clowes et al. (1976), who reported values (average for the first three 
post-operative days) of -12.7 (±1.4) g per 24 hours and -14.0 (±2) g per 24 
hours, respectively. A direct comparison is not possible, as in the present 
study the second post-operative day was not m easured. Losses in  the 
present study were considerably low er than those reported  follow ing 
accidental injury (Smith et al., 1975). By the third post-operative day net 
nitrogen excretion had fallen below values observed in 72 hour fasted 
volunteers, for which values of -9 (±2) and -9.2 (±0.8) were obtained by 
Clowes et al. (1976) and Foster et a l. (1979) respectively. This data suggests
127
that, in the majority of patients, the catabolic effect of surgery was not 
prolonged. However, by the sixth post-operative day patients were still in 
negative nitrogen balance and a m edian loss of -6.7 (-2.5 — 15.8) g /24  
hours was observed. The w ide range of values suggests that in some 
patients the effects of surgical stress were still manifest, while in others 
nitrogen losses may have been little other than the consequence of semi­
starvation. It is possible that adequate nutritional support m ay have 
prevented losses in some patients; section 3.3 (page 135), investigates this 
possibility. W hen the average net nitrogen losses for the first post­
operative week are estim ated, (the average of days one, three and six 
m ultiplied by 7) and converted into the equivalent of lean body mass 
(LBM), the estimated loss of LBM during the first post-operative week was 
1.7kg. Previous research tends to suggest that protein losses observed are 
retractable to nutritional support. However, in the present study the data 
suggests that not all patients were severely traum atised and therefore the 
extent of protein loss, especially that caused by semi-starvation, could have 
been partially prevented by adequate nutrition.
On comparing nitrogen balance between the two groups there were trends 
tow ards sm aller losses in  the hyperketonaem ic g roup , a lthough  
differences betw een the two groups did not reach a level of statistical 
significance. Rich and W right (1979) found significantly smaller nitrogen 
losses in hyperketonaemic patients, mean values they obtained were -4.8 
g /2 4  ho u rs  and  -10.8 g /2 4  ho u rs  for h y p e rk e to n aem ic  an d  
norm oketonaem ic groups respectively. In the p resen t study  m edian 
values were -10.4 g /24  hours and -13.8 g /24  hours, for these two groups 
respectively. The absence of a linear relationship betw een n itrogen 
balance and  insulin  suggests insulin  is no t a m ain determ inan t of 
nitrogen balance following surgery. There m ay be som e 'm etabolic 
resistance' to the actions of insulin in this respect. Frayn et al. (1984) also 
found that protein metabolism in injured patients was unresponsive to 
the normal anabolic effects of insulin.
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On adm ission m edian concentration of plasm a album in w as low, bu t 
inside the reference range of 35 to 55 g /L . The range of concentrations 
obtained was wide, reflecting different degrees of protein status prior to 
surgery. This is probably due to the wide range of conditions included in 
the surgical group, w ith the different underlying diseases causing variable 
effects on the nutritional status of the patient. Pre-operative values for 
plasma albumin are comparable with those obtained by Rich and W right 
(1979) in a group of patients who they classified as undernourished pre- 
surgically. In the present study pre-surgical values were 35 (24-42) g /L  and 
35 (27-45) g /L , for norm oketonaem ic and hyperketonaem ic groups 
respectively. Those obtained by Rich and W igh t (1979) were 35.3 (±1.0) g /L  
and 33.5 (±1.5) g /L , for normoketonaemic and hyperketonaem ic groups 
respectively. Values of similar m agnitude to those obtained on admission 
in the present study, have been associated w ith increased m orbidity and 
mortality following surgery (Seltzer et al. (1979). Interpretation of changes 
in plasm a albumin following surgery m ay be complicated by changes in 
fluid balance, haem odilution due to IV infusions, and blood loss. It is 
possible to correct for the influence of fluid balance by the application of 
formulae which take into consideration packed cell volume (Taggart et al.. 
1989). Such formulae have not been widely used to date, and were not 
employed in the current study. So long as care is taken in interpretation of 
plasma albumin measurements, according to the conditions in which it is 
m easured, it provides a valuable marker of nutritional status. Correct use 
of plasma albumin is demonstrated in the present study, w hen admission 
m easurem ents were used to assess pre-surgical nutritional status and to 
identify pre-surgical differences between the two study groups. Differences 
from admission to discharge, and not absolute values, were used to assess 
the effect of surgery on plasm a album in. The final m easurem ent of 
p lasm a album in w as taken im m ediately p rio r to  d ischarge, w hen 
fluctuations in fluid balance had  subsided. The absolute values on 
discharge were not interpreted as an index of nutritional status following 
surgery.
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The significant difference in serum  album in concentrations betw een the 
two groups on day one following surgery could reflect a greater extent of 
haem odilution in the hyperketonaem ic group, although data on fluid 
balance was not available to clarify this. All patients were discharged from 
hospital w ith plasm a album in concentrations below  the norm al reference 
range. The present study revealed only trends tow ards inferior protein 
status in the normoketonaemic group, in terms of nitrogen loss, decrease 
in plasm a albumin, and losses of MUAMC. A larger study group may 
have strengthened these trends, however, as they stand, no conclusiions 
on protein status between the two groups can be drawn.
Insulin-like growth factor 1 (IGF-1) is a polypeptide which has anabolic 
functions on muscle protein (Salmon and Du Vail, 1970; U thne et al.. 1974). 
It has also been suggested it is sensitive to protein provision (Clemmons et 
d .,  1985). Concentrations of IGF-1 are expressed as a proportion of a 
reference value from pooled serum  of norm al adults which is assigned the 
value of 1 unit. This complicates direct comparison betw een laboratories, 
since each may have its own reference pool. Insufficient quantities of the 
purified horm one prevent its use as a standard. Patterns of change rather 
that absolute values are used for the purpose of comparison. 
Concentrations obtained prior to surgery were low, approxim ately 50% of 
the reference value, despite that nutrition scores indicated only m ild 
m alnutrition of admission. The low values m ay have reflected reduced 
recent protein intake, although no inform ation on pre-surgical nu trien t 
intake was available to substantiate this suggestion. A lthough the group 
as a whole showed a significant decrease in IGF-1 following surgery, w hen 
patients were divided into two groups the changes w ithin each d id  not 
reach statistical significance - possibly due to the small num bers involved. 
The reduction in IGF-1 following surgery probably reflects the catabolic 
state. However, it is also possible that reduced IGF-1 is a neuroendocrine 
response to stress and a causative factor of muscle catabolism. Correlation 
analysis between IGF-1 and nitrogen balance did not support this theory, as 
no significant relationship was found. IGF-1 concentrations progressively 
declined throughout the post-operative period, an observation which also
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tends to suggest that IGF-1 is not reflecting protein catabolism but rather 
provision of exogenous protein. In a study by Frayn and coworkers (1984), 
IGF-1 concentrations fell to 50% reference value im m ediately following 
accidental injury, bu t unlike the present study, returned to above 80% 
norm al w ithin seven days. The difference between this study  and the 
present, may be attributed to the fact that the accidentally injured patients 
were receiving adequate nutritional support. In the present study, by the 
sixth post-operative day IGF-1 values were only one quarter the laboratory 
reference value, indicating a poor state of protein nutrition. Data from 
the present study is worthy of comment since very little data is available 
on IGF-1 changes following surgery. However, in a recent study by Burgess 
(1989) low post-surgical values were also obtained - but were subsequently 
increased on commencement of TPN (total parenteral nutrition).
Changes in Anthropometric Parameters Following Surgery
The ultim ate effect of surgery on anthropom etric indices show ed no 
major differences betw een the tw o groups. The w eight losses w ere 
substantial considering the length  of hospitalisation. W eight loss 
averaged 4% and ranged from +3.3 to -8.1%. Weight loss of greater than 
10% has been associated with a significant increase in septic complications, 
respiratory complications, and a trend towards increased w ound infections 
and m ortality  (Clark, 1973. U npublished data). Data form  TSF and 
MUAMC m easurem ents ind icated  th a t losses of ad ipose  tissue  
predom inantly contributed to the weight loss. W eight loss was probably 
the sum  effect of the catabolic response to surgery and inadequate  
nutritional support. As data from this study tends to suggest that patients 
were not severely stressed, it is possible that inadequate energy intake 
contributed substantially to the extent of w eight loss observed. An 
appropriate control experiment w ould be to place norm al adults on a 
similar energy and protein intake, and observe anthropom etric changes, 
although this would be difficult to instigate. Along the same lines, section 
3.3 (page 135) compares anthropom etric changes following surgery in  a 
group of patients on low nutrien t intake to a group of patien ts w ho
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received full nutritional support.
Losses of TSF w ere sim ilar in both  groups. H igher losses in the 
hyperketonaemic group might be expected if raised ketones resulted from 
an increased ability to utilise body fat. Rich and W right (1979) found 
normoketonaemic patients showed greater losses of MUAMC and smaller 
losses of TSF when compared to hyperketonaemic patients. In the present 
study, only a non-statistically significant trend  tow ards greater loss of 
MUAMC in the normoketonaemic group was observed. Absence of a 
significant change in MUAMC may be due to the relatively short period of 
hospitalisation, and the insensitive nature of this m ethod of muscle mass 
assessment. As yet, there is no sensitive reliable m ethod for m onitoring 
changes in muscle mass which can be easily applied to the clinical setting.
There are several recognised methods for measuring and m onitoring body 
fat, including densitom etry (Brozek et al., 1963), u ltrasound (Volz and 
Ostrove, 1984), bioimpedence (Hoffer, M eador and Simpson, 1970), near 
infrared interactance (Conway, Norris and Bodwell, 1984), and skinfold 
m easurem ents (D urnin and Womersly, 1974). In the p resent study, 
measurement of triceps skinfold thickness was used to monitor change in 
body fat due to its simplicity. This m ethod is non-invasive, economical 
and easy to apply to the clinical setting, w ithout the use of expensive, 
technically difficult apparatus which do not necessarily provide a m ore 
accurate assessment of body fat. A recent study carried out by the Dunn 
N u tritio n  U nit in  C am bridge (Elia, Park inson  and  D iaz, 1990), 
demonstrated that simple methods of estimating body fat, such as skinfold 
thickness and BMI (Body mass Index), were as accurate in the estim ation 
of body fat as more complicated techniques, such as impedance and near 
infrared interactance. In the present study the same skilled observer 
carried  ou t all m easurem ents to m inim ise possib le  inaccuracies. 
F risancho  (1974) p ro d u ced  percen tile  tab les of an th ro p o m etric  
m easurem ents in healthy adults. Values for the 50th percentile for 
MUAMC of men and women, in the 34 to 44 age group, were 27.0cm and 
21.6cm respectively. These values are higher than those obtained in the
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present study, however, the healthy subjects were younger. Values of the 
50th percentile for TSF were lower than those obtained in the present 
study, and were 12mm and 22mm for males and females respectively. 
These discrepancies in proportion of muscle and fat m ay be age related. 
A lthough it is appropriate to consider m easurem ents in context of other 
findings, the m ain purpose of m onitoring TSF and MUAMC in the 
present study was to evaluate the contribution of muscle and fat to weight 
loss following surgery and to compare the two groups of patients - to view 
these losses in terms of post-operative ketosis.
The present study has shown that patients vary in their ketotic response to 
surgery. The data from the present study suggest the m ain determ inant of 
post-operative ketotic status may be the circulating concentration of 
insulin. W hy circulating insulin concentrations following surgery are so 
variable is unclear, although variability may be related to the degree of 
stress resulting from the surgical procedure. NEFA supply was also a factor 
predisposing to circulating ketone concentrations.
M edian ketone body concentrations were of greater m agnitude than 
concentrations associated with an overnight fast, despite IV dextrose 
infusions in the majority of patients.
Carnitine fractions in serum  and urine and total carnitine concentrations 
bore no relationship to ketotic status, in the present group of m ild to 
m oderately stressed patients, over the relatively short study period. Long 
term  effects of carnitine free regimens, in more highly stressed patients, 
w arrants further investigation. U rinary carnitine excretion relates to 
nitrogen balance, and may provide a sensitive index of catabolic state. 
Information on tissue carnitine is required in order to fully elucidate the 
relationship between carnitine status and ketogenesis.
Data from this study also suggests that the study group did not fall into the 
'severely stressed' category. Glucagon concentrations or plasm a glucose 
concentrations were not substantially elevated. If counterregulatory
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horm ones are higher in severe stress, insulin  m ay not be the m ain 
determ inant of ketosis. A comparison of factors predisposing to ketosis 
following 'severe' injury to those of the present study is required.
The present study showed trends towards greater loss of body protein in 
the norm oketonaem ic patients, a study of larger num bers of patients 
would possibly strengthen these trends.
On completion of this initial study two areas in which fu ture research 
could progress were recognised. One was to extend the existing study, 
increasing the patient numbers, in an attem pt to strengthen some of the 
trends observed. However, due to a num ber of uncontrolled variables 
such as fluid and IV feeding regim ens betw een w ards, and practical 
restrictions on the num ber of patients which could be studied at any one 
time, it was decided this was not the appropriate direction to pursue. The 
second option was to carry out a longitudinal observational study of a 
group of m ore severely stressed patients in a m ore uniform, controlled 
environment. As access to such patients became available at Roehampton 
Burns Unit, a study of major bum s patients was established (which is 
presented in Chapter 4, page 153).
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3.3 N utritional and Hormonal Status in Surgical Patients: 
R elationship  to the M ethod of N utritional Support used  in  the Post- 
Operative Period.
3.3.1. INTRODUCTION
In the previous section it was clear the surgical patients studied received 
inadequate nutritional support. Semi-starvation may have superim posed 
upon the metabolic response to surgery; it is possible that some of the 
losses observed may have been prevented by adequate nutritional support.
Several previous studies have investigated the effects of perioperative 
nutritional support on clinical outcome. Simms, Oliver and Smith (1980) 
s tu d ied  the  effects of p e rio p e ra tiv e  feed ing  in  p a tien ts  w ith  
gastrointestinal cancer and found no significant difference in term s of 
w ound infection, major complications, or mortality. Mullen et a l. (1979) 
found  th a t w hen  the  Prognostic  N u tritio n a l Index (a score of 
m ultivariab le  nu tritional assessm ent) w as im proved by nu tritional 
support, patients had a reduced incidence of complications. However, in 
some of their patients, TPN (total parenteral nutrition) did  not im prove 
nutritional status, these patients had a higher incidence of complications 
and a higher m ortality rate. It is therefore possible that some patients do 
not respond to nutritional support; this failure to respond may be related 
to horm onal and metabolic disturbances which arise from the surgical 
stress. In a review of clinical trials of TPN on cancer patients, Klein, 
Simms and Blackburn (1986) concluded that perioperative nutritional 
support was able to decrease the incidence of post-operative complications, 
although there was no evidence of im proved mortality rate.
Technical factors such as ischaemia, suture placement, and intra-operative 
infection probably override the effect of nutritional status on development 
of post-operative complications. Nutritional support may, however, help 
to lessen effects of technical problems, helping to im prove recovery and 
reduce susceptibility to further illness.
M ost previous studies have concentrated on the effects of nutritional 
support on post-operative complications. Inform ation on the effects of 
feeding versus fasting on the m etabolic responses follow ing injury.
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m etabolic horm ones, and indices of protein status, is sparse. In the 
previous section (3.2 page 82), m arked nutritional losses were observed 
during  hospitalisation in  surgical patients w ho received inadequate 
nutritional support. In view of these findings it was decided to carry out a 
comparison of hormone and metabolic profiles between surgical patients 
receiving intensive nutritional support, and patients in whom  nutritional 
support was inadequate.
The aims of this investigation w ere firstly, to com pare the horm onal 
responses to stress in a group of nutritionally supported patients with a 
group of patients receiving inadequate nutritional support; to observe the 
extent to w hich feeding influences the horm onal response to stress. 
Secondly, to compare changes in indices of protein and nutritional status 
in nutritionally supported patients, w ith patients receiving inadequate 
nutritional support; to see if the catabolic effects of stress respond to 
nutrient provision. The overall aim of this investigation was therefore, to 
assess the effectiveness of nutritional support in the first post-operative 
week.
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3.3.2 METHOD
Clinical Routine
The clinical routine was identical to that described in the previous section 
(3.2.2 page 90).
Allocation of Patients into Study Groups
Patients were divided into two groups on a basis of the nutritional support 
provided in the week following surgery.
Seven patients who received intensive nutritional support, in the form of 
total parenteral nutrition  (TPN), form ed the nutritionally  supported  
group. These patients were compared to a low nutrient intake group of 
seven patien ts w ho received in travenous dextrose saline follow ing 
surgery, with m inimum oral intake from the fifth post operative day.
The TPN regim en consisted of IL of Vamin-9-Glucose/24 hours (7/7), 
(Kabi Vitrum UK) as the nitrogen source. The non-protein energy was 
provided by IL of 20% dextrose/24 hours. 500ml of 20% Intralipid (Kabi 
Vitrum UK) replaced 500ml of dextrose twice weekly as an energy source. 
TPN generally commenced 48 hours post-surgically. Prior to this patients 
w ere m aintained on intravenous (IV) infusions of electrolyte solutions 
and dextrose. In the low nutrient intake group, patients were m aintained 
p redom inantly  on dextrose/ electrolyte solutions un til oral feeding 
commenced. Oral food intake was re-introduced between the fourth and 
sixth post-operative day. Some patients in the low nutrient intake group 
received small quantities of Vamin-9-Glucose as part of the IV regim e, 
how ever, this was not accompanied by an adequate energy provision from 
either dextrose or lipid. In the low  nutrient intake group, IV dextrose 
infusion commenced on day one or two following surgery.
Due to the non-Gaussian distribution of the data results are presented as 
m edian values (with ranges), and non-param etric tests of statistics were 
used throughout.
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3.3.3 RESULTS
Both groups included patients adm itted for a variety of conditions, the 
m ajority for gastrointestinal surgery. The nutritionally supported group 
included two road traffic accident (RTA) victims. Details of patients are 
presented in table 3.7 (page 139). The nutritionally supported group 
contained four females and three males, the m edian age of which was 68 
years. Ages ranged from 17 to 87 years in this group. The low nutrient 
intake group contained two females and five males, the m edian age of 
which was 60 years and ranged from 52 to 78 years. Although there was a 
tendency towards older age in the nutritionally supported group, this did 
not reach statistical significance. A wide range of nutrition scores were 
obtained in both groups on admission. A lthough the m edian score was 
higher in the nutritionally supported group, no significant differences 
existed between the two groups. The nutritionally supported group had  a
significantly longer period of hospitalisation (a<0.05).
The standard TPN regimen was not adhered to strictly and varied betw een 
patients and days. Energy and nitrogen intakes are presented in table 3.8 
(page 140). The nutritionally supported group had significantly higher 
intakes of energy and nitrogen during the first post-operative week. 
Details of daily intakes of energy and nitrogen for each patient are 
presented in tables 3.vi to 3.ix Appendix A (page 260 - 261). Energy intake 
of the nutritionally supported group was greater than three fold that of the 
low nutrient intake group, and nitrogen intake was greater than six fold. 
In the low nutrient intake group, four patients were receiving no dextrose 
on day one following surgery and this was taken into consideration w hen 
interpreting the results.
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Table 3.7 Details of Patients in N utritionally Supported and Low 
N utrient Intake Groups.
a) Nutritionally supported Group
tient Nature of 
Injury/Operation
Sex+ Age Admission 
Nutrition Score
Length of 
H ospitalisation
a RTA F 21 0 28
b Oesophago-
gastrectomy
F 65 1 14
c Gastrectomy F 68 5 23
d Gastrectomy M 70 10 21
e Gastrectomy F 87 9 17
f Oesophago-
gastrectomy
M 72 7 21
g Road Traffic 
Accident
M 17 0 40
Median
(Range)
68
(17-87)
5
(0-10)
21
(14-40)
Low N utrient Intake Group
tient Nature of 
Injury/Operation
Sex+ Age Admission  
Nutrition Score
Length of 
H ospita lisation
h Gastrectomy M 52 8 14
i Aortic aneurysm  
repair
M 65 1 10
j Post Cholesysectomy 
/Sepsis
M 78 2 28
k Colectomy F 62 2 11
1 Colectomy F 59 2 16
m Gastrectomy M 60 3 11
n Gastrectomy M 52 2 14
Median
(Range)
60
(52-78
2
(1-8)
11
(10-28)
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Table 3.8 Energy (kcal) and Nitrogen (g) Intakes of N utritionally Supported 
(A) and Low N utrient Intake (B) groups. M edian Values (and ranges), n=7 
for the First Week Following Surgery/Injury.
GROUP
B
ENERGY INTAKE
k ca l/7 days 9,695 * 2,821
(8,480-14,955) (1,632 - 6,205)
NITROGEN INTAKE
g /7  days 50.0 * 7.8
(47.0 - 70.5) (0 - 122)
a <0.001 Mann-Whitney test
Figure 3.18 (page 141) compares the insulin to glucagon ratio (I:G) between 
the two groups following surgery. There were no significant differences 
between the groups on days one and three. Between days three and six, a 
significant increase in the LG ratio was seen in the nutritionally supported
group (a<0.01), rising to a value which was significantly higher to that 
observed in the low nutrient intake group (a<0.01).
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Figure 3.18 Comparison of the Insulin to Glucagon Ratio (I:G) between
Nutritionally Supported (A) and Low Nutrient Intake (B) Groups
Following Surgery. Median Values (with Ranges).
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** a<0.01 Mann-Whitney Test
• • «<0.01 Wilcoxon Signed Ranks Test
a - denotes a significant difference between groups
b - denotes a significant difference within a group between days
The histogram  presented in figure 3.19 (page 142) compares circulating 
concentrations of IGF-1 between the two groups. Pre-operatively (value 
excludes the two RTA patients), the nutritionally supported group had  a
significantly lower value than the low nutrien t intake group (a<0.01). 
M edian values were 0.28 (0.12-0.52) and 0.57 (0.30-0.64) U /m l respectively. 
In the nutritionally supported group, IGF-1 values did  not alter 
significantly in response to surgery. A gradual progressive increase was 
observed throughout the post-operative feeding period, w ith a significant 
increase in values between days one and six from 0.26 to 0.32 U /m l
(a<0.05). In the low nutrient intake group, IGF-1 values were significantly 
reduced in response to surgery from 0.57 (0.30-0.64) U /m l to 0.28 (0.16-0.53) 
U /m l (a<0.01). Concentrations progressive declined in the low nutrien t 
intake group throughout the post-operative phase, w ith a significant 
decrease between days one and six from 0.28 (0.16-0.53) U /m l to 0.20 (0.08-
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0.35) U /m l (a<0.05). On the sixth post-operative day the low nutrient 
intake group had significantly lower values for IGF-1 when compared to 
the nutritionally supported group (a<0.05).
Figure 3.19 Comparison of Plasma IGF-1 (Insulin-Like Growth Factor-1) 
Concentrations (U/ml) betw een N utritionally  Supported (A) and Low 
N utrient Intake (B) Groups. M edian Values (with Ranges).
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Figure 3.20 (page 143) presents nitrogen balance data. Both groups of 
patients were in negative nitrogen balance on all post-operative days. 
There was a tendency tow ards a greater m agnitude of loss in the low 
nutrient intake group, although differences between the tw o groups did  
not reach statistical significance. N o significant differences were observed 
w ithin groups, between days.
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Figure 3.20 Comparison of Post-Operative Nitrogen Balance (-g/24
hours) between Nutritionally Supoprted (A) and Low Nutrient Intake (B)
Groups. Median Values (with Ranges).
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Table 3.9 (page 144) presents plasma albumin concentrations on admission, 
before discharge and the changes in albumin concentrations observed 
during hospitalisation. On admission the m edian values (and ranges) 
obtained were 27 (24-40) g /L  and 35 (24-43) g /L  for nutritionally supported 
and low nutrient intake patients respectively. A lthough this indicates a 
tendency towards higher values in the low nutrien t intake group, the 
difference did not reach statistical significance. Immediately prior to 
discharge the low nutrient intake group had significantly higher values
for plasm a album in (a<0.01). However, the changes in album in 
concentrations from admission to discharge were similar for both groups, 
m edian values were '13 ('5 - '24) g /L  and '12 ('2 - '20) g /L  for nutritionally 
supported and low nutrient intake groups respectively.
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Table 3.9 Concentration of Serum A lbum in (g/L) on A dm ission and 
Discharge, and Change in  Concentration D uring Hospitalisation in 
N utritionally Supported (A) and Low N utrient Intake (B) Groups. M edian 
Values (with ranges).
GROUP ADM ISSIO N DISCHARGE CHANGE
D U R IN G
HOSPITALISATION
A  27 ««b 16 ‘ 13
(24 - 40) (14 - 22) (‘5 - ‘24)
B 35 ««b 22 ‘ 12
(24 - 43) (18 - 32) (‘2 - ‘20)
• • a  <0.01 Wilcoxon signed ranks test 
** a  < 0.01 Mann-Whitney test
a - denotes a significant difference between groups, 
b - denotes a significant change within a group with time.
Table 3.10 Changes in  Anthropom etric Parameters from  A dm ission to 
Discharge in  N utritionally Supported (A) and Low N utrient Intake (B) 
Groups. M edian Values (with ranges).
GROUP PERCENTAGE WEIGHT CHANGE IN CHANGE IN
LOSS TSF mm MUAMC cm
A  ‘5.25 ‘2.0 ‘0.7
(‘0 .6 - ‘6.9) ( 0 - ‘3.3) (+ 1 .5 -‘2.6)
B ‘6.10 ‘ 3.1 ‘0.1
(‘2 .0 - ‘9.1) (‘1 .0 - ‘9.2) (+ 1 .4 -‘0.8)
TSF= Triceps skinfold
MUAMC= Mid-Upper arm muscle circumference
144
Changes in anthropom etric param eters between admission and discharge 
are presented in table 3.10 (page 144). Although there was a slight 
tendency towards a greater percentage weight loss in the low nutrient 
intake group, it was not significantly greater than the loss observed in the 
nutritionally supported group. There were no significant differences in 
changes in TSF or MUAMC between the two groups.
Table 3.11 (page 146) compares circulating concentrations of glucose and 
lipid metabolites between the two groups. Pre-operatively the 
nutritionally supported group had significantly higher circulating 
concentrations of ketone bodies. Median values obtained were 0.68 (0.25- 
1.46) m m ol/L  and 0.08 (0.06-.16) m m ol/L , for nutritionally supported and 
low nutrient intake groups respectively. Following surgery there w ere no 
significant differences between the two groups. There was a tendency 
tow ards higher serum  NEFA concentrations in the nutritionally  
supported group pre-surgically, but the difference between the two groups 
did not reach statistical significant. Neither did post-surgical values for 
NEFA differ significantly between the two groups.
Glycerol concentrations were significantly higher in the nutritionally  
supported group prior to surgery. Following surgery values obtained were 
low and were similar for both groups. Both groups show ed a significant
increase in plasma glucose concentrations following surgery (a<0.01), but 
no significant difference existed between the two groups at any tim e point 
throughout the experiment.
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Table 3.11 Circulating Concentrations of Lipid Metabolites and Glucose
in Nutritionally Supported (A) and Low Nutrient Intake (B) Groups.
Median Values (and ranges).
PRE-OPERATIVE POST-OPERATIVE DAY
M etabolite Group
KETONE BODIES 
mmol/L
0.68
(0.25-1.46)
*a
0.08
(0.06-0.16)
0.11
(0.03-1.88)
0.17
(0.05-0.37)
0.09
(0.03-0.21)
0.15
(0.05-0.81)
0.08
(0.06-0.12)
0.10
(0.05-1.24).
NEFA
mmol/L
1.00
(0.19-1.40)
0.63
(0.10-0.82)
0.79
(0.04-3.59)
1.01
(0.49-4.31)
0.51
(0.35-1.14)
0.67
(0.37-1.67)
0.85
(0.13-1.67)
0.62
(0.18-1.60)
GLYCEROL
m mol/L
0.10
(0-0.24)
*»»a
0.05
(0.02-0.09)
0.05
(0 - 0.12)
0.04
(0.03-0.09)
0.06
(0.01-0.28)
0.03
(0.01-0.07)
0.06
(0.01-0.65)
0.03
(0.01-0.07)
GLUCOSE
m mol/L
5.6 b»'
(4.1-7.4)
6.7
(0.1 - 10.1)
9.9
(62 -143)
6.1
(45-8.6)
4.8 b*<
(45-5.2)
6.7
(3.8-10.9)
6.2
(55-7.3)
6.9
(5.3-8.6)
* a<0.001
** a  <0.011 Mann-Whitney Test
*** a  <0.05 '
• •  a  <0.01 Wilcoxon Signed Ranks Test
a - denotes a significant difference between groups, 
b - denotes a significant change within a group with time.
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Table 3.12 Serum Carnitine Status (jimol/L) and U rinary C arnitine 
Excretion (pmol/24 hours) of N utritionally  Supported (A) and Low 
N utrient Intake (B) Groups. M edian Values (and ranges).
PRE-OPERATIVE POST-OPERATIVE DAY
Group
0 1 3 6
A 42.3
(30.9-721)
57.7
(18.1-115.3)
52.0 ***b 
(205-146.7)
227
(13.4-51.5)
B 53.6
(33.7-95.8)
472
(36.6-95.3)
44.8
(285-982)
48.9
(23.8-111.0)
A - 2794 • • h  
(1166-4867)
517
(319-1033)
553
(144 - 768)
B - 2132 #b 
(1692 - 3967)
1428 ••b  
(205-1584)
345
(91-406)
SERUM
CARNITINE
(TASC)p.mol/L
URINARY
CARNITINE
(TASC)
pm ol/24 hours
• a  <0.001\
••  a  < 0.01 jwilcoxon Signed Ranks Test 
• • •  a  <0.05
b - denotes a significant change within a group with time. 
TASC - Total acid soluble carnitine
Table 3.12 compares serum  TASC and urinary TASC excretion in 
nutritionally supported and low nutrient intake groups. No significant 
changes in serum  TASC w ere observed throughout the experim ent in the 
low nutrien t intake group. However, the nutritionally supported  group 
showed a significant decrease in serum  TASC concentration between days
three and six (a<0.05). No significant differences existed in serum  TASC 
concentrations between the two groups. There were no significant 
differences in excretion of urinary carnitine between the two groups on 
any post-surgical day investigated. The nutritionally supported group 
showed a significant decrease in carnitine excretion between days one and
three (a<0.01), after which no further change was observed. The low 
nutrien t intake group showed a significant reduction in urinary  carnitine 
excretion between days one and three (a<0.001), and days three and six 
(a<0.01).
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3.3.4 DISCUSSION
Although the present study only dealt w ith small num bers, each group 
containing seven patients, a com prehensive range of param eters were 
investigated. It was thought that increasing numbers w ould have been at 
the expense of complete, comprehensive data. However, in view of the 
small num bers, future studies could be aim ed at clarifying some of the 
interesting, yet non-significant trends, investigating the param eters in 
question only, in a larger sample of patients.
The w ide range of nutrition scores on adm ission indicated that both 
groups included patients w ho w ere mildly, and  patien ts w ho w ere 
severely, malnourished. The RTA patients in the nutritionally supported 
group were assigned a score of zero. It was not possible to calculate a pre­
injury nutrition score in these patients, bu t on global assessm ent both 
were young well nourished adults. Despite no significant difference in 
nutrition score between the two groups, more patients in the nutritionally 
supported group had scores over six (indicative of severe m alnutrition); 
this is possibly due to a more advanced disease state in these patients.
Energy and nitrogen intakes of the nutritionally supported group w ere 
comparable to the calculated requirements and were 9695 kcal and 55.9g 
nitrogen (N) for the first post-operative week. Considering the extent of 
pre-surgical m alnutrition, intakes of 9700 kcal and 55 gN  w ere the 
calculated requirements. Energy and nitrogen intakes of the low nutrient 
intake group were grossly inadequate. The I:G ratios presented in figure 
3.18, (page 141) show the extent to which difference in feeding influenced 
the hormonal profile. On the first post-operative day, all the nutritionally 
supported group were receiving dextrose as part of their IV fluid regime. 
A t this time point four of the patients of the low nutrien t intake group 
w ere receiving no dextrose. A lower ratio m ight have therefore been 
expected in the low nutrient intake group. The four patients not receiving 
dextrose, did not have I:G ratios lower than those receiving dextrose. The 
absence of a difference in I:G ratio between the two groups m ay suggest
148
that the nutritionally supported group were more severely stressed. On 
day three, by which tim e TPN had commenced in the nutritionally  
supported group, absence of the normal hormonal response to feeding (ie. 
increased I:G ratio) suggests that at this point the metabolic effect of stress 
is overriding the response to feeding. By the sixth post-surgical day, 
how ever, the increase in ratio  in the nutritionally  supported  group 
suggests this group was responding hormonally to nutrient provision, as 
the effects of traum a subsided.
If IGF-1 is a horm one like factor sensitive to the provision of nutrients 
and protein status (discussed in the previous section), pre-operative data 
suggests that the nutritionally supported group had inferior pre-operative 
nutritional intake compared to the low nutrient intake group. However, 
the value obtained excludes RTA patients. If these patients, w ho were well 
nourished prior to admission, had  been included, less of a difference 
betw een the  tw o study  groups m ay have been observed. In the 
nutritionally supported group, values for IGF-1 were below one th ird  of 
the laboratory reference value for norm al adults. Following surgery the 
absence of a significant change in the nutritionally  supported  group 
suggests that if concentrations are already low, injury will not lower them 
further. In the low nutrient intake group, who had higher initial IGF-1 
concentrations, a significant fall in IGF-1 was observed following surgery. 
A decrease in IGF-1 concentration following injury has been previously 
reported (Frayn et al., 1984). IGF-1 concentrations responded to nutritional 
support and had significantly increased by the sixth post-operative day in 
the nutritionally supported group. Absence of nutritional support in the 
low nutrient intake group caused IGF-1 concentrations to further decline. 
Burgess (1989) has also reported an increase in IGF-1 concentrations in 
response to TPN in surgical patients. It m ay therefore be concluded that 
changes in IGF-1 concentrations throughout the post-operative course 
appear to be sensitive to nutrient provision once traum a subsides. As IGF- 
1 functions in m uscle anabolism, it could be suggested the increased 
availability in nutritionally supported  patients m ay favour im proved 
protein status in this group. However, indices of protein status m easured
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in the present study did not support this suggestion. N itrogen balance, 
change in albumin from admission to discharge, or changes in MUAMC 
did not differ significantly between the two groups.
The nutritionally  supported  group w ere in negative nitrogen balance 
despite the fact that their calculated nitrogen requirem ents w ere being 
met. This tends to suggest inefficient utilisation of the nitrogen provided, 
possibly a consequence of metabolic stress resulting from surgery and 
injury. This observation is not in keeping w ith that of Radrizzani et a l. 
(1986), w ho found  the m ain dete rm inan t of n itrogen  balance in  
m alnourished surgical patients to be nitrogen intake. The tendency 
tow ards lower serum  albumin in the nutritionally supported group on 
admission, is in keeping w ith the tendency tow ards a higher nutrition 
score in this group. Albumin values for both groups were low throughout 
the study. Provision of nutritional support was unable to prevent the 
album in losses observed. The low value obtained and the failure to 
respond to nutritional support are of major concern since Ching et a l. 
(1980) found that failure to increase album in tow ards norm al w ith 
nutritional support was associated w ith  a significant increase risk of 
mortality.
Both groups showed considerable weight loss. Despite a tendency towards 
a greater weight loss in the semi-starved patients, provision of nutrients 
did not significantly reduce w eight loss in the nutritionally  supported  
group. This data tends to suggest inefficient utilisation of nutrien ts 
provided. Extent of weight loss is of extra concern in the nutritionally 
supported group as it superim posed on existing m alnutrition. Data on 
TSF and MUAMC tends to suggest that loss of muscle as well as fat is 
contribution to weight loss, and data from nitrogen balance calculations 
supports this observation.
W hen in terpreting  this data, length of hospitalisation m ust also be 
considered. The period of hospitalisation was shorter in the low nutrient 
intake group. If the period of hospitalisation had been equal for the two
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groups, losses of weight, TSF, MUAMC and albumin m ay have differed 
betw een the two groups and the low nutrien t intake group m ay have 
suffered greater losses.
Ketone body concentrations of the nutritionally supported group prior to 
surgery suggest that this group was fasted on admission, as the values 
obtained were comparable to fasted healthy individuals. In the low 
nutrient intake group pre-operative ketone body concentrations were low 
and there were no signs of prolonged reduced food intake. NEFA and 
glycerol concentrations are also in agreement w ith the suggestion that the 
nutritionally supported group were deprived of food to a greater extent 
than the low nutrient intake group pre-operatively. It m ay be argued that 
the nutritionally supported  group w ere adapted to starvation prior to 
surgery and therefore sm aller nitrogen losses m ight be expected, as 
suggested by Giddings et al. (personal communication). This was not 
observed in the present study, which may suggest that ketotic capacity in 
response to starvation m ay have no bearing on the ketotic response to 
surgery and injury.
Data from the previous section (3.2.3 page 93) and other studies (Cederblad 
et a l., 1983; lapichino et al., 1988), have suggested that excretion of urinary 
carnitine is a catabolic index. The absence of a significant difference in 
urinary  carnitine excretion betw een nutritionally  supported  and  low 
nutrient intake groups in this study may therefore indicate a similar state 
of catabolism  in both groups. However, u rinary  carnitine was only 
m easured up  to day six, and no comparison of relative length of the 
catabolic period between the two groups was made.
The significant decrease in serum TASC concentration in the nutritionally 
supported group by the sixth post-operative day could reflect an increased 
requirem ent and utilisation of carnitine in this group, to accomm odate 
utilisation of lipid contained within the feed.
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This study has only been carried out on a very small num ber of patients 
and in order to draw  definite conclusions a much larger controlled clinical 
trial w ould be needed. The observations have nevertheless been 
interesting. In conclusion; this study, which has com pared nutritionally 
supported patients w ith patients on low nutrient intakes, has indicated 
that despite the fact patients m ay be receiving their calculated energy and 
protein requirem ents, they still show substantial loss of w eight and lean 
body tissue. This is probably due to the metabolic effect of traum a 
overriding the usual response to feeding. Mullen et al. (1979a) also found 
a proportion of patients who failed to respond to TPN, which was 
attributed to metabolic stress. If nutrients provided cannot be utilised 
efficiently until the metabolic response to traum a subsides, this suggests 
that greater emphasis should be placed on feeding beyond the first post­
operative week. Intensive nutritional support is often relaxed at this time 
once the patient becomes able to tolerate oral food intake, yet this m ay be 
the period during which nutritional support w ould be of greatest benefit 
in compensating for losses which have occurred as a consequence of 
metabolic stress. This is not, however, implying that nutritional support 
in the first post-operative week is of no benefit, as w ithout the support 
provided the losses observed in these patients m ay have been of even 
greater magnitude.
Data from this study suggests the majority of the nutritionally supported 
group were of poor nutritional status on admission. Poor pre-operative 
nutritional status is associated with poor outcome (Studley, 1936; Cannon, 
1944). In the present study nutritional support m ay have prevented 
nutritional outcom e in a group of patients who were m alnourished on 
admission, from being poorer than in a group of patients w ho were 
relatively well nourished pre-operatively. This study supports the need 
for further research to investigate when to feed patients, for how  long to 
feed, and also to evaluate the benefits of prolonged nutritional support on 
long term  recovery and quality of post-operative life.
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CHAPTER FOUR
THE KETOTIC RESPONSE TO THERMAL INJURY: 
RELATIONSHIP TO CARNITINE STATUS, CIRCULATING 
CONCENTRATIONS OF METABOLIC HORMONES, AND 
INDICES OF PROTEIN STATUS AND NUTRITIONAL
OUTCOME
4.1 INTRODUCTION
Extensive burns are probably the most severe form of injury to which man 
can be exposed and still survive. Mass civilian disasters and the high 
incidence of domestic accidents have stimulated num erous studies on the 
physiological responses to therm al injury, in order to render treatm ent 
m ore effective.
Death or survival following bum s injury are not only determ ined by the 
extent of the injury itself, bu t also by the post-burn  incidence of 
complications such as severe infection, respiratory tract infections and 
m alnutrition. Most investigators have concluded that one of the major 
contributions to a successful outcome in the treatm ent of extensive burns 
is m aintenance of good nutritional status. The metabolic response to 
burns may, however, compromise nutritional status due to the metabolic 
abnorm alities which are inherent in this stress response, including  
increased m etabolic rate, im paired glucose m etabolism  and excessive 
protein catabolism.
The metabolic response to therm al injury is neuroendocrine in nature 
and is m ediated through the hypothalam us, which responds to afferent 
nervous stim uli carried from the in jured area. The hypothalam us 
stim ulates the arterior p itu itary  to produce horm ones, in particu lar 
Adrenocorticotrophic Horm one (ACTH). ACTH stim ulates the adrenal 
cortex increasing the production of glucocorticoids. Cortisol concentration 
in blood, blister fluid and urine has been shown to correlate closely w ith 
the severity of the burn (Batstone et a l.. 1976; Bane et a l., 1974). Nervous 
stim uli also reach the adrenal m edulla via splanchnic innervation , 
resulting in the release of increased amounts of catecholamines. Increased 
sym pathetic ou tpu t results in  the release of increased quantities of 
glucagon. W ithin one hour following burns injury concentrations of 
glucagon four fold those found in fasting norm al individuals have been 
reported , the highest concentrations being associated w ith  the m ost 
extensive injury (Wilmore et al.. 1974). Initially following burns injury
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low circulating insulin concentrations have been found (Wilmore et a l.,
1976), which subsequently become m arkedly elevated. Blunted insulin 
release immediately post injury m ay be due to damage to the pancreas, or 
increased adrenaline or sympathetic activity (Porte et a l., 1966). Elevated 
circulating insulin concentrations have been found to persist for m any 
weeks following burns injury (Allison, H inton and Cham berlain, 1968; 
Dolecek et a l., 1974; Batstone et al.. 1976). The raised concentrations have 
been shown to be due to hypersecretion rather than decreased degradation 
(Davies, 1982).
The increased basal metabolic rate (BMR) observed in bum s patients is of 
greater m agnitude and duration than  that observed follow ing major 
surgery  or sepsis (W ilmore and Aulick, 1978; H enane, Bittel and  
Banssillon, 1981). Patients w ith 50% body surface area burns m ay have 
BMR approaching twice the norm al value. Raised energy expenditure 
persists until healing or autografting. By 24 hours following burns all 
patients have been shown to have a raised metabolic rate, which reaches a 
peak a few days later (Davies, 1982). Duration of the increase in BMR 
depends on the severity of the burn. Metabolic rate can, in part, be 
modified by the application of an occlusive dressing, which reduces heat 
losses from the w ound surface. It has been suggested that this reduces 
m etabolic rate  to near norm al (Lamke, N ilsson and  Reithner, 1977; 
Caldwell, Bowser and Crabtree, 1981), the increase in metabolic rate being 
accounted for entirely by the latent heat of evaporation. H ow ever, 
W ilm ore et a l. (1975) and Zawacki et al. (1970) oppose this theory. 
W ilmore and colleagues proposed that the increase in metabolic rate was 
due to increased energy production, in relation to endogenous reset of 
metabolic activity via a rise in the set point of the ’therm ostat' in the 
hypothalam us.
M etabolic rate  m ay also be reduced  by raising  the environm ental 
tem perature. Clinical studies have shown that in patients w ith  burns 
covering over 20% body surface area, increasing  env ironm en ta l 
tem perature from 22°C to 32°C reduced metabolic rate by one third (Barr et
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al., 1968; Wilmore et al., 1975). Despite intervention to m inim ise the 
increase in metabolic rate, for the m ajority of patients w ith extensive 
burns, BMR remains elevated and an increase in energy intake is required 
in order to m aintain energy balance. It has long been recognised that in a 
state of energy inbalance, in which energy production exceeds energy 
input, body reserves will be utilised w ith clinical evidence of tissue 
wasting and weight loss. Many investigators have observed weight loss 
following burns injury (Taylor et al.. 1943; Newsome, Masom and Pruitt, 
1973; Richards et a l., 1973). Newsome, Mason and Pruitt (1973), in a study 
of burns patients in whom  nutrition was not strictly supervised, observed 
weight losses of 6% admission weight by the third week following bum s, 
in patients with burns covering less than 20% body surface areas. Twelve 
per cent losses were observed in patients w ith bum s covering 20% to 39% 
body surface area. Patients w ith burns covering over 40% body surface 
area, lost an average of 22% admission weight by two m onths and only 
showed small gains over ensuing weeks. Intensive nutritional support is 
thought to reduce weight loss following extensive burns (Bartlett et al.,
1977).
The calculation of energy requirements for patients w ith a w ide range of 
ages and size of bum  have been derived from m any studies. These are 
usually related to body weight and surface area burned as basal energy 
production and expenditure are directly related to the body surface area 
and also to the severity of the burn. In 1976 Sutherland produced a 
formula to indicate the energy requirements of adults w ith burns, which 
takes into account both body weight and extent of bum  - which is defined 
below:-
24 H our Energy Requirement =
20kcal per kg body weight + 70kcal per 1% bum
An alternative m ethod used for assessing energy requirem ents in  bum s 
p a tien ts  is m easurem ent of daily  oxygen consum ption , ad justing
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subsequent 24 hour energy intake on the basis of energy expenditure in the 
previous 24 hours (Bartlett e ta l., 1977; Davies, Lamke and Liljedahl, 1977).
Increased provision of energy alone m ay not counteract the negative 
energy balance, since the energy provided m ay be poorly utilsed due to 
underlying disturbances of energy m etabolism, resulting in substantial 
loss of body reserves.
Hyperglycaem ia following therm al injury was first recognised in 1923 
(Underhill et a l., 1923). The extent of hyperglycaemia is thought to be 
related to the severity of the burn  (Wilmore, Mason and Pruit, 1976). 
Patients w ith under 10% burns on admission rarely show blood glucose 
concentration above 6 m m ol/L . In patients w ith 30% burns adm ission 
blood glucose concentrations in the region of 12 m m ol/L  have been 
reported, which increase towards 20 m m ol/L  in a m atter of hours (Taylor, 
Levenson and Adams, 1944). In patients w ith bum s greater than 70% body 
surface area, elevated blood glucose concentrations may persist for several 
m onths. The initial increase in blood glucose is due to glycogen 
b rea k d o w n  fo llow ed  by  in c reased  h e p a tic  p ro d u c tio n  from  
gluconeogenesis (Wilmore and Aulick, 1978). Hyperglycaemia w ithin the 
first 48 hours, appears to coincide with low insulin concentrations and 
glucagon concentrations four fold those norm ally observed (Wilmore et 
al'/ 1974). However, studies by Frayn (1975) in rats suffering 20% scald 
burns do not support the concept of reduced insulin production in  the 
early post bum  period. Two hours following burns insulin secretion was 
not suppressed, both insulin and glucose concentrations being elevated. 
Adm inistration of insulin to bum ed rats was not as effective at lowering 
blood glucose as in norm al rats. The study concluded that im paired 
glucose tolerance was due to reduced sensitivity to insulin as well as to its 
im paired release. Subsequent studies carried out in both animals (Wolfe 
e t al. 1976) and hum ans (Wolfe et al., 1979b), to investigate  this 
discrepancy, showed that infusion of insulin was ineffective at reducing 
hepatic glucose production. This is possibly due to high coexisting 
glucagon concentrations and may account for sustained elevated glucose
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concentrations. Peripheral insulin resistance has been observed in in  
vitro studies of the early post burn period, as far back as 1957 by Young, 
Seraile and Brown, and also by subsequent investigators (Turinsky et al., 
1977; Thomas, Aikawa and Burke, 1979). Young, Seraile and Brown (1957), 
incubated norm al rat diaphragm  in plasm a obtained from burned  and 
non-burned rats. Diaphragm tissue incubated w ith plasm a from the 
burned rats showed impaired glucose uptake. The investigators suggested 
that the factor inhibiting glucose uptake was noradrenaline, as it is known 
to be present in plasm a in high concentrations im m ediately following 
bum s injury. There was no difference in rat diaphragm  glucose uptake 
betw een norm al and bum ed rat diaphragm  tissue incubated in norm al 
plasm a (Turinsky et al., 1977), suggesting that the insulin resistance 
observed following burns is not due to decreased capacity of muscle to 
respond to insulin. Following burns injury the turnover of glucose is 
increased, bu t recycling also increases and less is used for complete 
oxidation (Wolfe and Burke, 1977; Wolfe et al., 1979b). Glucose flow 
during the second week post burn is related to the extent of injury and 
decreases to norm al values as the burn  heals. Raised circulating glucose 
concentrations at this point have been attributed to increased hepatic 
production rather than to reduced metabolic clearance, or alterations in 
extracellular fluid volume. Hepatic production of glucose does not appear 
to be suppressed by exogenous glucose (Allsop, Wolfe and Burke, 1978). 
The increased hepatic production of glucose has been attributed to raised 
glucagon concentrations. Once glycogen is depleted, gluconeogenesis is 
fuelled predom inantly by carbon units from muscle amino acids. In a 
study by Wilmore, Mason and Pruitt (1976a), femoral arteriovenous 
differences in amino acid concentrations were m easured in patients w ith 
12 to 74% burns. Only alanine showed a significant arteriovenous 
difference. Although peripheral release of m any amino acids was 
increased, only alanine release was consistently greater in burned than in 
control subjects. The increase in alanine release is related to the extent of 
the burn  injury and the generalised catabolic disturbance, rather than local 
inflam m ation and m etabolism  occurring in the limb w here the 
arteriovenous difference was m easured.
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The net loss of muscle amino acids and protein catabolism which occurs 
following bum s injury is reflected in an increased urea excretion. At least 
twice the normal amounts of nitrogen have been found to be excreted in 
both  severely burned patients (Davies, Ricketts and  Bull, 1959) and 
experimental animals (Roth, 1954). The proteolytic response is maximum 
at two to four weeks following burns injury. The net protein loss appears 
to be due to an increase in protein breakdow n rate above the rate of 
protein synthesis. Several studies have investigated the effects of bum s 
injury on rates of protein synthesis and breakdown. Jahoor et al. (1987), in 
a study of children w ith extensive burns (averaging 65% body surface 
area), found plasm a fluxes of leucine, valine and lysine increased during 
the acute post injury phase and to remain increased into the convalescent 
period. Urea production was only increased two to four weeks following 
injury; this may suggest that an accelerated rate of protein synthesis occurs 
during the acute phase (two - four days) and convalescent phase, which 
counteracts the increase in breakdown. Protein synthesis m ay be im paired 
during the peak catabolic phase post bum  (two to four weeks), accounting 
for the increased nitrogen losses observed during this period.
In addition to nitrogen lost in the form of urea, am inoaciduria has also 
been rep o rted  follow ing burns (K ow alew ski and  H eron , 1970). 
Concentrations appear to peak at the end of the first post bum  week. The 
concentration of amino acids in urine appears to be related to the severity 
of the burn. Urine concentration of hydroxyproline is particularly high 
during the healing of partial thickness skin loss bum s; concentrations up 
to three fold normal have been reported (Klein and Davies, 1964).
Peptides may also be present in urine. In patients w ith extensive bum s, 
urine peptide concentrations five times normal have been found 10 days 
following burns. W hole protein content of urine is usually  less than 
lOOmg/24 hours, and does not make a major contribution to nitrogen 
losses (Coombes, Shakespeare and Batstone, 1979). Recognition of the 
extent of negative nitrogen balance following bum s led to m any studies in 
which large quantities of nitrogen containing m aterials w ere given in
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order to establish the recommended level of nitrogen intake. They have 
generally  show n th a t nitrogen requirem ents of burns patien ts are 
m arkedly elevated, especially if w ounds are infected. Infected burns 
patients require 0.5g nitrogen per kg body weight, per 24 hours to maintain 
nitrogen balance. Septic and injured patients, by comparison, only require 
0.24g per kg body weight, per 24 hours for nitrogen equilibrium (Long et 
al., 1976). Healthy people maintain nitrogen balance on intakes of 0.075 to 
O.lg nitrogen per kg per day (Munro, 1972). Sutherland (1976) devised a 
form ula for determ ination of pro tein  requirem ents in  ad u lt burns 
patients, taking into consideration both body weight and extent of bum  
injury:-
24 H our Protein Requirement =
l.Og per kg body weight + 2.0g per 1 % burn
High intakes of protein and energy are not easy to achieve in practice. The 
burnt patient may have difficulty in absorbing nutrients, IV feeding carries 
a high sepsis risk, and even if nutrient provision is successful, nutrient 
utilisation m ay be com prom ised due to m etabolic disturbances. An 
altem ative approach to the maintenance of protein balance is to gain a 
better understanding of those mechanisms responsible for the extent of 
negative energy and nitrogen balances. Reducing pro te in  loss by 
m anipulation of factors controlling protein kinetics m ay be more effective 
than the present 'counteractory' approach, which attem pts to replace vast 
losses but does little to prevent their occurrence.
The protein sparing effect of ketone bodies has been considered in detail in 
the previous chapter (section 3.2, page 82). A lthough the picture is far 
from clear, evidence to date suggests that ketone bodies m ay have a direct 
p rotein  sparing effect on muscle. If this w ere so, the existence of a 
heightened ketosis following burns injury m ay dam pen the proteolytic 
response. It has been shown that in those patients w ith the m ost severe 
extent of injury that ketosis is blunted (Stoner et a l.. 1979). Batstone et a l.
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(1976a), in a group of bum s injury patients, found that circulating ketone 
concentrations did not rise above O.2mmol/L. As thermal injury probably 
presents the m ost severe form of traum a, it is a fair assum ption that 
ketosis m ay be blunted in these patients. The observation that both 
experimental animals (Harvengt, 1963), and patients (Birke, Carlson and 
Liljedahl, 1965; Carlson and Liljedahl, 1971) w ith burns have raised 
circulating concentrations of NEFA, w hich is though t to be due to 
production exceeding clearance, supports this theory, and suggests that 
catabolism of fatty acids in bum s patients may be impaired. In a study on 
dogs, Harvengt (1963) m easured circulating NEFA concentrations prior to 
and following the infliction of 33% body surface area bum s. Within six 
hours circulating NEFA concentrations had doubled, and had trebled by 48 
hours. A similar increase in circulating NEFA concentrations was found 
in clinical studies by Birke et al. (1972). Increased production of NEFA 
have been attributed to raised concentrations of noradrenaline which are 
present following burns injury (Harvengt, 1963). Raised circulating 
concentrations of triglycerides in the first week following burns (Birke, 
Carlson and Liljedahl, 1965; Batsone et al., 1976; Coombes et a l., 1979), 
raised circulating VLDL concentrations in bum s patients and the discovery 
of massive hepatic triglyceride deposits in burns patients upon autopsy 
(Feigelson et al., 1961), further suggest that fatty acid oxidation following 
burns is impaired.
Changes in insulin metabolism following burns cannot fully account for 
the abnorm alities in fat m etabolism  w hich are repo rted  to occur. 
A lthough  insu lin  is a po ten t stim ulus of trig lyceride  syn thesis, 
concentrations of this hormone are relatively low in the initial post bum  
phase - whereas triglyceride concentrations are already elevated (Davies, 
1982). The anticatabolic effect of insulin on lipid is also thought to be 
strongly  opposed follow ing bu rns in jury  due  to  coexisting h igh  
concentrations of catecholamines, glucagon and cortisol. It is therefore 
unclear to w hat extent insulin concentrations following burns control 
lipid metabolism. It is possible that other cofactors of lipid m etabolism  
contribute to the abnorm alities observed following burns. C arnitine
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(whose role in lipid oxidation and ketone body formation has already been 
em phasised) is thought to be lost from m uscle im m ediately following 
bum s. Experiments using animal models have shown that in rats w ith 
20% deep burns, plasma carnitine concentrations are significantly elevated 
six hours following injury when compared to unbum ed rats (van Alstyne, 
Sladek and Smith, 1977). Although the authors suggest that the loss of 
muscle carnitine is due to decreased utilisation of carnitine for fatty acid 
oxidation, it could be argued that loss of muscle carnitine is contributing to 
the reduced capacity to oxidise NEFA. Few clinical studies have 
investigated carnitine metabolism following therm al injury. Cederblad 
and coworkers (1981) m easured urinary  carnitine excretion following 
burns. The m ean value for total carnitine excretion was six fold on day 
two compared to controls. Carnitine excretion gradually decreased during 
the first week post-burn, bu t was still significantly above norm al on the 
eighth day following burns. Average weekly losses of carnitine am ounted 
to eight percent of the body pool, the greatest loss being 16.9%. Although 
this degree of carnitine loss could be accounted for by the extent of muscle 
catabolism during the first week, carnitine losses peaked on day one 
(followed by a progressive decrease) whereas muscle catabolism peaked at 
the end of the first week. Other factors are likely to be responsible for 
carnitine loss following bum s.
In summary; research to date suggests that following burns injury lipid 
m etabolism is abnormal, concentrations of NEFA are raised and there is 
triglyceride synthesis. The vast losses of carnitine show n to occur 
follow ing burns injury m ay lim it NEFA oxidation and com prom ise 
ketone body formation. Following burns injury, protein catabolism is 
extensive. Intervention to prevent net catabolism occurring m ay be a 
more effective therapeutic approach than attem pting to replace vast losses 
w ith high nitrogen and energy intakes, which are difficult to achieve in 
practice. Ketone bodies are thought to have a protein sparing effect on 
muscle, bu t before the therapeutic potential of ketones is investigated, a 
better understanding of ketone body status and its relationship to protein 
status following bum s is required. In view of the limited data available on
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carnitine status following burns injury, a principle aim of the current 
research was to carry out a longitudinal observational study of serum and 
urinary carnitine status following bum s injury.
A second aim was to m easure a com prehensive range of m etabolites 
following bum s, to obtain a complete picture of the metabolic effects of the 
m ost severe form  of traum a, w ith  particu la r em phasis on lip id  
metabolites including ketone bodies. To achieve this in practice the study 
aimed to investigate a relatively small num ber of patients, approximately 
20. To place findings in context of less severe forms of traum a, data 
obtained for the first day post injury were compared to that obtained in a 
group of surgical patients. The group of surgical patients chosen for 
comparison were those patients studied in the previous Chapter ( Section 
3.2. page 82), who received saline and electrolyte solutions alone on the 
first post-operative day and w ho w ere therefore in the sam e post 
absorptive state as the burns patients.
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4.2 METHOD 
Study Group
Ten patients adm itted to Roehampton Bums U nit between October 1988 
and August 1989, w ith burns covering 15% or more of body surface area 
were studied. Only patients 18 years of age or above were studied.
Experimental Protocol
A  record of extent and nature of the therm al injury was made. M orning 
blood samples were obtained on days 1, 3, 6 ,10 ,14  and 18 following injury.
Aliquots of serum and plasma were obtained which were stored at "18°C 
until time of analysis. A 24 hour urine collection was m ade on each of the 
days listed above, total volume was recorded, an aliquot taken for urea 
nitrogen determination and a further aliquot frozen for carnitine analysis. 
A record of body weight was m ade on admission (ambulance bed scales) 
and subsequently, whenever possible, at the time of dressing changes. The 
average weekly weight loss was calculated, and expressed as percentage 
admission weight. A detailed record of nutrient intake (oral, nasogastric, 
and parenteral), was kept, from which daily intakes of energy and nitrogen 
were determined.
Parameters Measured
The m ethods used are given in detail in Chapter 2 (page 18). Circulating 
concentrations of NEFA and glycerol were m easured to provide an index 
of lipolysis. Plasma ketone bodies were m easured as an index of ketosis. 
Carnitine analysis included m easurem ent of free carnitine (FC) and total 
acid soluble carnitine (TASC) in urine and plasma. A value for short 
chain acyl carnitine (SCAC) was derived by subtracting FC from  TASC 
values. Concentrations of plasm a insulin, glucagon and cortisol were 
m easured to provide information on the horm onal response to therm al 
injury. M easurem ent of plasm a insiriin-like grow th factor-1 (IGF-1)
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enabled the effects of therm al injury on this index of protein nutrition to 
be examined. Serum album in was m easured in order to m onitor the 
responsiveness of this protein to nutritional therapy, and in view of its 
im portant role in acting as a fatty acid carrier protein. Serum retinol 
binding protein (RBP) was m easured as an index of changes in short half 
life plasm a proteins following burns injury. Plasma concentrations of 
glucose provided information on glucose homeostasis following burns. 
From the 24 hour urine collections, 24 hour losses of urea nitrogen were 
m easured and this, together w ith inform ation on nitrogen intake, was 
used in the determ ination of nitrogen balance. A factor of 0 .2gN /l%  burn 
was applied to correct for exudate losses while w ounds were open. The 
factor was reduced to O.lgN/1% burn when partial thickness burns began 
to heal or autografting took place.
Nutrient Intake
D uring the initial 48 hours patients were m aintained on electrolyte 
solutions which were dextrose free. Following this the nutritional 
requirem ents of each patient were calculated using the form ulae of 
Sutherland (1976) stated previously (pp 155 and 159). N utrients were 
provided using Fresubin 750MCT, Fresubin Fibre and Protein Forte 
(Fresenius UK), milky drinks, Complan (Farley Health Products Ltd) and 
norm al food. From the nutrient intake records the percentage of the 
calculated requirement which the patient actually received was calculated.
Comparison of Bums and Surgical Patients
Five patients were selected from the study group presented in Section 3.2. 
This sub-group of surgical patients were all patients w ho were m aintained 
on electrolyte solution only following surgery and w ho were therefore in 
the same post absorptive state as the burns patients.
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Presentation of Results and Statistical Methods Used
Due to the non-Gaussian distribution of the data results were expressed as 
m edian values and ranges, and non-param etric m ethods of statistical 
analysis have been used  th roughout. L ongitudinal changes w ere 
determ ined using the Wilcoxon Signed Ranks Test. Linear relationships 
betw een param eters w ere investigated  using  Pearsons C orrelation 
A nalysis. Day one values for all param eters w ere com pared to 
corresponding day one values of a group of surgical patients, who also did 
not receive IV dextrose on the first day following injury. Statistical 
differences betw een the two groups were determ ined using the Mann- 
W hitney U test.
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4.3 RESULTS
Details of patients are presented in table 4.1a. The study group included 
five males and five females. Ages ranged from 18 to 87 the m edian being 
27 years. Extent of bum s ranged from 15 to 50% body surface area, the 
m edian value was 30%. Details of the nature of the injuries are also given 
in table 4.1.a. Six of the patients survived. Table 4.1.b (page 167) presents 
details of the surgical patients against whom  day one data for the burns 
patients were compared. Individual values for energy and nitrogen 
intakes of burns patients are presented in tables 4.i and 4.ii (appendix B 
page 263). Table 4.2. (page 167) presents the calculated daily requirements 
of each patient and the percentage of these requirem ents which was 
provided, from commencing the full feeding regimen (day five), to day 14 
following burns. The m edian percentage of energy requirem ent received 
was 54% and ranged from 36% to 134%. The m edian percentage of 
nitrogen requirements received was 48% and ranged from 33% to 123%.
Table 4.1a Details of Bums Patients.
Patient No. Sex Age % Burn N ature of Therm al 
Injury
Outcom e
1 M 87 15 flam e died
2 F 85 15 flam e died
3 M 24 40 petro l/inhalation surv ived
4 F 21 40 petro l/inhala tion surv ived
5 F 27 20 petrol surv ived
6 F 24 40 flame /  inhalation died
7 M 34 40 chem ical/flam e 
inhalation
died
8 M 18 25 flam e surv ived
9 M 27 25 electric su rv ived
10 F 35 35 flam e surv ived
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Table 4.1b Details of Surgical Patients.
Patient Sex Age N ature of Surgical Procedure Outcome
a F 23 Colectomy surv ived
b M 78 Cholecysectomy /  sepsis su rv ived
c M 65 Aortic aneurysm repair su rv ived
d M 52 Gastrectomy surv ived
e M 56 Aortic aneurysm repair su rv ived
Table 4.2 Calculated D aily Energy (kcal/24 hours) and N itrogen (g/24 
hours) R equirem ents of the S tudy Group According to the Form ula of 
S u therland  (1976), and  Percentage of D aily  requ irem en t w hich  w as 
Provided Between days 5 and 14 Following Bum s, w ith  G roup M edian 
Values (and Ranges).
Patient Energy Requirement 
kcal
% Daily Requirement 
received
Nitrogen 
Requirement g
% Daily Requirement 
received
1 2314 48 17.3 36
2 2482 44 18.7 33
3 4300 44 31.2 47
4 3900 36 28.0 38
5 2780 55 20.6 55
6 4160 54 30.1 48
7 4500 died day 5 32.8 died day 5
8 3294 94 24.4 60
9
10
3086
3944
134
88
22.7
28.8
123
75
Median
Range
54
(36-134)
M edian
Range
48
(33 -123)
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Table 4.3 presents admission weights and subsequent weights of the study 
group, the calculated weekly weight loss and weekly percentage weight 
loss. All patients lost weight. The median weekly weight loss was 2.2 kg 
and ranged from 0.5 to 4.9 kg. W hen average weekly weight loss was 
expressed as percentage admission weight, median weekly loss was 3.3% 
and ranged from 0.7 to 6,5%.
Table 4.3 Admission Weight, Subsequent Weight, Average Weekly 
Weight Loss (Expressed as Absolute Values and as a Percentage of 
Admission Weight) in Patients Following Bums, with Median Values 
(and Ranges).
Patient Admission 
Weight Kg
Subsequent 
W eight Kg
lim e
Lapsed Days
Average Weekly Weight Loss 
Kg % admission weight
1 63.2 57.6 14 2.8 4.4
2 71.6 54.0 60 2.1 2.9
3 75.0 54.0 30 4.9 6.5
4 55.0 45.0 30 2.1 3.8
5 69.0 68.0 14 0.5 0.7
6 68.0 died
7 85.0 died
8 77.2 74.2 10 2.1 2.7
9 66.8 63.8 14 2.5 3.7
10 74.7 70.2 14 2.2 2.9
Median 2.2 3.3 
Range (0 .5 -4 .9 ) (0 .7 -6 .5 )
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Circulating concentrations of total ketone bodies, acetoacetate (AcAc) and 
C-hydroxybuiyrate (fiOHB) are presented in table 4.4. Total ketone body 
concentrations, AcAc and fiOHB, were low, approaching the assay 
detection limits on some days. No significant differences were observed 
between days for total ketones, AcAc or fiOHB. The day one m edian value 
for total ketone body concentration was 0.12 m m ol/L  and ranged from 0.04 
to 0.74 m m ol/L  in the burns patients. In the surgical group day one 
m edian ketone body concentration was 0.17 m m ol/L  and ranged from 0.13 
to 0.24 m m ol/L  (table 4.8, page 173). The difference between the two 
groups was not statistically significant.
Table 4.4 Circulating Concentrations of Total Ketone Bodies, 
Acetoacetate (AcAc), and B-hydroxybutyrate (fiOHB), (mmol/L), Following 
Bum s Injury. M edian Concentrations (With Ranges).
DAY POST BURN INJURY 
1 3  6 10 14 18
TOTAL 0.12 0.20 0.07 0.06 0.05 0.05
KETONES (0.04-0.74) (0.04-0.50) (0.03-1.04) (0.05-0.13) (0.04-0.23) (0.04 - 0.05)
AcAc 0.03 0.03 0.03 0.03 0.03 0.03
(0.03-0.10) (0.03-0.44) (0.03-0.68) (0.03 - 0.07) (0.03-0.12) (0.03 - 0.03)
BOHB 0.07 0.06 0.04 0.03 0.03 0.02
(0.02-0.24) (0.02-0.32) (0.02-0.36) (0.02-0.06) (0.02-0.11) (0.02 - 0.22)
n  10 9 9 7 5 5
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Concentrations of serum  and urine carnitine fractions following burns are 
presented in table 4.5 (page 171). On day one serum  concentrations of 
TASC w ere relatively high, the m edian value w as 70.2 (40.7 - 132.3) 
pm ol/L . Serum TASC concentrations show ed a trend tow ard norm al 
values by day three, although the fall in concentration only reached
statistical significance by day 14 following burns (a<0.05). Serum FC
concentration was 40.8 (10.5 - 75.4) pm ol/L , on day one post burns. FC 
concentration fell significantly between days three and six from 44.3 to 24.2
pm ol/L  (a<0.05). No significant changes in serum  SCAC concentration 
were observed throughout the experim ental period. On the first day 
following burns a relationship was found betw een serum  TASC and 
circulating ketone body concentrations (r=0.6) which did not quite reach 
statistical significance (p<0.06). Non-significant trends tow ards higher 
serum concentrations of all carnitine fractions in burns patients compared 
to surgical patients were observed (table 4.6, page 172).
Urinary carnitine excretion was markedly elevated immediately following 
burns injury, declining over subsequent days w ith significant decreases in 
excretion betw een days three and six and days 10 and  14. M edian 
concentra tions ob tained  rem ained  above norm al th ro u g h o u t the 
experimental period. Excretion of FC and SCAC followed a pattern similar 
to TASC. A higher proportion of carnitine was excreted as non-esterified 
carnitine. A relationship between day one TASC excretion and percentage 
burn was observed which did not quite reach statistical significance 
(r=0.79, p<0.07). No significant differences in excretion of carnitine 
fractions existed between burns and surgical patients on day one following 
injury. Data from the two groups are presented in table 4.6 (page 172).
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Table 4.5 Concentrations of Serum Carnitine (|imol/L), and  U rinary 
Carnitine Excretion (pmol/24 hours), of Free (FC), Short C hain Acyl 
(SCAC), and Total Acid Soluble (TASC) Carnitine Following Bum s Injury. 
M edian Values (WithRanges).
DAYS POST BURN INJURY 
1 3 6 10 14 18
SERUM
TASC 70.2 51.5 37.7 39.6 50.1 43.5
(40.7- 132.3) (34.9 -65.4) (21.1-73.9) (30 - 60.1) (26.5 - 61.6) (29 .1-75.6)
FC 40.8 44.3 b»** 24.2 34.3 40.3 35.3
(10.5 - 75.4) (38.3 - 63.0) (173 - 56.2) (24.5 - 53.4) (33.2 - 54.6) (28.1 - 72.0)
SCAC 13.3 8.5 6.5 6.1 3.6 6.3
(0 -5 8 .3 ) (3 .1-15 .6) (2.1 - 8.7) (2 .4 -19 .2 ) (0 -1 4 .7 ) (0.9 - 8.3)
URINE
TASC 1887 1552 b # "  524 773 b ' "  455 435
(339 - 4846) (875 - 3032) (120-1455) (306 - 2015) (296-1083) (289 - 478)
FC 1367 1189 b "  526 392 295 141
(670 - 3970) (438 - 2603) (104-1120) (144-1439) (74 - 440) (122 - 314)
SCAC 824 368 140 363 144 167
(242-1050) (132 - 637) (16 - 335) (154 - 576) (15 - 720) (154 - 294)
n
• • a<0.01 )
• • • a  < 0.05 ) Wilcoxon signed ranks test, 
b -denotes a significant change between days
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Table 4.6 Com parison of Serum Carnitine Concentrations (pm ol/L), 
and 24 Hour Urinary Carnitine Excretion (pmol/24 hours). Between 
Therm ally Injured and Post-Surgical Patients on the First Day Following 
Injury. M edian Values (With Ranges).
BURN PATIENTS SURGICAL PATIENTS
SERUM
CARNITINE
TASC 70.2 51.3
(40.7-132.3) (20 .7-95.3)
FC 40.8 28.8
(105 - 75.4) (24.4 - 87.1)
SCAC 13.3 5.8
(0 -58 .3 ) (0 -2 1 .0 )
URINARY
CARNITINE
TASC 1887 1755
(339 - 4846) (1532 - 3967)
FC 1367 1167
(670 - 3970) (92-1673)
SCAC 824 430
(242-1050) (285 - 3875)
TASC - total acid soluble carnitine. FC - free carnitine. SCAC - short chain acyl carnitine.
Circulating concentrations of NEFA, glycerol and glucose are presented in 
table 4.7 (page 173). The m edian NEFA concentration on day one 
following burns was 0.5mmol/L, and ranged from 0.07 to 1.11 m m ol/L . 
The concentration significantly decreased between days one and three to a 
m edian value of 0.24 (0.15 to 0.62) m m ol/L . Following this NEFA 
concentrations rem ained low and no further significant changes were 
observed. No relationship existed between circulating concentrations of 
NEFA and ketone bodies, neither did a relationship exist betw een NEFA 
and insulin concentrations. No significant difference in day one NEFA 
concentrations existed between burns and surgical patients (table 4.8 page 
173).
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Table 4.7 Circulating Concentrations of NEFA, Glycerol and Glucose,
(mmol/L) Following Burns Injury. Median Concentrations (With
Ranges).
DAY POST BURN INJURY 
1 3 6 10 14 18
NEFA 0.50 b '"  0.24 0.22 0.25 0.22 0.16
(0.07-1.11) (0.15 - 0.62) (0.08 - 0.36) (0.13 - 0.31) (0.08 - 050) (0-023)
GLYCEROL 0.08 0.04 0.04 0.05 0.05 0.02
(0.05 - 0.21) (0.03 - 0.09) (0.01-0.06) (0.01-021) (0.01-0.14) (0.01-0.10)
GLUCOSE 10.8 b« » «  8.1 11.4 6.8 7.2 8.6
(8.5-15.8) (6.8-15.1) (55-162) (6.0-21.0) (6.1-9.3) (6.4-9.1)
•• •  a  < 0.05 Wilcoxon signed ranks test 
b - denotes a significant change between days
Table 4.8 C om parison  of C ircu la ting  C oncen tra tions of L ip id
M etabolites and G lucose (mmol/L) betw een T herm ally  In ju red  and  
Surgical Patients on the First Day Following Injury. M edian Values (W ith 
Ranges).
BURN PATIENTS SURGICAL PATIENTS
TOTAL KETONES 0.12 0.17
(0.08 - 0.74) (0.13 - 0.24)
NEFA 0.50 0.61
(0.07 -1.11) (0.40-121)
GLYCEROL 0.08 0.09
(0.05 - 021) (0.04 - 0.93)
GLUCOSE 108 a* 6.0
(8.5 - 15.8) (3.8 - 7.5)
* a  <0.001 Mann-Whitney Test
a - denotes a significant difference between groups
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Glycerol concentration following burns was low and did not change 
significantly throughout the experimental period. No significant 
difference in day one glycerol concentration existed between burns and 
surgical patients.
Circulating glucose concentration was elevated on the first day following 
burns. The m edian value obtained on day one was 10.8 (8.5 - 15.8) 
m m ol/L . The concentration was significantly reduced by day three to 8.1 
(6.8 - 15.1) m m ol/L , although still rem aining above norm al. N o further 
significant changes in glucose concentration was observed. No 
relationship between circulating concentrations of glucose and insulin 
existed.
On day one following burns, m edian glucose concentration was 
significantly higher than that obtained in surgical patients. M edian values 
obtained were 10.8 (8.8 -15.8) m m ol/L , and 6.0 (3.8 - 7.5) m m ol/L , for burns 
and surgical patients respectively (a<0.001) (table 4.8, Page 173).
Table 4.9 Circulating Concentrations of Metabolic Hormones in 
Thermally Injured Patients. Median Values (With Ranges).
DAY POST BURN INJURY 
1 3  6 10 14 18
INSULIN 86 b '"  169 168 296 96 334
pm ol/L  (25 - 290) (64 - 632) (25 - 352) (66 - 450) (65 - 947) (179-581)
GLUCAGON 75 70 70 95 68 120
pm ol/L  (10 - 240) (10 - 360) (20 - 400) (10 - 260) (20-140) (20-190)
CORTISOL 614 590 477 635 529 490
nm ol/L  (190 - 932) (198 - 682) (146 - 530) (322 - 706) (143 - 926) (331-648)
• •• a < 0.05 Wilcoxon signed ranks test b - denotes a significant change between days
174
Table 4.9 ( page 174), presents circulating concentrations of insulin
following burns. The day one median value of 86 (25 - 290) pm ol/L  was 
significantly increased to 169 (64 - 362) pm ol/L , by the third day following
burns (a  <0.05). N o subsequen t significant changes in  insu lin
concentration w ere observed. N o relationship  was found  betw een 
circulating insulin  and ketone bodies concentrations. N o significant 
difference in insulin concentration was shown between bum s and surgical 
patients on the first day following injury. Values obtained were 86 (25 - 
290) pm ol/L , and 54 (43 - 133) pm ol/L  respectively (table 4.10 page 176). 
Circulating concentrations of glucagon and cortisol following burns are 
presented in table 4.9 (page 174). M edian glucagon concentration on day 
one following bum s was 75 (10 - 240) pm ol/L . The concentration did not 
alter significantly from this value during the subsequent days m easured. 
No relationship was found between circulating concentration of glucagon 
and circulating concentration of glucose or lipid metabolites. N either 
were relationships between glucagon concentration and nitrogen balance, 
or glucagon and cam itine concentrations found. The day one glucagon 
concentration in the burns patients was significantly higher than in the
surgical patients (a<0.05). M edian values obtained w ere 75 (10-240) 
pm ol/L , and 10 (5 - 25) pm ol/L , for burns and surgical patients respectively 
(Table 4.10 page 176). The day one circulating concentration of cortisol 
ranged from 190 to 932 nm ol/L . The m edian value obtained w as 614 
nm ol/L . Concentration rem ained stable throughout the experim ental 
course. N o re la tionsh ips w ere found  to exist betw een cortisol 
concen tra tion  and  circulating concentrations of glucose o r lip id  
metabolites. Cortisol concentration on day one following burns was not 
significantly different to that obtained in surgical patients (table 4.10 page 
176).
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Table 4.10 Comparison of Circulating Concentrations of Metabolic
Hormones in Thermally Injured and Post-Surgical Patients on the First
Day Following Injury. Median Values (With Ranges).
BURNS PATIENTS SURGICAL PATIENTS
INSULIN
pm ol/L
86 
(25 - 290)
54
(43-133)
GLUCAGON
pm ol/L
75
(10 - 240)
a»»» 10
(5 - 25)
CORTISOL
nm ol/L
614 
(190 - 932)
665 
(592 -1792)
*** a <0.05 Mann-Whitney Test 
a - denotes a significant difference between groups
Table 4.11 Circulating concentrations of A lbum in (g/L), RBP (mg/L), 
and IGF-1 (U/ml) and N itrogen Balance (g/24 hours) Follow ing Burns 
Injury. M edian Values (With Ranges).
1 3
DAY POST BURN INJURY 
6 10 14 18
SERUM
ALBUMIN
18
(6-31)
12
(11-27)
18
(11-27)
18
(10-30)
18
(10-37)
12
(8-19)
SERUM
RBP
15.4
(10.3-44.8)
13.9
(7.6-23.3)
15.6
(10.2-30.2)
16.5
(13.6-20.8)
2 5 2
(16.2-35.9)
Insufficient
D ata
PLASMA
IGF-1
1
0.29
(0.19-0.72)
0.23
(022-0.34)
0.20
(0.17-0.27)
0 2 5
(0.18-0.44)
0.29
(020-1.20)
0.26
(020-0.56)
NITROGEN
BALANCE
'13.6
(-9.0--33.8)
"13.6 "14.5 
(-1.0--33.6) (+5.0--32.8)
"15.0
(-4.1--24.8)
"20.8
(+4.8--26.0)
Insufficient
D ata
• •• a  < 0.05 Wilcoxon signed ranks test
b - denotes a significant change between days
176
Table 4.11 (page 176) presents indices of protein status following burns 
injury. Serum album in concentration was low throughout the study 
period. A highly significant correlation betw een serum  album in and 
percentage nitrogen requirem ent received was found (r =0.69 p<0.001). 
Values for serum  albumin on day one following burns were significantly 
lower than values found in surgical patients. Median values ( and ranges) 
are presented in table 4.12, and were 18 (6 - 31) g /L , and 23 (22 - 25) g /L , for 
bum s and surgical patients respectively. Values obtained for serum  RBP 
were also low and did not alter significantly during the post bum  period of 
study.
Table 4.12 C om parison  of Serum  A lbum in , P lasm a IGF-1 an d  
N itrogen Balance betw een Therm ally Injured and Surgical Patients on the 
First Day Following Injury. M edian Values (With Ranges).
BURN PATIENTS SURGICAL PATIENTS
SERUM ALBUMIN 18 a** 23
g/L (6-31) (22-25)
PLASMA IGF-1 029 0.32
U /m l (0.19 - 0.72) (0 .16-0 .84)
NITROGEN BALANCE "13.6 ‘17.8
g/24  hours ( "9.0-"33.8) ("0.5-"23.1)
** a <0.01 Mann-Whitney test 
a - denotes a significant difference between groups
Plasma IGF-1 values on the first day following bum s ranged from 0.19 to 
0.72 U /m l, the m edian value was 0.29 U /m l. There w as a significant 
reduction in IGF-1 concentrations betw een days one and six following
burns to 0.2 (0.17 - 0.27) U /m l ( a<0.05). There were no further significant
changes subsequent to this. No significant difference in day one IGF-1 
values existed between bum s and surgical patients.
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N itrogen balance was negative on all days m easured. O n day one
following burns the median value was "13.6 g /24  hours, and range from "
9.0 to -33.8 g /24  hours. There were no significant longitudinal changes in 
nitrogen balance. There was, however, a non-significant trend tow ards a
more negative balance on day 14 post burns, to "20.8g (+4.8 - "26.0g) /24 
hours. N o correlation was found  betw een n itrogen  balance and  
circulating glucose concentration. No significant difference in day  one 
nitrogen balance betw een burns and surgical patients w as observed. 
Values for both groups of patients are presented in table 4.12 (page 177).
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4.4 DISCUSSION
Study Group, Nutrient Intake and Weight Loss
The num ber of patients studied was determ ined by the num ber of adult 
adm issions w ith greater than 15% body surface area bum s during  the 
period of patient recruitm ent. It was anticipated to study 20 patients, 
how ever, data from only 10 patients were obtained. Although the num ber 
of patien ts w as small, a com prehensive range of m etabolites w ere 
m easured so accuracy sacrificed due to small num bers was com pensated 
for by the completeness of the data.
Data from the burns patients were compared to data from a small group of 
surgical patients, in order to compare the metabolic response to burns 
injury w ith that of a group of patients who m ight be considered to be 
relatively less stressed. On day one following injury burns patients and 
surgical patients were being m aintained on energy free IV fluids. On 
subsequent days the nutritional support received by each group differed 
considerably, comparison has therefore been restricted to day one only 
when nutrient intakes are identical. The num ber of surgical patients to 
which the burns patients were compared was small (n=5), which was due 
to the small num ber of surgical patients w ho received no in travenous 
dextrose on the first post-operative day.
The figures obtained for percentage calculated nutritional requirem ent 
received (table 4.2 page 167), illustrate the difficulty involved in m eeting 
n u tritio n a l dem ands. These pa tien ts  received  close n u tr itio n a l 
surveillance and regim es were p lanned according to the theoretical 
nutritional requirem ents, bu t patients still failed to receive adequate  
intakes. Im paired ability of patients to tolerate nasogastric or oral intake 
contributed to failure to m eet nu tritional requirem ents. V entilated 
patients w ith inhalation damage are also vulnerable to respiratory stress 
which complicates feeding. These findings illustrate the need for the 
developm ent of therapeutic  approaches designed to m inim ise the
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metabolic response to traum a, so that energy and nitrogen balance can be 
maintained on intakes which are practically feasible to achieve.
W eight losses were substantial, the m edian loss for one week of 3.3% 
admission weight is comparable to the data obtained by Newsome, Mason 
and Fruit (1973) in bum s patients in whom  nutiriton was not carefully 
supervised. In their study, patients with bum s covering 20 to 39% body 
surface area (the extent of which is comparable to the p resent study) 
showed weight losses amounting to 12% admission weight by one m onth 
following bum s. The degree of weight loss observed in their study and the 
present study  m ay have detrim ental physiological and  psychological 
effects on the burns victims.
Ketotic Response to Bums Injury:
Relationship to Metabolic Hormones and Lipid Metabolites
Patients failed to develop a heightened ketosis following burns injury 
despite the fact that energy intakes were below theoretical requirem ents. 
On day one following bum s ketone concentrations were low in relation to 
circulating concentrations of both glucagon and cortisol, in view of the fact 
that glucagon promotes ketogenesis in the liver (see Chapter 1 page 12). 
Ketone concentrations observed on day one were also low in view  of the 
insulin concentration obtained on this day, which was low in relation to 
subsequent days. Factors other than metabolic horm one concentrations 
may therefore influence ketosis following bum s. The m edian ketone body 
concentration obtained (0.12 m m ol/L) is comparable to that m easured by 
Batstone et al. (1976a) (0.09 m m ol/L) for patients with burns ranging from 
16% to 30% body surface area. The present value is also similar to that 
obtained by Stoner and coworkers (1979) in severely injured patients, of 
0.135 (0.06 - 0.29) m mol/L.
A lthough there w as a non-significant trend  tow ards low er ketone 
concentrations in the burns patients compared to the surgical patients, the 
difference betw een the tw o groups m ay have achieved sta tistica l
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significance had the study group been larger.
If ketone body concentrations were low in the presence of relatively high 
NEFA, a block in fi-oxidation or subsequent ketone body formation may be 
suspected. However, desp ite  p rev ious reports of e levated  NEFA 
concentrations following bum s (Birke et al., 1972; Carlson and Liljedahl, 
1971), circulating concentrations of NEFA and glycerol were not found to 
be m arkedly  elevated in  the presen t study. O n day  one m edian  
concentration of NEFA was 0.5m m ol/L , w hereas Birke et al. (1972) 
obtained a value of 1.1 m m ol/L . These findings tend to suggest that 
im paired stim ulation of lipolysis could be a factor contributing to low  
ketone body concentrations. It is possible that following burns reduced 
peripheral circulation to adipose tissues reduces the release of NEFA into 
the circulation. NEFA are carried in the circulation bound to albumin. 
The low  album in concentrations following burns m ay also, in part, 
account for low circulating NEFA concentrations due to reduced capacity 
to carry NEFA w ith in  the  circulation. A lthough  ra ised  in su lin  
concentration  follow ing therm al in jury  m ay in h ib it lipo lysis, no 
relationship was found between this hormone and either NEFA or ketone 
bodies. However, on day one following burns when insulin concentration 
was relatively low compared to subsequent days, NEFA concentration was 
significantly higher than values obtained for subsequent days. The highest 
value for ketones was also obtained on this day. Batstone et al. (1976) 
found a strong negative correlation between insulin and NEFA, glycerol 
and ketones. In contrast to the present study, they found lipid metabolites 
were elevated and insulin concentration rem ained low  throughout the 
post burn  period. A pattern  of insulin concentrations sim ilar to that 
observed in  the present study  was found by Dolecek e t al. (1974); 
concentration  being in itially  low  du rin g  the  firs t 24 h o u rs , and  
subsequently  increasing to a m arkedly elevated concentration. The 
significant increase in insulin concentration observed betw een days one 
and three coincides with commencement of feeding and may be accounted 
for by nutrient stimulation. Alternatively more insulin m ay be produced 
in response to high concentrations of counterregulatory  horm ones, to
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oppose the Insulin  resistant' state which is reputed to occur. Previous 
stud ies have rep o rted  the  anom alous find ings of s im ultaneous 
hyperinsulinaem ia and raised NEFA concentrations in patien ts w ith 
extensive burns, and this has been attributed to insulin resistance (Davies, 
1982). Despite coexisting high concentrations of insulin, glucagon and 
cortisol in the present study, it would seem that insulin concentration was 
sufficient to restrict lipolysis. Despite the antilipolytic effect which insulin 
w as able to exert, in su lin  appeared  unable  to m ain tain  glucose 
hom eostasis. A lth o u g h  the  sig n ifican t red u c tio n  in  g lucose 
concentrations between days one and three coincided w ith the significant 
increase  in  in su lin  concen tra tion  betw een  these  days, g lucose 
concentration rem ained high in relation to insulin concentrations during 
the first week.
The suggestion of low rates of lipolysis in patients in the present study is 
interesting in view of the extent of weight loss observed. If body fat was 
not contributing to weight loss the decrease m ust be fully accounted for by 
losses of glycogen, water and lean body mass. The m edian cum ulative
nitrogen loss of the first week following bum s am ounted to "97.3 g which 
is equivalent to 3.2 kg tissue. It is therefore possible that the weight losses 
which occurred were of lean tissue and not fat. It was not possible to 
monitor body fat changes by means of triceps skinfold measurements (and 
in m any cases, any skinfold measurement) due to the nature of the injury.
Nitrogen Loss and Indices o f Protein Status Following Bums 
Injury
Simple calculation of nitrogen balance by subtracting nitrogen intake from 
outpu t is reasonably accurate in patients w ith closed surgical or injury 
wounds. Sweat and faeces only contain small am ounts of nitrogen and 
have usually  been ingnored except in the m ost accurate studies. In 
extensive bum s exudate losses of nitrogen containing com pounds m ay be 
considerable and m ust be taken into consideration. Previous studies have 
m easured the nitrogen content of exudate by applying n itrogen  free
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sponges to the w ound, w ashing them  after use, and determ ining the 
nitrogen content of the washings. (Co Tui et a l.. 1944; Reiss, Pearson and 
Artz, 1956; Soroff, Pearson and Artz, 1961). This procedure was considered 
too labour intensive for the purposes of the present study (which were to 
achieve a longitudinal picture of nitrogen balance rather than to quantify 
precisely the extent of n itrogen balance). In addition  the  practical 
problem s of obtaining dressings, due to infection control, had  to be 
considered. (Dressings were imm ediately disposed of to m inim ise the 
spread of infection).
The factors used to allow for exudate losses were based on the losses in 
exudate found by investigators previously cited. The present study m ay 
have underestim ated urine nitrogen content, since only urea nitrogen was 
m easured. This masks the contribution of am ino acids, peptides and 
small amounts of plasma proteins to total nitrogen loss. Am inoaciduria 
occurs following burns, with peak concentrations being obtained at the 
end of the first week (Smith et a l.. 1974). During healing hydroxyproline 
appears in urine, contributing to the total nitrogen content. Protein 
content, although m any times norm al, is usually less than  100 m g /24  
hours and so makes a negligible contribution. Many clinical laboratories 
employ the urease m ethod for urea nitrogen determ ination, due to the 
laborious m anual nature of the Kjeldahl m ethod. However, the fact that 
this may underestimate total losses m ust be considered when interpreting 
the data. The m ethod of urinary nitrogen determ ination m ust also be 
considered in situations where daily nitrogen intake is tailored to the 
previous days losses. The median values for nitrogen balance obtained in 
the present study are comparable to data obtained by Shenkin et a l. (1980) 
in a group of burns and traum a patients. Shenkin's group (1980) report
mean values for nitrogen balance of ‘10.0 and "15.0 g /2 4  hours for days 
three and six respectively. In the present study m edian values of "13.6 and 
"14.5 g /24  hours were obtained for days three and six respectively.
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The low serum  album in concentrations observed in the present study may 
be explained, in part, by altered permeability of heat dam aged capillaries, 
which results in album in being lost to blister fluid, oedem a and lym ph 
(Cope et al.. 1948). Previous studies in both animals (Arturson, 1961) and
hum ans (Alexander et al., 1966) have show n serum  album in
concentration to be m arkedly subnormal during the first few days after 
burning and to rem ain subnorm al even w hen the burn  was healed. 
Shenkin et al. (1980) reported a value of 35 g /L  for plasma albumin on day 
four following injury in a m ixed group of burns and traum a victims. The 
present value was relatively low in comparison to this. The m ixed nature 
of injury in the study of Shenkin et al. (1980) m ay explain the
discrepancy. Studies using ^^4-labelled album in have show n that 
albumin synthesis is decreased for m any weeks after burning (Davies, 
1982). This reduction in album in synthesis is thought to be due to a 'shift' 
in liver protein synthesis in favour of acute phase proteins. There is also 
thought to be increased albumin catabolism following burns injury (Birke 
et al., 1960). Increased rates of albumin catabolism have been shown to 
coincide w ith the peak of urinary nitrogen excretion (Musil et al., 1965). In 
the present study the low albumin concentrations observed were probably 
accounted for, in part, by the inadequate nutrient provision, as illustrated 
by the significant relationship between percentage nitrogen requirem ent 
received and serum  albumin concentrations. It could, however, be argued 
that this relationship simply reflected that more severely ill patients, w ith 
a lower albumin concentration were able to tolerate less nutrients. 
Prolonged dim inished concentration of album in following traum a has 
been attributed to the relatively long half life of album in in relation to 
other serum  proteins (Carpentier, Barthel and Bruyns, 1982). However, 
such studies have show n serum  proteins w ith short half lifes, nam ely 
thyroxine binding pre-album in and RBP, to fall initially following injury 
during the acute phase; concentrations have subsequently increased in 
response to nutrien t provision.
The failure of plasm a proteins to respond to nu trien t provision in the 
present study may suggest that following burns the acute phase is extended
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considerably, during which RBP synthesis is compromised (Szebeni, 
Negyesi and Feuer, 1981). Sub-optimal energy and nitrogen intakes may 
also account, in part, for the sustained dim inished concentrations of 
serum  proteins. In the present study, serum  concentrations of RBP were 
substantially lower than the reference range for healthy adults of 40 to 60 
m g/L . Shenkin et al. (1980) report values of 30 m g/L  and 38 m g /L  for RBP 
on days three and eight following injury respectively, in  a group of 
patients containing both burn t and accidentally injured patients. Greater 
m agnitude of traum a in the present study m ay explain the lower values 
obtained.
Data obtained from measurement of IGF-1 are interesting, firstly, as few 
data are available for this hormone-like substance in patients following 
burns. Belcher and coworkers (1989) obtained considerably higher IGF-1 
values, in adult burns patients, compared to the present study. In their
study IGF-1 values of 0.79 (^.14) U /m l and 1.16 (±0.15) U /m l were 
obtained for days one and fifteen following injury respectively, however, 
these investigators provided no inform ation on nu trien t intake of their 
patients. IGF-1 is thought to have properties similar to insulin and to be 
sensitive to protein nutrition (Teale and Marks, 1986). In the present 
study, IGF-1 concentrations were low in relation to insulin concentrations 
and did not respond to protein intake. It is possible that the acute phase 
response to injury overrides the response of feeding on IGF-1 
concentration, as previous studies have show n IGF-1 concentration falls 
during the acute phase following injury (Frayn et al., 1984). It is possible 
that IGF-1 concentration reflects the extent to which protein is being 
utilised and m ay have potential use in m onitoring the effectiveness of 
nutritional therapy.
Low concentrations of serum  proteins m ay have nutritional 
consequences. Low album in concentration m ay comprom ise NEFA 
supply to the liver (as peviously discussed). Low RBP will influence 
circulating concentrations of vitam in A. Vitamin A concentration in 
serum  following burns has been found to be subnorm al (Rai and
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Courtemanche, 1975; Szebeni et al.. 1981) and although there is increased 
utilsation of this vitam in, low RBP is partly  responsible for reduced 
circulating concentration.
Serum Carnitine Status and Urinary Carnitine Excretion 
Following hums Injury
On the first day following bum s, serum  carnitine concentration was high 
when compared to the value obtained for normal individuals of 48.6 (31.5- 
60.2) pm ol/L  (section 2.3, page 50). Elevated circulating concentrations of 
TASC following bum s injury have previously been observed in animal 
studies (van-Alstyne et al.. 1977) although no data from clinical studies on 
circulating carnitine concentration following burns have been found in 
the literature. The raised serum  cam itine concentration probably result 
from tissue losses. Previous studies have suggested that carnitine is lost 
from muscle following burns (Cederblad et a l., 1981; van-Alstyne, et a l., 
1977) although it is possible that cam itine is lost from other tissues also. 
The insulin concentration following bum s w ould norm ally inhibit the 
efflux of cam itine from the liver (Kispal et al.. 1987). However, no study 
appears to have investigated the effect of coexisting high concentrations of 
counterregulatory horm ones on liver carnitine flux. It is possible that 
follow ing traum a, due to the m etabolic horm one disturbances, that 
carnitine is lost from the liver. If this is so, ketotic capacity m ay be 
compromised. From day three onwards m edian TASC concentration was 
m ore comparable w ith normal. Patients w ere receiving carnitine from 
m ilk based drinks and norm al food which probably helped to m aintain 
circulating concentrations th roughou t the study  period . H ow ever, 
continued tissue loss m ay also have m ain tained  circulating TASC 
concentration. C ritically ill patien ts m ain tained  on carn itine  free 
commercial feeds for prolonged periods have been show n to have a 
p lasm a carnitine concentration below  norm al (H ahn, A llardyce and  
Frolich, 1982).
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The vast loss of carnitine in urine following burns indicates that the 
patients were in negative carnitine balance. On day one m edian losses 
approached 10 fold those observed in normal individuals (see section 2.3, 
page 51). The value from the present study is slightly less than the 
reported by Cederblad et al. (1981) of 2477 (±1353) pm ol/24 hours, for the 
second day following burns covering 25 to 90% body surface area. The 
discrepancy m ay be accounted for by differences in the extent of burns 
injury between the two studies. In both the present study, and that of 
Cederblad et a l. (1981) a w ide range of values for TASC excretion were 
obtained. This m ay be due to w ide variation in extent of injury w ithin 
groups, as a direct relationship between percentage body surface area burnt 
and TASC excretion was found in both studies. This relationship indicates 
that urinary carnitine may be an index of metabolic stress. The direct 
relationship between urine TASC and nitrogen balance also suggests that 
urine TASC is an index of catabolism. A relationship between urine TASC 
and nitrogen balance in surgical and injured patients has previously been 
found (discussed in section 3.2.4 page 121), however, the present study is 
unique in observing this association following burns injury. By day 14 
following burns, although urinary  carnitine excretion w as declining, 
values w ere still approxim ately two fold those observed for norm al 
individuals m easured in the same laboratory (section 2.3, page 51). In 
agreement with the findings of Cederblad et al. (1981), in the present study 
urine TASC decreased w ith time following burns bu t rem ained above 
norm al throughout the study. One explanation for the reduction in urine 
carnitine excretion between days three and six is that the requirem ent for 
carnitine is increased to cater for the elevated lipid metabolism which is 
occurring at this time. Alternatively, it could be argued that, as the initial 
shock phase subsides the body becomes able to conserve m ore carnitine; 
for example, renal reabsorption m ay be increased. Prolonged increased 
loss of carnitine may significantly reduce the body pool, and it is unlikely 
that carnitine biosynthesis will increase to fully compensate these losses 
when the body is in a state of catabolism. Small exogenous quantities of 
cam itine from the diet are unlikely to balance the losses. It is therefore 
possible that in prolonged recovery periods, a state of cam itine deficiency
187
may occur and this m ay ultim ately im pair lipid metabolism and ketone 
body formation. The importance of carnitine in ketone body metabolism 
is reflected in the relationship which was found to exist betw een these 
two param eters on the first day following burns injury. The absence of 
such a relationship on subsequent days m ay possibly have been due to 
dietary carnitine influencing circulating concentrations.
Comparison of the Metabolic Response to Bums Injury with 
Surgical Injury
The comparison of bum s and surgical patients has shown that the initial 
metabolic response to severe stress differs form the response to m oderate 
stress in several respects. A lthough insulin and cortisol concentrations 
were sim ilar betw een groups glucagon concentration was far h igher 
following burns than following surgery, indicating a greater extent of 
stress. The absence of a difference in cortisol between the two groups may, 
in part, be due to the non-specificity of this parameter. As catecholamines 
were not m easured no conclusion can be draw n on the overall horm onal 
response to the different degrees of stress. Despite the higher glucagon 
concentration in the burns patients they showed a trend tow ards lower 
concentrations of lip id  m etabolites. Factors o ther than  circulating 
horm one concentrations m ay therefo re  be responsib le  for lip id  
metabolism  following injury. The significantly higher day one glucose 
concentration in the burns patients compared to surgical patients provides 
further evidence that this group of patients were more severely stressed. 
It is possible that the difference in circulating glucagon accounts for the 
difference in glycaemia between the two groups. The tendency tow ards 
higher serum  TASC in the burns patients may reflect greater muscle loss. 
Although no significant difference between urinary cam itine excretion or 
nitrogen balance existed between the bum s and surgical patients this does 
not necessarily imply that both groups were similarly stressed, since in the 
burns patients the catabolic phase is likely to be more prolonged and is 
known to peak at the end of the second week.
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Summary
This study has shown that following burns injury lipid catabolism was 
relatively low  and ketosis was kerbed, despite an elevated glucagon 
concentration. It w ould seem that ketosis was prevented at the level of 
lipolysis, possibly due to raised insulin concentration, although it is 
possible that reduced peripheral blood flow m ay also contribute to 
decreased NEFA supply to the liver.
A lthough little association was found betw een carnitine concentration 
and ketone bodies following burns, the extent of cam itine loss and the 
prolonged nature of this loss, suggests that carnitine deficiency m ay 
develope in bum s injury and may lead to symptoms of im paired energy 
and lipid metabolism. In view of the extent of losses observed, an increase 
in carnitine intake may be appropriate in burns patients. To date only 
specialised infant nutrition has been supplem ented with camitine.
The m arked difference in glucagon concentration betw een burns and 
surgical patients probably reflects a more pronounced response to stress in 
the form er group. However, major differences in concentrations of 
circulating metabolites between the two groups were not shown. In the 
burns patients serum  protein concentrations, glucagon concentration and 
nitrogen balance data suggested a prolonged acute phase following injury. 
In view of this, em phasis should be placed on prolonged nutritional 
support, yet, once the  patien t is transferred  from  in tensive care, 
nutritional therapy is often relaxed. This may be the time w hen nutrient 
provision should be increased, as the body re-establishes the norm al 
response to feeding. Although nutrient utilisation may be compromised 
during  the acute phase following burns it m ay still be im portan t in 
minimising losses, but should be extended into the convalescent period to 
compensate body losses and encourage rapid healing.
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CHAPTER FIVE
THE RELATIONSHIP BETWEEN CARNIHNE STATUS AND 
KETONE BODIES DURING THE ONSET AND REVERSAL OF 
DIABETIC KETOSIS IN CARNIHNE SUPPLEMENTED AND 
NON-SUPPLEMENTED RATS
5.1 OVERVIEW
In previous chapters the relationship between carnitine metabolism, lipid 
catabolism, and ketogenesis has been evaluated under conditions in which 
a re la tive ly  narrow  range of norm al to reduced  ketone body  
concentrations exist. In the surgical study a num ber of uncontrolled 
factors inherent in clinical experiments were present (discussed in more 
detail in Chapter 3 page 115). The limitations of such experiments mean 
that it is difficult to investigate associations between carnitine and ketone 
bodies over a w ide range of values. Due to ethical considerations and 
potentially lim ited ranges of ketone body concentrations, the use of an 
animal m odel of traum a was dismissed. An animal m odel of another 
disease in which altered ketone body metabolism occurs, namely diabetes, 
was studied. An anim al m odel in which diabetes is experim entally 
induced provides an ideal model in which to investigate the relationship 
between carnitine and ketone bodies over a wide range of concentrations, 
from the induction of diabetes to the development of a ketoacidotic state 
and also during the reversal of ketosis by insulin treatm ent. Unlike 
clinical studies, such experim ents can be carried ou t under strictly  
controlled conditions.
This chapter sum m arises current know ledge concerning carnitine in 
diabetes and presents the details and findings of an animal experim ent in 
which the association between carnitine metabolism and the dynamics of 
fat oxidation, during the onset and reversal of diabetic ketosis, w ere 
investigated.
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5.2 INTRODUCTION
Diabetes m ellitus is a disease typically characterised by a relative or 
absolute lack of insulin, resulting in m arked changes in carbohydrate and 
lipid interm ediary metabolism. Uncontrolled diabetes is characterised 
biochemically by a combination of hyperglycaemia, hyperketonaemia and 
acidaemia. Accumulation of glucose, ketone bodies and hydrogen ions are 
due to an inbalance between rates of production, utilisation, and excretion.
Insulin is essential for cellular glucose uptake and to enable it to be 
subsequently utilised for energy. Therefore in diabetes, u tilisation of 
glucose is im paired. Endogenous hepatic production and ou tpu t are 
increased, since reduced insulin availability will increase the activity of 
the gluconeogenic and glycogenolytic pathw ays and  will decrease 
glucokinase activity increasing hepatic glucose output. Hyperglycemia is 
therefore a combination of increased production and reduced utilisation.
Inability to utilise glucose results in an increased dependency upon lipid as 
an energy source. Decreased circulating insulin concentration results in 
increased rates of peripheral and intrahepatic lipolysis by increasing the 
activity of lipoprotein lipase via a CAMP m ediated enzym e cascade 
system. The capacity for oxidation of fatty acids is enhanced due to a 
combination of factors. Raised concentration of NEFA (non-esterified fatty 
acids) and reduced insulin availability result in reduced m alonyl CoA, 
which is thought to be the locus of control of fatty acid oxidation (see 
Chapter 1 page 12). Reduced malonyl CoA concentration increases the 
activity of CAT. Sensitivity of fatty acyl CoA to CAT m ay also be enhanced 
as a resu lt of reduced  insu lin  availab ility  coup led  w ith  ra ised  
concentration of acyl CoA. These changes facilitate the transfer of fatty 
acids into the m itochondria and their subsequent oxidation via the fi- 
oxidation spiral. In uncontrolled diabetes the accelerated rate  of fi- 
oxidation is such that an excess of acetyl units are produced. All of these 
cannot enter the tricarboxylic acid cycle, since the activity of this cycle will 
be reduced due to depleted cycle intermediates; a consequence of reduced
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glucose utilisation. Excess acetyl units produced in peripheral tissues are 
shunted to the liver where they are utilised in ketogenesis.
H igh ketone body concentrations and rates of production have been 
reported  in both  clinical (Miles, H aym ond and  Gerich, 1980), and 
experimental (Heimberg, Dunkerley and Brown, 1966), insulin dependent 
d iabetes m ellitus. H yperketonaem ia is though t to orig inate from  
increased production of ketone bodies, and  is sustained by reduced 
utilisation (Freed et al.. 1988). These altered ketone body kinetics result in 
acidaem ia, as ketone body production is accom panied by equim olar 
generation of hydrogen, and ketone body utilisation is accompanied by 
equimolar regeneration of bicarbonate (Miles, Haym ond and Gerich, 1980).
In diabetes mellitus it m ay be argued that increased lipid m etabolism  
should result in a concurrent increased dependency on carnitine as a 
cofactor in these metabolic processes. Requirem ent for carnitine m ay 
increase; firstly to accom m odate the increase in in tram itochondrial 
transport of fatty acids, and secondly to transport acetyl units from their 
peripheral site of production to the liver w here ketogenesis occurs. 
Carnitine facilitated removal of acetyl units results in the regeneration of 
free CoA necessary for sustaining C-oxidation (see Chapter 1 page 8). 
Carnitine is also im portant for buffering and removal of long chain acyl 
derivatives, the production of which is increased in diabetes as a result of 
accelerated lipid metabolism.
Clinical data on the association betw een ketogenesis and carnitine in 
diabetes mellitus are limited. However, Genuth and Hoppel (1979) have 
shown that there is an increase in the esterified to free carnitine ratio in 
blood of ketotic and ketoacidotic diabetics, and that excretion of esterified 
carnitine increases in these conditions. These changes in carnitine 
m etabolism  probably reflect increased fat m obilisation and utilisation. 
Soltesz, Melegh and Sandor (1983) have likewise found a shift in  the acyl 
to free carnitine ratio in the blood of ketotic diabetic children. Plasma free 
carnitine was reduced and acyl camitine elevated, although total cam itine
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concentration rem ained unchanged. An inverse relationship was found 
between ketone bodies and free carnitine but no correlation existed with 
esterified carnitine. Differences in excretion rates and tissue uptake of 
carnitine fractions m ay help explain this. O ther clinical studies have 
investigated carnitine status and metabolism in the controlled diabetic 
state. Cederblad, Herrm ansson and Ludvigsson (1982) studied carnitine 
status in insulin  treated diabetic children. They found subjects had  
reduced plasm a total carnitine and increased acyl to free carnitine ratios 
w hen compared to non-diabetic children. No striking differences were 
found between urinary carnitine excretion when diabetic and non-diabetic 
groups were compared, although there was a tendency towards higher acyl 
carnitine excretion in female diabetics compared to non-diabetic females. 
In a study of insulin treated diabetics by Bohmer, Ryding and Solberg 
(1974) norm al serum  carnitine concentration was found. Peters et al. 
(1987) have also found no significant difference between concentrations of 
free, acyl and total carnitine in plasma of diabetic compared to non-diabetic 
Ethiopians.
Clinical studies have generally shown that in diabetic ketosis there is a 
red istribution  of carnitine w ith an increased proportion  of esterified 
carnitine in both blood and urine. To w hat extent changes in circulating 
carnitine represent changes in tissue carnitine in diabetes is uncertain, 
since hum an data of this kind are difficult to obtain. However, circulating 
carnitine fractions, together with information on urinary  excretion, will 
give some indication of whether carnitine is entering, or leaving tissues 
and being lost from the body. (The relationship between serum  and tissue 
carnitine is discussed in more detail in Chapter 1 page 4).
Animal studies enable data on tissue carnitine to be obtained. Such 
inform ation com plem ents clinical da ta  and enables a m ore com plete 
picture of carnitine redistribution in diabetes to be obtained.
The first studies on carnitine in experim ental diabetic anim als w ere 
carried out by Mehlman, Kader and Therriault (1969), who show ed that 
whole body carnitine was greatly reduced in uncontrolled diabetes (alloxan
193
induced) to 50% of normal values over a period of 14 days. Studies by 
these investigators using radioisotopes indicated that carnitine turnover 
increased four fold in diabetes and rem ained slightly elevated upon 
insulin treatm ent. O ther animal studies have investigated individual 
tissue d istribution of various carnitine fractions. Such studies have 
generally shown that in genetic and experimentally induced uncontrolled 
diabetes, liver carnitine increases to accommodate the increase in fatty acid 
oxidation and ketogenesis (Snoswell and Koundakjian, 1972; McGarry, 
Robles-Valdes and Foster, 1975; Snoswell and McIntosh, 1974; Stearns, 
1983; and Brooks, Bahl and Bressler, 1985). The increase in liver carnitine 
m ay be due to increased biosynthesis as postulated by Steams (1983). Other 
investigators have suggested that tissue redistribution is the cause of 
elevated liver carnitine concentration (Brooks, Bahl and Bressler, 1985). 
Studies in which individual camitine fractions have been m easured have 
shown that the rise in liver cam itine concentration is due to an increase 
in all fractions (Snoswell and Koundakjian, 1982; Fogle and Bieber, 1979). 
Disparate reports of changes in concentration of skeletal muscle carnitine 
in d iabetic  an im als have been  ob tained . Increased  carn itine  
concentrations in rat skeletal muscle have been reported by Steams (1980), 
and Brooks, Bahl and Bressler (1985). Reduced carnitine concentration 
was found in rat skeletal muscle by Mehlman and coworkers (1969), and in 
sheep by Stearns (1983). Snoswell and Koundakjian (1972) found no 
change in total camitine content of skeletal muscle but a greater than three 
fold increase in the esterified fraction.
Data on plasm a carnitine in diabetic animals are lim ited. However, a 
study by Macnab et a l. (1979) reported a reduced concentration. Fogle and 
Bieber (1979) also found reduced plasm a carnitine concentration in 
diabetic rats compared to controls. These studies only reported values for 
total camitine.
A num ber of studies in which the concentration of cardiac carnitine has 
been investigated have generally shown a reduction in  the total cam itine 
pool in diabetes (Feuvray, Idell-Wenger and Neely, 1979; Vary and Neely,
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1982; Stearns, 1983; Paulson et al., 1984; Brooks, Bahl and Bressler, 1985; 
Pieper and M urray, 1987). C ontrary to this majority, the studies of 
Snoswell and Koundakjian (1972) and Fogle and Bieber (1979) have 
reported reduced concentrations of free cam itine and a shift in the free to 
acyl ratio rather than a reduction in total cardiac carnitine.
The changes in carnitine availability and metabolism seen in diabetes 
mellitus may have considerable clinical implications. The heightened and 
sustained fatty acid metabolism which occurs in uncontrolled diabetes 
m ay result in insufficient carnitine to accommodate this level of lipid 
catabolism in addition to other essential camitine functions. Insufficiency 
of carnitine in acute diabetes m ay contribute to the m uscle weakness 
experienced, due to partial inhibition of B-oxidation resulting in reduced 
energy substrates. Increased lipolysis coupled w ith reduced carnitine 
availability may result in a raised NEFA concentration due to an inbalance 
between production and utilisation. NEFA are diverted towards the liver 
where, if not oxidised, they will be shunted into VLDL synthesis raising 
hepatic and circulating concentrations. Camitine insufficiency m ay in part, 
be responsible for the sustained hyperlipidaem ia in diabetes (Reaven, 
1987). As early as 1960, carnitine supplem entation was show n to have 
beneficial effects in lowering circulating lipids in diabetes (Bekaert and 
Deltour, 1960).
Diabetes is known to result in myocardial abnormalities and an intrinsic 
defect in cardiac energy metabolism with decreased contractility (Regan et 
al., 1977; Fein et a l.. 1980; Penpargkul et a l.. 1980), and a reduced ability to 
recover following anoxia or ischaemia (Hearse, Steward and Chain, 1975; 
Hearse, Steward and Green, 1978; Ingelbretsen et a l., 1980). The heart is 
exclusively dependent on fatty acids for energy production (Garland and 
Randle, 1964), interm ediates of fatty acid m etabolism  m ay therefore 
accum ulate in cardiac tissue (Feuvray, Idell-W enger and Neely, 1979). 
Carnitine plays an im portant role in buffering and rem oval of these 
potentially toxic substances.
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If, as previous reports have suggested. (Feuvray, Idell-Wenger and Neely, 
1979; Paulson e ta l., 1979; Vary and Neely, 1982; Stearns, 1983; Brooks, Bahl 
and Bressler, 1985; Pieper and Murray, 1987), cardiac camitine is reduced in 
diabetes, long chain acyl moieties will build  up. This m ay resu lt in 
reduced ATP production since long chain acyl derivatives are know n to 
inhibit adenine nucleotide translocases (Shug, Lerner and Elson, 1971), 
and reduce the sarcoplasmic reticulum  calcium uptake (Adams et a l., 
1979). Carnitine supplem entation has been shown to reduce long chain 
acyl CoA concentration, increase ATP concentration and im prove recovery 
of cardiac ou tpu t following ischaemia in animals (Pieper and M urray, 
1987; Paulson et al., 1984; Tahiliani and McNeill, 1986; Xiang, Rodriguez 
and McNeill, 1988), and  im prove m yocardiac function in hum ans 
(Rebouche and Engel, 1981; Tripp et al.. 1981; Waber et a l., 1982). Carnitine 
insufficiency may therefore account for some of the functional myocardial 
abnormalities observed in diabetes.
In view of the im portant role of carnitine as a cofactor in the pathw ays 
which lead to the production of ketones bodies, carnitine availability may 
be significant in the regulation of diabetic ketosis. At present the relative 
roles of NEFA, horm ones, carnitine palm itoyl-transferase (CPT) and  
carnitine in the regulation of ketone body production are not clearly 
defined. A recent study by Grantham and Zammit (1988) showed that the 
gradual onset of ketosis correlated well w ith the gradual rise in CPT 
activity, yet it d id  not correlate well w ith  the rap id  rise in NEFA 
availability which followed insulin w ithdraw al. The rap id  reversal of 
ketosis which occurred on insulin treatm ent was attributed to the sharp 
decline in circulating NEFA, while CPT activity declined more gradually. 
This means that different factors m ay control the onset to the reversal of 
diabetic ketosis. N o study has investigated the effects of carnitine 
availability on these processes controlling ketogenesis. N or have the 
effects of carnitine supplem entation on ketotic po ten tial and  tissue 
cam itine metabolism been investigated during the onset and reversal of 
diabetic ketosis, m ost investigators have only m easured cam itine at one 
time point.
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In the present study, the associations between ketone bodies and carnitine
were investigated during the onset and reversal of diabetes in rats. The
effect of cam itine supplementation on lipid metabolites was investigated.
The aims of the study were:-
1. To investigate the effects of carnitine supplem entation on lip id  
metabolism and both tissue and circulating carnitine concentrations 
in the non-diabetic rat.
2. To investigate the relationship  betw een carn itine sta tus, lip id  
m etabolism  and ketone bodies during  the onset and  reversal of 
diabetic ketosis in rats.
3. To investigate the effect of carnitine supplem entation  on lip id  
catabolism and ketone body production during the onset and reversal 
of diabetic ketosis in rats.
4. To investigate the effects of carnitine supplem entation on tissue and 
circulating carnitine concentrations in diabetes.
5. To investigate the relationship  betw een tissue and  circulating 
carnitine concentrations, in order to help clarify hum an data.
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5.3 METHOD
Animals and Experimental Procedure.
Animals included 60 male Wistar rats bred in the experimental unit of the 
University of Surrey. Animals were fed on chow (composition given in 
appendix C page 271). Half the animals received DL-carnitine (5 g /L ) in 
their drinking w ater (supplem ented group). The rem aining anim als 
drank tap w ater (non-supplemented group). Animals were grouped six 
per cage. Daily records of food and water consumption and supplementary 
camitine intake of each cage were kept, the values being divided by six to 
give an approxim ate value for each animal. A daily record of animal 
weight was also kept.
After receiving animals from the breeding unit they were m aintained for 
48 hours during  which the carnitine dose was adjusted to a level of 
palatability. After the period of maintenance, diabetes was induced by a 
single intraperitoneal injection of streptozotocin (STZ) (Sigma Chemical 
Company) (80mg/kg body weight in 1ml of ice cold 0.25M citrate buffer pH  
4.5). Six animals from each of the two groups (supplem ented and non- 
supplem ented) received citrate buffer only; these served as non-diabetic 
controls. Twenty four, 48 and 96 hours following STZ, six animals from 
each group were sacrificed. Non-diabetic animals were sacrificed 24 hours 
following injection of citrate buffer. A t 118 hours the rem aining six 
animals from each group received a subcutaneous injection of insulin (10 
lU  H um an  A ctrap id) (Novo In d u stri AIS D enm ark), an d  w ere 
subsequently sacrificed at 120 hours.
P rior to sacrifice, anim als w ere anaesthetised  using  d iethyl e ther 
(Anaesthetic Ether B.P.) and 8ml of blood was obtained by cardiac puncture. 
Aliquots of serum  and plasma were obtained and were refrigerated or 
frozen. Following cervical dislocation, liver, heart, left epididym al fat pad 
and a sample of quadriceps muscle were removed by dissection, weighed 
and frozen. A sum m ary of the study protocol is presented in figure 5.1 
(page 199).
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Figure 5.1 Study Protocol
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Biochemical Analysis,
Serum and tissue concentrations of free, short chain acyl (SCAC), and total 
acid soluble carnitine (TASC) were determ ined by the radioenzym e 
m ethod detailed in Chapter 2 (page 35).
Serum concentrations of non-esterified fatty acids (NEFA) were 
determ ined using a Wako NEFA C kit (Alpha Laboratories), adapted for 
use w ith a Cobas Bio centrifugal analyser. Serum glycerol concentrations 
were determined using a Randox glycerol kit, adapted for use w ith the 
Encore centrifugal analyser. Plasma ketone bodies were m easured using 
an enzymatic colorimetric m ethod based upon the betahydroxybutyrate 
dehydrogenase reaction, using the Encore centrifugal analyser. 
M easurements of plasma glucose were carried out using a Beckman 
Glucose 2 analyser. Details of all methods are given in Chapter 2 ( page 18).
Statistical Methods.
Results were expressed as m edian values w ith ranges and non-param etric 
methods of statistical analysis were applied to the data. Analysis of 
variance was carried out using the Kruskal-Wallis test. U npaired analysis 
was carried out between groups, and w ithin each group w ith time, using 
the M ann-W hitney U test.
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5.4 RESULTS
Animal Body Weights, Food and Water Consumption.
W eights of animals on commencing the experiment, prior to sacrifice and 
the difference between these two values are presented in tables 5.1 a and b 
(page 202). Induction of diabetes impaired weight gain in both groups of 
animals. The only significant difference in w eight change betw een the 
two groups was seen at 24 hours following STZ when the supplem ented
group lost m ore w eight (a<0.01). Insulin  treatm ent resu lted  in a 
significant weight gain in both groups of animals (a<0.01).
M edian values and ranges for food intake of both groups of animals at 
each time point are presented in table 5.2 (page 203). Figures in brackets 
represented the am ount of food consumed in the 24 hours im m ediately 
p rior to sacrifice. In the non-supplem ented anim als there w ere no 
significant changes in food consum ption throughout the experiment. In 
the carnitine supplem ented animals food consum ption decreased at 24 
hours following STZ. After this there were no further significant changes 
in the am ount of food consum ed. A significantly  low er food 
consum ption in the supplem ented group was observed upon  insulin  
treatm ent (a<0.01).
Values for w ater consum ption are presented in table 5.3 (page 203), as 
m edian values and ranges. Values for the 24 hours prior to sacrifice are 
placed in brackets. Induction of diabetes did not result in any significant 
changes in w ater consum ption in the non-supp lem ented  anim als, 
a lthough  m edian  values tended  to increase w ith  tim e. In  the 
supplem ented anim als, induction of diabetes was accom panied by a
significant reduction in water intake (a<0.01). W hen the supplem ented 
and non-supplem ented animals are compared, the supplem ented animals 
had significantly lower water intake at 24 hours following STZ (a<  0.01)
and on insulin treatm ent (a<0.05). Table 5.4 (page 204) presents data on
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the supplem entary carnitine intake of the supplem ented animals. Values 
represent g /k g  day. The greatest intake was seen in the 24 hour group.
Table 5.1 Anim al W eights (g) on Commencing Experiment and Prior to 
Sacrifice for Cam itine Supplem ented (C) and N on-supplem ented (NC) 
Animals. M edian Values (with ranges) For Each Cage.
a) N on-Cam itine Supplem ented
Hours post Streptozotocin
0 24 48 96
(insulin)
120
Commencing 185 168 163 168 152
W eight (175-190) (140-175) (154-183) (151-174) (122-165)
W eight prior 202 177 150 163 157
to sacrifice (198-212) (139-182) (140-185) (132-200) (132-192)
W eight +18.5 +6.0 "b  -5.5 3 5  "b +23
Change (+13-+23) (-11.0-+16.0) (-43.0-+27.0) (0--24.0) (+2-+35)
b) Carnitine Supplem ented
0 24
Hours post Streptozotocin
(insulin) 
48 96 120
Commencing 185 145 161 163 133
W eight (170-200) (129-147) (149-175) (156-170) (130-150)
W eight prior 202 130 145 154 148
to sacrifice (195-217) (118-135) (115-168) (100-165) (125-161)
W eight +205 -15"^ " b  -145 -13.0 **b +105
Change (0-+32) C27.0-+1.0) (-44.0--7.0) (+20--56) (-9-+31)
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
** a <0.01 Mann-Whitney Test
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Table 5.2 Food Intake g/24 H ours M edian Values w ith  Ranges of 
Supplem ented  (C) and N on-supplem ented (NC) A nim als D uring  the 
Course of the Experiment (Values for 24 Hours Im mediate to Sacrifice).
FOOD INTAKE g/24 HOURS 
hours post streptozotocin
(insulin)
0 24 48 96 120
NC 20.0 16.0 16.0 18.0 18.5
18.0-21.0 11.0-24.0 6.0-18.0 11.0-27.0 14.0-42.0
24 hours 
pre-sacrifice
(20.0) (16.0) (16.0) (27.0) (18.0)
c 185 "b 11.0 145 13.0 m
17.0-20.0 10.0-12.0 5.0-18.0 7.0-19.0 7.0-13.0
24 hours (18.0) (10.0) (5.0) (13.0) (13.0)
pre-sacrifice
Table 5.3 W ater Intake ml/24 H ours M edian Values W ith Ranges of 
Supplem ented  (C) and N on-supplem ented  (NC) G roups D uring  the 
Course of the Experiment (Values for 24 hours Immediate to Sacrifice).
WATER INTAKE ml/24 HOURS
NC
24 hours 
pre-sacrifice
h o u r s p o s t  S tr e p to z o to c in
(insulin)
0 24 48 98 120
265 28.0 395 m 65.0
24.0-32.0 15.0-36.0 22.0 - 64.0 5.0-65.0 14.0-137.0
(26.0) (36.0) (64.0) (65.0) (14.0)
235 "b m o 20.0 195 13.0
22.0 - 38.0 7.0-15.0 6.0-69.0 9.0-38.0 0.6-44.0
(23.0) (10.0) (69.0) (38.0) (7.0)24 hours 
pre-sacrifice
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
* a<0.01 *** a<0.05 Mann-Whitney Test
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Table 5.4 Supplem entary Camitine Intake During the Time Course of 
the Experiment, g/kg Body W eight, M edian Values (with ranges) n=6.
HOURS POST STREPTOZOTOCIN CARNITINE INTAKE
0 0.27
(0.25 - 0.29)
24 0.58
(0.53-0.63)
48 0.31
(0 .29-0.34)
96 0.30
(0.26 - 0.32)
120 0.29
(0.21 - 0.34)
The Effect o f  Carnitine Supplem entation, on Serum and Tissue Carnitine 
Concentrations, Prior to Induction o f Diabetes.
Concentrations of free (EC), short chain acyl (SCAC), and total acid soluble 
(TASC) carnitine in non-diabetic animals are presented in table 5.6. (page 
206). Values are presented as medians with ranges.
The carnitine supplem ented group had a tendency tow ards higher TASC 
concentrations in serum  although this did not reach statistical 
significance. M edian TASC concentration in the non-supplem ented group 
was 49.0 pm ol/L , compared to 83.8 p m o l/L  in the carnitine supplem ented 
group. The EC fraction was significantly higher in the supplem ented
group (a<0.05), who had a m edian value of 87.6 pm ol/L  compared to 19.6 
p m o l/L  in the non-supplem ented group. The free to acyl carnitine ratio 
was also significantly higher in the supplem ented group (a<0.01).
204
Table 5.5 Organ and Tissue Weights (g) of Camitine Supplemented (C) 
and Non-supplemented (NC) Animals Median Values (with ranges), n=6.
Liver
NC
HOURS POST STREFTOZOTOQN
9.8
(8.9-11.6)
24
9.3
(6.3-9.7)
48
6.9
(5.4-9.6)
96
7.2
(6.2 - 11.1)
(insulin)
120
7.0
(6.7-8.8)
H eart
NC
10.1 "b 6,1- a
(9.5-11.1) (45-6.9)
.77 *'b
(.70-.80)
.91
(.80-1.5)
5.8
(4.0-7.1)
.71
(.61-.86)
75
(5.9-10.1)
.70
(.59-.75)
6.6
(6.7-8.0) 
.67
(.50-.89)
Epididym al 
Fat Pad
m g / k g
b o d y w d g h t
NC
.75
(.60-.94)
.62"a
(.49-.71)
59 " a
(50-.60)
59
(50-.70)
52
(.39-.62)
111.2 102.8 75.1 66.0 51.0
(84.8-140.6) (82.0-190.8) (65.3 - 95.0) (27.7-140.0) (27.0-136.3)
142.3 35.8 34.0 522 322
(127.9-1845) (23.6-37.7) (265-75.6) (21.9-83.3) (15.6-64.4)
a . denotes a significant difference between groups at a given time
b. denotes a significant difference within a group between time points.
** a<0.01
*** a<0.05 Mann-Whitney Test
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Table 5.6 The Effect of Cam itine Supplem entation on Tissue (n mol/g 
wet weight) and Circulating (|imol/l) Concentrations of C am itine, Prior to 
the Onset of Diabetic Ketosis in  Cam itine Supplem ented (C) and Non- 
supplem ented (NC) Animals M edian Values (and ranges), n=6.
CARNITINE FRACTIONS
SERUM
NC
C
TASC
49.0
(13.6 - 772) 
83.8
(45.7-135.0)
PC
19.6
(4 .9-41 .0)
87.6'" a
(65.2 -121.0)
SCAC
26.7
(11.9 -70.1) 
12.5
(7.3 -13.1)
FGSCAC
0.9
(0.1 -1 .4)
9.3 "a  
(8.8 - 11.8)
LIVER
NC
C
318
(270 - 614)
480***a
(393 - 665)
206
(178 - 273)
360 " a
(244 - 640)
96
(24 - 436)
82
(11-321)
2.5
(0.4 -11.9)
4.5
(1.1 - 58.2)
MUSCLE
NC
C
433
(209 - 651) 
510
(343-943)
432
(169 - 540) 
470
(343 - 830)
38
(20 -  201) 
27
(54 -113)
7.4
(4.9 -12.2) 
6.1 
(2.2 -18.1)
HEART
NC
C
1805
(968 - 2844) 
2261
(719 - 3338)
1171
(926 -1242) 
1268
(543 -1456)
857
(267-1602)
1547
(831-2636)
1.2
(0 .6 -4 .2 )  
0.7
(0.3 -1 .7 )
a . denotes a significant difference between supplemented and non-supplemented groups at 
that time point.
** «<0.01
*** «<0.05 Mann-Whitney Test
TASC - total acid soluble camitine. PC - free camitine. SCAC - short chain acyl carnitine.
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The carnitine supplem ented group had significantly higher concentrations 
of both FC (a<0.01) and TASC (a<0.05) in liver, com pared to the non- 
supplem ented group. M edian values obtained were 480 and 360 n m o l/g 
wet weight for supplemented animals, and 318 and 206 n m o l/g w et weight 
for non-supplem ented animals for TASC and FC concentrations 
respectively. Concentrations of SCAC were similar in both groups. Liver 
weights of both groups of animals are presented in table 5.5. (page 205). 
There were no significant differences in liver weights betw een the two 
non-diabetic groups.
Concentrations of carnitine fractions w ere similar in both m uscle and 
heart for both groups of animals. M edian values w ith ranges are 
presented in table 5.6 (page 206). There was a tendency towards a higher 
concentration of SCAC in cardiac tissue from supplem ented anim als, w ho 
had a m edian concentration of 1547 n m o l/g wet weight com pared to 857 
n m o l/g w et w eight in the non-supplem ented animals. This difference did 
not reach statistical significance, as a w ide range of values were obtained. 
Cardiac weights are presented in table 5.5 (page 205). There were no 
significant differences in heart weight between the two groups.
The Effect o f Carnitine Supplementation on Serum Metabolites in the 
Non-Diabetic Rat.
Concentrations of serum  m etabolites of supplem ented and non- 
supplem ented non-diabetic groups are presented in table 5.7 (page 208). 
There were no statistically significant differences in circulating 
concentrations of glucose, NEFA or glycerol between the two groups. The 
concentration of total ketone bodies was significantly higher in the
supplem ented group (a<0.01) who had a m edian concentration of 0.59 
m m ol/L , com pared to 0.39 m m ol/L  in the non-supplem ented group. The 
concentration of acetoacetate was also significantly higher in the 
supplem ented non-diabetic group compared to the non-supplem ented 
non-diabetic group. M edian values were 0.42 m m ol/L  and 0.19 m m ol/L  
respectively. The C-hydroxybutyrate concentration was sim ilar in both 
non-diabetic groups.
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Table 5.7 The Effect of Cam itine Supplem entation on Serum M etabolite 
Concentrations (mmol/L) in  the Non-diabetic Rat. M edian Values (with 
ranges), n=6.
NON-SUPPLEMENTED SUPPLEMENTED
GLUCOSE 102
(9.0-11.0)
10.1
(9.3-115)
NEFA 0.40
(0.24 - 0.46)
035
(0.22 - 0.47)
GLYCEROL 0.16
(0.14-0.21)
0.15
(0.14-0.19)
TOTAL KETONES 039
(0.25-0.51)
0.59 ** 
(0.51-0.93)
fi-HYDROXYBUTYRATE 0.11
(0.07-0.32)
0.14
(0.1-0.51)
ACETOACETATE 0.19
(0.16-0.38)
0.42
(0.37-0.52)
ACETOACETATE:
fi-HYDROXYBUTYRATE
1.63
(059-5.29)
2.80
(1.07-3.31)
«<0.01
*** «<0.05 Mann-Whitney Test
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The Effect o f Streptozotocin (STZ) on Circulating Glucose and Lipid  
Metabolites.
Figure 5.2 illustrates the sequence of change in plasm a glucose 
concentration throughout the experim ent in both groups of animals. 
Streptozotocin treatm ent resulted in significantly raised plasm a glucose
concentration in both supplem ented and non-supplem ented (a<0.01) 
animals. In the supplem ented group m edian concentration increased 
from 10.1 to 24.0 m m ol/L  and in the non-supplem ented group m edian 
concentration increased from 10.2 to 22 m m ol/L .
Figure 5.2 Plasma Glucose Concentrations (mmol/L) D uring the O nset 
and Reversal of Diabetic Ketosis in  Cam itine Supplem ented (C) and Non- 
Supplem ented (NC) Rats. M edian Values (with Ranges). n=6.
40-1
3 0 -
FIGURE 5.2
STZ
I 20^
I^ (973-11.5)' **b3
o  10
(9.0-11.0)
(13.0-56.2)
- I  1 I I I 1— I r— I 1------ 1------ I I I I I------ I------1 I I I
24 48 72
HOURS POST STZ
NC
0
(11.6-36.2)0. 
(11.0-32.0)NC
insulin
i
(8.3-26.8)
(20.2-25.8)(8.6-25.6)
(3.2-5.9)C. 
(2.4-16.8)NC.
—I I I I—I
96 120
STZ: Induction of diabetes with streptozotocin 
«< 0.01 )
*** «<0.05 ) Mann-Whitney Test
b - denotes a significant difference within a group with time
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Although there was a tendency tow ards a higher concentration of plasm a 
glucose in the supplem ented group at 48 hours, the difference was not 
statistically significant. There were not any significant differences between 
the supplem ented and non-supplem ented groups at any time point 
throughout the experimental course. Insulin treatm ent caused a sharp 
significant decrease in plasma glucose concentration to sub-baseline values
in both groups of animals (a<0.01).
Circulating concentrations of NEFA are presented in figure 5.3 (page 211). 
In the non-supplem ented group serum  NEFA concentration was
significantly elevated 24 hours following STZ (a<0.05), from a baseline 
value of 0.4 m m ol/L  to 0.62 m m ol/L . The concentration rem ained 
elevated and only showed a tendency to decline following insulin 
treatm ent. In the carnitine supplem ented anim als NEFA concentration 
showed a sharp significant increase, from 0.35 to 0.81 m m ol/L , w ithin 24 
hours of STZ (a<0.01). Thereafter, no significant changes in NEFA 
concentration was seen in the supplem ented group. Sequential changes in 
serum  glycerol concentrations are presented in figure 5.4 (page 211). 
Concentrations of glycerol did not alter significantly in the non- 
supplem ented animals throughout the study period. The average 
concentration was 0.16 mmol, although the range of concentration 
obtained was wide. In the supplem ented animals glycerol concentration
was significantly elevated 24 hours following STZ (a<0.01), from 0.15 to 
0.35 m m ol/L . At 96 hours glycerol concentration significantly decreased to 
0.11 m m ol/L . Insulin treatm ent produced no significant effect. A t 24 
hours following STZ the supplem ented group had a significantly higher 
circulating glycerol concentration com pared to the non-supplem ented 
group (a<0.05).
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Figure 5.3 Serum NEFA Concentrations (mmol/L) D uring the O nset and 
Reversal of Diabetic Ketosis in  Carnitine Supplem ented (C) and Non- 
Supplem ented (NC) Rats. M edian Values (with Ranges) n=6.
FIGURE 5.3 NC
1.2
(0.29-1.78)
1.0 -
(035-0.90) (0.26-1.31)(0.12-0.96)
(037-0.79)
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(0.44-0.88)0.4
Y  (0.24-0.46)NC. 
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0.2
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Figure 5.4 Serum Glycerol Concentrations (mmol/L) D uring the O nset 
and Reversal of Diabetic Ketosis in  Carnitine Supplem ented (C) and Non- 
Supplem ented (NC) Rats. M edian Values (with Ranges) n=6.
FIGURE 5.4
1  STZ NC
(0.17-0.45)
(0.06-0.41)
0.3 -
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(0.1-0.37)0.2 -
(0.1-0.24)(0.03-0.43)
(0.09-0.^
(0.14-0.19)0
(0.14-0.21)NOpj 0.1-
(0.04-0.21)
(0.02-0.13)
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96 12048 72240
HOURS POST STZ
** a<0.01 )
*** a <0.05 ) Mann-Whitney Test 
a - denotes a significant difference between groups 
b - denotes a significant difference within a group with time 
STZ: Induction of diabetes with streptozotocin
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Figure 5.5a (page 213) presents total circulating ketone concentrations for 
supplem ented and non-supplemented groups. In both groups of animals 
the concentration was significantly elevated 24 hours follow ing STZ
(a<0.05). In the non-supplem ented animals m edian values for ketones
increased from 0.39 to 0.94 m m ol/L , and in the supplem ented group 
m edian values increased from 0.59 to 1.30 m m ol/L . Peak concentrations 
were obtained at 48 hours in both groups of animals; m edian values were 
1.42 and 1.51 m m ol/L  for non-supplem ented and supplem ented groups 
respectively. A t 96 hours there was a tendency for ketone body 
concentration to fall in both groups of animals, although decreases did not 
reach statistical significance. Insulin treatm ent caused a further tendency 
for ketone body concentration to decline in both groups. A part from 
baseline concentrations, there were no statistically significant differences 
in total ketone body concentrations between the two groups.
W hen data on individual ketone body concentrations was examined, both 
groups showed a significant increase in fi-hydroxybutyrate concentration 
w ithin 24 hours following STZ. In the non-supplem ented group the
m edian concentration increased from 0.11 to 0.46 m m ol/L  (a<0.05), and in 
the supplem ented group the median concentration increased from 0.14 to 
0.72 m m ol/L . Insulin treatm ent resulted in a significant decrease in fi- 
hydroxybutyrate concentration in both groups, to 0.18 m m ol/L  in the non-
supplem ented group (a<0.05) and to 0.16 m m ol/L  in  the supplem ented
group (a<0.05). There were no statistically significant differences in fi- 
hydroxybutyrate concentrations between the two groups throughout the 
experim ental period. Induction of diabetes resulted  in a significant 
increase in  acetoacetate concentration in both  groups. In  the  non- 
supplem ented animals, the m edian concentration increased from  0.19 to 
0.50 m m ol/L , and in the carnitine supplem ented anim als the m edian 
concentration increased from 0.42 to 0.69 m m ol/L . B-hydroxybutyrate and 
acetoacetate concentrations are presented graphically in  figures 5.5b and 
5.5c (page 213). Median values and ranges for ketone bodies are presented 
in tabulated form in table 5.i Appendix C (page 265).
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Figures 5.5a - 5.5c Plasma Ketone Body Concentrations (mmol/L) During the Onset and 
Reversal of Diabetic Ketosis in  Carnitine Supplemented (C) and Non-Supplem ented (NC) 
Rats. Figure 5.5a: Total Ketone Bodies; Figure 5.5b: C -Hydroxybutyrate (fiOHB); Figure 
5.5c: Acetoacetate (AcAc). M edian Values (with Ranges) n=6.
1.6 F IG U R E  5 .5 a (0.38-3.64)
NCSTZ
1.4
(0.67-4.67) in su lin(0.34-2.81)
(0.7-1.32)
1.0
(0.05-3.14)
(0.53-1.47)P  0.8
(0.43-0.87)0.6 (0.51-0.93)
P  0.4 (0.25-0.51)
0.2
72 96 12048240
H O U R S  P O S T  S T Z
F IG U R E  5 .5 b NC
IS T Z (0.1-2.95)
in su lin1.0 _
0.8 - (0.15-3.91) (0.17-1.91)
0.6
(0.07-2.66)
§  0 .4 (0.07-1.93) (0.17-0.7)
((U-0.51)
(0.07-0.32)
(0.07-0.86)
(0.07-0.29)
0.0
48 72 9 6 120240
H O U R S  P O S T  S T Z
F IG U R E  5 .5 c
NC(0.29-1.48) (0.28-0.84)0.7 STZ in su lin
#  0.6 (0.47-0.78) (0.36-0.58)
(0.43-1.21) (0.37-0.8)
(0.17-0.9)
(0.16-0.38)
0.1
48 7 2 96 120240
HO URS PO ST STZ
«<0.01 ) •** a<0.05 ) Mann-Whitney Test
a - denotes a significant difference between groups 
b - denotes a significant difference within a group with time 
STZ: Induction of diabetes with streptozotocin
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Table 5.i (Appendix C, page 265) compares acetoacetate to B- 
hydroxybutyrate ratios between groups and within groups w ith time. In 
the non-supplem ented group a significant decrease in the ratio was seen
betw een 0 and 48 hours, from a m edian value of 1.63 to 0.38 (a<0.05). In
the carnitine supplem ented group a significant decrease, from 2.86 to 0.73,
was observed w ithin 24 hours (a<0.05). Insulin treatm ent resulted in a
significant increase in the acetoacetate to B-hydroxybutyrate ratio (a<0.05). 
The supplem ented group had a significantly higher acetoacetate to B- 
hydroxybutyrate ratio at 48 hours post STZ (a<0.05). A part from  this no 
significant differences existed between the two groups.
Carnitine Metabolism During the Onset and Reversal of Diabetic Ketosis
Serum Carnitine.
Serum concentrations of TASC, FC and SCAC are presented graphically in 
figures 5.6a, 5.6b and 5.6c respectively (page 215). M edian values with 
ranges are tabulated in table 5.ii appendix C (page 266). In the non- 
supplem ented animals TASC concentration was reduced from 49.0
fim ol/L  to 26.8 pm o l/L  48 hours following STZ treatm ent, (a<0.01) and
rem ained reduced until insulin treatm ent which caused a significant
increase from 21.4 pm ol/L  to 54.6 jim ol/L  (a<0.01). FC showed no
significant change following STZ in the non-supplem ented group. 
How ever, insulin treatm ent caused a significant increase in serum  FC
from 16.2 to 39.8 pm ol/L  (a<0.01). Induction of diabetes caused a 
significant elevation in serum  SCAC from 26.8 to 34.1 pm ol/L  (a<0.01).
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Figure 5.6a - 5.6c Serum Carnitine Concentrations (pmol/L) During the Onset and Reversal 
of Diabetic Ketosis in  Carnitine Supplemented (C) and Non-Supplemented (NC) Rats. 
Figure 5.6a: Total Acid Soluble Carnitine (TASC); Figure 5.6b: Free Carnitine (FC); Figure 
5.6c: Short Chain Acyl Carnitine (SCAC); M edian Values (with Ranges) n=6.
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In the carnitine supplem ented animals there was only a tendency tow ards 
reduced TASC following STZ treatm ent, and an elevated concentration on 
insulin treatm ent, bu t these changes did not reach statistical significance. 
In supplem ented animals, serum  FC concentration show ed a sharp 
significant decline w ithin 24 hours of STZ treatm ent from a baseline
concentration of 87.5 pm ol/L  to 18.4 pm ol/L  (a<0.01). The concentration 
rem ained low, only showing a non-statistically significant tendency to rise 
from 48 hours onwards. The supplem ented group show ed a significant 
increase in SCAC at 24 hours following STZ from 12.5 to 35.3 pm ol/L
(a<0.01). The supplem ented animals had higher serum  TASC at 0,48, and
96 hours post STZ (a<0.05). FC concentration did not differ significantly 
between the two groups, although from 48 hours onw ards there was a 
tendency towards a higher concentration in the supplem ented animals.
Liver Carnitine
Sequential changes in liver carnitine fractions in supplem ented and non- 
supplemented groups are presented in figures 5.7a, 5.7b and 5.7c (page 217). 
M edian values and ranges are presented in tabulated form in table 5.iii 
Appendix C (page 267).
The carnitine supplem ented animals had  significantly higher liver TASC 
concentrations at 0, (a<0.05) 48 (a<0.01) and 96 hours (a<0.01) following
STZ and on insulin  treatm ent (a<0.01) w hen com pared to the non-
supplem ented group. Peak concentrations in  the supplem ented group 
(1232 n m o l/g wet weight) was greater than two fold that obtained in the 
non-supplem ented group (540 nm o l/g  wet weight).
In the non-supplem ented group liver TASC concentration was 
significantly increased 48 hours following STZ from a baseline
concentration of 318 to 540 nm ol/g  wet weight (a<0.05). Following this the
concentration did not alter significantly.
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Figure 5.7a - 5.7c Liver Carnitine Concentrations (nmol/g Wet Weight) During the Onset 
and Reversal of Diabetic Ketosis in  Carnitine Supplemented (C) and Non-Supplemented  
(NC) Rats. Figure 5.7a: Total Acid Soluble Carnitine (TASC); Figure 5.7b: Free Carnitine 
(FC); Figure 5.7c: Short Chain Acyl Carnitine (SCAC). M edian Values (with Ranges) n=6. 
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In the supplem ented anim als, liver TASC rem ained unchanged betw een 0 
and 24 hours and then increased dramatically between 24 and 48 hours 
from 480 to 1232 nm o l/g  wet weight (a<0.01). By 96 hours the 
concentration had significantly fallen to 731 n m o l/g  w et weight (a<0.01). 
The supplem ented group had a tendency tow ards higher concentrations of 
liver FC; a significant difference existed between the two groups at 0 and 48
hours (a<0.01). Induction of diabetes caused a significant increase in liver 
FC concentration in the non-supplem ented anim als from 206 to 377 
n m o l/g  wet weight. Following this, concentration was stable until insulin 
treatm ent, which caused a further significant increase to 612 n m o l/g  wet
weight (a<0.01). In the supplem ented group the liver free carnitine 
concentration increased significantly between 24 and 48 hours post STZ, 
from 253 to 1012 nm o l/g  wet weight (a<0.01), followed by a decrease at 96 
hours to 533 nm ol/g  wet weight (a<0.01).
There was little difference in liver SCAC concentration betw een the two 
groups except in the insulin treated anim als w hen the supplem ented
group had a significantly higher concentration (a<0.05). Concentrations of
SCAC were lower than those of FC in both groups of animals. In both 
groups of animals, liver SCAC concentration was increased significantly by 
STZ treatm ent. Insulin treatm ent led to a fall in SCAC, only reaching
significance in the non-supplem ented group (a<0.05).
Muscle Carnitine.
Concentrations of muscle TASC, FC and SCAC are presented in  figures 
5.8a, 5.8b and 5.8c respectively (page 219) and are tabulated in table 5.iv 
Appendix C (page 268). Although no statistically significant differences 
existed in m uscle TASC concentrations betw een the tw o groups, m edian 
values tended to be higher in the supplem ented animals.
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Figures 5.8a - 5.8c Carnitine Concentrations in  Quadriceps Muscle (nmol/g w et weight) 
During the Onset and Reversal of Diabetic Ketosis in Carnitine Supplemented (C) and Non- 
Supplemented (NC) Rats. Figure 5.8a: Total Acid Soluble Carnitine (TASC); Figure 5.8b: 
Free Carnitine (FC); Figure 5.8c: Short Chain Acyl Carnitine (SCAC). M edian Values (and 
Ranges) n=6.
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In the non-supplem ented group m uscle carnitine concentration was 
significantly increased 48 hours following induction of diabetes, from a
baseline concentration of 433 to 890 nm o l/g  wet weight (a<0.05). There
was a tendency towards a reduced concentration 96 hours following STZ, 
although this decrease did not reach statistical significance. Supplemented 
animals also showed a significant increase in muscle TASC concentration 
by 24 hours. The m edian concentration increased from 510 to 865 nm ol/g  
wet weight (a<0.05), following this the concentration rem ained stable.
A trend  tow ards higher m uscle FC concentrations w as seen in the 
supplem ented animals, although differences between the two groups only
reached statistical significance at 96 hours (a<0.05). In the non-
supplem ented group no significant changes in muscle FC concentration 
was seen throughout the experiment. In the carnitine supplem ented 
group muscle FC concentration increased significantly 24 hours post STZ
(a<0.05), following this the concentration rem ained stable.
A smaller proportion of muscle carnitine was present as SCAC. Induction 
of diabetes caused a significant increase in muscle SCAC concentration in 
both groups. In the non-supplem ented animals, this increase was seen 
between 24 and 48 hours following STZ when the concentration increased 
from 99 to 345 n m o l/g wet weight (a<0.05). In the carnitine supplem ented 
animals, a significant increase was seen by 24 hours following STZ w hen 
the concentration increased from 88 to 221 nm ol/g  w et weight (a<0.05).
Cardiac Carnitine.
Sequential changes in cardiac TASC, FC and SCAC are presented in figures 
5.9a, 5.9b and 5.9c respectively (page 221). M edian values and ranges are 
tabulated in table 5.v Appendix C (page 269).
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Figure 5.9a - 5.9c Concentrations of Cardiac Carnitine (nmol/g w et weight) During the 
Onset and Reversal of Diabetic Ketosis in  Carnitine Supplemented (C) and Non- 
Supplemented (NC) Rats. Figure 5.9a: Total Acid Soluble Carnitine (TASC); Figure 5.9b: 
Free Carnitine (FC); Figure 5.9c Short Chain Acyl Carnitine (SCAC). M edian Values 
(with Ranges) n=6.
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In the non-supplem ented animals a two fold drop in cardiac TASC 
concentration was seen following induction of diabetes, m edian 
concentration fell from 1805 to 768 nm o l/g  wet weight. The concentration 
rem ained low until insulin treatm ent, which resulted in a significant 
increase in cardiac TASC concentration to 1431 nm o l/g  wet weight
(a<0.01). The carnitine supplemented group also showed a significant 
decrease in cardiac TASC concentration following induction of diabetes, 
from 2261 to 676 n m o l/g wet weight (a<0.01). However, between 24 and 48 
hours the concentration was replenished and significantly increased from 
676 to 1719 nm ol/g  wet weight (a<0.01). Insulin treatm ent had no 
significant effect on the TASC concentration in cardiac tissue of 
supplem ented animals. Although m edian concentrations of cardiac TASC 
tended to be higher in the supplemented group, they were only 
significantly so at 48 and 96 hours post STZ.
Sequential changes in cardiac FC showed a similar pattern in both groups. 
Following STZ treatm ent concentrations were significantly reduced; in
the non-supplem ented group from 1171 to 19 n m o l/g  wet weight (a<0.01), 
and in the supplem ented group from 1268 to 651 n m o l/g w et weight 
(a<0.01). Following this both groups showed a significant increase in 
cardiac FC between 24 and 48 hours to 781 and 1450 n m o l/g w et weight, for 
non-supplem ented and supplem ented groups respectively. Insulin 
treatm ent resulted in a further significant increase in cardiac FC 
concentration in the non-supplem ented group to 1319 n m o l/g  w et weight. 
Concentration of cardiac FC was significantly higher in the supplem ented
group at 24 (a<0.01), 48 (a<0.01), and 96 hours (a<0.05).
In the non-supplem ented animals a significant reduction in cardiac SCAC 
concentration was seen between 24 and 48 hours from 757 to 142 n m o l/g
wet weight (a<0.01). The concentration rem ained low throughout the
rem aining experimental period. In the carnitine supplem ented animals
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cardiac SCAC concentration was significantly reduced betw een 0 and 24 
hours from 1547 to 53 nm o l/g  w et weight (a<0.01). Following this, the 
concentration was significantly increased to 289 n ino l/g  w et weight at 48 
hours (a<0.01) and to 597 nm ol/g  wet weight at 96 hours (a<0.05). Insulin 
treatm ent caused a significant reduction in cardiac SCAC concentration to 
153 n m o l/g  w et w eight (a<0.01). Cardiac SCAC concentration was 
significantly greater in the supplem ented group at 24, 48 and 96 hours 
following STZ treatm ent (a<0.01).
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5.5 DISCUSSION
Animals, Diets and Carnitine Supplements,
The rat has been widely used for the study of carnitine metabolism. The 
animal model used in the present study was a modification of that of 
Blackshear and Alberti (1974), w ho w ithdrew  insulin  treatm ent from 
streptozotocin (STZ) diabetic rats and m onitored sequential changes in 
serum metabolites. This animal model has recently been used for studies 
of carnitine palm itoy l-transferase  (CPT) m etabolism  (G rantham  and 
Zam mit, 1988). In the present study the m odel w as applied  to the 
sequential m easurem ent of carnitine fractions and interm ediates of lipid 
metabolism, during the onset and reversal of diabetic ketosis.
In the present study STZ was used as a pancreatoxin. Other m ethods for 
inducing diabetes include pancreatectom y and alloxan treatm ent (a 
pancreatoxin) (Chernick and Scow, 1959; Steiner, Rauba and W illiams,
1961). Pancreatectomy is technically difficult and also removes a  cells.
Alloxan also has hepatotoxic and nephrotoxic effects (Vargus, Friederici 
and Maibenco, 1970). STZ is relatively less toxic (Arison et al., 1967), 
although may still cause hepatotoxicity by depletion of cellular NAD and 
NADH (Schein and Loftus, 1968). Extent of hepatotoxicity m ay vary from 
animal to animal, and as the liver is the site of ketogenesis this m ay cause 
a variable degree of ketosis w ith in  groups. If anim als h ad  been 
m aintained on insulin for 48 hours, this w ould have enabled toxic effects 
on the liver to pass p rior to the beginning of the m etabolic study. 
However, attempts to stabilise diabetes w ith insulin to the same extent in 
all anim als can prove difficult and will also introduce variability  in 
severity of diabetes w ithin groups. As the present objective w as to 
investigate carnitine metabolism in conditions of altered ketosis (to some 
extent regardless of causative factors) hepatotoxic effects were not of major 
concern, bu t m ay have contributed to the wide ketotic variability w ithin 
groups.
224
In the present study the carnitine supplem ent was adm inistered in the 
drinking water at an average dose of 0.4 g /k g /2 4  hours. The concentration 
was adjusted in the maintenance period, prior to the onset of the 
metabolic study, in order to reach a palatable concentration. Tahiliani and
McNeil (1986), also adm inistered carnitine in drinking w ater but at a 
relatively higher dose of 3g /kg  body w eight/24 hours. In the present study, 
doses in excess of 0.5g/kg body w eight/24 hours were unpalatable. Studies 
of carnitine supplem entation in rats report doses ranging from 200 mg to 3 
g /k g  body w eight/24 hours. The majority of studies have adm inistered 
the carnitine supplem ent by intraperitoneal injection (Paulson et al., 1984;
Pieper and Murray, 1987; Xiang, Rodriguez and McNeil, 1988). This 
enables much higher doses to be administered, but is technically more 
difficult, and invasive, inducing additional stress on the anim al which 
m ay influence the experim ental results. A non-invasive rou te  of 
adm inistration was preferable; dietary supplem entation was avoided as 
preparation of specialised diets is extremely costly. Brooks, Bahl and 
Bressler (1985) adm inistered carnitine in animal diets at a concentration of 
44.5 nm o l/g  diet, however, they did not present figures on food 
consum ption so the actual dose is unknown. In any study where carnitine 
is adm inistered in diet or water, unless animals are caged individually, the 
exact dose of carnitine administered will be unknown.
Carnitine supplem ented animals consum ed less food than  their non- 
supplem ented counterparts, although this was not reflected in major 
differences in weight changes between the two groups (table 5.1, page 202). 
It is possible that carnitine had an anorexic effect. However, reduced food 
consum ption may have been a consequence of lower w ater intake in the 
supplem ented animals. Differences in water intake may indicate reduced 
palatability of the carnitine supplem ented water, however, it is possible 
that the non-supplem ented animals had a larger urine output. Failure to 
m easure urine ou tpu t and urinary carnitine m eant it was not possible to 
calculate the proportion of carnitine retained.
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Carnitine Metaholism in Carnitine Supplemented and Nan- 
Supplemented Non-Diabetic Rats.
The value obtained for serum  TASC concentration of 40.4 (13.6-77.2) 
|im o l/L , in the non-supplem ented non-diabetic group was lower than 
values obtained by several other investigators. Fogle and Bieber (1979)
obtained a value of 65.3 (± 6.2) pm ol/L , Brooks and McIntosh (1975) 
obtained a value of 87 pm ol/L , and Macnab et al. (1979) obtained a value of 
63 (± 6.6) p m o l/L  for TASC in serum. The present value was more 
comparable with that of Cederblad and Lindstedt (1976) of 39.9 (± 0.8) 
|im o l/L  and w ith that of Brooks, Bahl and Bressler (1985) of 30 (± 2) 
pm ol/L . Data on circulating individual carnitine fractions in rats is 
lim ited, however. Brass and Hopple (1978) have reported values of 50, 32 
and 17 fxmol/L for TASC, FC and SCAC respectively in non-fasted rats. 
The distribution of carnitine between these three fractions was comparable 
to that found in the present study.
Carnitine supplem entation resulted in a significant increase in serum  
TASC concentrations, largely due to an increase in FC. Previous studies 
have also show n carnitine supplem entation to increase the serum  
concentration. Brooks, Bahl and Bressler (1985) found TASC to increase
from 30 (± 2) pm ol/L  to 75 (± 7) |im ol/L , when the diets of rats were 
supplem ented w ith  carnitine. Paulson et al. (1984) also found raised a 
serum  carnitine concentration from 68 to 88 p m o l/L  in carnitine 
supplem ented animals. The present study is unique in reporting the effect 
of carnitine supplem entation on individual carnitine fractions, and  has 
indicated that supplem entation results in a significant increase in the FC 
fraction and free to acyl ratio, whereas no significant effect was seen on 
SCAC. Several hum an studies have reported the effects of carnitine 
supplem entation upon the circulating concentration of carnitine, and 
have shown TASC to increase (Fagher et al.. 1982; Greig et al.. 1987). In 
agreem ent with the present findings, Bowyer and coworkers (1988) found 
carnitine supplem entation caused a significant elevation in total carnitine 
concentration due to a significant increase in the non-esterified fraction.
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Ability of supplem entation to increase the circulating concentration of 
carnitine, demonstrates that carnitine is absorbed from the gut and that 
the blood is able to retain the additional carnitine for subsequent tissue 
distribution.
The value obtained for liver TASC in the non-supplem ented non-diabetic 
group of 318 (270-614) n m o l/g  wet weight is slightly higher than values
previously reported. Snoswell and McIntosh (1974) reported a value of 227 
(± 59) nm o l/g  wet weight. Pearson and Tubbs (1967) a value of 296 (± 24) 
n m o l/g  w et weight Macnab et a l. (1979), a value of 181 (± 9) n m o l/g  wet 
weight, and Brooks, Bahl and Bressler (1985), a value of 148 (± 14) nm ol/g  
wet weight. However, Bohles and Akcetin (1987) report a relatively higher 
value of 1075 n m o l/g  w et w eight for liver TASC. Few studies have 
rep o rted  concentrations of ind iv idual carn itine fractions in liver, 
how ever, in an early study by Pearson and Tubbs (1967), values of 173 and 
41 nm o l/g  wet weight were obtained for FC and SCAC respectively. These 
values are lower than the concentrations of 206 and 96 nm o l/g  wet weight, 
obtained in the present study. Bohles and Akcetin (1987) have reported 
much higher values for FC and SCAC, of 820 and 255 nm o l/g  w et weight 
respectively. Differences in assay m ethod used, animal species, age, sex 
and diet may help to explain these disparate data.
In the present study carnitine supplem entation significantly increased the 
concentration of TASC in liver from 318 (270-614) to 480 (393-665) nm o l/g  
w et weight. Carnitine supplem entation has previously been show n to 
increase the liver carnitine concentration. In studies of Brooks, Bahl and 
Bressler (1985), liver carnitine increased from 148 to 164 n m o l/g  w et 
weight; no data on individual carnitine fractions was given. Bohles and 
A kcetin (1987) found  carnitine supp lem enta tion  increased  hepatic  
concentrations of all fractions. Data from the present study indicates that 
the increase in liver carnitine concentration was due to an increase in the 
FC fraction w ith  little change in SCAC. If all fractions had  increased 
proportionally, it could be argued that the raised liver concentration m ay 
have been due to a reduction in liver weight. However, no significant
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difference in liver weight between the non-diabetic groups was found.
Clinical studies have also investigated the effects of carnitine 
supplem entation on liver carnitine concentration. Bowyer et al. (1988) 
have shown that intravenous carnitine supplem entation significantly 
increases the total carnitine concentration in hum an liver.
In the non-supplem ented, non-diabetic anim als, the m edian skeletal 
muscle TASC concentration was 433 (209-651) nm o l/g  wet weight. This 
value is lower than that obtained in several previous investigations
(Pearson and Tubbs, 1967; Brooks and McIntosh, 1975; Stearns, 1980; 
Paulson et al.. 1984; Brooks, Bahl and Bressler, 1985). The highest value 
reported was 1030 nm ol/g  wet weight (Brooks and McIntosh, 1975). In the 
present study, although the m edian value for muscle TASC tended to be 
higher in the supplem ented animals, there were in fact no significant 
differences between the two groups. Contrary to this, other investigators 
have found the muscle carnitine concentration to significantly increase 
upon supplem entation in anim als (Paulson et al., 1984; Brooks, Bahl and 
Bressler, 1985), and in hum ans (Fagher et al., 1982), indicating that the 
muscle concentration responds to supplem entation. Failure for carnitine 
supplem entation to have a significant effect on the m uscle carnitine 
concentration in the present investigation, may have been due to the low 
dose used over a short period. The muscle mass is large and therefore 
small changes in concentration of carnitine m ay go undetected. It is also 
possible that w ide within group variability in muscle TASC concentration 
m asked any effect supplementation m ay have had.
The m edian value for cardiac carnitine concentration of 1805 n m o l/g  wet 
weight was significantly higher than values obtained for carnitine 
concentrations of other tissues. This value is also higher than  values 
previously reported for cardiac carnitine concentration (Pearson and
Tubbs, 1967; Brooks and McIntosh, 1975; Fogle and Bieber, 1979; Paulson et 
d ., 1984; Brooks, Bahl and Bressler, 1985). The highest value reported was
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that of Brooks and McIntosh (1975) of 1420 nm o l/g  wet weight, and the 
lowest value reported was that of Pearson and Tubbs (1967) of 779 nm ol/g  
w et weight. The higher value in the present study was due to higher 
concentrations of both FC and SCAC, as concentrations of both were 
higher when compared to published data (Pearson and Tubbs, 1967; Fogle 
and Bieber, 1979).
Supplemented animals had significantly higher concentrations of cardiac 
carn itine  w hen  com pared  to non-supp lem en ted  anim als. O ther 
investigators have also shown that supplem entation w ith carnitine raises 
cardiac carnitine concentration. Brooks, Bahl and Bressler (1985) found 
the concentration of TASC increased from 534 to 1032 nm o l/g  w et weight, 
when animals received a carnitine supplement. Paulson et al. (1984) have 
also show n an increase in cardiac carn itine  concentra tion  upon  
supplem entation, from a baseline value of 1300, to 1750 n m o l/g  w et 
weight. Variations in the m agnitude of effect may be due to differences in 
carnitine dose and route of adm inistration. M ost studies have not 
investigated the effect of carnitine supplem entation on individual cardiac 
carnitine fractions. However, in agreem ent w ith the present findings, 
Paulson et a l. (1984) found the increase in cardiac carnitine to be due to an 
increase in the esterified fraction.
The present study has shown that supplem entation w ith carnitine results 
in body retention, with a significant increase in carnitine concentrations of 
some tissues. Many studies have shown similar findings, although direct 
comparison between studies is complicated by variations in study design, 
dose used and route of adm inistration of carnitine. The oral route of 
adm inistration may favour enhanced liver and serum  concentrations to a 
greater extent than other tissues. Intravenous adm inistration m ay have 
resulted in a more uniform effect on tissues since the supplem ent w ould 
be received into the general circulation, by-passing the liver and hepatic 
portal vein.
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The Effect of Carnitine Supplementation on Serum Metabolites in the 
Non-Diabetic Rat
The results p resented  in table 5.7 (page 208) show  tha t carnitine 
supplem entation caused a significant increase in circulating ketone body 
concen tra tions, p rim arily  d u e  to an  increase  in  acetoacetate . 
Concentrations of serum  NEFA and glycerol were similar for both groups, 
which tends to suggest that enhanced peripheral lipid catabolism could 
not be the cause of raised ketone body concentrations. It is more likely that 
hepatic lipid catabolism and ketogenesis were enhanced, possibly due to 
increased liver carnitine availability in the supplem ented group. As the 
glucose concentration was similar in both groups of animals, differences 
in absorptive state was ruled out as a factor accounting for differences in 
ketotic status. A stress response to supplementation is unlikely to account 
for the enhanced circulating ketone body concentrations since if this were 
the case, raised circulating concentrations of glucose, NEFA and glycerol 
would also be expected.
Contrary to the present findings, Meijer and Beynen (1988) found carnitine 
supplem entation to have no significant effect on plasm a ketone bodies. 
However, several other studies in both animals (Bohles, Segerer and Feki, 
1984), and hum ans (Helms et al., 1986), have shown enhanced ketogenesis 
following supplem entation w ith carnitine. These findings, together w ith 
those of the present study, indicate a potential therapeutic  role for 
carnitine as a ketogenic agent in a clinical setting, which w arrants further 
attention.
The Effect of Inducing Diabetes on Circulating Concentrations of Glucose 
and Lipid Metabolites.
The significant increase in plasma glucose concentrations within 24 hours 
of STZ treatment, indicated that diabetes had been successfully induced in 
both groups of animals. Water intake for the 24 hours preceding sacrifice 
only increased in the non-supplem ented animals, however, by 48 hours
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the supplemented animals had also increased their water intake.
Figure 5.2 (page 209) illustrates that no significant difference existed 
between the two groups for plasma glucose concentration at any time 
point during the course of the experiment; this suggests the severity of 
diabetes was similar in both groups. O ther investigators have found that 
carnitine supplem ented diabetic animals have a lower blood glucose 
concentrations compared to their non-supplem ented counterparts (Xiang,
Rodriguez and M ^ e i l ,  1988; Paulson et al., 1984), bu t no proposed 
m echanism  for this has been given. The m agnitude of increase in plasm a 
glucose between 0 and 24 hours following STZ is small compared to that 
observed by Blackshear and Alberti (1974) who observed a six fold increase 
in blood glucose concentration 24 hours following insulin w ithdraw al. 
Their animals m ay have been m ore severely diabetic due to the higher 
doses of STZ (150 m g/kg  body weight) used. In the present study, the rapid 
fall in blood glucose concentration on insulin treatm ent confirm ed the 
reversal of the diabetic state.
Figure 5.3 (page 211) illustrates that induction of diabetes caused a 
significant increase in circulating NEFA concentration, probably a direct 
consequence of increased peripheral lipolysis which occurs upon insulin 
depletion. The m agnitude of increase was similar to that observed by 
Blackshear and Alberti (1974). The absence of a concurrent increase in 
glycerol concentration in the non-supplem ented animals, m ay have been 
due to the wide range of values obtained (figure 5.4 page 211, and table 5.i 
Appendix C, page 265). Alternatively, glycerol clearance may have been 
increased due to enhanced hepatic gluconeogenesis. There may possibly 
have been reduced NEFA clearance, a process in which carnitine plays a 
vital role.
The supplem ented animals showed a sharper m ore significant increase in 
NEFA concentration com pared to the non-supplem ented animals. In the 
supplem ented animals, the glycerol concentration was also significantly 
increased between 0 and 24 hours following STZ. It m ay therefore be
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suggested that carnitine may exert an effect on lipolysis by an indirect 
mechanism, enhancing NEFA clearance and thereby providing a feedback 
stim ulus for further lipolysis. The supplem ented anim als drank less 
w ater between 0 and 24 hours compared to the non-supplem ented group, 
and the possibility that dehydration contributed to the relatively higher 
NEFA concentrations in the supplem ented group cannot be overlooked. It 
is also possible that if the animals were drinking little that they were 
under additional metabolic stress. However, neither dehydration or stress 
are reflected in circulating glucose concentrations; decreased urine volume 
in supplem ented animals cannot be ruled out. Further evidence to 
support a role of carnitine in enhancing lipolysis is provided by the lower 
epididym al fat pad weights of the supplem ented animals, which indicate a 
loss of adipose tissue in this group.
An intriguing observation was m ade upon insulin treatm ent. In the non- 
supplem ented animals insulin treatm ent resulted in a tendency for the 
NEFA concentration to decline (figure 5.3 page 211), which is in keeping 
w ith the known antilipolytic action of insulin. Contrary to this, there was 
a tendency for the NEFA concentration to increase in the supplem ented 
anim als, following insulin treatm ent, and this finding rem ains 
unexplained. Few other studies have investigated the effects of carnitine 
supplem entation on NEFA, glycerol or indices of lipolysis during diabetes, 
however, Paulson et al. (1984) found the NEFA concentration to be lower 
in carnitine supplem ented animals, due to carnitine-enhanced clearance.
The pattern of ketone body concentrations observed over the duration of 
the experiment, differed from that reported by previous investigators who 
used a similar experimental design (Blackshear and Alberti, 1974; 
Grantham  and Zammit, 1988). In such studies the ketone body 
concentration was reported to increase gradually following insulin 
w ithdraw al. Blackshear and Alberti (1974) obtained m axim um  
concentration of ketones at 96 hours post insulin w ithdraw al, of 9.6 
m m ol/L , and Grantham  and Zam mit (1988), obtained a m axim um  
concentration of 4.6 m m ol/L  at 120 hours following insulin w ithdraw al.
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In the present study the maximum ketone body concentration obtained 
was 1.42 m m ol/L , which was substantially lower. In the studies referred to 
above, ketone bodies continued to increase in parallel w ith  the time 
period of insulin withdrawal, in contrast to this, in the present study the 
maximum ketone body concentration was obtained at 48 hours. This data 
indicates that an advanced state of ketosis was not achieved. It is possible 
that depletion of body fat, and therefore substrate supply for ketogenesis, 
was the causative factor. If epididymal fat pad weight (m g/kg  body weight) 
represents adiposity, both groups showed a considerable loss of body fat 
and hence ketogenic substrate by 96 hours (table 5.5 page 205). However, 
low body fat was observed by 24 hours in the supplem ented group bu t 
ketosis was not suppressed until 96 hours - a time at which adiposity was 
relatively higher. NEFA concentrations did not decrease significantly at 96 
hours in either group (although there was a tendency towards a decreased 
concentration between 48 and 96 hours in the supplem ented group). If 
substra te  supp ly  w as exhausted , decreased  NEFA an d  glycerol 
concentrations would be expected. The glycerol concentration did show a 
tendency to decline, the decrease reaching statistical significance in the 
supplem ented group. It could be argued that STZ treatm ent d id  not 
induced diabetes, and initial raised ketone concentration was due to a 
stress effect of hepatotoxicity, therefore as the toxic effects subsided so did 
ketogenesis. Although absence of insulin was not confirmed, the extent of 
osmotic diuresis and hyperglycaemia observed in the present study ruled 
out this theory.
In the earlier studies of Blackshear and Alberti (1974), and Grantham  and 
Zam m it (1988), the acetoacetate to fi-hydroxybutyrate ratio (AAiEOHB) 
declined as ketone body concentration increased. Continued rem oval of 
acetoacetate, by its conversion to fi-hydroxybutyrate, is an im portant redox 
reaction which buffers hydrogen ions in attem pt to minimise acidaemia. 
The reaction is also essential in order for the HMG-CoA cycle to be 
sustained. In the present study the AA:fiOHB was initially reduced bu t 
subsequently increased by 96 hours, when ketosis appeared to be kerbed. 
Depletion of hepatic NADH (a hepatotoxic effect of STZ), w hich is an
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essential cofactor in the conversion of acetoacetate to fi-hydroxybutyrate 
(and therefore for sustaining the HMG-CoA cycle), was considered as a 
possible causative factor of kerbed ketosis at 96 hours.
It is possible that the animals killed at 96 hours were not (or some were 
not) diabetic, w hich w ould explain the lower ketone concentrations 
observed at this time. However, glucose concentrations obtained for these 
anim als do no t su p p o rt th is theory  and  a lthough  the  glycerol 
concentration was low at this tim e point, the NEFA concentration 
rem ained relatively high. One final possibility for the reduced ketosis 
seen at 96 hours is that the anim als w ere deteriorating and  hepatic 
function was impaired.
The p ro found  effect w hich carnitine supp lem enta tion  had  on the 
concentration of ketone bodies in the non-diabetic rat, was not observed in 
the diabetic rat. It is possible that carnitine is only able to exert a ketogenic 
effect up to a 'threshold' ketone body concentration; the effects of insulin 
removal may override any ketogenic effect of carnitine supplem entation 
in diabetes. The ketogenic effect of carnitine is probably dependent upon 
an adequate substrate supply. Data on epididym al fat pad  w eights 
(table 5.5, page 205) suggests that the supplemented group had low body fat 
stores from 24 hours. However, it is unlikely that reduced substrate supply 
was a factor preventing carnitine enhancem ent of ketogenesis since 
neither NEFA or glycerol concentrations were significantly lower in the 
supplem ented animals.
In both groups of animals insulin treatm ent resulted in a tendency for the 
total ketone body concentration to decline, a lthough no statistically 
significant decrease was seen. A more obvious effect of insulin on ketone 
body concentration was possibly m asked by the depression of ketosis 
which occurred prior to insulin treatment.
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Effect o f Diabetes on Carnitine Metabolism in Carnitine Supplemented 
and Non-Supplemented Animals,
There are th ree  possib le  m echanism s by w hich  liver carn itine  
concentration m ay increase. Firstly by enhancem ent of biosynthesis, 
secondly by redistribution within the body, resulting in liver uptake, and 
finally by a reduction in liver weight. In the present study the increase in 
liver carnitine seen between 0 and 48 hours following STZ is likely to be 
due to a redistribution of body carnitine pool, since changes in liver 
weights (with no change in  liver content of carnitine) could not account 
for the changes in carnitine concentration seen (table 5.vi, A ppendix C 
page 270). The increase in liver carnitine also appears to coincide w ith a 
reduction in serum  carnitine; although no significant inverse relationship 
w as found betw een liver and serum  carnitine concentrations. The 
possibility of changes in biosynthesis were not investigated. Other studies 
have also reported an increased liver carnitine concentration in diabetes
(M %arry, Robles-Valdes and Foster, 1975; Fogle and Bieber, 1979; Macnab et 
al., 1979; Brooks, Bahl and Bressler, 1985), and a reduced serum  carnitine 
concentration (Fogle and Bieber, 1979; Macnab et al.. 1979; Paulson et a l., 
1984). Brooks, Bahl and Bressler (1985) found no significant differences in 
rates of biosynthesis of carnitine between diabetic and non-diabetic rats, 
the increase in liver carnitine they observed could neither be accounted 
for by reduced liver weight. Therefore, like the present study, they 
concluded the raised liver carnitine concentration w as due to body 
carnitine redistribution. Liver and serum  carnitine are thought to be in a 
constant state of exchange, w ith insulin and glucagon governing liver 
influx and efflux. Insulin suppresses liver uptake of carnitine (Kispal et 
al., 1987), and therefore a raised liver carnitine concentration m ight be 
expected in diabetes. The function of increased liver carnitine w ould seem 
to be to facilitate the oxidation of fatty acids w ithin the hepatocyte. It also 
reflects the increased transport of acetyl units, from extrahepatic sites, into 
the liver cell mitochondrial matrix.
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In view  of the im portant role of carnitine in the processes which lead to 
ketone body production, it is interesting to notice that sequential changes 
in these two param eters follow a similar pattern (illustrated in figures 5.5a, 
page 213 and 5.7a, page 217). No significant correlation was found 
betw een liver carnitine concentrations and circulating concentrations of 
ketone bodies in the present study. Previous studies have found a close 
correlation between liver carnitine and circulating ketones (McGarry, 
Robles-Valdes and Foster, 1975). In the present study the observation that 
the liver carnitine concentration fell, or rem ained stable, w hen the ketone 
body concentration decreased m ay suggest that fluctuations in liver 
carnitine concentration are a consequence, rather than a cause, of 
ketogenic capacity. Although increased ketogenesis in diabetes partly 
depends upon increased liver carnitine it is unlikely that a raised 
concentration in liver is accompanied by an obligate enhancem ent of 
ketogenesis, since raised liver carnitine concentrations have also been 
observed in non-ketotic hyperosmotic coma (Macnab et al., 1979).
In the non-supplem ented anim als, the initial rise in liver carnitine 
between 0 and 24 hours was due to a raised FC concentration. This 
increase continues to 48 hours, a proportion becoming esterified to SCAC, 
probably a consequence of increased intrahepatic fatty acid metabolism. At 
the time w hen the ketone body concentration tailed off, the liver carnitine 
concentration rem ained stable, and there was no significant change in 
distribution between FC and SCAC fractions. It can therefore be said that 
when liver is actively catabolising fatty acids, liver carnitine (and the 
extent to which it is esterified) increases. W hen hepatic fatty acid 
catabolism decreases, carnitine metabolism stabilises. These observations 
support the role of carnitine in hepatic fatty acid metabolism. N o data 
from previous studies were found regarding changes in m etabolism  of 
individual carnitine fractions in diabetic animals.
On induction of diabetes, the carnitine supplem ented group show ed an 
increase in  liver carnitine of much greater m agnitude that was observed
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in  the non-supplem ented group. The peak concentration in the 
supplem ented group was greater than two fold that which was obtained in 
the non-supplem ented group. This m ay indicate that once horm onal 
conditions (ie. reduced insulin) favour liver influx, transport of carnitine 
into the liver is in part dependent on carnitine supply. It m ay also suggest 
that in the non-supplem ented animals, full requirem ents for carnitine are 
no t being m et in this pathological state. The carnitine supplem ented 
animals showed no exchange between free and esterified carnitine 
fractions (figure 5.7b and 5.7c page 217). This may be due to the 
supplem ent providing a continued and adequate supply of free carnitine 
to the liver.
Few studies have reported the effects of carnitine supplem entation on 
individual carnitine concentrations in diabetes. Brooks, Bahl and Bressler 
(1985) found carnitine supplem entation, adm inistered by the oral route, 
raised the liver carnitine concentration in diabetic rats, although they 
report no data on individual carnitine fractions.
Although in the present study the TASC concentration was reduced 48 
hours into the diabetic phase, there was an increase in the proportion of 
esterified carnitine in serum  w ithin the first 24 hours. This m ay reflect 
transfer of acetyl units from peripheral tissues to the liver. This increase 
in serum  SCAC is accompanied by a drop in cardiac, but not muscle, SCAC 
carnitine. However, muscle SCAC may be continually produced and 
released into the blood w ithout a decrease in muscle concentration. The 
tendency for serum  SCAC to increase upon insulin treatm ent m ay be due 
to a period of continued release from muscle at a time w hen liver uptake 
of carnitine is inhibited by insulin. This theory suggests that the 
inhibitory effect of insulin on liver carnitine uptake is a rapid  process. On 
insulin treatm ent FC may also enter the blood from peripheral cells w here 
it is no longer functional, the serum  acting as a m edium  through  which 
redistribution of carnitine occurs, following metabolic and horm onal 
changes.
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Brooks, Bahl and Bressler (1985) found that carnitine supplem entation 
during diabetes significantly increased the circulating concentration of 
carnitine. Likewise the present study showed carnitine supplem entation 
to increase the serum  carnitine concentration. In the carnitine 
supplem ented group, the serum  carnitine concentration did not alter 
significantly throughout the diabetic phase. This may have been due to 
the w ide range of values obtained, but also due to a continued supply of 
free carnitine through the gut which m ay mask underlying changes in 
carnitine m etabolism due to diabetes. The sequential changes in serum  
carnitine metabolism are not dissimilar betw een the two groups (figures 
5.6a to 5.6c page 215). In the supplemented group, the sharp decrease in 
serum  FC on induction of diabetes is accompanied by a significant increase 
in  SCAC. This possibly reflects FC influx from serum  into tissues to 
accommodate increased lipid oxidation, and efflux of acetylcarnitine for 
transport to the liver. In the non-supplem ented anim als, initiation of 
diabetes did not result in a fall in serum FC. This m ay be due to 
inadequate serum  concentrations lim iting tissue uptake, ie. rem oval of 
carnitine from serum  into tissues m ay be dependent on concentrations 
initially present in serum.
Muscle TASC concentrations increased gradually between 0 and 48 hours, 
probably to accommodate increased muscle C-oxidation. A more rapid 
increase in muscle carnitine was not seen possibly due to continued 
rem oval as SCAC to the liver. Therefore, although absolute muscle 
carnitine increased gradually, turnover m ay have increased more rapidly. 
The FC concentration rem ained unchanged which m ay reflect a constant 
state of turnover. SCAC concentration showed a greater than three fold 
increase from 24 to 48 hours, the time at which fatty acid catabolism 
appears to be maximum. At 96 hours the tendency for TASC and its 
fractions to decrease, coincides with the reduced ketone body 
concentration seen at this time. If these changes in muscle carnitine 
metabolism reflect a decrease in muscle cell C-oxidation, reduced 
peripheral cell fatty acid catabolism may be a factor predisposing to the 
reduced ketosis observed at this time point. Published data on changes in 
muscle carnitine metabolism on induction of diabetes have produced
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conflicting results. Increased muscle carnitine concentration has been 
found by Stearns (1980) and Brooks, Bahl and Bressler (1985), whereas a 
reduced concentration was reported by Mehlman, Kader and Therriault 
(1969). Differences in time lapse from induction of diabetes m ay account 
for these discrepancies; carnitine may initially increase and then become 
depleted, as Brooks, Bahl and Bressler studied one week diabetic animals, 
whereas the data of Mehlman referred to a group of animals which had 
been diabetic for two weeks.
In the p resen t study, carnitine supp lem entation  failed  to  have a 
statistically significant effect upon muscle carnitine concentration. The 
m axim um  concentration for muscle TASC was sim ilar in both groups, 
but was achieved m ore rapidly in the supplem ented group due to the 
increased carnitine availability. Supplem entation was able to m aintain 
the muscle carnitine concentration which, unlike the non-supplem ented 
group, did not decrease at 96 hours. The decreased muscle TASC seen in 
the non-supplem ented group at 96 hours is therefore more likely to be a 
consequence of the reduced fatty a d d  catabolism, which seems to occur at 
this tim e, rather than  a cause, and m ay be preven ted  by carnitine 
supplem entation. Supplementation had a more m arked effect on m uscle 
FC than muscle SCAC. This m ay be because SCAC has a m ore rap id  
turnover and is constantly being rem oved and transported to  the liver. 
Insulin treatm ent had little effect on m usde carnitine concentration. This 
is probably because, in contrast to its effect on the liver, insulin does not 
have a m arked influence on carnitine transport systems in muscle tissue. 
Brooks, Bahl and Bressler (1985) found that carnitine supplem entation 
increased the m usde concentration in diabetic rats.
Analogous to previous findings (Fogle and Bieber, 1979; Paulson et a l., 
1984; Brooks, Bahl and Bressler, 1985) the present study has show n that 
cardiac carnitine decreases as a result of diabetes, and  tha t carnitine 
supplem entation may significantly replenish these losses. The increase in 
SCAC between 24 and 48 hours and the resulting shift in the ratio between 
SCAC and FC (table 5.v, Appendix C, page 269), probably reflects an
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increase in  cardiac lipid oxidation at this time. Following this the 
FCiSCAC stabilises, which m ay indicate that fatty acid catabolism may 
have reached a steady state. Carnitine supplem entation did  not prevent 
the initial loss of cardiac carnitine but subsequently replaced lost carnitine. 
H igher SCAC concentrations m ay reflect enhanced cardiac fatty acid 
oxidation. SCAC concentration increased from 48 to 96 hours, possibly 
due to acetyl units, from C oxidation, becoming esterified to carnitine. The 
non-significant trend towards an increase in the FCiSCAC ratio on insulin 
treatm ent may reflect inhibition of fatty acid catabolism brought about by 
this hormone. In the non-supplem ented group, SCAC did  no t decrease 
significantly on insulin treatm ent. It is possible that long chain acyl 
groups are released from carnitine and are converted to triglyceride, and 
that this results in a significant increase in FC.
Summary -  Effects of Carnitine in Diabetic and Non-Diabetic Animals,
The present study is unique in that sequential changes in individual 
carnitine fractions w ere m onitored in a num ber of tissues, w hile 
sim ultaneously following changes in circulating metabolites, during both 
the onset and reversal of diabetic ketosis. In addition to this the effect of 
carnitine supplem entation on all these measurements was investigated.
It is im portant to consider the relationship betw een serum  carnitine, 
tissue carnitine, and ketone bodies, in view of clinical studies in which 
serum  carnitine may provide the only index of carnitine status. Data from 
the present study indicates liver carnitine m ay provide a m ore reliable 
index of the role of carnitine in ketogenesis. Serum carnitine status does, 
how ever, reflect changes in fatty acid metabolism, through shifts in the 
free to esterified ratio. The tendency tow ards an inverse relationship 
between serum  and liver carnitine needs further investigation, as serum  
carnitine m ay possibly provide an indirect index of liver carnitine which 
would be useful in clinical studies.
In the present study ketogenesis tended to decrease at 96 hours, various
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possible reasons for this are discussed although it seems m ost likely that 
depletion of body fat stores, coupled with a general deterioration of the 
animals physical condition, account for this observation.
One of the problems encountered when interpreting data from the present 
study was the w ide within group variability. This w as possibly due to 
varying severity of diabetes between animals in the same group. Despite 
the fact all animals were STZ injected w ithin five minutes, differences in 
absorptive state and response to stress are thought to influence the potency 
of STZ. The wide w ithin group variation did  not, however, m ask the 
most striking and interesting findings of the study.
Another criticism of the study was the failure to m easure long chain acyl 
carnitine (LCAC). LCAC, how ever, contributes a relatively  sm all 
proportion towards total carnitine and is virtually absent in serum. LCAC 
is technically difficult to assay and existing m ethods are not entirely 
sensitive. In the present study low concentrations coupled w ith w ide 
w ithin group variability, m ay have resulted  in sm all changes being 
undetected. It w ould have nevertheless been interesting to investigate 
cardiac LCAC concentrations, since these are rep u ted  to increase 
dramatically in diabetes (Pieper and M urray, 1987). For the purpose of the 
present investigation SCAC was used as the index of the participation of 
carnitine in lipid catabolism, due to abundancy and assay reliability of this 
fraction.
Data on urinary carnitine would have been a useful adjunct to existing 
data, as SCAC excretion would provide an additional index of fatty a d d  
metabolism. Total carnitine excretion w ould provide inform ation on 
body losses and retention of the supplement. Collection of urine w ould 
have been technically difficult and labour intense, involving the use of 
metabolic cages.
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Interpretation of data from the present study has lead to the following
conclusions
1. Carnitine supplem entation can significantly increase both circulating 
and tissue carnitine concentrations, thereby indicating that carnitine 
supplements will, at least in part, be retained by the body.
2. C arnitine supplem entation  can significantly enhance ketogenic 
capacity in the non-diabetic rat, if this observation can be extrapolated 
to hum ans, this m ay have considerable clinical im plications in 
situations where a heightened ketosis is favoured.
3. Despite the m arked effect which carnitine supplem entation had upon 
ketosis in the non-diabetic rat, supplem entation had  little effect on 
ketosis during diabetes; insulin deprival probably overrides the effect 
of carnitine supplementation.
4. Sequential changes in circulating ketone body concentrations, during 
the onset and reversal of diabetic ketosis, were accom panied by 
similar changes in liver carnitine, which support an im portant role 
of carnitine in ketogenesis.
5. A direct relationship did not exist betw een circulating and tissue 
carnitine, therefore caution is needed w hen interpreting data from 
serum  carnitine measurements in clinical studies.
6. Carnitine supplem entation was not able to prevent cardiac carnitine 
losses that occurred on immediate induction of diabetes, bu t was able 
to  subsequen tly  rep len ish  these losses to the  p re -d iab e tic  
concentration.
7. Further studies could include; m easurement of urinary carnitine, and 
analysis of LCAC in tissues, especially heart. The effects of different 
doses of carnitine and different routes of adm inistration w ould also 
be interesting to investigate.
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CHAPTER SIX
DISCUSSION OF HNDINGS OF THE EXPERIMENTAL
CHAPTERS
6.0 Discussion of Findings of the Experimental Chapters
In this final section of the thesis, the overall aim of the research and the 
major conclusions of each chapter are redefined. The findings of each 
chapter are discussed in relation to each other and overall conclusions are 
sum m arised. Finally, suggestions are m ade as to the direction in which 
future research should proceed.
The overall aim of this thesis was to investigate if carnitine status and 
metabolism bore any relationship to ketotic status, under pathological and 
physio log ica l cond itions associated  w ith  a lte red  ke tone  body  
concentrations. The conditions investigated in the present study included 
surgery, burns injury, and diabetes.
6.1 Summary of the M ain Findings
A study of ketotic status and carnitine status following surgery show ed 
that post-surgical ketone body concentrations are comparable w ith those 
observed following an overnight fast, even w hen dextrose infusion is 
used to maintain post-operative fluid balance. A wide variation in ketotic 
response to surgery was show n, which was associated w ith  a w ide 
variation in insulin concentrations. It was concluded that insulin was an 
im portant determinant of post-operative ketosis, it may be speculated that 
high concentrations of this hormone are due to a greater degree of trauma.
Surgical patients in the present study d id  not appear to be severely 
traum atised, and glucagon concentrations were relatively low. It m ay be 
that in m ore severe traum a, insulin is no t the m ain determ inant of 
ketone body concentrations and this w arran ts fu rther investigation. 
Losses of urinary carnitine were large and were related to the degree of 
p ro te in  catabolism . N either serum  carnitine nor 24 hour u rinary  
ca rn itin e  excretion  show ed  any  re la tio n sh ip  w ith  c irc u la tin g  
concentrations of ketone bodies in this group of m oderately traum atised 
patients, over the short period of study. The m agnitude of carnitine loss.
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and the reduction in serum carnitine by day six following surgery, had no 
affect on lipid catabolism in this group of patients. It was concluded that 
carnitine loss, and effects of these losses, needed to be investigated in more 
severely traum atised patients over a longer time period.
Strong trends tow ards greater losses of pro tein  w ere observed  in 
normoketonaemic compared to hyperketonaemic patients, but due to the 
relatively small num ber of patients studied, differences did not quite reach 
statistical significance.
The appropria te  reciprocal relationships found betw een insu lin  and  
NEFA, and insulin and ketone bodies, suggests that insulin was able to 
exert control over lipid catabolism. However, no association w as found 
betw een insulin and glucose concentration, which suggests that after 
surgery insulin is unable to exert a normal control over glucose uptake or 
production. The study of nutritionally supported patients compared with 
patien ts on low n u trien t intakes, show ed that m etabolic horm one 
concentrations, and concentrations of IGF-1, do not start to respond to 
feeding until the end of the first post-operative week, which is norm ally 
considered to be the time when traum a begins to subside. A lthough the 
nutritionally supported patients were receiving their calculated energy 
and protein requirements, substantial loss of weight and lean body mass 
occurred. It was concluded that emphasis on feeding once initial traum a 
subsides, should be encouraged. This is not, however, an argum ent 
against early nutritional support as it may be speculated that greater losses 
m ay have occurred in the nutritionally supported group, had  they not 
received intensive nutritional support in the first post-operative week.
Data from the observational study of bum s patients complemented that of 
the study of surgical patients. The m ain findings and conclusion of this 
study were, that following burns injury, the level of lipid catabolism and 
ketosis is low, at a time when other metabolic indices indicate a catabolic 
state. It was concluded that the prim ary reason for blunted ketosis was 
im paired NEFA supply. A lthough insulin  concentration show ed no
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relationship w ith ketone bodies or NEFA, it cannot be ruled out as an 
antilipolytic  factor and therefore a de term inan t of im paired  lip id  
catabolism . Reduced peripheral circulation, secondary to increased 
sympathetic activity, was suggested as a factor reducing NEFA supply to the 
liver. As glucagon concentrations were elevated there may have been an 
increased hepatic capacity for ketogenesis, but insufficient substrate.
Carnitine losses following thermal injury were very high and prolonged, 
and were positively associated with nitrogen loss and extent of injury. It 
was concluded that carnitine insufficiency m ay arise due to the m agnitude 
and duration of loss. M arkedly dim inished concentrations of serum  
proteins did not respond to subsequent nutrient provision, and rem ained 
low. It was suggested that this was due to a prolonged acute injury phase. 
This suggestion was supported by the observations of sustained elevated 
glucagon concentration and negative nitrogen balance. The suggestion of 
an extended acute phase, during which protein synthesis does not respond 
to nitrogen provision, led to the postulation that burns patients should 
receive extended intensive nutritional support, to compensate losses and 
encourage healing.
The investigation of the association between carnitine and ketone bodies 
during the onset and reversal of diabetic ketosis in rats, and the effects of 
carnitine supplem entation upon these processes, show ed that carnitine 
supplem entation significantly increased circulating and tissue carnitine 
concentrations, ie. supplementary carnitine is retained by the body tissues.
Carnitine supplem entation was able to enhance ketosis in non-diabetic 
rats, bu t did not exert this effect during the onset of diabetic ketosis 
possibly  due to insu lin  deprival being the  m ain  de te rm inan t of 
ketogenesis in these circumstances.
Liver carnitine concentrations and plasm a ketone body concentrations 
show ed sim ilar patterns of sequential change. This, and the m arked 
increase in liver carnitine on induction of diabetes, suggests an im portant
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role for carnitine in ketone body production. Changes in serum  carnitine 
did  no t reflect changes in tissue carnitine concentration, and it was 
concluded th a t care is needed w hen in te rp reting  serum  carnitine 
concentrations obtained from clinical studies.
6.2 Determ inants of Ketosis Following Traum a
In the surgical patients, the negative correlation betw een insulin  and 
ketone body  concentrations suggested  th a t in su lin  w as a m ain 
determ inant of ketone body production under these conditions. The 
associations between NEFA and ketone body concentrations, and between 
NEFA and insulin concentrations, suggested that insulin was blunting 
ketosis by reducing hepatic NEFA supply. By contrast, in the burns 
patients no associations between insulin and ketone body concentrations 
or insulin and NEFA were found. Raised insulin concentration m ay in 
part, account for the low NEFA concentration, and absence of a clear 
relationship between these two param eters m ay have been due to other 
factors influencing NEFA supply, such as impaired peripheral blood flow. 
It may be speculated that NEFA supply is a m ain determ inant of ketone 
body concentrations following traum a in both surgical and bum s patients, 
but that factors determining NEFA concentrations m ay differ in the two 
groups.
Although the m ain control site for ketogenesis is thought to be hepatic 
CPT-1 activity (see section 1.7 page 12), it appears that the insulin  
concentration following traum a is sufficient, in some cases, to inhibit 
ketogenesis at the level of lipolysis by reducing NEFA concentration. 
Increasing  NEFA supp ly , eg. by in trav en o u s in fu sio n , in  the  
normoketonaemic surgical patients and the burns patients m ay have led 
to quite different effects, as the major difference between these two groups 
of p a tien ts  w ere  g lucagon  concen tra tions. F o llow ing  in ju ry  
norm oketonaem ic surgical patients had  a low glucagon concentration, 
whereas burns patients had an elevated glucagon concentration. Since 
glucagon has a m ajor influence on the fate of NEFA in the  liver.
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increasing the activity of CPT-1 and reducing malonyl Co A availability, 
differences in glucagon concentration between the two groups may have 
resulted in m arked differences in hepatic utilisation of NEFA. In the 
norm oketonaem ic surgical patients, w ith a low glucagon concentrations 
(and a relatively high insulin concentration), malonyl CoA concentration 
m ay be expected to be high, and in this situation NEFA would be expected 
to be diverted towards triglyceride synthesis. In the burns patients 
glucagon concentration was high in relation to insulin. This m ay m ean 
that hepatic CPT-1 and fatty acid oxidation pathways were activated, 
therefore provision of NEFA w ould be expected to lead to enhanced 
ketone body formation - particularly as there is evidence of im paired 
glucose metabolism in these patients. It is possible therefore that NEFA 
supplem entation of burns patients may be expected to enhance ketosis, 
whereas it may be expected to have little effect on ketosis in the 
normoketonaemic surgical patients. This suggests that lipid containing 
feeds, especially m edium  chain triglyceride (MCT) containing feeds in 
which triglycerides pass directly to the liver, may be able to enhance ketosis 
in burns patients.
Once ketotic pathways are activated (as assumed in burns patient) E- 
oxidation and subsequent ketogenesis are not only dependent on a supply 
of fatty acids but also upon carnitine availability, as this is an im portant 
cosubstrate for CPT-1 (discussed in section 1.4 page 7). Both clinical 
studies showed carnitine loss to be substantial following traum a, but in 
the burns patients the period of carnitine loss was prolonged. If liver 
efflux contributed to these losses there m ay have been insufficient 
carnitine to sustain fi-oxidation, especially if associated w ith im paired 
hepatic carnitine synthesis. It is not possible to deduce w hether carnitine 
loss contributed to any reduction in ketotic potential in the present 
studies, since it was not possible to m easure hepatic carnitine 
concentration and reduced NEFA supply w ould be expected to override 
any effect of reduced liver carnitine. A suitable animal study which could 
be carried out to investigate the effects of carnitine loss on ketogenesis 
following burns, w ould be; to remove livers from burned rats several
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weeks following injury (in which time substantial loss of carnitine 
occurred), perfuse them with an ample supply of NEFA, and measure 
ketone bodies produced. Due to the very high carnitine losses and reduced 
NEFA supply to the liver, supplem entation w ith both NEFA (possibly as 
MCT in feeds) and carnitine may be beneficial in the developm ent of a 
heightened ketosis. Figure 6.1 summarises the proposed dual benefit of 
both MCT and carnitine supplem entation in prom oting ketogenesis 
following traum a. Animal studies w ould be needed in order to test the 
benefits of such a regime.
Figure 6.1 Hypothesis for the Proposed Dual Role of M edium  Chain 
Triglycerides (MCT) and Carnitine Supplem entation in  Promoting 
Ketogenesis Following Trauma.
CARNITINE
BIOSYNTHESIS
LIVER
CARNITINE
MCT
NEFA
OUTPUT
If following burns and surgical traum a liver m etabolism is directed 
tow ards oxidation of fatty acids, carnitine supplem entation alone w ould 
enable im proved oxidation of lipid in feeds. Ketosis w ould thereby be 
enhanced, even in the presence of peripheral shut dow n of blood supply  
to adipose tissue.
In hyperketonaemic surgical patients it appeared that the relatively lower 
insulin concentrations favoured ketosis to some extent, despite the fact 
that glucagon concentrations were not m arkedly elevated. It is possible
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that increased carnitine supply, in conditions favouring ketogenesis, could 
enhance ketosis further by a mass action effect. The supplem entation 
study carried ou t in rats, show ed that carnitine was able to enhance 
ketogenesis in  the non-diabetic rats. It is possible tha t both  non- 
supplem ented and carnitine supplem ented animals were slightly stressed 
and that carnitine, in the presence of a favourable metabolic horm one 
environment, enhanced ketogenesis in the carnitine supplem ented group. 
In the diabetic rat, w ith  higher ketone concentrations, supplem entary  
carnitine had no additional effect on ketone body concentrations, to 
insulin deprivation. In diabetes, insulin deprivation m ay override the 
effect of carnitine, however, this m ay not be the case in traum a. W here 
there is insu lin /g lucagon  antagonism , carnitine supplem entation m ay 
push lipid metabolism in favour of oxidation by increasing the activity of 
CPT-1, aiding acetyl transport to the liver, and buffering free CoA.
Ketone body concentrations above that observed in the hyperketonaemic 
group may have been beneficial, since the protein sparing effect of ketone 
bodies seen in starvation is associated with ketone body concentrations of 
7-10 m m ol/L  (Balassse and Fery, 1989). Previous studies have found 
im proved indices of protein status and clinical outcome in patients w ith 
ketone body concentrations much lower than this (Rich and Wright, 1979). 
If the hyperketonaemic patients in the present study had achieved higher 
ketone body concentrations than those obtained, a more distinct difference 
between groups, in terms of protein status and nutritional outcome, may 
have been observed. It m ay be desirable to achieve a ketone body 
concentration similar to that observed in prolonged fasting, during  the 
catabolic phase of the injury response.
The extent of carnitine loss observed in the hyperketonaemic group m ay 
have compromised ketosis at the level of CPT-1, although it is not clear if 
liver efflux of carnitine contributes to losses. Losses may be largely from 
muscle; this m ay also compromise ketogenesis, by im pairing peripheral 
fatty ad d  oxidation and carnitine fadlitated acetyl transport to liver.
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6.3 Carnitine Losses Following Trauma
One of the most interesting observations in both the study of surgical and 
the study of burns injury patients, was the m agnitude of carnitine loss 
following traum a. A lthough m agnitude of loss w as sim ilar in both 
groups of patients, the period over which losses occurred w as m ore 
p ro longed follow ing therm al injury. These high renal losses w ere 
probably due to mass tissue efflux entering the circulation and  being 
filtered by the kidney, yet only a proportion being reabsorbed since 
reabsorption is a saturable process which occurs by active transport. It is 
not known to w hat extent, if any, carnitine biosynthesis compensated for 
losses. However, synthesis is unlikely to increase in patien ts w ith 
negative protein balance, w hen the lim iting step in biosynthesis is the 
availability of TML protein bound residues. There is also likely to be 
reduced  availability of vitam in C for carnitine biosynthesis due to 
increased demands on this vitamin for de novo synthesis of collagen. It is 
also possible that the activities of biosynthetic enzymes are reduced. For 
these reasons, it is not unreasonable to assum e that patients w ere in 
negative carnitine balance. U ntil patien ts resum ed a norm al diet, 
carnitine losses were not compensated for by exogenous provision.
The above discussion has indicated a possible argum ent for carnitine 
supplem entation  follow ing injury. The anim al s tudy  of carnitine 
supplem ented rats indicated that tissues were able to retain, or partly  
retain, supplem entary carnitine. Maximum effects were seen in the liver. 
This may be due to the relatively faster turnover rate of carnitine in this 
organ, compared to either skeletal muscle or cardiac muscle. Due to the 
saturable nature of renal reabsorption it has been suggested, that in order 
for supplementation to be effective, small doses should be given over long 
periods so that reabsorption and tissue uptake are maximised. A bolus 
dose would exceed the renal threshold for reabsorption, and would be lost 
in urine. Considering the influence of the renal threshold on carnitine 
retention, the efficacy of carnitine supplem entation following traum a is 
not known. It may be speculated that in a condition of tissue efflux, such
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as in traum a, additional supplem entary carnitine may not be retained by 
the tissue. C arnitine supp lem enta tion  m ay only be effective at 
replenishing losses once muscle efflux has slowed down. In both forms of 
traum a studied, carnitine losses were related to the degree of negative 
nitrogen balance, and this suggests that losses w ere related to muscle 
catabolism. In contrast in diabetes increased carnitine losses have been 
reported to be due to increased lipid metabolism, as a means of excreting 
excess acetyl units. The major difference in carnitine loss due to enhanced 
lipid catabolism and carnitine loss due to muscle efflux, is the relative 
proportion of esterified carnitine which is excreted, ie. in diabetes a high 
proportion of carnitine excreted is esterified, w hereas in traum a the 
increase in carnitine excretion can be largely accounted for by free 
carnitine.
Carnitine losses following burns injury m ay not, however, be entirely due 
to muscle catabolism. M aximum carnitine losses occurred during  the 
early acute phase, whereas maximum muscle catabolism is not thought to 
occur until the end of the second week following burns injury. It is 
possible that carnitine loss is due to 'factors' of metabolic traum a acting on 
tissue influx/efflux transport m echanisms. This m ay be horm onal in 
nature, as horm ones have been shown to have a direct action on liver 
carnitine transport mechanisms (Kispal et al., 1987). It is also possible that 
tissue injury factors exert some effect; the positive relationship betw een 
extent of burn  and m agnitude of carnitine loss, show n in the present 
study, provides some indication of this possibility.
Im mediately following injury there is a rise in intracellular sodium  ions 
(Na+) and a depression of potassium ions (K+), (Cunningham  et a l., 1971) 
w hich is thought to occur due to injury related m em brane dam age. 
Rennie and coworkers (1986) suggested that as glutam ine transport is
associated w ith Na+ co-transport w ith a stoichiometry of 1:1, glutam ine 
loss from muscle (which like carnitine loss is very high immediately post­
injury) occurs as a means of pum ping Na+ ou t of the cell to regain 
m em brane potential. In view of the Na+ dependent nature of cellular
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carnitine transport, it is possible that carnitine efflux following injury 
occurs as a means of reducing intracellular Na+, in an attem pt to m aintain 
membrane potential. A hypothesis for this scheme is presented in figure 
6.2. If losses of glutam ine and carnitine occur by m uch the same 
mechanism, this may explain the strong correlation which has been found 
between nitrogen balance and carnitine loss in the present study, and in 
those of previous investigators (Cederblad et al., 1981; lapichino et al., 
1988). The hypothesis proposed needs to be further investigated. More 
studies on the effects of traum a on tissue carnitine transport mechanisms 
are needed since, if losses are an inevitable consequence of traum a, 
supplementation may prove to be inefficient.
Figure 6.2 Postulated M echanism for Tissue Carnitine Efflux Following 
Injury
Na+ Na+ K +K+Na+
CARNITINE-
SODIUM
CO-TRANSPOR'
MEMBRANE
UAK/GE
AlTPase
Na+Na+ Na+ K+
K+
The efficacy of carnitine supplem entation following traum a is therefore 
questionable. However, carnitine supplem entation in diabetes m ay have 
considerable benefit, since the anim al s tudy  has show n carn itine  
supplem entation to replenish cardiac carnitine losses caused by induction 
of diabetes. M aintenance of cardiac carnitine concentrations has been 
shown by previous studies to be of vital importance for norm al cardiac 
function. In diabetes carnitine supplem entation m ay p reven t tissue
252
deficiency w ithout exacerbating ketogenesis, as the present animal study 
showed carnitine supplem entation to have no significant effect on ketone 
body concentrations in insulin treated or uncontrolled diabetic rats.
6.4 Interpretation of Serum Carnitine Concentrations
A lthough a relationship  betw een serum  carnitine and ketone body 
concentrations was not found in either the surgical or bum s patients, it 
cannot be concluded that carnitine has no relationship to ketogenesis. In 
the  d iabetic  an im al m odel sequen tia l changes in  ketone  body  
concentrations were quite sim ilar to those of liver carnitine, however, 
timing of changes in serum carnitine differed w ith those of liver carnitine. 
Serum carnitine concentrations m ay not reflect hepatic carnitine status 
and therefore the capacity of carnitine supply to influence ketogenesis. Yet 
serum  carnitine is often m easured in clinical studies since, for practical 
reasons, liver samples cannot be obtained. Care in the interpretation of 
serum  carnitine concentrations is therefore im portant. Raised serum  
carnitine concentrations m ay actually reflect tissue efflux, such as that 
observed on the first day following bum s injury (section 4.3. table 4.5 page 
171). Alternatively, raised serum  cam itine concentration could reflect an 
increase in recent carnitine intake, such as that observed in the cam itine 
supplemented diabetic rats (section 5.3, figure 5.6a, page 215). In these two 
situations the interpretation of raised serum  carnitine concentrations is 
quite different. Low serum  cam itine concentrations, on the other hand, 
m ay reflect carnitine deficiency due to low carnitine intake, increased 
requirem ent, reduced biosynthesis or continued losses, ie. negative 
carnitine balance.
In the present study of bum s patients, despite m arked urinary losses, the 
serum  carnitine concentration was w ithin the norm al range on day  18 
following bum s. This m ay be due to sustained m uscle efflux, m asking 
signs of deficiency. In the surgical patients, high urinary cam itine losses 
resulted  in a significant decrease in serum  concentration by day  six 
following surgery, by which time m uscle efflux in these patients had
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probably ceased. In the TPN group of surgical patients, the reduction in 
serum  carnitine by day six was even more pronounced, probably due to 
increased requirem ents of carnitine to utilise the lipid w ithin the feed. 
Abnormally low serum camitine concentrations may also arise in cases of 
renal insufficiency, where reabsorption m ay be inefficient. In order to 
m easure true losses of carnitine, and m onitor status, tum over studies are 
needed and the future use of stable isotopes in hum an studies may assist 
in providing this information.
6.5 The Metabolic Response to Trauma: Influence on the Extent and 
D uration of N utritional Support
In the past, feeding studies and assessm ent of benefits of nutritional 
su p p o rt have been largely  concerned w ith  de te rm in ing  optim al 
composition of feeds and diet. However, the nature of the metabolic 
response to traum a has im portan t im plications no t only  to the 
composition of the feed and the quantity to provide. Nutritional therapy 
m ay have neglected a factor of key importance to successful nutritional 
outcome, and that is, how long should specialised feeding be continued?
Investigation of the response to feeding and nutritional outcome, of both 
burns injury patients and patients following surgery, has show n that 
during the acute phase following injury there are indications of inefficient 
u tilisation of nutrients. This was illustrated in the parenterally  fed 
surgical patients (section 3.3 page 135) by failure of the calculated nitrogen 
requirem ents to m aintain  nitrogen balance, and  failure of n u trien t 
provision to m aintain energy balance. However, in these patients IGF-1 
and metabolic hormones began to respond to feeding tow ards the end of 
the first post-operative week. Likewise in the burns injury patients, 
negative nitrogen balance and w eight loss were also observed despite 
substantial intakes of energy and nitrogen. N o response to pro tein  
provision was seen on the basis of m easurements of serum  proteins and 
IGF-1. In general, surgical patients (nutritionally supported group) were 
intensively fed for one week then support was reduced as oral feeding
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resum ed. In the burns patients, intensive nutritional support was 
provided while on the acute intensive care unit bu t was relaxed when 
patients were transferred to the sub-acute unit (approximately 2-3 weeks 
post injury). In both these cases, the relaxation of intensive nutritional 
support coincided w ith the decline in the acute phase. It seems 
paradoxical that patients may be being fed intensively when they are least 
able to utilise nutrients, and when response to feeding is resum ed 
intensive nutritional support is not provided. In conclusion, study  of 
both surgical and burns patients has lead to the suggestion that greater 
emphasis should be placed on prolonged nutritional support.
6.6 Summary of the Thesis and Proposals for Future Research
In sum m ary, the overall findings were:- Following surgical traum a a w ide 
variation in ketotic response is observed, probably related to the degree of 
metabolic stress. In severe traum a, ketosis appears to be blunted. Serum 
carnitine concentration is unrelated to the ketone body concentrations 
following injury. H igh losses of carnitine following injury m ay lead to 
deficiency, which has the potential to compromise ketogenesis.
Ketone body concentrations bear greater similarity to liver carnitine 
concentration than to serum  carnitine concentration. It w ould therefore 
be more appropriate (nevertheless impractical) to m easure liver carnitine.
In view  of the losses of carnitine which occur following traum a, 
supplem entation may be indicated, however, before this can be 
im plem ented, a better understanding of the nature of carnitine loss and 
the effects of traum a on carnitine transport mechanisms are needed.
The findings of this research have highlighted several areas into which 
future research could be directed. Studies on the optim al composition of 
feeds, the m anipulation of feeding form ulae to encourage ketosis, and the 
assessment of benefits of those feeds should be carried out. For example, 
supplem entation with MCT may be potentially ketogenic. The dual effect
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of bo th  MCT and  carn itine  sup p lem en ta tio n  on ketone  body 
concentrations following traum a could also be investigated, in view of the 
carnitine losses and reduced NEFA supply observed. In order for camitine 
sup p lem en ta tio n  to be effective, research  in to  tissue  tran sp o rt 
mechanisms in traum a are needed. Dose and response studies using 
different routes of adm inistration could also be carried out. Research 
should also aim to resolve the question of the optimal duration of feeding. 
M onitoring the response to feeding using indices such as IGF-1 m ay be 
very useful in this context.
N utritional care of the critically ill patien t should  therefore aim  to 
m inim ise losses in the acute phase; m anipulation  of ketone body 
concentrations may be of benefit in this respect, so research into the best 
m ethod for achieving this should continue. In the m eantim e there is 
much evidence to suggest that patients should be provided with intensive 
nutritional support during the rehabilitation stage, to com pensate for 
losses which have occurred during the acute phase, in order to prom ote 
healing and improve the long term quality of life.
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APPENDIX A
INFORMATION SUPPLEMENTARY TO CHAPTER
THREE
Table 3.1 Energy Intake (kcal.) of Normoketonaemic Patients in the First
Post-operative Week.
Post-Operative Day
Subject No. 1 2 3 4 5 6 7
1 160 208 320 50 120 650 820
4 368 592 344 320 320 420
6 176 304 184 420 670 1010 980
8 320 400 245 400 525 2250 2065
22 224 416 352 320 342 342 1350
23 0 320 320 392 480 660 742
24 563 580 553 420 680 1172 1200
28 0 0 0 210 520 680 1101
31 0 40 20 290 960 1150 750
33 160 160 160 540 590 1262 1700
Median 168 312 283 356 510 1080 1146
(range) (0-563) (0-592) (0-553) (50-540) (120-960) (342-2250) (742-2
Table 3.ii Energy Intake (kcal.) of Hyperketonaem ic Patients in  the First 
Post-operative Week.
Post-Operative Day
Subject No. 1 2 3 4 5 6 7
3 125 370 365 205 320 320 200
5 66 384 192 344 168 168 198
10 304 336 320 290 810 750 1100
12 104 504 224 320 272 208 0
15 416 448 304 320 224 536 150
17 320 176 50 100 550 1000 1300
20 150 850 750 900 1000 1000 1420
21 0 0 0 520 750 980 1150
30 0 0 100 320 320 960 980
Median 125 370 224 320 320 960 980
(range) (0-416) (0-850) (0-750) (100-900) (168-1000) (168-1000) (0-1420)
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Table 3.iii Nitrogen Intake (g) of Normoketonaemic Patients in the First
Post-operative Week.
Post-Operative Day
Subject No. 1 2 3 4 5 6 7
1 0 0 0 0 1.0 15 2.4
4 0 0 0 0 0 0
6 0 0 0 0 1 21 3.4
8 0 0 4.7 4.7 4.7 9.4 9.4
22 0 0 0 0 0 0 7.8
23 0 0 0 1.0 43 3.7 3.0
24 0 0 1.7 1.0 45 4.7 3.9
28 0 0 0 0 0 3.2 5.4
31 0 0 0 0 1 2.0 4.5
33 0 0 0 5.0 4.6 10.1 10.2
Median 0 0 0 0 1 26 4.5
(range) (0-0) (0-0) (0-4.7) (0-5.0) (0-4.7) (0-10.1) (2.4-10.2)
Table 3.iv N itrogen Intake (g) of Hyperketonaem ic Patients in  the First 
Post-operative Week.
Post-Operative Day
Subject No. 1 2 3 4 5 6 7
3 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0
10 0 0 0 0 24 4.0 4.2
12 0 0 0 0 0 0 0
15 0 0 0 0 0 0 35
17 0 0 0 2 5 7.0
20 0 4.0 4.1 4.3 5.0 7.1 6.9
21 0 0 0 12 1.8 7.8 8.0
30 0 0 0 5.3 5.9 9.0 8.3
Median 0 0 0 0 1.8 4.0 4.2
(range) (0-0) (0-4.0) (0-4.1) (0-55) (0-5.9) (0-9.0) (0-8.3)
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Table 3.V Circulating Concentration of Total Ketones, C- 
hydroxybutyrate and Acetoacetate (mmol/L) in  Norm oketonaem ic and 
Hyperketonaemic Groups Prior to and Following Surgery. M edian Values 
(and ranges).
PRE-SURGERY
0
POST SURGICAL DAY 
1 3 6
TOTAL KETONES
N
H
0.08
(0.05-0.73)
0.11 b#'
(0.06-1.20)
0.12
(0.02-0.18)
0.32
(0.20-0.61)
0.17 0.09
(0.05-0.63) (0.03-0.17)
0.26 0.14
(0.14-0.81) (0.07-1.24)
IH i YDROXYBUTYRATE 
N 0.02
(0-0.09)
0.03 0.06 0.03
(0.02-0.14) (0.01-0.22) (0.02-0.12)
H 0.05
(0-0.73)
0.15 0.17 0.04
(0.10-0.46) (0.04-0.30) (0-0.58)
ACETOACETATE
N 0.06
(0.03-0.64)
0.07 0.12 0.05
(0.03-0.16) (0.03-0.41) (0.03-0.07)
H 0.09 b##
(0.04-0.47)
0.15
(0.04-0.25)
0.13
(0-0.42)
0.10
(0.04-0.66)
N = Normoketonaemic 
H = Hyperketonaemic
* a <0.001 ) Mann-Whitney Test
** a<0.01 )
• •a<0.01 Wilcoxon SignedRanks Test
a - denotes a significant difference between normoketonaemic and hyperketonaemic groups 
b - denotes a significant change within a group between days
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Table 3.vi Energy Intakes (kcal.) of Nutritionally Supported Group in
the First Week Following Surgery/Injury.
Post-Operative Day
Subject 1 2 3 4 5 6 7
a 2100 1955 1900 2100 2700 2100 2100
b 100 105 1259 1280 2640 1590 2050
c 1563 2425 2155 2050 2425 2153 2200
d 2100 2100 2100 2100 2100 2100 2100
8 885 610 1800 1800 1800 1800 1800
f 100 1450 1800 1800 1800 700 1370
8 300 240 1650 2050 2050 1450 1450
Median 1168 1450 1850 1925 1950 1695 1925
(range) 100-2100 105-2425 1259-2155 1280-2100 1320-2700 700-2153 320-2200
Table 3.vii Energy Intake (kcal.) of the Low N utrient Group in  the First 
W eek Following Surgery/Injury.
Post-Operative Day
Subject 1 2 3 4 5 6 7
h 0 0 100 320 320 960 980
i 0 0 0 210 520 680 1101
j 0 320 320 392 480 660 742
k 224 416 352 320 342 342 1350
1 416 448 304 320 224 536 150
m 104 504 224 320 272 208 0
n 320 400 245 400 525 2250 2065
Median 52 360 234 320 411 670 1040
(range) 0^16 0-504 0-352 210-520 224-750 208-2250 0-2065
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Table S.viii Nitrogen Intakes (g) of the Nutritionally Supported Group
in the First Week Following Surgery/Injury.
Post-Operative Day
Subject 1 2 3 4 5 6 7
a 9.4 14.1 9.4 9.4 9.4 9.4 9.4
b 0 0 8.3 10.8 9.4 9.4 9.4
c 4.7 9.4 9.4 9.4 9.4 9.4 9.4
d 9.4 9.4 9.4 9.4 9.4 9.4 9.4
e 0 0 10.0 10.0 10.0 10.0 10.0
f 0 9.4 9.4 9.4 9.4 4.7 4.7
8 0 0 4.7 9.4 9.4 65 7.2
Median 2.4 9.4 9.4 9.4 9.4 9.4 9.4
(range) 0-9.4 0-14.1 4.7-10.0 9.4-10.8 9.4-10.0 4.7-10.0 2.0-10.0
Table 3.ix N itrogen Intake (g) of the Low N utrient Group in  the First 
W eek Following Surgery/Injury.
Post-Operative Day
Subject 1 2 3 4 5 6 7
h 0 0 0 5.3 5.9 9.0 8.3
i 0 0 0 0 0 3.2 5.4
j 0 0 0 1.0 4.5 3.7 3.0
k 0 0 0 0 0 0 7.8
1 0 0 0 0 0 0 3.5
m 0 0 0 0 0 0 0
n 0 0 4.7 4.7 4.7 9.4 9.4
Median 0 0 0 0.5 0.9 3.5 6.8
(range) 0-0 0-0 0-4.7 0-5.3 0-5.9 0-9.4 0-9.4
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Table 5.1 Circulating Concentrations of Metabolites (mmol/L), During
the Onset and Reversal of Diabetic Ketosis in Carnitine Supplemented (C)
and Non-Supplemented (NC) Animals. Median Values (with ranges), n=6.
HOURS POST STREPTOZOTOCIN
0 24 48 96
(insulin)
120
GLUCOSE NC
c
10.2
(9.0-11.0) 
10.1 **b 
(9.3-113)
22.0
(8.6-25.6) 
24.0 ***b 
(83-26.8)
21.9
(20.2-25.8)
313
(13-56.2)
28.9 **b 
(11.0-32.0) 
29.0 **b 
(11.6-363)
5.3
(2.4-16.8)
4.1
(33-5.9)
NEFA NC
C
0.40
(0.24-0.46) 
0.35 **b 
(0.22-0.47)
0.62
(0.19-132)
0.81
(0.12-0.96)
0.68
(0.37-0.79)
1.02
(0.29-1.78)
0.69
(0.28-0.99)
0.78
(0.35-0.90)
0.52
(0.44-0.88)
1.01
(036-1.31)
GLYCEROL NC
C
0.16
(0.14-0.21) 
0.15 *^ b 
(0.14-0.19)
0.18
(0.03-0.43) 
0.35 ■^^♦a 
(0.17-0.45)
0.20
(0.1-0.37) 
0.33 ***b 
(0.06-0.41)
0.10
(0.04-0.21)
0.11
(0.09-0.16)
0.15
(0.10-0.24) 
0.07 ***a 
(0.02-0.13)
KETONES NC
C
0.39 ’^ *b 
(0.25-0.51) 
0.59***a*'**b 
(0.51-0.93)
0.94
(0.05-3.14)
1.30
(0.67-4.67)
1.42
(0.34-2.81)
131
(0.38-3.64)
0.93
(0.23-4.42)
1.05
(0.70-1.32)
0.72
(033-1.47)
0.67
(0.43-0.87)
fiOHB NC
C
0.11 ***b 
(0.07-0.32) 
0.14 ***b 
(0.1-0.51)
0.46
(0.07-1.93)
0.72
(0.15-3.91)
1.41
(0.17-1.91)
0.67
(0.10-2.95)
0.49 * *’^ b 
(0.07-2.66) 
0.42 ***h  
(0.17-0.70)
0.18
(0.07-0.86)
0.16
(0.07-0.29)
AcAc NC
C
0.19 ***b 
(0.16-0.38) 
0.42 ***h  
(0.37-0.52)
0.50 ***b
(0.43-1.21)
0.69
(039-1.48)
0.28
(0.17-0.90)
0.69
(0384).84)
0.62
(0.37-0.80)
0.57
(0.47-0.78)
0.72
(0.53-1.47)
0.51
(0.36038)
ACACtfiOHB NC
C
1
1.63
(0.59-5.29) 
2.86 ***b 
(1.07-3.31)
1.54
(0.63-6.14)
0.73
(0.38-337)
I
0.38
(0.22-1.05) 
1.25 *»*a 
(033-280)
0.94
(036-2.94) 
1.30 ***b 
(0.85-3.11)
2.98
(0.71-6.57)
3.30
(2.00-5.14)
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
** a<0.01)
*** a<0.05)Mann-W hitney Test 
AcAc - Acetoacetate 
COHB - fi-Hydroxybutyrate
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Table 5.ii C oncentration of C arn itine  Fractions in  Serum  (|imol/L), 
D uring  the  O nset and R eversal of D iabetic  K etosis in  C arn itine  
Supp lem ented  (C) and  N on-S upplem ented  (NC) A nim als. M edian  
Values (with ranges), n=6.
HOURS POST STREPTOZOTOQN
Grotç>
NC
Fraction 0 24 48 96
(Insulin)
120
TASC 49.0 48.8 »*b 263 21.4 **b 546
(13.6-77.2) (37.8-79.8) (15.1-54.1) (13.8-403) (41.8-1303)
FC 19.6 17.8 143 16.2 **b 39.8
(4.941.0) (4.3-21.4) (6341.2) (128-38.4) (17.743.0)
SCAC 26.2 34.1 163 7.9 25.8
(11.9-70.1) (223-613) (8.6-24.0) (1.0-20.6) (7.8-90.7)
FOSCAC 0.9 0.4 0.6 22 1.7
(0.1-1.5) (0.1-0.9) (03-0.8) (0.7-12.4) (0.4-5.5)
TASC 83.8 60.3 51.6 ’^ ‘^ a 53.7 ***a 753
(45.1-134.9) (31.3-128.5) (21.2-98.2) (293-78.6) (40.4-150.0)
FC 87.5 **b 18.4 35.0 393 61.3
(65.2-121.0) (7.4-573) (8.5-76.1) (13.7-62.6) (30.9-75.0)
SCAC 12.5 **b 35.3 22.1 363 65.1
(7.3-13.1) (3.4-85.1) (6.947.2) (5.0-621) (36.9-114.6)
FOSCAC 0.9 0.8 0.7 28 03
(0.8-1.2) (0.1-83) (0.2-10.6) (0.2-8.8) (0.3-1.6)
TASC - total acid soluble carnitine
FC - free carnitine
SCAC - short chain acyl carnitine
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
** a<0.01)
*** a<0.05) Mann-Whitney Test
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Table S.iii Concentrations of Carnitine Fractions in  Liver (nmol/g wet 
weight). During the Onset and Reversal of Diabetic Ketosis in  Carnitine 
Supplem ented (C) and N on-Supplem ented (NC) Anim als. M edian 
Values (with ranges), n=6.
HOURS POST STREPTOZOTOCIN
(insulin)
NC
Fraction 0 24 48 96 120
1
***b---------
1
TASC 318 431 540 594 651
(270-614) (267-651) (409-812) (530-682) (442-812)
FC 206 "^ b 377 330 397 **b 612
(178-273) (248-450) (257-734) (182-640) (369-660)
SCAC 96 58 ***b 221 202 ***b 73
(24-436) (19-220) (76-436) (73-352) (0-166)
FCrSCAC 2.0 3.5 1.3 2.1 5.4
(0.4-11.9) (2-13.1) (0.9-4.4) (0.5-8.0) (0-9.0)
TASC 480 480 ■^ b 1232 **a 731 * * a * * b 884
(393-665) (314-940) (985-1583) (594-777) (653-1201)
FC 360 253 **b 1012 * *a**b 533 755
(244-640) (112-849) (660-1345) (284-712) (520-1124)
»**b
SCAC 82 158 314 240 142 """"a
(11-321) (91-393) (69-332) (40-310) (110-272)
FOSCAC 4.5 2.0 2.6 2.2 3.9
(1.1-58.2) (0.5-9.3) (1.1-9.5) (0.9-17.3) (2.7-9.9)
TASC- total acid soluble carnitine
FC- free carnitine
SCAC- short chain acyl carnitine
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
** a<0.01 )
*** a<0.05) Mann-Whitney Test
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Table 5.iv Concentrations of Carnitine Fractions in  Quadriceps Muscle 
(nmol/g wet weight). D uring the Onset and Reversal of Diabetic Ketosis in 
Carnitine Supplem ented (C) and N on-Supplem ented (NC) Animals. 
M edian Values (with ranges), n=6.
HOURS POST STREPTOZOTOCIN
(insulin)
NC
Fraction 0 2 4 4 8 9 6 1 2 0
1 —  ***b 1
T A S C 433 601 890 *^ b 466 498
(209-651) (201-1233) (482-1369) (344-1439) (353-1106)
F C 432 473 5 14 324  * 412
(169-540) (112-1083) (402-1482) (216-842) (339-880)
S C A C 65 99 ***b 345 116 100
(20-201) (26-244) (68-393) (51-597) (5-420)
F O S C A C 6.1 6.6 1.9 2.8 4.6
(2.2-18.1) (1.3-23.2) (1.2-6.1) (0.9-9.0) (1.3-69.6)
T A S C 510 865 855 998 934
(343-943) (519-1289) (219-906) (791-1126) (478-1014)
F C 4 6 8  ***b 805 726 771 729
(343-830) (142-1401) (193-761) (736-1098) (237-1136)
S C A C 88 ***b 221 138 81 205
(54-113) (21-815) (26-171) (19-326) (63-777)
F O S C A C 7.4 2.9 5.4 21.5 3.6
(4.9-12.2) (0.2-40.5) (1.2-7.6) (2.4-40.6) (0 3 -6 .6 )
TASC - total acid soluble carnitine
FC - free carnitine
SCAC - short chain acyl carnitine
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
a<0.01
*** a  <0.05) Mann-Whitney Test
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Table 5,v. Concentrations of Carnitine Fractions in  Heart (nmol/g wet 
weight). During the Onset and Reversal of Diabetic Ketosis in  Carnitine 
Supplem ented (C) and Non-Supplem ented (NC) Anim als. M edian 
Values (with ranges), n=6.
HOURS POST STREPTOZOTOCIN
Group
NC
Fraction 0 24 48 96
(insulin)
120
TASC 1805 768 967 930 **b 1431
(968-2844) (630-1236) (705-1158) (692-1093) (1118-1603)
FC 1171 **b 19 •♦b 781 858 **h 1319
(926-1242) (8-442) (587-903) (662-1139) (1024-1596)
SCAC 857 757 **b 142 115 76
(267-1602) (244-1212) (71-308) (3-228) (7-242)
FOSCAC 1.2 0.02 5.2 5.9 12.6
(0.6-4.2) (0.01-1.8) (2.3-11.9) (3.8-22.1) (4.3-28.6)
TASC 2261 **b 676 •*b 1719 **a 1813 **a 1588
(719-3338) (521-692) (1383-2020) (1376-2192) (1376-1971)
FC 1268 **b 651**a **b 1450*"*a 1225 *’^ *a 1444
(543-1456) (577-695) (1117-1615) (1024-1544) (1226-1803)
SCAC 1547 **b 53’^ a -^ b 289 **a* **b 5 9 7 * * a * * * h 153
(831-2636) (26-115) (172-405) (327-877) (98-282)
FOSCAC 0.7 10.1 **b 5.2 2.4 **a 9.6
(0.3-1.7) (4.8-252) (4.0-8.1) (1.5-3.2) (53-16.1)
TASC - total acid soluble carnitine
FC - free carnitine
SCAC - short chain acyl carnitine
a . denotes a significant difference between supplemented and non-supplemented groups.
b. denotes a significant difference within a group with time.
** a<0.01\
*** a<0.05) Mann-Whitney Test
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Table 5.vi Total Acid Soluble Carnitine Content of Livers and hearts 
(}imol) of Carnitine Supplem ented (C), and N on-supplem ented (NC), 
Animals. M edian Values (with ranges) For Each Cage, n=6.
Hours Post Streptozotocin
LIVER
N C 3.2
(2.4-6.0)
* * * S L
5.1 ***h
(3.9-6.4)
24
**»b
33
(2.1-5.9)
3.2 *b 
(1.4-5.6)
48
4.8
(2.6-7.3) 
6.6
(5.7-10.8)
96
43
(3.3-5.9) 
4.6
(4.3-7.4)
(insulin)
120
4.6
(3.0-5.8) 
5.8
(4.1-8.7)
HEART
N C  1.4 ***b 0.7 0.7 0.7 0.8
(0.7-2.0) (0.6-1.8) (0.4-0.8) (03-0.7) (3.0-5.8)
*a **a **a
C 1.6 *b 0.4 *b 1.0 1.0 0.9
(0.6-3.0) (0.3-0.5) (0.7-1.1) (0.7-1.5) (0.6-1.0)
«<0.001 )
** a  <0.01 ) Mann-Whitney Test
*** «<0.05 )
a . denotes a significant difference between supplemented and non-supplemented groups
b. denotes a significant difference within a group with time.
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Diet for Rodents
Moisture % 8
Ether extract % 4
Crude Protein % 21.5
Crude Fibre % 3.7
Total Digestible Nutrients % 76.0
Lysine % 1.1
M ethionine % .39
Calcium % 0.9
Phosphorus % % 0.8
Vitamin A lU /kg  11000
Vitamin D ^IU /kg 1200
a-tocopherol lU /kg  24
Vitamin Kg m g/kg 10
Riboflavin m g /k g  7
Pyridoxine m g/kg  1
Pantothenic acid m g/kg  17
Nicotinic Acid m g/kg  80
Folic Acid m g/kg  0.2
Choline Chloride m g /k g  450
Cyanocobalamin m g/kg  15
Magnesium m g /k g  65
Iron m g /kg  100
Iodine m g/kg  0.5
Copper m g/kg  20
Zinc m g/kg  40
Cobalt m g/kg  1
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